0001019687-15-001847.txt : 20150511 0001019687-15-001847.hdr.sgml : 20150511 20150511160824 ACCESSION NUMBER: 0001019687-15-001847 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150511 DATE AS OF CHANGE: 20150511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 15850773 BUSINESS ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 10-Q 1 rdnt_10q-033115.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-33307

RadNet, Inc.

(Exact name of registrant as specified in charter)

Delaware	13-3326724
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification No.)


1510 Cotner Avenue
Los Angeles, California	90025
(Address of principal executive offices)	(Zip Code)

(310) 478-7808

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer o	Accelerated filer x	Non-accelerated filer o	Smaller reporting company o
		(do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

The number of shares of the registrant’s common stock outstanding on May 7, 2015 was 44,269,449 shares.

RADNET, INC.

Table of Contents

	Page

PART I – FINANCIAL INFORMATION

ITEM 1. Condensed Consolidated Financial Statements (unaudited)	3

Condensed Consolidated Balance Sheets at March 31, 2015 and December 31, 2014	3

Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2015 and 2014	4

Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2015 and 2014	5

Condensed Consolidated Statement of Stockholders’ Equity for the Three Months Ended March 31, 2015	6

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2015 and 2014	7

Notes to Condensed Consolidated Financial Statements	9

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	31

ITEM 4. Controls and Procedures	32

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings	33

ITEM 1A. Risk Factors	33

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	34

ITEM 3. Defaults Upon Senior Securities	34

ITEM 4. Mine Safety Disclosures	34

ITEM 5. Other Information	34

ITEM 6. Exhibits	34

SIGNATURES	35

INDEX TO EXHIBITS	36

PART I - FINANCIAL INFORMATION

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

	March 31,			December 31,
	2015			2014
	(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents	$	154		$	307
Accounts receivable, net		153,258			148,235
Current portion of deferred tax assets		17,246			17,246
Due from affiliates		1,778			1,561
Prepaid expenses and other current assets		21,884			24,671
Total current assets		194,320			192,020
PROPERTY AND EQUIPMENT, NET		222,171			223,127
OTHER ASSETS
Goodwill		200,304			200,304
Other intangible assets		46,856			47,624
Deferred financing costs, net of current portion		5,560			6,122
Investment in joint ventures		30,184			32,123
Deferred tax assets, net of current portion		38,912			35,334
Deposits and other		4,098			4,026
Total assets	$	742,405		$	740,680
LIABILITIES AND EQUITY
CURRENT LIABILITIES
Accounts payable, accrued expenses and other	$	102,275		$	97,816
Due to affiliates		1,304			6,289
Deferred revenue		1,762			1,964
Current portion of notes payable		19,437			19,468
Current portion of deferred rent		2,192			2,100
Current portion of obligations under capital leases		5,691			5,637
Total current liabilities		132,661			133,274
LONG-TERM LIABILITIES
Deferred rent, net of current portion		21,798			20,965
Line of credit		24,700			15,300
Notes payable, net of current portion		545,988			551,059
Obligations under capital lease, net of current portion		4,697			6,143
Other non-current liabilities		6,022			6,241
Total liabilities		735,866			732,982
EQUITY
RadNet, Inc. stockholders' equity:
Common stock - $.0001 par value, 200,000,000 shares authorized; 43,810,279, and 42,825,676 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively		4			4
Paid-in-capital		181,572			177,750
Accumulated other comprehensive loss		(149	)		(112	)
Accumulated deficit		(176,834	)		(172,280	)
Total RadNet, Inc.'s stockholders' equity		4,593			5,362
Noncontrolling interests		1,946			2,336
Total equity		6,539			7,698
Total liabilities and equity	$	742,405		$	740,680

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

(unaudited)

	Three Months Ended
	March 31,
	2015			2014
NET REVENUE
Service fee revenue, net of contractual allowances and discounts	$	165,030		$	158,763
Provision for bad debts		(7,475	)		(6,893	)
Net service fee revenue		157,555			151,870
Revenue under capitation arrangements		23,712			17,006
Total net revenue		181,267			168,876
OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization		168,921			145,030
Depreciation and amortization		14,294			15,571
(Gain) loss on sale and disposal of equipment		(38	)		246
Severance costs		36			481
Total operating expenses		183,213			161,328
(LOSS) INCOME FROM OPERATIONS		(1,946	)		7,548

OTHER INCOME AND EXPENSES
Interest expense		9,996			11,772
Meaningful use incentive		(3,270	)		(1,762	)
Equity in earnings of joint ventures		(1,102	)		(1,067	)
Loss on early extinguishment of Senior Notes		–			15,456
Other expenses (income)		(3	)		2
Total other expenses		5,621			24,401

LOSS BEFORE INCOME TAXES		(7,567	)		(16,853	)
Benefit from income taxes		3,091			4,478

NET LOSS		(4,476	)		(12,375	)
Net income attributable to noncontrolling interests		78			49

NET LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	(4,554	)	$	(12,424	)

BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	(0.11	)	$	(0.31	)

WEIGHTED AVERAGE SHARES OUTSTANDING Basic and Diluted		42,747,329			40,010,080

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(IN THOUSANDS)

(unaudited)

	Three Months Ended March 31,
	2015			2014

NET LOSS	$	(4,476	)	$	(12,375	)
Foreign currency translation adjustments		(37	)		(18	)

COMPREHENSIVE LOSS		(4,513	)		(12,393	)
Less comprehensive income attributable to non-controlling interests		78			49

COMPREHENSIVE LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$	(4,591	)	$	(12,442	)

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

(IN THOUSANDS EXCEPT SHARE DATA)

(unaudited)

	Common Stock				Paid-in		Accumulated			Accumulated Other Comprehensive			Total Radnet, Inc.'s			Noncontrolling			Total
	Shares		Amount		Capital		Deficit			Loss			Equity			Interests			Equity
BALANCE - JANUARY 1, 2015		42,825,676	$	4	$	177,750	$	(172,280	)	$	(112	)	$	5,362		$	2,336		$	7,698
Issuance of common stock upon exercise of options		260,180		–		324		–			–			324			–			324
Stock-based compensation		–		–		3,498		–			–			3,498			–			3,498
Issuance of restricted stock and other awards		724,423		–		–		–			–			–			–			–
Distributions paid to noncontrolling interests		–		–		–		–			–			–			(468	)		(468	)
Change in cumulative foreign currency translation adjustment		–		–		–		–			(37	)		(37	)		–			(37	)
Net (loss) income		–		–		–		(4,554	)		–			(4,554	)		78			(4,476	)
BALANCE - MARCH 31, 2015		43,810,279	$	4	$	181,572	$	(176,834	)	$	(149	)	$	4,593		$	1,946		$	6,539

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

(unaudited)

	Three Months Ended March 31,
	2015			2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(4,476	)	$	(12,375	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		14,294			15,571
Provision for bad debts		7,475			6,893
Equity in earnings of joint ventures		(1,102	)		(1,067	)
Distributions from joint ventures		3,041			1,866
Deferred rent amortization		925			343
Amortization and write off of deferred financing costs and loan discount		1,288			1,833
(Gain) loss on sale and disposal of equipment		(38	)		246
Loss on early extinguishment of Senior Notes		–			15,456
Stock-based compensation		3,554			1,025
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:
Accounts receivable		(12,498	)		(13,923	)
Other current assets		2,787			(4,503	)
Other assets		(289	)		(575	)
Deferred taxes		(3,578	)		(4,536	)
Deferred revenue		(202	)		(39	)
Accounts payable, accrued expenses and other		6,288			(11,075	)
Net cash provided by (used in) operating activities		17,469			(4,860	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of imaging facilities		–			(360	)
Purchase of property and equipment		(19,826	)		(17,047	)
Proceeds from sale of equipment		205			4
Equity contributions in existing and purchase of interest in joint ventures		–			(789	)
Net cash used in investing activities		(19,621	)		(18,192	)

CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on notes and leases payable		(2,030	)		(1,929	)
Proceeds from borrowings		–			210,000
Payments on Term Loan Debt/Senior Notes		(5,190	)		(204,468	)
Deferred financing costs		–			(6,650	)
Net proceeds on revolving credit facility		9,400			18,100
Distributions paid to noncontrolling interests		(468	)		(133	)
Proceeds from issuance of common stock upon exercise of options/warrants		324			29
Net cash provided by financing activities		2,036			14,949

EFFECT OF EXCHANGE RATE CHANGES ON CASH		(37	)		(18	)
NET DECREASE IN CASH AND CASH EQUIVALENTS		(153	)		(8,121	)
CASH AND CASH EQUIVALENTS, beginning of period		307			8,412
CASH AND CASH EQUIVALENTS, end of period	$	154		$	291

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest	$	8,624		$	14,508

The accompanying notes are an integral part of these financial statements.

RADNET, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(unaudited)

Supplemental Schedule of Non-Cash Investing and Financing Activities

We acquired equipment and certain leasehold improvements for approximately $12.3 million and $5.0 million during the three months ended March 31, 2015 and 2014, respectively, which were not paid for as of March 31, 2015 and 2014, respectively. The offsetting amounts due were recorded in our consolidated balance sheet under accounts payable, accrued expenses and other.

RADNET, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At March 31, 2015 we operated directly or indirectly through joint ventures, 259 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 12.3% of our outstanding common stock as of March 31, 2015. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues owns a controlling interest in four medical groups (“Crues Entities”) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (“NY Berger Entities”) which provide professional medical services at one of our Manhattan, New York facilities. The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the “B&C Entities.”

RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.

We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. BRMG and the B&C Entities on a combined basis recognized $25.5 million and $20.6 million of revenue, net of management service fees to RadNet for the three months ended March 31, 2015 and 2014, respectively, and $25.5 million and $20.6 million of operating expenses for the three months ended March 31, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $99.0 million and $89.0 million of total billed net service fee revenue relating to these VIE’s for the three months ended March 31, 2015 and 2014, respectively, of which $73.5 million and $68.5 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended March 31, 2015 and 2014, respectively.

The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at March 31, 2015 and December 31, 2014, we have included approximately $84.3 million and $79.7 million, respectively, of accounts receivable and approximately $8.7 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.

The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014 filed on March 16, 2015, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

Revenues

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):

	Three Months Ended
	March 31,
	2015			2014

Commercial insurance	$	99,885		$	98,881
Medicare		37,036			36,202
Medicaid		5,470			5,774
Workers' compensation/personal injury		7,400			9,635
Other		15,239			8,271
Service fee revenue, net of contractual allowances and discounts		165,030			158,763
Provision for bad debts		(7,475	)		(6,893	)
Net service fee revenue		157,555			151,870
Revenue under capitation arrangements		23,712			17,006
Total net revenue	$	181,267		$	168,876

Provision for Bad Debts

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the three months ended March 31, 2015, and 2014, respectively, relating to this incentive. These amounts were earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources

We had cash and cash equivalents of $154,000 and accounts receivable of $153.3 million at March 31, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $61.7 million and $58.7 million at March 31, 2015 and December 31, 2014, respectively. We had net loss attributable to RadNet, Inc. common stockholders for the three months ended March 31, 2015 and 2014 of $4.6 million and $12.4 million respectively. We also had stockholders’ equity of $4.6 million and $5.4 million at March 31, 2015 and December 31, 2014, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at March 31, 2015 is $563.3 million of senior secured term loan debt (net of unamortized discounts of $11.2 million), broken down by loan agreement as follows (in thousands):

	Face Value		Discount			Total Carrying Value
First Lien Term Loans	$	394,559	$	(8,681	)	$	385,878
Second Lien Term Loans	$	180,000	$	(2,558	)	$	177,442
Total	$	574,559	$	(11,239	)	$	563,320

Our revolving credit facility has a $24.7 million aggregate principal amount outstanding as of March 31, 2015.

As of March 31, 2015, we were in compliance with all financial covenants under our Refinance Agreement, as amended by the 2014 Amendment, and the Second Lien Credit and Guaranty Agreement, each as defined below. Also described below are details of our $200 million senior notes, redemption of which was completed in 2014.

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the “2013 Amendment”) (collectively, the “Refinance Agreement”), and subsequently by entering into a second amendment to the Refinance Agreement on March 25, 2014 (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Refinance Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Refinance Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Refinance Agreement. The revolver bears interest based on types of borrowings as follows: (i) unpaid principal at 6.5% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate (as defined in the Refinance Agreement) plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. With respect to all of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at March 31, 2015 was 0.40%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, has been increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Scheduled amortization increased by $16.8 million from pre-amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Guarantees and Collateral. The obligations under the Refinance Agreement, as amended by the 2014 Amendment, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Refinance Agreement, as amended by the 2014 Amendment, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of Radnet Management’s and the guarantors’ tangible and intangible assets, including, but not limited to, pledges of equity interests of Radnet Management and all of our current and future domestic subsidiaries.

Restrictive Covenants. In addition to certain covenants, the Refinance Agreement, as amended by the 2014 Amendment, places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Financial Covenants. The Refinance Agreement, as amended by the 2014 Amendment contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Refinance Agreement, as amended by the 2014 Amendment, include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Refinance Agreement, as amended by the 2014 Amendment, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Refinance Agreement, as amended by the 2014 Amendment, to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at March 31, 2015 was 0.40%. The rate paid on the Second Lien Credit Agreement at March 31, 2015 is 8%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13 (a) or events of default per section 8.01 as described below.

Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “senior notes”). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

We completed the retirement of our $200 million in senior notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption all of our remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

NOTE 2 – NEW ACCOUNTING STANDARDS

In April 2015, FASB issued ASU No. 2015-03 (“ASU 2015-03”), Interest – Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In February 2015, FASB issued ASU No. 2015-02 (“ASU 2015-02”), Consolidation – Amendments to the Consolidation Analysis, (Topic 810). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

In May 2014, the FASB issued ASU No. 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers, (Topic 606). ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

NOTE 3 – EARNINGS PER SHARE

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

	Three Months Ended March 31,
	2015			2014

Net loss attributable to RadNet, Inc. common stockholders	$	(4,554	)	$	(12,424	)

BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period		42,747,329			40,010,080
Basic and diluted net loss per share attributable to RadNet, Inc. common stockholders	$	(0.11	)	$	(0.31	)

For the three months ended March 31, 2015 and 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

NOTE 4 – INVESTMENT IN JOINT VENTURES

We have ten unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the three months ended March 31, 2015 (in thousands):

Balance as of December 31, 2014	$	32,123
Equity in earnings in these joint ventures		1,102
Distribution of earnings		(3,041	)
Balance as of March 31, 2015	$	30,184

We earned management service fees from the centers underlying these joint ventures of approximately $2.4 million in each of the three months ended March 31, 2015 and 2014, respectively. At the end of the period we eliminate from total fees recorded the uncollected portion of these fees that are associated with our ownership interests and offset this with an increase to our equity earnings.

The following table is a summary of key financial data for these joint ventures as of March 31, 2015 and for the three months ended March, 2015 and 2014 (in thousands):

Balance Sheet Data:	March 31, 2015
Current assets	$	18,566
Noncurrent assets		49,222
Current liabilities		(8,237	)
Noncurrent liabilities		(5,915	)
Total net assets	$	53,636

Book value of RadNet joint venture interests	$	25,206
Cost in excess of book value of acquired joint venture interests		4,978
Total value of Radnet joint venture interests	$	30,184

Total book value of other joint venture partner interests	$	28,430

Income statement data for the three months ended March 31,	2015		2014

Net revenue	$	26,442	$	22,806
Net income	$	3,030	$	2,149

NOTE 5 – STOCK-BASED COMPENSATION

Stock Incentive Plans

Options and Warrants

We have one long-term incentive plan which we refer to as the 2006 Plan. As of March 31, 2015, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.

As of March 31, 2015, 1,699,176, or approximately 97.5%, of the 1,742,509 outstanding stock options granted under our 2006 Plan are fully vested. During the three months ended March 31, 2015, we did not grant options or warrants under our 2006 Plan.

The following summarizes all of our option and warrant transactions during the three months ended March 31, 2015:

				Weighted Average		Weighted Average Remaining
				Exercise price		Contractual		Aggregate
Outstanding Options and Warrants				Per Common		Life		Intrinsic
Under the 2006 Plan	Shares			Share		(in years)		Value

Balance, December 31, 2014		2,092,509		$	3.58
Granted		–			–
Exercised		(325,000	)		2.69
Canceled, forfeited or expired		(25,000	)		2.22
Balance, March 31, 2015		1,742,509			3.76		1.03	$	8,230,904
Exercisable at March 31, 2015		1,699,176			3.80		0.97		7,955,304

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March 31, 2015 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on March 31, 2015. Total intrinsic value of options and warrants exercised during the three months ended March 31, 2015 and 2014 was approximately $1.9 million and $16,000, respectively. As of March 31, 2015, total unrecognized stock-based compensation expense related to non-vested employee awards was $30,000, which is expected to be recognized over a weighted average period of approximately 1.6 years.

Restricted Stock Awards (“RSA’s”)

The 2006 Plan permits the award of restricted stock. As of March 31, 2015, we have issued a total of 3,441,208 RSA’s of which 881,194 were unvested at March 31, 2015.

The following summarizes all unvested RSA’s activities during the three months ended March 31, 2015:

				Weighted- Average
				Remaining		Weighted-
				Contractual		Average
	Shares			Term (Years)		Fair Value
RSA's outstanding at December 31, 2014		942,023				$	1.96
Changes during the period
Granted		724,423				$	8.66
Vested		(785,253	)			$	4.53
RSA's outstanding at March 31, 2015		881,194			1.21	$	5.17

We determine the fair value of all RSA’s based of the closing price of our common stock on award date.

In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at March 31, 2015, we had 7,944,958 options, shares of restricted stock and other bonus awards issued and 3,055,042 shares of common stock available for future awards.

NOTE 6 – FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

	As of March 31, 2015
	Level 1		Level 2		Level 3		Total Fair Value		Total Face Value
First Lien Term Loans	$	–	$	395,052	$	–	$	395,052	$	394,559
Second Lien Term Loans			$	178,200	$	–		178,200	$	180,000

	As of December 31, 2014
	Level 1		Level 2		Level 3		Total		Total Face Value
First Lien Term Loans	$	–	$	394,753	$	–	$	394,753	$	399,750
Second Lien Term Loans		–		178,200		–		178,200		180,000

The carrying value of our revolving credit facility at March 31, 2015 and December 31, 2014 of $24.7 million and $15.3 million, respectively, approximated its fair value.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

NOTE 7 – SUBSEQUENT EVENTS

On April 1, 2015, RadNet purchased substantially all of the assets of New York Radiology Partners (NYRP) for $31.4 million in total consideration, consisting of $29.8 million in cash and issued a promissory note for the remainder in the amount of $1.6 million.

On April 30, 2015, RadNet entered into a joinder to its existing senior secured first lien credit agreement to provide for the borrowing of $75.0 million of incremental first lien term loans. The incremental first lien term loans will be treated as part of the same class as the existing tranche B term loans currently outstanding under the existing first lien credit agreement and will bear the same interest rate as the rate currently payable on the existing tranche B term loans under the existing first lien credit agreement, which is (a) the adjusted LIBOR rate plus 3.25% or (b) the base rate plus 2.25%. Proceeds from the incremental term loans were used to repay all the borrowings outstanding under the first lien revolving loan facility and pay approximately $1 million of fees and expenses associated with the transaction.

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes and other financial information appearing elsewhere in this quarterly report.

Forward-Looking Statements

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.

In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “assumption” or the negative of these terms or other comparable terminology. Statements in this quarterly report concerning our ability to successfully acquire and integrate new operations, to grow our contract management business, our financial guidance, our future cost saving efforts, our increased business from new equipment or operations and our ability to finance our operations and repay our outstanding indebtedness, including our increased amortization payments, are forward-looking statements.

The factors included in “Risk Factors,” in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended or supplemented by the information, in Part II – Item 1A below, among others, could cause our actual results to differ materially from those expressed in, or implied by, the forward-looking statements. You should consider the inherent limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of predictions contained in such forward-looking statements. These forward-looking statements speak only as of the date when they are made. Except as required under the federal securities laws or by the rules and regulations of the Securities and Exchange Commission, we do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of those statements. Additionally, we do not undertake any responsibility to update you on the occurrence of any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this quarterly report.

Overview

We are the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue. At March 31, 2015, we operated directly or indirectly through joint ventures, 259 centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures.

We seek to develop leading positions in regional markets in order to leverage operational efficiencies. Our scale and density within selected geographies provides close, long-term relationships with key payors, radiology groups and referring physicians. Each of our facility managers is responsible for managing relationships with local physicians and payors, meeting our standards of patient service and maintaining profitability. We provide corporate training programs, standardized policies and procedures and sharing of best practices among the physicians in our regional networks.

We derive substantially all of our revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our facilities. For the three months ended March 31, 2015 and 2014, we performed 1,211,797 and 1,115,847 diagnostic imaging procedures, respectively, and generated total net revenue of $181.3 million and $168.9 million, respectively.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. The contracted radiology practices generally have outstanding physician and practice credentials and reputations; strong competitive market positions; a broad sub-specialty mix of physicians; a history of growth and potential for continued growth. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when securing medical care will result in significant out-of-pocket expenditures.

Critical Accounting Policies

The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company’s financial condition and results of operations and require management’s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. In Note 2 to our consolidated financial statements in our annual report on Form 10-K for the year ended December 31, 2014, as amended, we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The most significant areas involving management’s judgments and estimates are described below.

Use of Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally accepted accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These estimates and assumptions affect various matters, including:

our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements;

our disclosure of contingent assets and liabilities at the dates of the financial statements; and

our reported amounts of net revenue and expenses in our consolidated statements of operations during the reporting periods.

These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could differ materially from these estimates.

During the period covered in this report, there were no material changes to the critical accounting estimates we use, and have described in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

Revenues

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):

	Three Months Ended
	March 31,
	2015			2014

Commercial insurance	$	99,885		$	98,881
Medicare		37,036			36,202
Medicaid		5,470			5,774
Workers' compensation/personal injury		7,400			9,635
Other		15,239			8,271
Service fee revenue, net of contractual allowances and discounts		165,030			158,763
Provision for bad debts		(7,475	)		(6,893	)
Net service fee revenue		157,555			151,870
Revenue under capitation arrangements		23,712			17,006
Total net revenue	$	181,267		$	168,876

Provision for Bad Debts

Accounts Receivable

Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.

Depreciation and Amortization of Long-Lived Assets

We depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives or the lease term of the facility for which these assets are associated.

Deferred Tax Assets

Valuation of Goodwill and Indefinite Lived Intangibles

Goodwill at March 31, 2015 totaled $200.3 million. Indefinite Lived Intangible Assets at March 31, 2015 totaled $7.5 million and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. Management evaluates goodwill and trade name intangibles, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable. Impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit. The fair value of a reporting unit is estimated using a combination of the income or discounted cash flows approach and the market approach, which uses comparable market data. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount of impairment loss, if any. Impairment of trade name intangibles is tested at the subsidiary level by comparing the subsidiary’s trade name carrying amount to its respective fair value. We tested both goodwill and trade name intangibles for impairment on October 1, 2014, noting no impairment, and have not identified any indicators of impairment through March 31, 2015.

Long-Lived Assets

We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment whenever indicators of impairment exist. The accounting standards require that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset’s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. No indicators of impairment were identified with respect to our long-lived assets as of March 31, 2015.

New Accounting Standards

In May 2014, the Financial Accounting Standard Board issued a GAAP update "Revenue from Contracts with Customers". This GAAP update requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. This GAAP update also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The GAAP update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

Industry Updates

On April 16, 2015, the President signed into law the Medicare Access and CHIP Reauthorization Act (H.R. 2), which provides for sweeping changes to how Medicare pays physicians, as well as averts the 21% reduction to Medicare payments under the Medicare Physician Fee Schedule that was scheduled to take effect on April 1, 2016. H.R. 2, among other things, repealed the Sustainable Growth Rate (“SGR”) formula enacted in 1997 and freezes payment rates at their current levels until rates increase by 0.5% for services furnished during the last 6 months of calendar year 2015. For services paid under the physician fee schedule and furnished during calendar years 2016 through 2019, Medicare’s payment rates will increase by 0.5% per year. Fees will remain at the 2019 level through 2025, but high performing providers participating in alternative payment models will have the opportunity for additional payments. Such payments will be based upon quality, resource use, clinical practice improvement activities and meaningful use of electronic health record technology.

Results of Operations

The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to revenue, net of contractual allowances and discounts and inclusive of revenue under capitation contracts.

RADNET, INC. AND SUBSIDIARIES

(unaudited)

	Three Months Ended March 31,
	2015		2014

NET REVENUE
Service fee revenue, net of contractual allowances and discounts		87.4%		90.3%
Provision for bad debts		-4.0%		-3.9%
Net service fee revenue		83.5%		86.4%
Revenue under capitation arrangements		12.6%		9.7%
Total net revenue		96.0%		96.1%

OPERATING EXPENSES
Cost of operations, excluding depreciation and amortization		89.5%		82.5%
Depreciation and amortization		7.6%		8.9%
(Gain) loss on sale and disposal of equipment		0.0%		0.1%
Severance costs		0.0%		0.3%
Total operating expenses		97.1%		91.8%
INCOME FROM OPERATIONS		-1.0%		4.3%

OTHER INCOME AND EXPENSES
Interest expense		5.3%		6.7%
Meaningful use incentive		-1.7%		-1.0%
Equity in earnings of joint ventures		-0.6%		-0.6%
Loss on early extinguishment of Senior Notes		0.0%		8.8%
Other (income) expenses		0.0%		0.0%
Total other expenses		3.0%		13.9%

LOSS BEFORE INCOME TAXES		-4.0%		-9.6%
Benefit From income taxes		1.6%		2.5%

NET LOSS		-2.4%		-7.0%
Net income attributable to noncontrolling interests		0.0%		0.0%

NET LOSS ATTRIBUTABLE TO RADNET, INC.
COMMON STOCKHOLDERS		-2.4%		-7.1%

Three Months Ended March 31, 2015 Compared to the Three Months Ended March 31, 2014

Service Fee Revenue

Service fee revenue for the three months ended March 31, 2015 was $165.0 million compared to $158.8 million for the three months ended March 31, 2014, an increase of $6.2 million, or 3.9%.

Service fee revenue, including only those centers which were in operation throughout the first quarters of both 2015 and 2014 decreased $1.3 million or 0.8%. This 0.8% decrease resulted from inclement weather on the eastern seaboard that affected our operations during the first quarter of 2015. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, service fee revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $7.8 million. For the three months ended March 31, 2014, service fee revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $267,000.

Provision for Bad Debts

Provision for bad debts increased $582,000, or 8.4%, to approximately $7.5 million, or 4.0% of revenue, for the three months ended March 31, 2015 compared to $6.9 million, or 3.9% of service fee revenue, for the three months ended March 31, 2014.

Revenue Under Capitation Arrangements

Revenue under capitation arrangements for the three months ended March 31, 2015 was $23.7 million compared to $17.0 million for the three months ended March 31, 2014, an increase of $6.7 million or 39.4%.

Revenue under capitation arrangements, including only those centers which were in operation throughout the first quarters of both 2015 and 2014 increased $5.7 million, or 34.0%. This 34.0% increase was mainly due to both new and expanded contractual relationships with private insurers. This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, revenue under capitation arrangements from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $1.1 million. For the three months ended March 31, 2014, capitation revenue from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $127,000.

Operating Expenses

Cost of operations for the three months ended March 31, 2015 increased approximately $21.9 million, or 13.6%, from $161.3 million for the three months ended March 31, 2014 to $183.2 million for the three months ended March 31, 2015. The following table sets forth our cost of operations and total operating expenses for the three months ended March 31, 2015 and 2014 (in thousands):

	2015			2014

Salaries and professional reading fees, excluding stock-based compensation	$	90,200		$	80,713
Stock-based compensation		3,554			1,025
Building and equipment rental		17,117			15,615
Medical supplies		11,503			8,787
Other operating expenses *		46,547			38,890
Cost of operations		168,921			145,030

Depreciation and amortization		14,294			15,571
(Gain) loss on sale and disposal of equipment		(38	)		246
Severance costs		36			481
Total operating expenses	$	183,213		$	161,328

* Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, utilities, marketing, travel and other expenses.

Salaries and professional reading fees, excluding stock-based compensation and severance

Salaries and professional reading fees increased $9.5 million, or 11.8%, to $90.2 million for the three months ended March 31, 2015 compared to $80.7 million for the three months ended March 31, 2014.

Salaries and professional reading fees, including only those centers which were in operation throughout the first quarters of both 2015 and 2014, increased $6.8 million, or 8.5%. The 8.5% increase is consistent with the rise in total net revenue over the same period in the prior year when adjusted for certain bonuses recorded in the current quarter not reflected in the prior year’s quarter. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $3.0 million. For the three months ended March 31, 2014, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was approximately $265,000.

Stock-based compensation

Stock-based compensation increased $2.5 million, or 246.7%, to approximately $3.5 million for the three months ended March 31, 2015 compared to $1.0 million for the three months ended March 31, 2014. This increase was driven by the higher fair value of RSA’s awarded and vested in the first quarter of 2015 as compared to RSA’s awarded and vested in the prior year’s first quarter.

Building and equipment rental

Building and equipment rental expenses increased $1.5 million or 9.6%, to $17.1 million for the three months ended March 31, 2015 compared to $15.6 million for the three months ended March 31, 2014.

Building and equipment rental expenses, including only those centers which were in operation throughout the first quarters of both 2015 and 2014, increased $710,000, or 4.6%. This 4.6% increase is mainly related to additional radiology equipment operating leases in support of operations. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $881,000. For the three months ended March 31, 2014, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was approximately $89,000.

Medical supplies

Medical supplies expense increased $2.7 million, or 30.9%, to $11.5 million for the three months ended March 31, 2015 compared to $8.8 million for the three months ended March 31, 2014.

Medical supplies expenses, including only those centers which were in operation throughout the first quarters of both 2015 and 2014, increased $1.9 million, or 21.5%. This 21.5% rise is primarily due to increased purchases stemming from volumes along with supplier price increases. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, medical supplies expenses from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $833,000. For the three months ended March 31, 2014, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $3,000.

Other operating expenses

Other operating expenses increased $7.6 million, or 19.7%, to $46.5 million for the three months ended March 31, 2015 compared to $38.9 million for the three months ended March 31, 2014.

Other operating expenses, including only those centers which were in operation throughout the first quarters of both 2015 and 2014, increased $4.5 million, or 11.7%. This 11.7 % increase is due in part to higher utility costs driven by both usage and rates. Also included are phone service rebates recognized for the three months ending March 31, 2014 not granted in the current year’s quarter . This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, other operating expense from centers that were acquired or divested subsequent January 1, 2014 and excluded from the above comparison was $3.3 million. For the three months ended March 31, 2014, other operating expense from centers that were acquired or divested subsequent to January 1, 2014 was $150,000.

Depreciation and amortization

Depreciation and amortization decreased $1.3 million, or 8.2%, to $14.3 million for the three months ended March 31, 2015 compared to $15.6 million for the three months ended March 31, 2014.

Depreciation and amortization, including only those centers which were in operation throughout the first quarters of both 2015 and 2014, decreased $1.7 million, or 11%. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2014. For the three months ended March 31, 2015, depreciation expense from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $512,000. For the three months ended March 31, 2014, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2014 and excluded from the above comparison was $99,000.

Gain on sale and disposal of equipment

We recorded a gain on sale of equipment of approximately $38,000 for the three months ended March 31, 2015.

Interest expense

Interest expense for the three months ended March 31, 2015 decreased approximately $1.8 million, or 15.1%, to $10.0 million for the three months ended March 31, 2015 compared to $11.8 million for the three months ended March 31, 2014. Interest expense for the three months ended March 31, 2015 included $1.3 million of combined non-cash amortization of deferred loan costs, discount on issuance of debt, and unfavorable contracts. Interest expense for the three months ended March 31, 2014 included $1.9 million of non-cash amortization and write-off of deferred loan costs due to refinance, discount on issuance of debt and unfavorable contracts. Excluding these non-cash amounts for each period, interest expense decreased approximately $1.2 million for the three months ended March 31, 2015 compared to the three months ended March 31, 2014. This decrease was primarily due to a reduction in interest expense stemming from the redemption of the $200 million senior notes. See “Liquidity and Capital Resources” below for more details on our debt refinancing.

Meaningful use incentive

For the three months ended March 31, 2015 and March 31, 2014, we recognized other income from meaningful use incentive in the amount of $3.3 million and $1.8 million, respectively. These amounts were earned under a Medicare program to promote the use of electronic health record technology. See Note 1 to the condensed consolidated financial statements contained herein for more detail regarding this meaningful use incentive.

Equity in earnings from unconsolidated joint ventures

For both periods in the three months ended March 31, 2015 and 2014, we recognized equity in earnings from unconsolidated joint ventures of $1.1 million, respectively.

Loss on early extinguishment of Senior Notes

For the three months ended March 31, 2014, we recognized a $15.5 million loss on early extinguishment of debt through our tender offer for our senior notes. Completion of the tender was conditioned on the closing of the amendment to the First Lien and Second Lien Credit and Guaranty Agreement. As of March 31, 2014, holders of 96.73% of the outstanding senior notes, amounting to $193.5 million face value, accepted the 105.688% tender offer consideration, totaling $204.5 million. The net carrying amount adjusted for unamortized discount, note issue costs and related expenses was $189.0 million. See “Liquidity and Capital Resources” below and Note 1 to the condensed consolidated financial statements contained herein for more details on our debt refinancing.

Adjusted EBITDA

We use both GAAP and non-GAAP metrics to measure our financial results. One non-GAAP measure we believe assists us is Adjusted EBITDA. We believe that, in addition to GAAP metrics, these non-GAAP metrics assist us in measuring our cash generated from operations and ability to service our debt obligations. We believe this information is useful to investors and other interested parties because we are highly leveraged and our non-GAAP metrics remove non-cash and certain other charges that occur in the affected period and provide a basis for measuring the Company's financial condition against other quarters.

We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking place during the period.

Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

Adjusted EBITDA is most comparable to the GAAP financial measure, net income (loss) attributable to RadNet, Inc. common stockholders. The following is a reconciliation of GAAP net income (loss) attributable to RadNet, Inc. common stockholders to Adjusted EBITDA for the three months ended March 31, 2015 and 2014, respectively:

	Three Months Ended March 31,
	2015			2014

Net income attributable to RadNet, Inc. common stockholders	$	(4,554	)	$	(12,424	)
Plus provision for (benefit from) income taxes		(3,091	)		(4,478	)
Plus other expenses (income)		(3	)		2
Plus loss on early extinguishment of Senior Notes		–			15,456
Plus interest expense		9,996			11,772
Plus severance costs		36			481
Plus loss (gain) on sale and disposal of equipment		(38	)		246
Plus depreciation and amortization		14,294			15,571
Plus non-cash employee stock-based compensation		3,554			1,025
Adjusted EBITDA	$	20,194		$	27,651

Liquidity and Capital Resources

Under the 2014 Amendment to the Refinance Agreement explained in further detail below, the scheduled annual amortization payments on the First Lien Term Loan increased from 1% per annum to 5% per annum. As a result, scheduled amortization increased by $16.8 million from pre-amendment terms. This $16.8 million additional cash obligation will be partially offset by annual interest savings of approximately $5.0 million under the terms of the Second Lien Term Loan as compared to that under the retired senior notes. We expect to fund this approximately $11.8 million net increase in amortization payments from cash provided by operating activities.

At March 31, 2015 we had borrowed $24.7 million under our $101 million revolving credit facility, which expires in October 2017. Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise. However, we have no formal plan of doing so at this time.

	Face Value		Discount			Total Carrying Value
First Lien Term Loans	$	394,559	$	(8,681	)	$	385,878
Second Lien Term Loans	$	180,000	$	(2,558	)	$	177,442
Total	$	574,559	$	(11,239	)	$	563,320

Sources and Uses of Cash

Cash provided by operating activities was $17.5 million for the three months ended March 31, 2015 compared to cash used in operating activities of $4.9 million for the three months ended March 31, 2014.

Cash used in investing activities was $19.6 million and $18.2 million for the three months ended March 31, 2015 and 2014, respectively. For the three months ended March 31, 2015, we purchased property and equipment for approximately $19.8 million.

Cash provided by financing activities was $2.0 and $14.9 million for the three months ended March 31, 2015 and 2014, respectively. The cash provided by financing activities for the three months ended March 31, 2015, was primarily due to amounts received from borrowings under our revolving line of credit, offset by principal payments on our $394.6 million face value term loan and equipment notes and capital leases. (See Note 1 to the condensed consolidated financial statements herein).

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, as amended by that certain first amendment date April 3, 2013 (the “2013 Amendment”) (collectively, the “Refinance Agreement”), by entering into a second amendment to the Refinance Agreement on March 25, 2014(the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Credit and Guaranty Agreement dated October 10, 2012 was unaltered by the agreements above and remains in place.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate plus 3.25% or (b) the Base Rate plus 2.25%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on all of the term loans under the Refinance Agreement. The Adjusted Eurodollar Rate at March 31, 2015 was 0.40%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement has been increased from quarterly payments of $975,000 to quarterly payments of $5.2 million starting in June 2014, with the remaining balance to be paid at maturity.

The other material terms of the Refinance Agreement remain unchanged as described in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

The Second Lien Credit Agreement provides for the following:

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. All principal will be due and payable on the termination date described below.

Termination. The termination date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by acceleration or otherwise.

Restrictive Covenants. In addition to certain customary covenants, the Second Lien Credit Agreement places restrictions on indebtedness, liens, and investments, and places limits on distributions to stockholders (including the repurchase of shares) and other junior payments.

Financial Covenants. The Second Lien Credit Agreement contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements, subject to applicable grace periods and/or notice requirements, or a material breach of any representation or warranty contained in the loan documents. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Senior Notes

Subsequent Events

On April 1, 2015, we purchased New York Radiology Partners (NYRP) for $31.4 million in total consideration, consisting of $29.8 million in cash and issued a promissory note for the remainder in the amount of $1.6 million. In connection with the purchase we borrowed an additional $29.8 million under our first lien revolving credit facility.

On April 30, 2015, RadNet entered into a joinder to its existing senior secured first lien credit agreement to provide for the borrowing of $75.0 million of incremental first lien term loans. The incremental first lien term loans will be treated as part of the same class as the existing tranche B term loans currently outstanding under the existing first lien credit agreement and will bear the same interest rate as the rate currently payable on the existing tranche B term loans under the existing first lien credit agreement, which is (a) the adjusted LIBOR rate plus 3.25% or (b) the base rate plus 2.25%. Proceeds from the incremental term loans were used to repay all the borrowings outstanding under the first lien revolving loan facility, fund cash to the balance sheet and pay approximately $1 million of fees and expenses associated with the transaction.

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Exchange Risk. We sell our services exclusively in the United States and receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.

We maintain research and development facilities in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. A hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Hungarian Forint would have resulted in an annual increase of approximately $31,000 in operating expenses.

Interest Rate Sensitivity. We pay interest on various types of debt instruments to our suppliers, investors and lending institutions. The agreements entail either fixed or variable interest rates. Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities, which allows elections of either Adjusted Eurodollar or prime rates of interest. Under the 2014 Amendment to the Refinance Agreement and Second Lien Credit Agreement’s election facilities’, borrowed funds bear a 1.00% floor or 6 month Adjusted Eurodollar Rate plus an applicable margin of 3.25% for the 2014 First Lien Term Loans and 7% for the Second Lien Term Loans. At March 31, 2015, we had $394.6 million outstanding subject to an Adjusted Eurodollar election on the 2014 First Lien Term Loans and $180.0 million on the Second Lien Term Loans. As the Adjusted Eurodollar floor exceeds the current spot rate of 6 month Adjusted Eurodollar, the spot rate would have to increase more than 60 basis points before an additional interest expense would be accrued. An increase of 160 basis points would be necessary to realize a hypothetical 1% increase in the borrowing rate and an annual increase of $5.7 million of interest expense under our first and second lien term loans. At March 31, 2015, an additional $29.9 million in debt instruments tied to the prime rate. A hypothetical 1% increase in the prime rate for 2014-2015 would have resulted in an annual increase in interest expense of approximately $299,000.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain controls and procedures designed to ensure that we are able to collect the information we are required to disclose in the reports we file with the SEC, and to process, summarize and disclose this information within the time periods specified in the rules of the SEC. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has conducted an evaluation of the design and operation of our “disclosure controls and procedures” as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the three months ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. Legal Proceedings

We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We do not believe that the outcome of any of our current litigation will have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.

ITEM 1A. Risk Factors

The following is an update to risk factors described in our annual report on Form 10-K for the year ended December 31, 2014, as amended, and should be read in conjunction with the other risk factors therein. The risks described below and in our Form 10-K, as amended, are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Changes in the method or rates of third party reimbursement could have a negative impact on our results.

From time to time, changes designed to contain healthcare costs have been implemented, some of which have resulted in decreased reimbursement rates for diagnostic imaging services that impact our business. For services for which we bill Medicare directly, we are paid under the Medicare Physician Fee Schedule, which is updated on an annual basis.

Medicare program reimbursements for physician services as well as other services to Medicare beneficiaries who are not enrolled in Medicare Advantage plans are based upon the fee-for-service rates set forth in the Medicare Physician Fee Schedule. Each year, on January 1^st, the Medicare program updates the Medicare Physician Fee Schedule reimbursement rates. Many private payors use the Medicare Physician Fee Schedule to determine their own reimbursement rates.

In 2013, Congress adjusted Medicare payment rates for physician imaging services in an attempt to better reflect actual usage, by revising upward the assumed usage rate for diagnostic imaging equipment costing more than $1 million to 90% effective January 1, 2014. Other changes in reimbursement for services rendered by Medicare Advantage plans may reduce the revenues we receive for services rendered to Medicare Advantage enrollees.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

Reference is made to the Exhibit Index immediately following the signature page of this report on Form 10-Q.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	RADNET, INC.
	(Registrant)

Date: May 11, 2015	By:	/s/ Howard G. Berger, M.D.
		Howard G. Berger, M.D., President and Chief Executive Officer (Principal Executive Officer)


Date: May 11, 2015	By:	/s/ Mark D. Stolper
		Mark D. Stolper, Chief Financial Officer (Principal Financial and Accounting Officer)

INDEX TO EXHIBITS

Exhibit Number		Description

31.1		Certification of Howard G. Berger, M.D. pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Mark D. Stolper pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Howard G. Berger, M.D pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Mark D. Stolper pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**		XBRL Instance Document

101.SCH**		XBRL Schema Document

101.CAL**		XBRL Calculation Linkbase Document

101.LAB**		XBRL Label Linkbase Document

101.PRE**		XBRL Presentation Linkbase Document

101.DEF**		XBRL Definition Linkbase Document

*	This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

**	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

EX-31.1 2 rdnt_10q-ex3101.htm CERTIFICATION

EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Howard G. Berger, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d –15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 11, 2015

	/s/ Howard G. Berger, M.D.

	Howard G. Berger, M.D.
	President, Chief Executive Officer and Chairman of the Board of Directors
	(Principal Executive Officer)

EX-31.2 3 rdnt_10q-ex3102.htm CERTIFICATION

EXHIBIT 31.2

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark D. Stolper, certify that:

1. I have reviewed this quarterly report on Form 10-Q of RadNet, Inc.;

3.. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d –15(f)) for the registrant and have:

(a)

(b)

(c)

(d)

5.. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: May 11, 2015

	/s/ Mark D. Stolper

	Mark D. Stolper
	Executive Vice President and
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1 4 rdnt_10q-ex3201.htm CERTIFICATION

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2015, as filed with the Securities and Exchange Commission on May 11, 2015 (the “Report”), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.

	/s/ Howard G. Berger, M.D.

	Howard G. Berger, M.D.
	Chairman, President and Chief Executive Officer
	(Principal Executive Officer)
	May 11, 2015

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 rdnt_10q-ex3202.htm CERTIFICATION

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2015, as filed with the Securities and Exchange Commission on May 11, 2015 (the “Report”), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	/s/ Mark D. Stolper

	Mark D. Stolper
	Chief Financial Officer
	(Principal Financial Officer)
	May 11, 2015

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 6 rdnt-20150331.xml XBRL INSTANCE FILE 0000790526 2015-01-01 2015-03-31 0000790526 2015-03-31 0000790526 2014-12-31 0000790526 2014-01-01 2014-03-31 0000790526 rdnt:OutstandingOptionsandWarrantsMember 2015-01-01 2015-03-31 0000790526 us-gaap:FairValueInputsLevel1Member 2015-03-31 0000790526 us-gaap:FairValueInputsLevel2Member 2015-03-31 0000790526 us-gaap:FairValueInputsLevel3Member 2015-03-31 0000790526 us-gaap:FairValueInputsLevel1Member 2014-12-31 0000790526 us-gaap:FairValueInputsLevel2Member 2014-12-31 0000790526 us-gaap:FairValueInputsLevel3Member 2014-12-31 0000790526 rdnt:TotalFairValueMember 2015-03-31 0000790526 rdnt:TotalFairValueMember 2014-12-31 0000790526 us-gaap:RestrictedStockMember 2015-03-31 0000790526 2013-12-31 0000790526 2014-03-31 0000790526 2014-05-07 0000790526 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0000790526 us-gaap:CommonStockMember 2014-12-31 0000790526 us-gaap:CommonStockMember 2015-03-31 0000790526 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0000790526 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000790526 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0000790526 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0000790526 us-gaap:RetainedEarningsMember 2014-12-31 0000790526 us-gaap:RetainedEarningsMember 2015-03-31 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000790526 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0000790526 rdnt:TotalRadnetMember 2015-01-01 2015-03-31 0000790526 rdnt:TotalRadnetMember 2014-12-31 0000790526 rdnt:TotalRadnetMember 2015-03-31 0000790526 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-03-31 0000790526 us-gaap:NoncontrollingInterestMember 2014-12-31 0000790526 us-gaap:NoncontrollingInterestMember 2015-03-31 0000790526 rdnt:FirstLienTermLoanMember 2015-03-31 0000790526 rdnt:SecondLienTermLoanMember 2015-03-31 0000790526 us-gaap:ShortTermDebtMember 2015-03-31 0000790526 us-gaap:RestrictedStockMember 2014-12-31 0000790526 us-gaap:RestrictedStockMember 2015-01-01 2015-03-31 0000790526 rdnt:OutstandingOptionsandWarrantsMember 2014-12-31 0000790526 rdnt:OutstandingOptionsandWarrantsMember 2015-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure RadNet, Inc. 0000790526 10-Q 2015-03-31 false --12-31 No No Yes Accelerated Filer Q1 2015

-4476000

-12375000

-4554000

78000

4593000

5362000

325000

260180

2400000

44269449

-176834000

-172280000

-149000

-112000

181572000

177750000

4000

.0001

200000000

43810279

42825676

43810279

42825676

-0.11

-0.31

42747329

40010080

-37000

-18000

78000

49000

-4513000

-12393000

-4591000

-12442000

42825676

43810279

324000

3498000

724423

-468000

-37000

-15456000

17469000

-4860000

-19621000

-18192000

2036000

14949000

8624000

14508000

We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At March 31, 2015 we operated directly or indirectly through joint ventures, 259 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York.  Our operations comprise a single segment for financial reporting purposes.   The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or Radnet Management) and Beverly Radiology Medical Group III, a professional partnership (BRMG).  The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc.,  Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (DIS), all wholly owned subsidiaries of Radnet Management.  All of these affiliated entities are referred to collectively as RadNet, we, us, our or the Company in this report.   Accounting Standards Codification (ASC) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (VIE). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIEs economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIEs variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.   Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 12.3% of our outstanding common stock as of March 31, 2015. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with Californias prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.     John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG.  Dr. Crues owns a controlling interest in four medical groups (Crues Entities) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (NY Berger Entities) which provide professional medical services at one of our Manhattan, New York facilities.  The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the B&C Entities.   RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.   We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity.  BRMG and the B&C Entities on a combined basis recognized $25.5 million and $20.6 million of revenue, net of management service fees to RadNet for the three months ended March 31, 2015 and 2014, respectively, and $25.5 million and $20.6 million of operating expenses for the three months ended March 31, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $99.0 million and $89.0 million of total billed net service fee revenue relating to these VIEs for the three months ended March 31, 2015 and 2014, respectively, of which $73.5 million and $68.5 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended March 31, 2015 and 2014, respectively.   The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows.  All intercompany balances and transactions have been eliminated in consolidation.  In our consolidated balance sheets at March 31, 2015 and December 31, 2014, we have included approximately $84.3 million and $79.7 million, respectively, of accounts receivable and approximately $8.7 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.   The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.   Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice groups professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.  We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.   The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014 filed on March 16, 2015, as amended.   Significant Accounting Policies   During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.   Revenues   Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.   Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">March 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 64%">Commercial insurance</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">99,885</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">98,881</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">37,036</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">36,202</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">5,470</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' compensation/personal injury</td> <td> </td> <td> </td> <td style="text-align: right">7,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">9,635</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Other</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">15,239</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,271</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">165,030</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,763</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Provision for bad debts</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,475</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(6,893</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">157,555</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">151,870</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Revenue under capitation arrangements</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">23,712</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">17,006</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total net revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">181,267</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">168,876</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Provision for Bad Debts   We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.   Deferred Tax Assets   Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.   Deferred Financing Costs   Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.   Meaningful Use Incentive   Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the three months ended March 31, 2015, and 2014, respectively, relating to this incentive. These amounts were earned under a Medicare program to promote the use of electronic health record technology.   Liquidity and Capital Resources   We had cash and cash equivalents of $154,000 and accounts receivable of $153.3 million at March 31, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $61.7 million and $58.7 million at March 31, 2015 and December 31, 2014, respectively. We had net loss attributable to RadNet, Inc. common stockholders for the three months ended March 31, 2015 and 2014 of $4.6 million and $12.4 million respectively.  We also had stockholders equity of $4.6 million and $5.4 million at March 31, 2015 and December 31, 2014, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.  In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment.  Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.   Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at March 31, 2015 is $563.3 million of senior secured term loan debt (net of unamortized discounts of $11.2 million), broken down by loan agreement as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Face Value</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Discount</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Carrying Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 46%">First Lien Term Loans</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">394,559</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">(8,681</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">385,878</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Second Lien Term Loans</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">180,000</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">(2,558</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">177,442</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">574,559</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(11,239</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">563,320</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Our revolving credit facility has a $24.7 million aggregate principal amount outstanding as of March 31, 2015.   As of March 31, 2015, we were in compliance with all financial covenants under our Refinance Agreement, as amended by the 2014 Amendment, and the Second Lien Credit and Guaranty Agreement, each as defined below. Also described below are details of our $200 million senior notes, redemption of which was completed in 2014.   2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the 2013 Amendment) (collectively, the Refinance Agreement), and subsequently by entering into a second amendment to the Refinance Agreement on March 25, 2014 (the 2014 Amendment) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.   Revolving Credit Facility. The $101.25 million revolving credit line established in the Refinance Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Refinance Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Refinance Agreement. The revolver bears interest based on types of borrowings as follows: (i) unpaid principal at 6.5% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance.   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate (as defined in the Refinance Agreement) plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. With respect to all of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at March 31, 2015 was 0.40%.   Payments. The scheduled amortization of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, has been increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Scheduled amortization increased by $16.8 million from pre-amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.   Guarantees and Collateral. The obligations under the Refinance Agreement, as amended by the 2014 Amendment, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Refinance Agreement, as amended by the 2014 Amendment, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of Radnet Managements and the guarantors tangible and intangible assets, including, but not limited to, pledges of equity interests of Radnet Management and all of our current and future domestic subsidiaries.   Restrictive Covenants. In addition to certain covenants, the Refinance Agreement, as amended by the 2014 Amendment, places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Financial Covenants. The Refinance Agreement, as amended by the 2014 Amendment contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Refinance Agreement, as amended by the 2014 Amendment, include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Refinance Agreement, as amended by the 2014 Amendment, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Refinance Agreement, as amended by the 2014 Amendment, to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at March 31, 2015 was 0.40%. The rate paid on the Second Lien Credit Agreement at March 31, 2015 is 8%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.   Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13 (a) or events of default per section 8.01 as described below.   Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the senior notes). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   We completed the retirement of our $200 million in senior notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.   Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption all of our remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

In April 2015, FASB issued ASU No. 2015-03 (ASU 2015-03), Interest Imputation of Interest, (Subtopic 835-30). ASU 2015-03 changes the accounting method for debt issuance costs from a deferred charge (i.e. an asset) to a contra liability in part because such costs provide no future economic benefit. Debt issue costs related to a recognized debt liability are to be presented in the balance sheet as a direct deduction from the carrying amount of the debt liability, consistent with the presentation of debt discounts. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2015. Early adoption is permitted for financial statements that have not been previously issued. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In February 2015, FASB issued ASU No. 2015-02 (ASU 2015-02), Consolidation Amendments to the Consolidation Analysis, (Topic 810). ASU 2015-02 changes the analysis that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. It is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.   In May 2014, the FASB issued ASU No. 2014-09 (ASU 2014-09), Revenue from Contracts with Customers, (Topic 606). ASU 2014-09 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update is effective for fiscal years (and interim reporting periods within fiscal years) beginning after December 15, 2016. We are currently evaluating the impact of the GAAP update on our consolidated financial position, results of operations and cash flows.

Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center">Three Months Ended March 31,</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 68%; text-align: justify">Net loss attributable to RadNet, Inc. common stockholders</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 13%; text-align: right">(4,554</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 13%; text-align: right">(12,424</td> <td style="width: 1%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt; text-align: left; text-indent: -11pt">BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; text-align: justify; text-indent: -11pt">Weighted average number of common shares outstanding during the period</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">42,747,329</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">40,010,080</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt; text-align: justify; text-indent: -11pt">Basic and diluted net loss per share attributable to RadNet, Inc. common stockholders</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.11</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(0.31</td> <td style="padding-bottom: 2.5pt">)</td></tr> </table>   For the three months ended March 31, 2015 and 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

We have ten unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.      The following table is a roll forward of our investment in joint ventures during the three months ended March 31, 2015 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%">Balance as of December 31, 2014</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">32,123</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt">Equity in earnings in these joint ventures</td> <td> </td> <td> </td> <td style="text-align: right">1,102</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt; padding-left: 11pt">Distribution of earnings</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(3,041</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance as of March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">30,184</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   We earned management service fees from the centers underlying these joint ventures of approximately $2.4 million in each of the three months ended March 31, 2015 and 2014, respectively. At the end of the period we eliminate from total fees recorded the uncollected portion of these fees that are associated with our ownership interests and offset this with an increase to our equity earnings.   The following table is a summary of key financial data for these joint ventures as of March 31, 2015 and for the three months ended March, 2015 and 2014 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">Balance Sheet Data:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">March 31, 2015</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%">Current assets</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">18,566</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent assets</td> <td> </td> <td> </td> <td style="text-align: right">49,222</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Current liabilities</td> <td> </td> <td> </td> <td style="text-align: right">(8,237</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Noncurrent liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(5,915</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt; padding-left: 11pt">Total net assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">53,636</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt">Book value of RadNet joint venture interests</td> <td> </td> <td>$</td> <td style="text-align: right">25,206</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 22pt">Cost in excess of book value of acquired joint venture interests</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">4,978</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 33pt">Total value of Radnet joint venture interests</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">30,184</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 33pt">Total book value of other joint venture partner interests</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">28,430</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">Income statement data for the three months ended March 31,</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 60%; padding-left: 11pt">Net revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">26,442</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">22,806</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt">Net income</td> <td> </td> <td>$</td> <td style="text-align: right">3,030</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2,149</td> <td> </td></tr> </table>

Stock Incentive Plans   Options and Warrants   We have one long-term incentive plan which we refer to as the 2006 Plan. As of March 31, 2015, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.   As of March 31, 2015, 1,699,176, or approximately 97.5%, of the 1,742,509 outstanding stock options granted under our 2006 Plan are fully vested.  During the three months ended March 31, 2015, we did not grant options or warrants under our 2006 Plan.   The following summarizes all of our option and warrant transactions during the three months ended March 31, 2015:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average Remaining</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Exercise price</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Aggregate</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Outstanding Options and Warrants</td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Per Common</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Life</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Intrinsic </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Under the 2006 Plan</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">(in years)</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%">Balance, December 31, 2014</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">2,092,509</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">3.58</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(325,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.69</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Canceled, forfeited or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(25,000</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right">2.22</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,742,509</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">3.76</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">1.03</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td>$</td> <td style="text-align: right">8,230,904</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,699,176</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">3.80</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">0.97</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">7,955,304</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March 31, 2015 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on March 31, 2015. Total intrinsic value of options and warrants exercised during the three months ended March 31, 2015 and 2014 was approximately $1.9 million and $16,000, respectively. As of March 31, 2015, total unrecognized stock-based compensation expense related to non-vested employee awards was $30,000, which is expected to be recognized over a weighted average period of approximately 1.6 years.   Restricted Stock Awards (RSAs)   The 2006 Plan permits the award of restricted stock. As of March 31, 2015, we have issued a total of 3,441,208 RSAs of which 881,194 were unvested at March 31, 2015.   The following summarizes all unvested RSAs activities during the three months ended March 31, 2015:   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2"> Weighted- Average</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Remaining</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted-</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Average</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Term (Years)</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Fair Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 52%">RSA's outstanding at December 31, 2014</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">942,023</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">     1.96</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Changes during the period</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 30pt; text-indent: -10pt">Granted</td> <td> </td> <td> </td> <td style="text-align: right">724,423</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">8.66</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 30pt; text-indent: -10pt">Vested</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(785,253</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td>$</td> <td style="text-align: right">4.53</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">RSA's outstanding at March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">881,194</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1.21</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">5.17</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>    We determine the fair value of all RSAs based of the closing price of our common stock on award date.   In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at March 31, 2015, we had 7,944,958 options, shares of restricted stock and other bonus awards issued and 3,055,042 shares of common stock available for future awards.

FAIR VALUE MEASUREMENTS Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:   Level 1Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.   Level 2Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.   Level 3Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.   The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of March 31, 2015</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">395,052</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">395,052</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,559</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of December 31, 2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,753</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,753</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">399,750</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">180,000</td> <td> </td></tr> </table>   The carrying value of our revolving credit facility at March 31, 2015 and December 31, 2014 of $24.7 million and $15.3 million, respectively, approximated its fair value.   We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

On April 1, 2015, RadNet purchased substantially all of the assets of New York Radiology Partners (NYRP) for $31.4 million in total consideration, consisting of $29.8 million in cash and issued a promissory note for the remainder in the amount of $1.6 million.   On April 30, 2015, RadNet entered into a joinder to its existing senior secured first lien credit agreement to provide for the borrowing of $75.0 million of incremental first lien term loans. The incremental first lien term loans will be treated as part of the same class as the existing tranche B term loans currently outstanding under the existing first lien credit agreement and will bear the same interest rate as the rate currently payable on the existing tranche B term loans under the existing first lien credit agreement, which is (a) the adjusted LIBOR rate plus 3.25% or (b) the base rate plus 2.25%. Proceeds from the incremental term loans were used to repay all the borrowings outstanding under the first lien revolving loan facility and pay approximately $1 million of fees and expenses associated with the transaction.

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.   Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.   Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.   Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">March 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 64%">Commercial insurance</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">99,885</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">98,881</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">37,036</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">36,202</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">5,470</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' compensation/personal injury</td> <td> </td> <td> </td> <td style="text-align: right">7,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">9,635</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Other</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">15,239</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,271</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">165,030</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,763</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Provision for bad debts</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,475</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(6,893</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">157,555</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">151,870</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Revenue under capitation arrangements</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">23,712</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">17,006</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total net revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">181,267</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">168,876</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patients ability to pay nor are revenues recognized based on an assessment of the patients ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">Three Months Ended</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="6" style="text-align: center">March 31,</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 64%">Commercial insurance</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">99,885</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">98,881</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Medicare</td> <td> </td> <td> </td> <td style="text-align: right">37,036</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">36,202</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Medicaid</td> <td> </td> <td> </td> <td style="text-align: right">5,470</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5,774</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Workers' compensation/personal injury</td> <td> </td> <td> </td> <td style="text-align: right">7,400</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">9,635</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Other</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">15,239</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,271</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Service fee revenue, net of contractual allowances and discounts</td> <td> </td> <td> </td> <td style="text-align: right">165,030</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">158,763</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Provision for bad debts</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(7,475</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(6,893</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net service fee revenue</td> <td> </td> <td> </td> <td style="text-align: right">157,555</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">151,870</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt">Revenue under capitation arrangements</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">23,712</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">17,006</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total net revenue</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">181,267</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">168,876</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Face Value</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Discount</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Carrying Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 46%">First Lien Term Loans</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">394,559</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">(8,681</td> <td style="width: 1%">)</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">385,878</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Second Lien Term Loans</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">180,000</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">(2,558</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">177,442</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">574,559</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(11,239</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">563,320</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%">Balance as of December 31, 2014</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">32,123</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt">Equity in earnings in these joint ventures</td> <td> </td> <td> </td> <td style="text-align: right">1,102</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt; padding-left: 11pt">Distribution of earnings</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(3,041</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance as of March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">30,184</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following table is a summary of key financial data for these joint ventures as of March 31, 2015and for the three months ended March, 2015 and 2014 (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">Balance Sheet Data:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">March 31, 2015</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 80%">Current assets</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">18,566</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Noncurrent assets</td> <td> </td> <td> </td> <td style="text-align: right">49,222</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Current liabilities</td> <td> </td> <td> </td> <td style="text-align: right">(8,237</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Noncurrent liabilities</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(5,915</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt; padding-left: 11pt">Total net assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">53,636</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 22pt">Book value of RadNet joint venture interests</td> <td> </td> <td>$</td> <td style="text-align: right">25,206</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 22pt">Cost in excess of book value of acquired joint venture interests</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">4,978</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 33pt">Total value of Radnet joint venture interests</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">30,184</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 33pt">Total book value of other joint venture partner interests</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">28,430</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt">Income statement data for the three months ended March 31,</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2015</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 60%; padding-left: 11pt">Net revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">26,442</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">22,806</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 11pt">Net income</td> <td> </td> <td>$</td> <td style="text-align: right">3,030</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2,149</td> <td> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average Remaining</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Exercise price</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Contractual</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Aggregate</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">Outstanding Options and Warrants</td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Per Common</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Life</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Intrinsic </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center">Under the 2006 Plan</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Share</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">(in years)</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 36%">Balance, December 31, 2014</td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right">2,092,509</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 12%; text-align: right">3.58</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"> </td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">(325,000</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">2.69</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt">Canceled, forfeited or expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(25,000</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right">2.22</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,742,509</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">3.76</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">1.03</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td>$</td> <td style="text-align: right">8,230,904</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2015</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,699,176</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">3.80</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">0.97</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td> </td> <td style="text-align: right">7,955,304</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of March 31, 2015</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Fair Value</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">395,052</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">395,052</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,559</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">180,000</td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center">As of December 31, 2014</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 1</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 2</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Level 3</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Total Face Value</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 30%">First Lien Term Loans</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,753</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right"></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">394,753</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 11%; text-align: right">399,750</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Second Lien Term Loans</td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">178,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">180,000</td> <td> </td></tr> </table>

15239000

8271000

7400000 9635000

5470000

5774000

37036000 36202000

99885000

98881000

563300000

53636000

5915000

8237000

49222000

18566000

4978000

25206000

28430000

3030000

2149000

26442000 22806000

25000

2.22

2.69

P1Y11D

P11M19D

24700000

15300000

30184000

32123000

3041000

1866000

1102000

1067000

181267000

168876000

157555000

151870000

7475000

6893000

165030000

158763000

3554000

1025000

38000

-246000

925000 343000

7475000

6893000

6288000

-11075000

-202000

-39000

12498000

13923000

789000

205000

4000

19826000

17047000

360000

9400000

18100000

210000000

2030000

1929000

154000

307000

8412000

291000

-153000

-8121000

-37000

-18000

1778000

1561000

222171000

223127000

194320000

192020000

21884000

24671000

17246000

153258000

148235000

742405000

740680000

4098000

4026000

38912000

35334000

5560000

6122000

46856000

47624000

200304000

132661000

133274000

5691000

5637000

2192000

2100000

19437000

19468000

1762000

1964000

1304000

6289000

102275000

97816000

735866000

732982000

6022000

6241000

4697000

6143000

545988000

551059000

24700000

15300000

21798000

20965000

742405000

740680000

-1946000

7548000

183213000

161328000

36000

481000

38000

-246000

168921000

145030000

5621000

24401000

3000

-2000

-15456000

-1102000

-1067000

9996000

11772000

-3091000

-4478000

-7567000

-16853000

78000

49000

-4554000

-12424000

1946000

2336000

6539000

7698000

4000

177750000

181572000

-172280000

-176834000

-112000

-149000

5362000

4593000

2336000

1946000

23712000

17006000

14294000

15571000

-3270000

-1762000

1288000

1833000

-2787000

4503000

289000

575000

3578000

4536000

324000

29000

468000

133000

5190000

204468000

6650000

12300000 5000000 Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the three months ended March 31, 2015, and 2014, respectively, relating to this incentive. These amounts were earned under a Medicare program to promote the use of electronic health record technology.

394559000

180000000

574559000

8681000

2558000

11239000

385878000

177442000

563320000

25500000

20600000

25500000

20600000

73500000

68500000

99000000

89000000

84300000

79700000

8700000

9000000

61700000 58700000

881194

942023

724423

785253

P1Y2M16D

5.17

1.96

8.66

4.53

1900000

16000

30000

P1Y7M6D

7944958

3055042

394559000

399750000

395052000

394753000

395052000

394753000

180000000

178200000

2092509

1742509

1699176

3.58

3.76

3.80

8230904

7955304

Liquidity and Capital Resources   We had cash and cash equivalents of $154,000 and accounts receivable of $153.3 million at March 31, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $61.7 million and $58.7 million at March 31, 2015 and December 31, 2014, respectively. We had net loss attributable to RadNet, Inc. common stockholders for the three months ended March 31, 2015 and 2014 of $4.6 million and $12.4 million respectively.  We also had stockholders equity of $4.6 million and $5.4 million at March 31, 2015 and December 31, 2014, respectively.   We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations.  In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment.  Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.   Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.   On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.   We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.   Included in our condensed consolidated balance sheet at March 31, 2015 is $563.3 million of senior secured term loan debt (net of unamortized discounts of $11.2 million), broken down by loan agreement as follows (in thousands):   <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Face Value</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Discount</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Carrying Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 39%; text-align: left">First Lien Term Loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">394,559</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(8,681</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">385,878</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Second Lien Term Loans</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">180,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,558</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">177,442</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">574,559</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,239</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">563,320</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>   Our revolving credit facility has a $24.7 million aggregate principal amount outstanding as of March 31, 2015.   As of March 31, 2015, we were in compliance with all financial covenants under our Refinance Agreement, as amended by the 2014 Amendment, and the Second Lien Credit and Guaranty Agreement, each as defined below. Also described below are details of our $200 million senior notes, redemption of which was completed in 2014.   2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:   On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:   2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the 2013 Amendment) (collectively, the Refinance Agreement), and subsequently by entering into a second amendment to the Refinance Agreement on March 25, 2014 (the 2014 Amendment) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the 2014 First Lien Term Loans).   Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the Second Lien Credit Agreement) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the Second Lien Term Loans). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading Senior Notes, to pay the expenses related to the transaction and for general corporate purposes.   Revolving Credit Facility. The $101.25 million revolving credit line established in the Refinance Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Refinance Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Refinance Agreement. The revolver bears interest based on types of borrowings as follows: (i) unpaid principal at 6.5% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance.   The 2014 Amendment provides for the following:   Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate (as defined in the Refinance Agreement) plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. With respect to all of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at March 31, 2015 was 0.40%.   Payments. The scheduled amortization of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, has been increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Scheduled amortization increased by $16.8 million from pre-amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.   Guarantees and Collateral. The obligations under the Refinance Agreement, as amended by the 2014 Amendment, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Refinance Agreement, as amended by the 2014 Amendment, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of Radnet Managements and the guarantors tangible and intangible assets, including, but not limited to, pledges of equity interests of Radnet Management and all of our current and future domestic subsidiaries.   Restrictive Covenants. In addition to certain covenants, the Refinance Agreement, as amended by the 2014 Amendment, places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Financial Covenants. The Refinance Agreement, as amended by the 2014 Amendment contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.   Events of Default. In addition to certain customary events of default, events of default under the Refinance Agreement, as amended by the 2014 Amendment, include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Refinance Agreement, as amended by the 2014 Amendment, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Refinance Agreement, as amended by the 2014 Amendment, to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   The Second Lien Credit Agreement provides for the following:   Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at March 31, 2015 was 0.40%. The rate paid on the Second Lien Credit Agreement at March 31, 2015 is 8%.   Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.   Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13 (a) or events of default per section 8.01 as described below.   Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.   Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.   Senior Notes   On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the senior notes). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Managements current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the Indenture), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.   We completed the retirement of our $200 million in senior notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:   Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the Consent Payment Deadline). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the Consent Payment) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.   Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption all of our remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the Redemption Date). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date.  As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding.  With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

EX-101.SCH 7 rdnt-20150331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 2. NEW ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 3. EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 4. INVESTMENT IN JOINT VENTURES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 5. STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 6. FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 7. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - 3. EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - 5. STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - 1. NOTES PAYABLE (Details - Term Loans) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - 3. EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details-Key financial data) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - 5. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - 5. STOCK-BASED COMPENSATION (Details - RSU's) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - 5. STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 rdnt-20150331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 rdnt-20150331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 rdnt-20150331_lab.xml XBRL LABEL FILE Outstanding Options and Warrants [Member] AwardType [Axis] Non-Plan Outstanding Warrants [Member] Level 1 FairValueByFairValueHierarchyLeve [Axis] Level 2 Level 3 Total Fair Value TotalCarryingValueMember RestrictedStockMember FairValueInputsLeve1Member Warrant [Member] Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive Income / Loss Total Radnet Inc Equity Noncontrolling Interest First Lien Term Loan Short-term Debt, Type [Axis] Second Lien Term Loans Short-term Debt [Member] Restricted Stock Awards Document and Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer Is Entity a Voluntary Filer Is Entity's Reporting Status Current Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable, net Current portion of deferred tax assets Due from affiliates Prepaid expenses and other current assets Total current assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Goodwill Other intangible assets Deferred financing costs, net of current portion Investment in joint ventures Deferred tax assets, net of current portion Deposits and other Total assets LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY CURRENT LIABILITIES Accounts payable, accrued expenses and other Due to affiliates Deferred revenue Current portion of notes payable Current portion of deferred rent Current portion of obligations under capital leases Total current liabilities LONG-TERM LIABILITIES Deferred rent, net of current portion Line of credit Notes payable, net of current portion Obligations under capital lease, net of current portion Other non-current liabilities Total liabilities STOCKHOLDERS' (DEFICIT) EQUITY Common stock - $.0001 par value, 200,000,000 shares authorized; 43,810,279, and 42,825,676 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively Paid-in-capital Accumulated other comprehensive loss Accumulated deficit Total RadNet, Inc.'s stockholders' deficit Noncontrolling interests Total equity Total liabilities and equity Common stock - par value (in Dollars per share) Common stock - shares authorized Common stock - shares issued Common stock - shares outstanding Income Statement [Abstract] NET REVENUE Service fee revenue, net of contractual allowances and discounts Provision for bad debts Net service fee revenue Revenue under capitation arrangements Total net revenue OPERATING EXPENSES Cost of operations, excluding depreciation and amortization Depreciation and amortization (Gain) loss on sale and disposal of equipment Severance costs Total operating expenses (LOSS) INCOME FROM OPERATIONS OTHER INCOME AND EXPENSES Interest expense Meaningful use incentive Equity in earnings of joint ventures Loss on early extinguishment of Senior Notes Other expenses (income) Total other expenses LOSS BEFORE INCOME TAXES Benefit from income taxes NET LOSS Net income attributable to noncontrolling interests NET LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS WEIGHTED AVERAGE SHARES OUTSTANDING: Basic and Diluted Statement of Comprehensive Income [Abstract] NET LOSS Foreign currency translation adjustments COMPREHENSIVE LOSS Less comprehensive income attributable to non-controlling interests COMPREHENSIVE LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Issuance of common stock upon exercise of options, shares issued Issuance of common stock upon exercise of options, value Stock-based compensation Issuance of restricted stock and other awards, shares Issuance of restricted stock and other awards, value Purchase of non-controlling interests Distributions paid to noncontrolling interest Change in cumulative foreign currency translation adjustment Net (loss) income Ending balance, shares Ending balance, value Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Provision for bad debts Equity in earnings of joint ventures Distributions from joint ventures Deferred rent amortization Amortization and write off of deferred financing costs and loan discount (Gain) loss on sale and disposal of equipment Loss on early extinguishment of Senior Notes Stock-based compensation Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: Accounts receivable Other current assets Other assets Deferred taxes Deferred revenue Accounts payable, accrued expenses and other Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of imaging facilities Purchase of property and equipment Proceeds from sale of equipment Equity contributions in existing and purchase of interest in joint ventures Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Principal payments on notes and leases payable Proceeds from borrowings Payments on Term Loan Debt/Senior Notes Deferred financing costs Net proceeds on revolving credit facility Distributions paid to noncontrolling interests Proceeds from issuance of common stock upon exercise of options/warrants Net cash provided by financing activities EFFECT OF EXCHANGE RATE CHANGES ON CASH NET DECREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for interest SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Purchase of equipment and leasehold improvements not yet paid for Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF BUSINESS AND BASIS OF PRESENTATION New Accounting Pronouncements and Changes in Accounting Principles [Abstract] NEW ACCOUNTING STANDARDS Earnings Per Share [Abstract] EARNINGS PER SHARE Equity Method Investments and Joint Ventures [Abstract] INVESTMENT IN JOINT VENTURES Disclosure of Compensation Related Costs, Share-based Payments [Abstract] STOCK-BASED COMPENSATION Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS NATURE OF BUSINESS AND BASIS OF PRESENTATION Significant Accounting Policies Revenues Provision for Bad Debts Deferred Tax Assets EX-101.PRE 11 rdnt-20150331_pre.xml XBRL PRESENTATION FILE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#Z2U=:XP$``)\5```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F-%NVC`4AN\K[1TBWT[$ MV&R4381>=-ME5ZG=`[CV@40XMF6[';Q]3T)!$Z(@5*2=&R(2^_Q??/%)^:,6%?OS^&LP847*RAEEO8.*K2&QF]FGJ^GC.D`J M<+=+%:MS#M\Y3[J&5J72!W#X9.YCJS+^C0L>E%ZJ!7`Y'(ZY]BZ#RX/;BY\KO+TAB6`3*VXW"[NLBJD0;*-51E+^XLQ>RN`MH<2=_9I4-R%] M1@S&#R9T3]X/>-OW&X\F-@:*>Q7SG6H1@Z\L_^OC\LG[97E\R`%*/Y\W&HS7 MSRV>0)E"!&52#9!;6_;7LE6-VW(?R>\7)]Y?Q(5!NO?K!Y_)(8EPC(AP?"'" M\94(QY@(QS41C@D1CF]$.,20"@@5HPHJ2A54G"JH2%50L:J@HE5!Q:N"BE@% M%;-**F:55,PJJ9A54C&KI&)62<6LDHI9)16S2BIFE53,.J)BUA$5LX[^EUDS MUD_`^]^/GT4_YD3_D?+:0KKP-\MFZ*GD6D4P#SEB47=Q@']GG^#0RNK;&ANK M"Q_";NZQ?*S1[J,/"0O%".<#;!O#;O<@X""(N8%=9WBH>]LE8AEY?N!>^0== MW6G`',CF?;TZ>P4``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L` M"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7 M^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X M8<'%#U1?````__\#`%!+`P04``8`"````"$`@8V+B>(!``"$%```&@`(`7AL M+U]R96QS+W=O%7KOM M#Q"V$ILZLI&T'_GW%=FBI-"=7LR[&"3CIV$T;\;2[=W?_5#]=B'VHZ\5+9:J M;$[IWFY7.EP7D-MWM6L'MI:A8>6 MC*J>#E->^O/BXW;;-^[[V/S:.Y\^6$/_&<-+[)Q+N:@-.Y=J5::B/KXAL\B8 ME?X/G,R'+)PU@L,K83B\0G"D]PIN%9,T-P2YN9@33DR'(;=B4?&_,5K_:L[E M2].<$)2IMSZZ0F"(A=$00SC2Y!!DAR^%V>%+Q(Z9M:U3S@9WDLUQJ(]/V#[2 M@L%ZD;9=@K;+.;5%0XF72"]\+0WG&L&1C@$H8VGA0-V0.#60&YXU(4L>G;RF M3+U%%%\@W1AIRS'0$@PLYI.8X?F MOK.]/[%3IE`[D71($0PID@XI@B%EI*W80"N6=F)HQ-([!3>*I*DAR`U+AQ3# MD&+I@Q3#@Y21]AP#/X>04` M`/__`P!02P,$%``&``@````A`,2IU55%`P``P0H```\```!X;"]W;W)K8F]O M:RYX;6R45EMSFD`4?N],_P/#>\-5?S2DV?^_8\K6DK\])\BH!0)SUY%6>;VX4)5NLV#K(+I(-B^'. M,DG700YC^J)DFY0%8;9B+%]'BJZJ764=\%C>(]RDYV`DRR5?L%&RV*Y9G.]! M4A8%.=#/5GR3R?W;)8_8?*]("C8;)U@#[[=(EJ(@RTG(<)1%BX;H,R39;2&PXGJ1UJ!7&,,G2=$7$\,J)PYKEC M>V3Y,`RLL>4,"4(Q#`2C?PT&&%1L,$QI^!EL/!](33`;$Y$QSR3S@8+)@/N5 M-9VOP>A8$Z93=N-\4>!'YSJ8>;9#/(]:3I&59WL( MI>A9I>JJ":-3ASQ1:SAT9XYO.S\IV.*,K.FH!M%%$-=-"(,2:^K`NQY])%/J M/5A3G(V!96AJ\VV3VLZ<>/Z$.#ZC+BDA(FA/NJ"84]F;.`@ZL+NW=CLVRW&9RM5K*. M@X=!!')]`LO'^FL-QH2.6![P**,^2]=TC'!,O`9TH<#MA""E(R&&CO+V>GNEX]R^/KL_P<``/__`P!02P,$%``&``@````A M`,@F5314!0``S!0``!@```!X;"]W;W)K[+ M;H*/Q\=GQL=DUE_>JY/U*IJVK,\;FRU=VQ+GHMZ5Y\/&_ONOQT5L6VV7GW?Y MJ3Z+C?U=M/:7[<\_K=_JYKD]"M%9$.'<;NQCUUU6CM,61U'E[;*^B#.,[.NF MRCOXVAR<]M*(?-=/JDX.=]W0J?+R;&.$57-+C'J_+POQ4!RNY[']2VJF+U[7"NF_SI!/M^9WY> M#+'[+[/P55DT=5OONR6$E;`#*;O5B/W&_LI6&4]L9[ON M!?JG%&^M]MEJC_7;+TVY^ZT\"U`;\B0S\%37SQ+Z;2___K=QUQXWMA9=OUTW]9D'1P)+M)9-@8TABW>FVGL$49Y*N,TL>"3;20 MGM=MQ-;.*RA:*$B*$#@0(X0@L@$A$P'L1HJP;TK1@PS^O_8#(SF),.*$T1Q" M$-D<$7EC$(,C2*=S_)B;!&]L7Y,B\L>PO:`I0K"4I,*9]L!8&*+H"\O\?2Z. MG`0XG4!`""`DZ7/)PL#U7!.0&8`@CL(KRD!]ZP0_5D:"";'07#=%2-036T1^ M1(AGQG@8)U=HA??0DF!"*R*T$(*T6!`%`>5E`E@<38(:"8U,8K,A$38S`&$, MA39&,(@E]Q"38/,$QE,ZD!A"M!.H/3`69N!%NB2W9:R?96H3$T-,%4:)`[7, M"2(S$;YQ3$V2Q.<_SAM#*]8-(B;UDBJ,(N?SA%A89@*"0+L13&H_Y.\,O=F@ M.!UU3*'"!.@5'CD1F3',_2MUQ:3SWESQ/9JDE0B3*@S2\J9E>]*9,>IK-6&* M1GS_DWS.#3\F_I0RQ`PGT>.,R)F9B)!Y?%+4)'>7Y\OW*.(2,1$E51@DMV") MEBREFF[[4>!?8W:7[3/T;!!F?&>)B3VE"J/YA/[$E(58^R7J;&[K,;5UA5$)\[AVVZF$Z;Z^8%%XC=I=OL[0 MI'572*BQ*\Q02\R=5E;4,,@`<+4KR5"-_Y#Q][-,ATB(K:<*@PY!^&=J$.FQ MP`^FK)OT[K)\/K?\A`B3*LS@I^,]C+(9H]-4DQ/Q^H^/`)][O/8ZAT=`85"- M()S=D,8X]WUWTMID=I?-.^'TW&8Q*[R^CE3UTJVE2[*IVZCR]@90+(5)!!-'B3 MG?9FTB4_B-_SYE"> M6^LD]C#574:0C@:[4?BEJR]]T^.I[J"+U'\\0M=00`?!70)X7]?=\$6V6<8^ MY/8_````__\#`%!+`P04``8`"````"$`#A)*9NT#``!/#@``&0```'AL+W=O MY1LE)V1 M9J75:B_/&-HV"M"(;L?)WT]U5X=+$WM,'AQ?#G7JU.70K+^^5:7SREI1\'KC M$B]P'59G/"_JP\;]]Y_GNWO7$3*M\[3D-=NX[TRX7[>_?5F?>?LBCHQ)!R+4 M8N,>I6Q6OB^R(ZM2X?&&U?#+GK=5*N%C>_!%T[(TUQ=5I4^#8.%7:5&[&&'5 MWA*#[_=%QIYX=JI8+3%(R\I40O[B6#3B(UJ5W1*N2MN74W.7\:J!$+NB+.2[ M#NHZ5;;Z?JAYF^Y*T/U&HC3[B*T_3,)71=9RP??2@W`^)CK5G/B)#Y&VZ[P` M!:KL3LOV&_>!K!YIZ/K;M2[0?P4[B\%[1QSY^8^VR'\4-8-J0Y]4!W:G:I0HP$52=_T_W.1R^/=>O`Q"`G!GQX1\+E1(U\E.0O+J?P01 M$PJ#4!,$_IL@9.G1^YC$BU]'\3$C+?`IE>EVW?*S`U,#G*))U0R2%416RB+( M"?/HM%Z2"AI5D`<59>/"N,/E`OKSNHU(L/9?H::9P3PB!EX[#.D0/F33I01I M#%/ZO,@?S`JLF%7152J/^,60AGY.$XYIE/(0)N,ZG;H(<`,1$>EE8`:(T7,P MTA6-":\3*3"T8D34"T$BQ$R)H'^W%U"!;45A5S$D0LQ2-Y8&"8V#I$.,)"[F M,"OPF!GVH8N+S(B)-7,_4"/.Y1Q.!;8Y(XL3,:CV+@2QP05F9>^#W;G>4`4> M,T?$9D:,8;Y"G,PA5F";.+8D(P:)R3*ZW&`"&W*[9HVVN1<6MP$9\D62D&4/ M&76:*`L9%/RVE=57V:NTM)-`=YKN$IGE1AIM"[:WR8!`MS+*T(OONV3&M\9UV"6H9&IHT6DKRXZF@%UW;\X[+-\C4R- M+2+]&AEJ!'74E^;.\K4;UPS-:WS'ZAE,!@CZ9,UF61JYQ=,,:#CK$;DP<'26 MK6FTO>5VL0UH1$\OW$BH96S7YUVC+4.C]B'$@*:5IK,,3:,MJ;1?%NRJ`27: MS^YI&"1!OWZC?8)#^HS%UFB;W'93`T+R91+'X80V"_L[(43L9/ MZLQ.(.WNV^YYXH'J)X+N!SC.-^F!_9FVAZ(63LGV<&G@+:&_+3X0X`?)&WVH MWG$)!WG]]@@/;@R.IH$'X#WG\N.#>N3H'@6W/P$``/__`P!02P,$%``&``@` M```A`.30Z45P`@``R@4``!D```!X;"]W;W)K&UL ME)1=;]HP%(;O)^T_6+YOG`3Z`2)4!=2MTBI-TSZNC7.26,1Q9)O2_OL=VT#) MZ*3V!F+[]9/W?&5V^ZQ:\@3&2MT5-$M22J`3NI1=7=!?/^\O;BBQCGBJD@)66FP5="Y"#+3:$J\!Z>XV6S[ M"Z%5CXBU;*5["5!*E)@^U)TV?-UBW,_9F(L#.RS.\$H*HZVN7((X%HV>QSQA M$X:D^:R4&(%/.S%0%?0NFR['E,UG(3^_)>SLR3.QC=Y],;+\)CO`9&.9?`'6 M6F^\]*'T6WB9G=V^#P7X;D@)%=^V[H?>?059-PZK?8D!^;BFY$>P9?*7MN>_`;(K@0V#1QC'4_T6* M(7K(G:<$%@9AL3I/\W%Z,V-/F%*QURRB!@?BJ,F&BN5!X2N!]HX>,?!_/8ZP MA&\G_V#)7QI:RD?#]RW>D`P5RW/%]2MDX!%S]W&/_E)!QR^2&UBZB) M3>5SO3S9&#A`S,<=^$O8C"<.QNEDF(1%U$Q"6?-QF@Z/<>P\XHWCZ"[.5.PY M!::&);2M)4)O_;QD2#WNQE%>X"B'QF?'`QREGM?PR$TM.TM:J/!JFESC[)@X MC''A=!]*OM8.AR@\-OC-!$Q;FJ"XTMH=%K[)CE_A^5\```#__P,`4$L#!!0` M!@`(````(0!_?Q:EU`,``+$,```9````>&PO=V]R:W-H965T-^_V? MQX?$=:3*VS*O1?)XL2;7,Y$ MQUN('$3?Y`H>^Z,GNY[GY3"IJ;W`]^=>DU>M2PZK_AX/<3A4!=^)XMSP5I%) MS^M<`;\\59V\NC7%/79-WC^=NX="-!U8[*NZ4J^#J>LTQ>K;L15]OJ]AW2\L MRHNK]_!P8]]412^D.*@9V'D$>KOFI;?TP&F[+BM8`:;=Z?EAXWYEJQV+7&^[ M'A+TH^(7J?WOR).X_-97Y1]5RR';4">LP%Z()Y1^*W$()GLWLQ^'"OS5.R4_ MY.=:_2TNO_/J>%)0[AA6A`M;E:\[+@O(*-C,@AB="E$#`/QUF@I;`S*2OPR? MEZI4IXT;SF?QP@\9R)T]E^JQ0DO7*9?$K'1BDR"T20$^C$>?-HD&DW@ M\\TD2&(6SW^.XM&RABSMS\*BF$?&"C!M,2A="EIED,OL"2>S\UX1O$W MU)TV8)#!+KN?#,4VF56?E#0+ZM)E$%CD&<4U,FW`()M_A@S%-ME;6U#.2$-D M#TD0+JR<45PCTP8,LL5GR%!LD\7F-Z>D&#;A!37 M"+4!@Y#!$:AVBZ]W9ZC:,2;1Y%]'IJ"(+$;>#<*WJ'%,_U^ M6GH#F,FT&C&%JR(NB=XKH7^;2ST>L&AI-C)>-7&^QDHW1[H3-;P_\HS7M70* M<<9;(8/7Q#1*-]:4K>"F@E>2*0`7QBX_\C_S_EBUTJGY`:;ZLP6\.7JZ&PO=V]R:W-H965T M:MR+@9;HE2ITM_SX8;$5\DEUE.H`'`95HD[K<1Y%BG248Q6*D0ZPTPC)L8:E M;",U2HIK>XCW41K'><0Q&Y!SF,MK/$33,$(?!-EP.FAG(FF/-?"KCHUJ[\;) M-78$,$'\%BS7JF7ZTI"CB9?VD'(?&ZA[A?D@DF>V^[N+#GC$BA1*-# ML(LTTSA*0!VNJ]",S MEB@@&Z4%_^-$R<[*F:0[DPSH=_OIM2:1`[+Q/6"-EPLIM@'T##Q2C=AT8#(' MXWU@#N,0ZK\BA1"-R;UQL5X0A(+J/"^S(E]$SY!2LM.LG`9>B(,F\1757F$J M`7@'1@C\G#&#$KZ=_#V2.>0CI9G_O-4;$E]172JF1Q./$7+W?D9SJ$23DY2D M^='?IG;E-*ZI3*ZKDQL>`=B<$OP_.T8,37CRY*R8^L&OG*9PY4R3\_15;M^2 M>2#0T=>#&/$YR.P,Q&FF%B1)XM3?KKSM.#^&X5'E[Z$R8I\JS0O_L2NG<50W M63PY[V9O/YGEQ_?!XYJ^A\N(?:ZL..=RFEW9XF0V\;EA3!J/D[*YJ>>F`J>R MI17M>Q40L3$3+8&T'^ZZ8;N"86M'4W38@&$WXI9^P[)E@PIZVL#1.)Q";:0; MEVZAQ6A?RK70,.;L90=?-0J-'8<@;H30^X49`X?OY/(O````__\#`%!+`P04 M``8`"````"$`Q8C'>-H"``"/!P``&0```'AL+W=OLQ*VM>%^^OGP]6-ZPB) M^A*UK">%^T*$>[OY^&%]9/Q1-(1(!QAZ4;B-E,/*]P5N2(>$QP;2PTK%>(L0?SP,5YAU`U#L:4OEBR9UG0ZOOM0]XVC?0M[/88+PR*T'"_J.8LX$ MJZ0'=+X1NLPY]W,?F#;KDD(&RG:'DZIP[\+5+G/]S5K[\YN2HYA].Z)AQT^< MEE]I3\!L*),JP)ZQ1P7]4JHI"/87T0^Z`-^Y4Y(*'5KY@QT_$UHW$JJ=0D(J MKU7Y[LB9`/ M5%&Z#CX(R;H_!A2>J`Q)="*)0?UI/7HOB6\$Z?SND42;-6='!\X,;"D&I$Y@ MN`+B,3$C8TKUM4PA145RIU@T%R0AH#I/FSB/UOX36(I/F*W!P(68,*&-V(T( M50F0-VF$Q"\UQE#"?YL_2E)!MJ3L4M$2)6F: MV`IWUGH8)=$98`F$$WXI,'GU[HSE4T&V17%^YC<"#69FT6S"4G"]5/"V12K( MMBA*,]N"K<%DVJ(DRI(LCG(;LK,@01`&P&PO=V]R:W-H965T-\VSAT9 M.&7=R@UFONN0KF(U[0XK]]?/FP^9ZW!1=G79L(ZLW`?"W8_K]^^69S;<\B,A MP@&'CJ_L)QU$]FQH2P&/P\'C_4#*6B6UC1?Z?N*U)>U< M=%@,;_%@^SVM2,&J4TLZ@28#:4H!_/Q(>WYQ:ZNWV+7E<'OJ/U2L[<%B1QLJ M'I2IZ[35XLNA8T.Y:Z#N^V!>5A=O]3"Q;VDU,,[V8@9V'H).:\Z]W`.G];*F M4(%LNS.0_:/V5=@2Z#>LD5V#'V*V4 M?JGE*TCV)MDW:@6^#TY-]N6I$3_8^3]"#T'2Q,-6HVJ('?U543F(KM M12%70=H6%UNYP,![A89^VM`13,;3:WIAE$DF8QB9`)LG)*9B.U6DEDDQE83S MJXM1!HR#7<;\V=&\E"&35BXLU6,;DT=_U;<-:G"<92.W]HM">V$@@:^.]')' MI1A^#QI*E%G=V*`F5S,1QK'O7UNA4+=&W$_L>(%Q58H!"GW20>7ORM85CCU?7&A!BX`6RM>H-? M'EVEMD%S"W04(6D23%%'@<9JI,29GF+2RD-#&X=7:/&(,?:PW-JC-@&*D#9. MHNDDC`H=%W/4&Y-/G@]OY\/3Q.2SSLT-W)_D;(R;[%QO#2[\*-#Q])0@UBM" M6KQ0X56A)<.!;$G3<*=B)WE9"F![O+[%B]PF6,`!+D_J:P#N47UY(-_*X4`[ M[C1D#ZG^+(4M<<$W*#4OT>X,1,XN?P9B/>,B&ULG%;;;J,P$'U?:?\!\5[`7')32-5NU=U*6VFU MVLNS`R98!8QLIVG_?L<>0@)MVF9?0H#COVXN9ZRA-FYQ6HF&I^\R4>[GZ_&FY$_)!E8QI!Q@:E;JEUNW" M]U56LIHJ3[2L@3>%D#75<"LWOFHEH[E=5%=^&`03OZ:\<9%A(3_"(8J"9^Q& M9-N:-1I))*NHAOA5R5NU9ZNSC]#55#YLVXM,U"U0K'G%];,E=9TZ6]QM&B'I MNH*\GTA,LSVWO7E!7_-,"B4*[0&=CX&^S'GNSWU@6BUS#AD8VQW)BM2](HMK M$KK^:FD-^L/93AW]=U0I=E\ES[_SAH';4"=3@;40#P9ZEYM'L-A_L?K65N"' M=')6T&VE?XK=-\8WI89R)Y"126R1/]\PE8&C0..%B6'*1`4!P*]3<],:X`A] MLM<=SW69NM'$2Z9!1`#NK)G2M]Q0NDZV55K4?Q%$.BHD"3L2N'8D8>B1.)B\ MS^%C/#:]&ZKI:BG%SH&>`4754M.!9`&\)J\(W,$H^DQ/)0H9&I(KPY*ZT.RP M7$%U'E=Q&"_]1W`TZS#7B('?'D-ZA`_1]"%!&,5$6.K/\@G/D?(@,="DY$08J;6YWD&PO=V]R:W-H965T M/9,0:L M`D:VT[3_?M=V8,&L:K:7@.'@AG5DX[X2X=YL/WY8'QE_$C4AT@&&3FS<6LI^Y?L"UZ1% MPF,]Z>!-R7B+)"QYY8N>$U3HH+;QHR!8^BVBG6L85OP2#E:6%),[A@\MZ:0A MX:1!$O2+FO9B8&OQ)70MXD^'_@JSM@>*/6VH?-6DKM/BU4/5,8[V#>3]$B8( M#]QZ,:-O*>9,L%)Z0.<;H?.<,S_S@6F[+BADH&QW."DW[FVXRJ]=?[O6_ORD MY"C.[AU1L^,G3HLOM"-@-I1)%6#/V)."/A3J$03[L^A[78"OW"E(B0Z-_,:. MGPFM:@G57D!"*J]5\7I'!`9#@<:+%HH)LP8$P*_34M498`AZT=.E MMTB#.`2XLR="WE-%Z3KX("1K?QE0>*(R)-&)!*XGD@@"+@R.3\%P/06'T:4* M?).--N<.2;1=L@G\422WBD5S@0,"2ON\ M3>+EVG^&>N`39F^4&22IH*BF-IM_; MS2$6(I\CTG@DF6@$[VR-R9O=-6A401LW.;,DRH*17UN[,QC3D=TD%02>?*4CBU%)@,)DN:Y@%EL!\\OI/T2?:P(E_UZ:";&W7EC:#,=IB M6YEYJ:V;J%G^CQH59*O)+#4&`Y\=6SQ);%$#QF[R="[J_09209:HQ-I5.X-) M=?G2+$FRA65B;A!SG]3)9\V&]SM*!=F2K&VU,Q@C*0X6BR"Q$'`0*)8S26:N MF]'5$EZ1G#2-<#`[J)D=0G;C4W.<[.`XT38,PF#7-_6<&X3V'V!!^"2,3DL5!G'?P+;WP```/__`P!0 M2P,$%``&``@````A`,DJD,;[`P``,@\``!D```!X;"]W;W)K&ULE%==;Z,Z$'U?Z?X'Q/L&S$?SH22K#57OKK0K75W=CV<"3H(* M&-E.T_[['7L(M2%+0Q]*,,=GCF>&@[W^\EJ5S@OEHF#UQB4SWW5HG;&\J(\; M]]]_GCXO7$?(M,[3DM5TX[Y1X7[9_O%I?6'\69PHE0XPU&+CGJ1L5IXGLA.M M4C%C#:WAR8'Q*I5PRX^>:#A-^BJE#^?F\\9JQJ@V!=E(=\TJ>M4V>K[L68\W9>P M[E<2I=F56]\,Z*LBXTRP@YP!G8="AVM>>DL/F+;KO(`5J+0[G!XV[E>R2@+B M>MNU3M!_!;T(X[BER>-F[X,(OG?D@`[NRID$^%HG2=["PDJ_Y'D%Y11Q*T)'!M24@PF21L M2>#Z3A(L8A(_?"S%PV7I+#VF,MVN.;LXT'H@7#2I:F2R`F:5GA"2?#L]D!PH\,:-C)6'D=\M3&=PAQAL.!W9&+`B`\W] MD148ZF=$CJ+WE&)DQ"QUU<)E%,=+6UIB`Y;S^%V[I0S:_WYE"MQ7%MN!=XB9 M:V5DX<.?#4A&`):RARG*%-A6%D9S._`.,4:UC`$K\GQ*9`7^J$\08T0V!JS( MZGMEO,?C':K`]IJ'?8*86%>C7XC;SRP]RREZ%+BOI]\=B+FMY_I,?0A,WR#@ M9/=G1:-M&6&TZ+5""S(J8H[8T7O>.EX3@G8(;U]GF$/;:$%F=)RF1^SH/=/\ M(#HZW[AU$`3A&QHN8S\>6+J-B.;QN^7:ZI3?W=VO!-W15M=OD!;4^L=\`1LM MNW;)&,)6ISSP?G7HF*:Z,.JYZHX@R*R<,6)'G^2L:C/SH8VT(#,Z3KO1-Y/< MDPSMCVN_N;AW9&)ODJ08\TZQ%%@VZY&JG:O0P:Y?9#6],DQR5#RPV- M#RM^FEN06:6KTPZ<;9*_$C1(:+@Q;S%<5.M)VFG#'@DF^:I&V[XZ[)$6-.(M M/<3OO268Y+L:W5?7[Y86A+LF@!*?S:'EYSCF0=O M)&OTEGC/))Q5],\3G$TI['W]&8`/C,GKC6JY[K2[_04``/__`P!02P,$%``& M``@````A`)_RZ9^R!@``KQP``!@```!X;"]W;W)KY(.])JM9=GFI`$31(BH*=G_G[+ ME!.[BNXDO'0:?%P^U.64P8\??ASVL^]5V]7-<>6)N>_-JF/9K.OC=N7]\_?G MA\2;=7UQ7!?[YEBMO)]5YWUX^O67Q]>F_=;MJJJ?@85CM_)V?7]:+A9=N:L. M13=O3M411C9->RAZN&RWB^[45L5ZF'38+Z3O1XM#41\]M+!L[['1;#9U67UJ MRI=#=>S12%OMBQ[X=[OZU)VM'S/0P3^;&?K:E.\[/N_FM??JWJ[ZR'<(3R1?K#E^N>GJBO!HV!F M+D-MJ6SV0`#^S@ZU3@WP2/%C^'VMU_UNY:EH'L:^$@"?/5==_[G6)KU9^=+U MS>$_!`EC"HU(8P1^C1$A)QM1Q@C\6B,R"448W::RP,<:O/2IZ(NGQ[9YG4'J M`?'N5.A$%DNPK-VCP,EONP?\HN=\U).&J8#N(*;?GZ1\7'R',)0&DB$$JLA" M*")_`Q%<(`N@=^$(;IO.44]B'-7%_/`8&4*2(53ZN7+G!B$`CG$)7'>.!J^\ MP'WRD"V,$$RW86'G!ED8K-R_L`9#]-R%([8P0M(A9"*T[A[\D;NCRH\O[($'*F%3/6.1D.(W&934CI[C:YZO4D2D[Y%_,83(0@ M.2F2A&<8&0^B^!UZ*:5WO=XTF-&R9I$60HS/TD!)QCNG`.D[`.(W`=+H.NXZ MLP'-J(UT4EM<><9E4@K')YC_QLH9`8W'EA`EQ[3\!CG47ZCYBT(K+I`",8Y0 MN7?HXDRD;RR.2NMJE6*YD@G$F.?V?>4S1'X-04I-BZY#["<0B'$5S;E#2$BF]?>1&&91S0]8\F0& M@R$4OI0Q]Q1!I'$BWHFBG"3Y`YIQLZ6%Q6DPAMM8<\EX)!.;GM1YD]J!'+># MP.JE(>:V`P&"2K<>N;%AB*>1G4^):>%V]/9ZWDN4>5=G`Q:KS&#."P>*Z5W. M`9$M64J-M8(;U,8M@&]1,^FV`"G2D<_HN/]..>K72]=G=U;"N!4$S#798/F\ M^PFCE)5KSL8=UU+/L49PPW/C!A#8D)AL_6?J71+*PVE;$8#`:)Q2I, M(MNH,>480J:))4_):2V^GQPJMRL3_!4D4XAQ9,*]0Q=_0^%3*((;B3]6^)#E M3*80$P[?=ZQ"&N>\/4BI3=)V-=9V_D$I,Q@,FDA$&-N0&%Y$V^,X=E20DF/: M?F4&A!"?IOQKK/W]MS`P&O?<`&['$ M>?!ZI09C]8^81S*#06)1R%\\ M1T[?I\0FJ3\<_7"1=7;NQF.(P:_6;[Y8&BMGQ!LOEG@^A"S MLGG19S\2U.ER%\^E,K&$\P$X#V+W-3_\# M``#__P,`4$L#!!0`!@`(````(0`L;QYYD0(```H'```8````>&PO=V]R:W-H M965T&ULE)5=;]HP%(;O)^T_6+YOG`224$2H6KINE39IFO9Q M;1R'6(WCR#:E_?<[MBD0Z+K"!?G@/2_/>8_CS*Z>9(L>N39"=25.HA@CWC%5 MB6Y5XE\_[RXF&!E+NXJVJN,E?N8&7\T_?IAME'XP#><6@4-G2MQ8VT\),:SA MDII(];R#7VJE);5PJ5?$])K3RA?)EJ1QG!-)18>#PU2_QT/5M6#\5K&UY)T- M)IJWU`*_:41O7MPD>X^=I/IAW5\P)7NP6(I6V&=OBI%DT_M5IS1=MM#W4S*F M[,7;7YS82\&T,JJV$=B1`'K:\R6Y).`TGU4".G"Q(\WK$E\GTT6.R7SF\_DM M^,8T>K[EAD&@8!.EF7-BJ@4`^$92N)4!@=`G?]R(RC8E'N51 M5L2C!.1HR8V]$\X2([8V5LD_091LK8))NC6!X]8D2<\V&6U-X+@W22=9DN7_ M1R&A+9_2+;5T/M-J@V#E`;CIJ5O'R12<73PC"/GU>"`75W/MBGPIJ`V,]'&> M9S/R"&-@6\G-J20=*A:O*,8["0&\'2/$=CZC*RKQ&*,]8[ZS]VWXKT].R<^PIH< M805)X:E@MPJ?H6;QMF:`!\_)^_&<^`COF*?Z-Z)3J#6E[#S+A=LN=V^Q^5\```#__P,`4$L# M!!0`!@`(````(0"W!2T6C$X``"_[```4````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`HVEU50X'1?49)*OAMG#'B%/TPYS+QSZ=S%"JNY\Y.CX\VCL^ M_6.Q?;!;[/W^X_[1!VBV6ASLG;8W>'CZW=[Q+=3\=C(97`]'H\X[XF$Q1,?& MYT,H=QL5(J'.AN-RW)>6]2?U#%F`T*)DW$0@;GN:_?&GJIX9S`S'Q9\F3(@5 M&<_F*$?[V=TX5\.4ATZS"P;40T0A<:`]N)-\.3O>[V^_W7^_?[J_=V+4/CD] MW/G==X?O=_>.3WY=K.SNO=O?V3]]8EPX_6-[Y"2&5^6-RV#9[T_G"%=7+MKO M2LAFDSM$+-%D6D&V>0?%`]85F6R/)XAJ$1;3GG#)\TD7!/@/>'[2&PW/RQD& MM080!DA1O[P:2J!'('Z7K8O"CB;U4*?9L/O@^\.#;]=.]XX_%!E#V@O*"#+& MM#Y,"M\/QY4)*RH_[.SQ("?80X<\O)L*#Q[&U'`\&:]%1;J#0$[).Q[X,L$- M!JN6P2K6BL?KSYX]VT!PI@6`.P=+\;]6^4S_+6JW9^5\=C&9#O]<#7Y3;+Y8 MW=IXMOK\]9M5T[O-YZM;SU^NOGK]*CX]E.4?N%(VAK`H9P7>5?\BN5?V!":C MNNPA3L'IVEP%V&5@9L-/U:ACEH]`WK4A='/A:\L)6CF_G(_,:@=(GESB75Z` MU(Q7C"9U!X#R=]"*8;\K*\Z"W+'#`S$*7DQ&Z$+]:]F696\>3'"7,]TX7F7PX<].VD$M?/"(I%,=[W^\=?-QK?W5233\-^S@X5862F65I$$M2 M"BOG,+@?[8/V4#@D#W]XY5MBW"<&205C MU[B[-@'DQJV!#:Q)2GXE#6S/=`*QH`K,-,>L_;63)>R(742?I/W+=\>&'3)+;#[O#&9XU__06BNX'E(O3M@?Z4)5C:'LV'Q5SPHDA MVR"2_-1Q<_8,#OF^(!#5&P0A9_>XD^]!>)&3-T8W+$`AXGQ87T08.ZG&0X3U M0-:_O:Y#,\N15L*J_N2RZJ!3(.["P^VA1-?B[=Z[P^.]2-W3[3]TA>]M-<9P MS#SF\/D4G737)K76H.V)I%SAO7(VFPY[\YG<4?F7^!*T\/B>'N7[\AD'.RL$T9^^'!X4.3.1GLM;[=/]G?,E][=?_]1X68: M&G@DYMR&&C]WDA_V]K_]3F-O?P_D?JM0EF$!X8^G0/+![O[!MU\5;\MZV#=M MVAV.YL3P[:7>8B<709TM'QWO?0=J['^?V'A+R+Q@*[%?`$%T.O9-C.ZPEN\F MTVIX/@Y15?^F4'*IQHLQS!G\:>ZQ5$=>%]>W3#K>*W!'B+/5W"XL:P^2ENZD M/YNE]S%#!C:7NU^'F.PGFMJ.+&0IG/9WVP-"!]@@MT>N)U9\YW[7DW!EF3.8 M>YJ.-4L%Y6DA$&NOQ%$''U3&#I$J'!W;C[4],[2QY,?IL][RI+*&9,8`=.54JS2.3^95`_',U[2OC9.8YV.8[ MO;N?,)Z%/6U26#YOK4=D.S#](7Y8:O'S^>383X=]90Q]#RDM4937Y52I-%][ M>[)=I9.%W'(^",5(+MT.W^V7=R[D',E(AM!'<0[^V$,0I3V6C,F*8J0GP::T M'R"MO%P$3;.Z?[ MWUL"J+UB$6)IK-B`L5B$LX>-)55M&0F]8(SC9_C)DB)?M1>P*!*6D7Q@<2^'R2E^S1T">Q2I`PN'ER4X?EZ(-3K M5]6@=D?58A5FNO7QX+F;0Y&`#296GX$ZK4V3)8YJS3%DX*&[!5VJ:=H5%(I7 ME6RV09,^W4?2=_L'E$'N(>D45VEXA>4GJZKPP>**L:4-34XM[WE;RG618+W) M=#JY9HT=LWZ4C7U:32^Q_>C8+G'TT[M"E22$+35M;US4@L/..RPJ4?)D]$G$ MZEM6-`I))^FT"$#WV*3NKN*4AEQ*Q'R1D7^*N51]M3-N8CY[2M#:D*`!U#8= M]MZ]V]LYE2.Y]X>=[[8/B!O(U^P5_F\LR4$AM6N_IOAE=V_G>&_[1`&`/6,! MCNFHZC/?;[_?(P?4?M&^5XS MDE+;[XO=_9,=8H*/Q%QLV]8A.\DVB$H_6+*J,Z]J;\;KP1SI/R^(<<-4EN*) M6MI^;V'>DYWO]G8_$D$RZ\'AP9K-G&$81'F0^F6(EG#ὫXE7D$YRX)DA MPMU9<2-QE_^$`]1>Y,9Z<;!]&LCQ]N/)_L$>,;IXI+C5G`FBO1.XN90VA]-S MLA:>]UDM=C`^D]&0S)W%:##E"/=5W(P_-B2,N2WQ['X=, MYX@`M\9.#U;S!4_+P7`RFIPSTQ_6IN4-`YV-YI/IA/3CE=NGB25=II5G^`W8 MD-2J7B^V.]6%:WP:2^FQBP'>17]&0HC4SQ`?-OPUNYA.YN<7+8M#">3EFT00 MY:;(\.,.]JVL@(':*4=#!&P$&N+!WM#K,1.WHTHD0SX:)?E`6#L^J"Z+OZ5 MEZN;U>+X8C*HZ(K0PR;&^O*/D^F/ZW_[Z]_^>CB?1J]),8"%[`I\RJ)&#W$P MZ^K<4EC,6P3`PS)1B@Y=$!A3.`,EVF)_B@ICAP>J52N6B7++'\TX="MXIC]* M"6X6[Y71FT*>0^3YH1R7GHOU#I=BA07]^U_^3^?K?__+_WUB^WRK5"6DYXG` MW@\2"U;_+=2_*O;W]ZDD28+/R%8@4&9QI[,QA+L87A4KC/[V^,.W&M!H]:4[ M*D?U)`A_U=U&P>R$T^MPR&/K9H MH/IBNXL/-&)RRR-&Q]U&M9?/9)0"]44H*#H:%=>@I(3^6@TY];Q7#\&'*458 MF9#.=HVXV[S&EW!?TA>;(/`,U>NC-Q%LQ"XV4DR0J-$H5NOPUX,L8*A9QJK^ MNJ[BO^9U_-=D/N6?TD:)&0\I$5*.;_0A"C:[&*J_0[+=D>?@XQGA0G6AJ?4;)KFUL$IT/KZQ(2+AV06[CG"0L M[5A0BB7X3F^*Z^&,AA0%PO4<,O2'4,`<7EQE0C_7'7`3M[!Q.^PM:DE%V>2- MH/MD2MALZ)&IW/Q*^XO(;4&BIJ=6)CJOBCB])W'&4&>T]<);YBS.I3VKQ:BD MCBLJ$AVI@(-#(?BG/AF[=)RB%:TB.TC$D`IL)=])J%\*$%)ULEE<-/2K!8P0 M9O"\Q6?%]\B/)9AC9BEV@8GJW^_OB>KK-(3E2&.RR'<6&_H*!,YTBY48AC\! MF]#TT\1\^#BSB;QDV-X3ZJ47)8':\-44HT6O6,]RZ-1HIC+('>9?I^NJ(N46*-P>#VVV,7M8P:"C^#FJU4D9'CB;K(]M M92G]OBI6-IXX<2?7$`Y!=V-IGV5R[A`1B(8*7:J(5I/$-C4 M_OTO_[LNE"Z97.)W8)=AZ:5Y'EK1RG.?M>DRT=1EKYY,>Y:(,<@RG1#GI\/S M"T:V!`P]8%40`511\<9JG)/_9VDD!'`5KXC;X)MI>0]SVBQ5XVA08\`^B09? MFV@*3"7NKTJ*HBJ81..&5)_4!4J@+11@'_WAE"P3:RT+J&,P,ECG:*"!E$$?&H=V_8@N638RT8]-*=Z>3-F?MNQJ&5#+T4M1 MLV5!&R)+'H3K%055(P+#`RCAWV9O`O!V`/\[:M'30?'M>O&VFIY74WRN]=UU M";'8A>*3:>K[_X ME3[6G%F/`7S-O%+IW(OF.D#0^&R4VDXNRKQ9LW-K86J0@) M$(V084@KIXDA^-]H9-AD,N_ZK'&XS%,O1[%.SX.NN0F>PQZ:G-)RASA4[X7K MT4\LRO.I:(JBF&#-@^!4EU>CR0WY[@O`%?3&[44H&H&WAR7!-**&_DI<]^J* M"%AC9:^)#>E/MXN6B&6',G3&Q7MW:P@6.05)IYF;'[,D@+Y9F,9AF/1F5/'O MH:4E08P//)H'#_0;:")@RH:PQ=9SI"#%;)'9(DVT3KDC)XSA.ZRS8$QA`U)G ME&OF,2A@_Q?#GM6R8`AK!J\E./T)<8/:G-F#\!VG`"+$P&V]0/ODOP>?`V4C M>(L"W2?C+6?0*Y7FK-O4N>3"&NW,LABGI&F]F/Q9+O#=[N"<7B2%6) M"#*K0SOK,:"9%AO/G@$X%DQ0T6BX;(%#.^[\U\G%N/B^V*$G%J)9D)?C=EQB MQ-\'0W19;/@B`-0SDRVFM\785`:3$-!P!.=(W(NH*,$XDP!$R3(7NK:`P5_> M"U&.Q0[!L@40N1=`:GI%HN1D,,F<1)1(/$Z!,V$ZF?PXNAE[>D`9`!&:$+\A MZ'V;F%U/ENWAX(_18/RU1R-)=C3GA"_$B MZ%<1&9U)]?.@,GC.A!1O_T=Y>?6;'8\RA+^PIBUJ1++2C@`.M1I?U@*+\8ZJ M_L78T@U2^')`8*!RJ[OV23L!3P-H/:/%MZ>U]&?0!_6:Z>@!/NF"G:.M#G28 M3Y7L!ES=JXRYJF7V$&-R&B(.!XNE#QE!);5=H+5((!,;K5Y_!J4#C2Y*\-:Z MV:S_-33RXBF0-L6WQ1O(B(7O0[6=<'GMLOQ1BA,7'_8R&9_3RD]WP)RDE!T) ML?P:+Y@#\;$&BN/]4;6DI49W9'%49!LD-4,WM2#N&.&3<&EETC8TUDYC*YS:)]@7^)? M%#;WV!M3FF#6K%[C6QAW((M5N\X(\XS*MLE[2"T+JA:B)DLS[R8&?PC2D3@B MR<>NWC\VH4KPX>P%N'I'=.W$E1G&1\5NCFY2).4)=/?/0ONF6B_Q\$ADRN/0 M"1V3AHQ9DA(S4.8H,2!^KY#H[F63`I)-N.PAN*1::`^S`T03`E:ZVHO'SU^N MOX3]V`L]B7@\?OYL_57ZA#G3`LF<:PV9K@;&JJ_6_,Z`1TI:2,CQVVBXI;5% MIP[EO0Y:OKY-R('#5N^[4^X!2VO*[9%X!E<_9^YUI0/SFS?JS1$XC\%;^"02=V?$HCHF,()"(G)$U4M\121CD MD(2O%G,+/Y_:K,%5\?'K%VUI>+65?7*->=)T71'(/-1[+8K#.5OQ/-80QSW@ M;&.R<,TM??E0\OQ<(G2"[U/D=Q%_[M8S`8%G/6`BHF(@3Q7!LKOBFX`@Z#TI MZ:;LP`Z;>:3/V]@F<]S"R[$GS0'!X$WQBFR/07ZOJJA)C3,7CVG, M?6(E@+CYG$6&5C=:LSA^S."=.I*$E>ZW]BF5:%S3;A!GO$#"Q7+D3Q@./5F`Z^Z*$?6ZG2G)&>1;Z_JES2; M:$,2YP4W+$#]9:DT-%^%/B9F#-YH7F0+&7^^[+O[1;I_"78CN3H>HCYVUND8 MBN8$`]0UY-M*@'EC3I].'N4C8M&2?S9Y`&>])X!,#3">U-BDIK$66>PHBW1M M1$;`4104C22NA?5WTJLM>A&)C`Q6)F8S=\90F#OJ)LWRG+MA)^8SN#.;Y3YA MZ_A\C4U+PSD:B;B!WM6T\K2$9("B7;NH MSYK[E96^/0.$MBQY*A!/CBS"FJ/#80!2ZG7EQ(^O" M5!Z%(`V)Y.>;;&DOTKW(I)0)#%SJ+BEF[U9F-U<*VC"*F\]HZ^"\&&6EC_@< MYE,Q7:[V1H-8IP1*Z+?:;="C1V.=(!A//*$?+ MW`(QUG&=E=L!++'9?$&#@TLYO M=G)7HF8.;"N*W0V5<4;MWZUDR9-E2O\;ZM5D?:E(GX=8;.`V.'.+C''-@A;] M-$?$!D0@H)F3W+-;]NY2?T%K2+%LV,S]`S4!9%YG2;Y) MJS":<#CQR/R(0?(:T;MWU"`1M;7?FVD\GI.$XR^.0R/AW/*B'@'%@R=K?]`# M"X(::!:\/[-;P^;2&1OO;#*9X=O@=HR1ZKI6K5JZS=[XOTNSM+)5']=/UJ.O M`]ZQ<(Z&L@GM8$Y\ZR&">E&YAR.,0)Z?REPF,PV+?E-0V/.V2@="BR]-CU6A'4DHNMM`Z\D<7-P6H*>\!!VJ@W^G&"*)Z MPS3K'6,EYBQ02,@]'+%$*-E$`0D(S2(.+T,GXCTQ="8.E^6@"@A@=8OV=&*& M6BX6Q\>RR+N<):XI,E/3F-I+R*:%77G^QOG!YF4_9:9L/LQ3'/-+!+GFSA5* MU>9(U<1:6W( MP'FSC?SCJ!._2^37MD+>HA,'P5R%Z[SGY M+P3TXV6H#!=Z$/F;P4G+4@Y*:*>R*'E(N_T(H(QGX@.&I\^8IJ#UI^X[%S M[@L">^2<9J8HI1IF#,)IS>:4(H@HBN0;P+81B=:3\;@:<4R!*N6/575E9E]/ M-D#=,"UJBH:*A3V9]X4)HP#J(4Z9J<7`P`NHYT1DQ4&4F5K>F%-Z?64NEYY% MP<9U?SKT3YI)+6BMQN;:88SC\!)D.V3I^Z*^-6//XW,UGZN/*6Z$M5W2Z61] MQ@J)O`VK:Z2Z&(9%`UY]'D2"\-O8*86#I!,)"?_$2T#EH]KZ.T8/3&$`(4,? M/:R#2[)0D/?2SZT-N!O*4"T;RQTC2SBLX=^2<'"HDZ]!$F+ALP@-P`5A6^"R MN0:T?=#S"=$YBQCCZ-`IP*Y$M`_65L#I"99+K_YE31NQ.XMRRWCHHBI'.*P8 M0K4BX;A?ZGPNDZA)%F[!6??F-8M&]!X?A&J]V`M;-4B_Q0CXNFZ=TLCO,)XH M&`"0,J^ZYCH]KQ&$%B:,_4BL:B>S1HM#8447%I+E+D2*IDR7+0ATS:II9CXD M&F:1D(L4G#E@$+-=?"*J")+L?+HBE%I'>\$94 MX"+(@\F&^62(6.@`R[H(E@ANVY'X:`+IESJY_N=)7;.7T?TU-D+6%IZ[HB^+:BU1/=(D8?P*RJ?=(X!TU:!%'Q`N>^XZ-6[+=NBN+,$U=K//&Y_X,@Y[=Q@ M$Q&U_?P/=/V`BK\VN+3,'_;HJ5M?@],_S;M7DAXB(YU3;2NO5S=?=T[<=^ZL M67FUNO7F16L9NJ'WJ_JJ['-S+]`ET:\>?7.4G`4I_5M8J=.H==%Z^9L?S,^T MGD4]B)HD'SEU&":X0MC#99VP+95H>J@`B4M<)*EM@!P$&AB=8TM*.R0XG^'^`:$>Z.K> M&4C<-(]3+L-U78A)L\IO\I[-@Q.MHWZQQR;.F.`'A&!@$<2QN-<.'G/2%7*B M&R3W6DDPWJP!\VXGXL!5.M8PWS.+89P]F6%PK>]GMI@Y=>`<1!4P#O"W`;V+^ M%PXJ_RN6(R.^4@51;SQ;E90S8#@&$25<(L85#789B#I]":5B9B)`'3K!(0EU MR=A9'7TZ)QJR)$0S7A!57'^U?<)>\N)D3*4@.5?:DH!R]>A%(3&F2REN897M MBQQ6W(M,R7`\!VV)G'VU)LG:7G=9G9VZU&-:@O(I%8F]4$JT8X'2N?93KNC= M7GI%[[Y?IZ3K8D.[BV1"?J<=6%5OFNX7,/&0G#2M7C?$"L@WSC8?^G,:P6YL M"B2&&#X#UBR?@8(`@3$_?TJ\4&KWCZ+8F$?36+,-CE/E52,I[-%6;ET=A.3M:IR8X!B9:`@AA>2<``XXY$^WK5-<:F3>PR1KTS*!*\CANG?+N2'DL^NDZF@B369>,)Z<:3;;$ M%VPT=0X0T-[P-]F=A!^!OGT4$]#KWDD8L8#CE`2_Q%KCXAC$)MO@)]2/Z6B(8% M'TCPJ:H#M0D5@TRS#==F7/KR9U(+?L)>)^A4(T M!1;GKW.!/>VJD[.9CK'#-F[BG5S9#+.*]2.'.QSO&902[)1!A1*3WI\B>B)> M\R'%C%*-A.'<=_:K#,7)#89_"B]HE0_40G:;^G\W145^H3TY$A66N5!,3%%TY4 M'>PYA\J,MC9-6K0A4$\4'_JEZG+1##`3#B[CJ[5."(OLZ(X[M,J,X10DYL.6 MX-(U`G`Y1Y3E+_%_)CU,=>-V>%#A>#IB#`3Y^2V;R*'6M$@<..F]M#-%[N&1 M(*9(`3)HEM0F5A"I'$@O MAR!(@#,E)0SMV+)^F:$11KC9]#4T`B(#LCBUQ4>^8M[/\!2(>?RBWQGS1.B]<;['0,N:G2V6T;*0%5.P1(KHC[H#(M,**H6\O#.L3(*80)91V#J9 M7H\C*>9)OA^`BAW3\)X?GN'B!-*NDL5P_2.H7X, MWS_=YM;Z\\13HI=.L=$71MIDKS;:+:HOM_)/VALQ MLG8FLQX!.><8X9$?[-?4I71[5`0K^&,5Z=$%'Y7A&U M]4A";3>;V3$`<>LQ9WHW$YEP[ILUAH8>2^1JK78+9)B>F#0>TA5#.J.^S`:% M]HN'@1]$H25RZ&AC%6%./X3?:[!*LDX#K9(PYO*;L^'G:L#=KY@3NAPP+G@R M9E="-ROIN*Q>'W603<0!D3YJ3?AQ9#D,C[RU:1^,"K=@2$";;P,T6JNL/+_. MZ*)['#QRC0Z6F2H-.!S3V1K7QH@7N6?".V-NU%F2TFT:$]VNE[IM,%QASUMQ MD0S>/&G#WS)>Z@ZT#JZWL3L8-R+O75&>I=FSVV=S9E0K21>*1-H1HVC7&#AP M*NX],$".%]X_`84%V^$(-/0.V2KW,G35'^W$N<_MV!@N>LO[)6,O2>Q@);KH MH-Y;RRHPA_RC?OAA&W)6LH&I+1EOPQ;6RT_V)BIXLBDC@J%=3-S%*;>S- M4>MX69,YVEFF*BVU-5>0]FS@?)4HDY%OUJAL&<^%0#6TRPI^U`]#ZUC)TX1IR MVU-(VIK.-_*\I&V^QC]<4,D8:IH3P-"*N&`PK3U$@J'H:'"%?B3NAZG#Z?PF M"C5'R?<6K+=ID=4.W:VUF!S2S>$D61"@&-7L*,>A0M:0%I,9M'C5-,'`/P7^ M,2MHI6R(::1G=%P;0F]4O=8/K(3[8CS#+>I7G!>6[RVA36SQ/)*6E3(%&9)) M\,#T>N9B:`*S>)%F]**4M#8G9&%18H7/(,\V"(YI,EY4N#Y2)<`0CG!9L<`J MED$+LKK0@7*^0D]T)02H@@HEB[*%+JQ3CRZLLB!LUZU(HH+&]P0W%>EX?4M2 M.IGXH879)/^(!L@)(Q97@@0%UI[MM^R>:P(#:B5A9]F"U*I/_#=5FY]AT-WX MU>!2SHGTJ8-5M)(-G#D6BZ'W@9AH$@,>62"9&R&[NHL!@'B99A>Q%>@$E[R@1#RRJ(2\Y9:T.)N[(IZJ)]1-5..C.P.I);X+]S'*+T,, M]'^Z*D5OZ!$T4^25:=`PS<^I^*IY*NS#P-NO$D/0(/TG8!K29_?/\#!&0_5W M]6TL7/@+3.&=5!:ET4M2V8I-H?7+=!T]W?<^*8O6M"X!X))3B]%[M3-@TOF6 M^T50]_CEJ]P;9Y\M/JH!`<\4=#(VK= M_,B>!VJ;9X\V4NHY4)SK)5`J_Y#MCM+G.\IYW-+%3SFU'<+=4+%M?VYWP1/7 MA$+;TG??#:?XA^]I(RA.M5'=4MN)?%:V5E]M=7ZSD"O89"GN>_?YZLN76^VE MK6QLK#Y_\:;]\2&LI)"S_"9;O"3,&P=X-_.@XYRF#WZ_3`@!?MJUOJZD"[+* MF[!FD?L=H=I>\I!AO\6E<`=HNN)HG1##@$;O35.*JIQ^LRR"DU2[!LNW' M>KNM`"VNP%9)VQ*NK(?N`)'Y'TIIHGP!ZX?L=JF@(N8#*KMI>;N[E$"_MP4! M#RG4ZH?G^#$[L>>YFQ8KVX91S@ST3`>E;^&];1!D5+RPEUX4*Z((]Y0PP@N5 M!%PU[?Z8E5@)50+#0T\>7$(]/>W*++N-G60RY`RE-WF0@VD"0:SL6-HL26*R MG"5-3WZ4OWRMFZVU,@Y^7FSF8#&D3V(CJ9*7YRBX)FK\'%;798;L&MG0!B+X M((^OC:!<`H4%B^82@]:0<)-KDY<8&A$HH$:N8[<+[H,!XC]0(2?I:2&O;/[?/>HL*FL[+2=%/LA\08^E* M8"@LLL%#/X(*Z2/#F*">6:1E:UY5,^EJC8C/I'AP;YZ*1*<2H4GIT4*[,JZ^V-*2"6G:\[ M#)]3,'QT^V[4^`5]0NMUG\N%V98YC/B8I:X+7+:AK74_9BE*+3&)EJP(),1& M]ZPG)!7R4Z=)RF4DNX3/G$(E;K-E<_.QG;G-_/Y9\6K]Y:^L,UMM/UP8:]SC M1"4;%XEQJI18E`\-%/D13#N"0FBXV7I5#SD5,RKSL,9YMO!L3-C.QX9+3E%M MSFLG2PS<[!LI5\L+"W;:^P)$/@\,@:<'^W7[YF;6LU\4(Q+W0E^\_VYV),H= M4*XP1/NTRB_HDHW1)(9=Y:4ATF6N'*;TVP;8=BT`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`"GOE/"ON#BJ:U!`^ZG1J=1OPC-+8314EEEA2C[;BA^35M3]=O]#$;USQF99'"RTW M^FN\IB?#%V/-[+9\OL44,#322[9+AX)C)=6SZS13D&TG!QT$6,]*YU/E]/J6 MPA@[I`-?J395*.;]^&,S#S,2[U*2]9>78^'D3Y)2[5094J*'M/PD_6)Z^-E[ M76S,KQC@X?FUG&K\F$JFK,/'">V2+D%7%%6.DMCF_1!?!`Y[*73<]=#Q/QP8 MYJC@I4+H3E2+5*;5QD#W9WO>S@"\'6HN&"B9F9A;RDNJ32R+V579-2BQ:P`, MD?A;(H(S`M04YQ1X6T/JK6@.G(6AYHA.6YU<$6Q0;[F\<_+?+,7:(W[V-J6W M@-,9#0LL\X9EV^U9MFJR"5IYL^!LBZQ`I]]E?%5B"_5Z+3?*L-:J7CG^<3J_FM%[+$"EX017 M"A6$()K$6FX$!):9LJ-$^@IORP13_XYRR4%=_02..2I.$=`;W`T52-'])Z&) M)3^C69/GX()"U[[]WJGNRFFU=X6+1Y/D:6/*K-A(/8C"E0*XE]81H,22OH]B MIW_#^N9'P5FW#(XGF72X:=`TLN48[FF4/)<<8M&)?AUVUYC1>1RTQ;@92; M]?Y@8O6FHI&)`&9-\7PJDU@*%W)TW;/\2:L_6"IWH>?EBUC_GR&6O8NV.F7* M`99;(M9HU_\YPM7_'ZW^O&AU+P4K_R2A54<]<]-BW19V'_%P"CG5=LX*1R),/G/'/[D/2M>P*B']$+R7\*D MV3>''&7%>1H5?GDK_7!DS+(?"J47W'X09Z&M:^-9\>+IUJ]B0\V.^II3_P(\8*`?/4S7`0R6'O_!IU%%G"VB6;T-7<&VZ&;O<@6@H_P+/-$0X9I*K)PN]PX^M:!IP,05[]\&@DWZEO(_#! MD9#@7GG8L=T@H33)8)%SB:[[\2D1U3H;M7?"M$16GU'DPA*R;Q;^(VRYE;]HLFZX2U%#]AZK# M43`=&;$Q)4<[?@=\:V)^$&%8TS5EKKUVIP,4')CR')C>2V+NVK-0'*#J83U[ M;%^/+NY"GYQDG7R6$VF%@0]NISFU;)I^;+CB_N]?2$H`;0_;:#Y3-X"!-HR# MIFHFXY=-?%5^2@8BI)J18D4[XZ3$J<&"PK;LQ$[.3KNE@G0CUP$9&U)K0#Z\ MS1U.OC4+X"U&XBRDW:D=4J4LQ&M'"^RSO%[\[2;EC[A#87A&,C74C2-F*F$< M4[VU+JCHM-ACN>SB"C]0_K MV6]>VJ_B^#DI5"A$R]XVOID@=R=L]RC,NXO\J>TQF#6KN6K3MSUG1*1]7[\L MB2(;]SRA'PAI?AN4L.X?-/'QQIL7JYNOPD4"=QQP669$4P9;4/+FU?IK_YUJ M+?`V40!A)"CI;(=0)MT%(J&*$A:4T7[/36O7'4B>*-=3AF:/-ZP[I4G9A!(# MHR_PA[,6PP&VVLDAN08&\!;,5QY,RVML..>L=+UTX-]=)'9IC]>7Y$NVIE,M MZB4M*ENPPGLIO>X1JC)2JL"*)%S1CVDQ53P7I:P9_IEU&CYPQZ9OL>SJ%%\@ MR"+!@Z@EJ>%;^V$O42GT/29CBAYDPF,H;&Y7.`T(XT?\?G#RHM(6Y68LDCSW.\U@L;;L;2RA[4N3R3XLL?5R_I??]+7W61<[D\/C MY4,[TX7?=DRK0CS@E5`PG&WZY/-7B=@]D0EJDT6JH"*L,<"6/I6EDNPW= M#%4B@F7VX'X9(@2,.41K36=%ZI]3,)R68LH!,5V8DV<4X2,C[2[JYB;CXQ72 MD(W!7XNONU[%^TT876M=D.`>MY'IE^/48P)]&IS(Q_7@C!8A>(P!W'CVWS?I"DPQ9.7*H*T<"I'6AXSW1!8<8$/$FR.5FE1I_&15_Q]U MY[841Y+>\5>I"]G#1``+`H0(1RBB@=8LLQ+@[D:*B0U?2(`DU@S(`L:KO=IW M6#_`/LL^BI_$O__WY:$JLZJ[F=D=VS$7(ZHKL_+PG8])$EPU%_!GHJ2)7^`L MP:4GS];W4L46X8@X4UN/+&(AM[>,.;'_>?24&B21VGE8FXY:ZRHNTYI9AG7" MJP0)#K-R82'(_?-J.#@Y.SX]G1\7?-=#8Z/AQ-#J;Q_T+M3L+JO`BA]S9,OQ^]5Z&U\_M_ MJR9?:A'#M/&8/KR_I]/5>?-\:X>2;#(E MY:-)17:%H"(F#QY='`K"BG$8?Q67#GT,Q*@MZIBTVECX,FB?*U?KF"LPQEB4 M&I']R!`2#0$(G"DQY$_TC7@5^<&L?ZB)7"X`A!P.^5?+&BVAINHZDDRH]B"5 M1XMI)96)MZ3J\;;P_%D,-5K0>PEM%J,"WHOHL?$8Q!WJ',CS&C*&+V):4)8& M2XH0V$'W:[)(6*<>*7I)-PP?3L!@8U+U`Q?W'CX;3\3)G"MUZAI:+9,(U1$U M,PF6]E^H+!*FH+(Q2$OIZJS!8V-D3_,U*!D_E)NZ#V3!$HRM`M.-U1I!`&6?/UUYYK:;ZRUZS,G#AM=BG3TRYE"JL"6Q$5S)T20![\4B2Z%?\$6(%2A69"F<3U M53(WNLG)6PM]Y(29`9*2(24ES%U3#>-:@;56B@6M$\VO1,40UEGA'=R]A98% M,E*:!+U!UDK.]I?A8D=$2\@*U945G'VGEH#(,E@M_Q_BW6L2AT$YC'G<^$5UB.^Z9W];"74CE%U,U)(673@R3F6FT2QQ*\H8F91GN2- MF&.@(>2)H&*PUQ8/S%G1+D-F2;^6H@.-8=)X3!J9RF%QJ*1BB9$9$$!>VD"0 M3NA_F;T_^S_,@^]?;"%\C";':"?3YG0\:::_'4W&CC99/4$\D?QRUYP2VC15 MA;AF6-UXQ'10:B\X)U+O.=2IC]9_6GEFP.U="/0/Y9!X/1NF>X_P6:_M;E:GC5>3K>\/;:>;#G1RC8%K+:KI]25V7Y: M/7X[?-KQ2,.AYW-LEUEVGEM^C.1BU!^=T`7I`Q)FI=F;73$?V2_>Y\;Z9E7C M:V5C?:MZ^#*0O$<4W,5[X[84`6+AE7)A791=AJSL0[^_I<&.58@WBBLB2W?# M\X?KK'Z$TT`F<;S*IQ%U,T:I@9!U_Z#09VC#J^0].TI<,D&DSEBZ#>4^?C.> MSEZ/CV?\L_G^Y(A_O.&OL\FXLCF,O8S?:^]`@#M0Z+LY MZ/Z83R(3F;Z""1M6T!('0T1$HY@P^YZQ<2K/P5,^77UVZ8HC1N=4SF&D^%L[ M_R1>N!,RO1'S.K4;I:%^=I73%-\P6Q`2$`L_7V%W0RH,_0B\,K^QVB^I1\!G MV52,Z^J>S0(O61=XB!P4&RW*D)FF6;$6IS=#E5G^ZJD`?,X^V=IZ@Z4G%T-/ M_!VN+:CI;&;.-"9H`D)A7<2E1E;(*OMV`AX@RE=;Y*-\628"VAY_AF\G^.VL MQ,O4YN0\HYI6)[CS&H,!);=LA-,R]F];"_F?;NVPLL4QFB'#\XPC2*4DR#V5 ME*$I&_6^T^F3XL(Y>P1`=SG%0B[(">"MC%\>475C`.;U>TKKM,]Q"' M-5;-V4!+3`(P6C),RP;C@.N"W+7U0>-4J[WH:`H;=KM(N9T& M;25X:[D[$4*Y6@(ZY_KFS<@1!2OKWE#@`A M.F2]WMB^F7-D]K!UL2NKL>*J+S(/QK78Z<7I$WZ=[8G=6]S0I-9A8_(`FF?U'[=->S+D_&"CQ@K8OC MF8^5ZSKP:O?9+!T9M]FR\_E:9>F+B]&Z.V1Q>#$^6/V6\P(\ M>[H[@3@%/'5XHB/O199T0/F:$GS.)<7E^4@J#CI@WT]X06T22J?IBI`53/VA MB:(T\Q!9,T\\6G8!4Y,:.3`(K(**3NFW5<&T>[Y=0'OK^9W5.U'&4K_;:Z(K MUV2/XXKBQ*18Q-09B"2F`BX0>@1M$"FFFNHS^S;."@/#+K4P/Z&)_R8Q#.DZB$VN7()TU'(+[6-VMWI6:44)"65A;_KTG2^F5/E*S6B66K M*@^(.COZ!4G3`8#;T]K,4N,+Y$Y2(*^!4\_Y@1+V4SP.$VH#*,42@'BH5;C= M^X>JZ"OKM]1H,Z(:&_!P&'^JW2'0^X^V:=#\?N96EI(OE[\W$*AR".>6;*4+'HC?*7P^";0[T*7\: MQ4#!\H>3EJGA)!RPP'6(\IU"*Z#<&(3*F5[1KJ]XUN^V.<*"2"T*C!;%ZR_. M:E)4OF*>1A?L)* M20OB'\X&/&()S:&[4D-:K>`RAJ_9BZ0.4H62L`WQ$;1UO9&MFUYK!:?'W M(,/E-C&PFVAWM$7 M>V4:!X*'F^25"=P]2'F(EED:E"N%*'+FQ9SG0H=8NG.2))E$\Y]62LBM+\5# M>-$'W1WC@]]KJA0YH;:=&#@JVW?0:CG0[KXWZ05F=*3B+),L"SC#'\$\+K!D MJ^+W=*0,(;GL2L2;=60M/FNEHP2@9M`4"RZEC$62H@;JYMZVV]D>S";).54DH-JNUIUM104C3?/$S\FB]Y.W_'@, M!`YRS[7R&`>XZ2#SG$E&7_D!2\!==24OWV$([F4+;.<;`+K%)CFHA1:IO_TU M_@?2/"M7?A#BS%KGXL!7OOC&9*?RZI7:)93E$JRR?H=SD M``-!)46$OF0E55)3O&/7T``LO1:I=:#3;C($K[/S"*+F$"[9M0(OE`)@*DN@ MBU0:(C%Z=C9O78V+; M)F-Y'J;EI64`;K*:/4]G7G;>_L][M(W9E>Q,6G8>Y3?&:HDMR*'M*!Z_&&R) M=A`0@4VC`QWGZY()OER_NFK^YG[?I'70DUF@413(/%I MBTG!0U)L'H!Z=4.$GJ#+`OH5!G0\Y306HL[1O)0!P>W0U6[5*"<1`OU0.<> MG8H'9L5VVC_GJ\_!GX^4J\1Y$%#0 MA3#\J-(IO6&?;=4%%_AAN^$B&^^<;NMN*O+[BMB)Z[_]=?.___Q?+_-],&$Z M.A.OU$;N([:$=[&"\G\\D-UK$?463&&13=QZAGY=L5B$-&QU?/(J3-X.&%?> MP+E7*!+61TC:$NL+M^\8C$AWT\3M`3.]Z_5(291U[I@D7.NTHK_HV/'E)XG. M,F882*E%'?802ND)`-N3"<]I^7*E:M(#T%0?!F/J61:=C@"&LC2=8UU'G70Q M*NQ>"W6#1EBM!V\92C!>4GUPHB:3"(G@[@5S/J#V4OPIN)(;B_Y M>B4//W9E9#4'/7U-^*#:8!0(,WD.<3D?8+A^,UL.W>[68VXWN1(>;EI?$2VX MP990+L2!S[_>G"%T.K+QCW!<.+WHM'BHQPZU?IG4"/7 MC-Y;D2$CS#W'D> MBV7W%')R0\25O%5L$5#""N[JI8@,?SC-ZGIL;%/Q461S8@HB\'F=^C827%XH M".G!Z0[KXI%@O!H6(;2H$6-6A?$>0>G6J#\^8A!%1J@Y1FG>J`@<)EQ+J^.093L(N?8I;#0&:FE5:.RSW&I-Q=0GI M3+`:R.6=#X73!@H4HV8RDEQQAKPT;^4:DD/CSHL(Q.(GGGII#9!P/EL3D=C0 M3Z@8\S[BLE/;$MO^[DZW1,C)=KC35,%M4O.KVT/<7'4MF_V;?L,CB1BD4'$;PTU*&L_^CTT[2#FR/OGNH.*C;8O+%]F,,($=03#J7F;2,ED1(*3KOTA M[ZUUTID56GVGU'5(!VYS9G;`#3[9C+@A:/`F-[P8[&Z(#R=-N3A-7B%CZ9Z>DIT',3.',/-RJE5A[BL#3&< MVT^$&W/)PI;]=Q>6$7572B24,[LD=N&"SG&6M`,I,==Q^=ZC%S8S=EO9AZ9( M^RIFI!8_`RYRJ[):?G^K+_*W61GXRH+@PL%QOZOC4R"(G3B"Z@1G7&E6*%U& M!?ZIC?3P(QP,+/_0_-*X%P%?)'I_I["7.>$&@\]JV-@R M./.CP>O0&ZM^VZR<30^;)Q6_$6/JPT`-Y-)O/? MG/+DECPBAOV!P.IR;UKHR6Q,^/GHA]'^JW&S$E;2K#4S<1:#WL%EO>SISUA^ MPJ9Q5@'UN72#X9R79/!10N;@*X707[XWE:3J@1>'2IK\_6M+^*LRSQ.+!8]F?O/[.9/#]?W[WX^=_.6C&(;,JTH@*ZX9'Y%#62(7+#<],EGH/ M5P>0%6DD$\0"HM1JF1K>MIP7M:(P^]?@>LJ/#[X8HT^M(`7>,-'/GS$X'V\X+L M\2&TK<#!-5BN0-SRP/CFX=&KLQGQ5,?C6?/J!&::\D::T6PV.=H_FQD>STZ: MR>B0MRCG=GRP_LU4$5BO3XX]*.NW)Z\.QY-*P=C_I2D#R^UF(3L+)[OVO<7! MQ[CT871+.;[A,LOC"W'`,=8S:`6(9_-9X1B['C`V,.G2NZBY\.!.ZE>-3\Y? MYD$G6A/"/?_U5A1FT.,6C8@?:%L2%HUI?>4QPYR6B8C%MQ!I7FWZI8^D)2H2SP$O)^`LB/_>%N<*Q$)I2SA/#7F1EA_VI"%3Y2D#2 M@0F*6!93$&^J.:I`JS#,*ETALB!$A>`FCT`MUU"-3[YFAGE>I,KI]$1"O=BT M$`+B-+$T?ZT@@<=X2>\_W36;>[TOY/";HQ1^TVMSS2\&2VG6UE\NU5J[M=I;Y`.'V,2%(L7]"CRCI M_ZTE*%"D>BZ+B'"Q%D(2<@!?!RXD(9??"G!!3;!P_\]Z[S]]X9V'$+:,N4N< MQ-S1`P`\`*M6")/]&2$-Y?J6^W);Q"UG MF*=>+Q*Q@YR_C!H:7FT7\$X*[L]8TERAX#=W=_6QEVS$VW=,)CI@_.^KCG!,ERY MP<-,_^N==3;1M6UL!RO;"P-GIC\[6_W;Z]_^YFH;/WO.QT?'B340$6QG^F,< M;RY[O>WRT?'M[7FX<0+X9AU&OAW#Q^BAM]U$CKW:8B/?ZQG]_D7/M]U`3R1< M^DL1(;X=?=IMSI:AO[%C]][UW/B9R=(U?WGY_B$((_O>`ZA/`]->9K+9AY)X MWUU&X39NU^[2*:.<]J8]D'1]%>Q\RX^WVC+?/'-V_Z__KZFW_\X*S^^>-7Y>]^_%KO96J( M3/!!O63"H;%%IOQ^].1J=\9576I6GX5#T`.YQ<%EWHNC7]>VSA MWRGBY,0#VE$\5A[+6,\K4N.=ZSM;[=;YHOT0^G:`O-(QC?V:&Y*I>^1+IU$M M7_J.A)9\Z8C]6.PP%VS!-Z[GY>7F<(0%&1RYOH+*-W:BP((/6OK^[GD#Y5@` M13HZM9?\KN'7#Y']/#!842+68!MZ[@I1/"Q8$9@.PHN+&VMQP_029*(H*H1: MUF)\!*$W\^E"/M+%="I;J&'!GV2A;T?X)UFH!?\6TCA-T[`I"V0N3XM=G+3U MS\?3Z70RN)A,)E-S.#!-1O)]&M%NL'*>')S'2:.IC&`$"*;#R?3"`"!]<\)4 MG13!$`",1Z/):#`U3/C/$O_Q$ZL(BWV#I+&UULU@CS MU/LP6L$YI.S$R.`"YHC)L>LKSUG'8$+D/CSB:QQNT*`PCN&,R_75RK4?PL#V MX&TO:Y&]UK2$G0?0=;UJ3?3Y;[ M1/74"R3`#T3,81"D39G/QB8'&&ULT]96R"^EOC$W\(]5QP9=3GB^=('I^0"2/;ZYG[\,!BA*&F9X]I)@FI_P+$1R'D(XW?'F MEO3LF2)+C[`9A%W`UFY8?(D2X38O\V,FOI%68G?6YD@NS\2W@53ABK14@1ZQ%_K[.RQ]84;R^>EJ3#1RPJP9W..#^$'P+R_;IVZ3423Z`KJI&1F4C MS=YLO.?;G7_O1!;;:L-4L*-X>J#X-&<^!+[#UD3U1,SW41@[RYAM M!6+GIZKPP'Z1@T8,4D$B>+KH-ROT`T_"?'31#VMN!^T'7I3JA^`2UB\S'G#3 M4QK4X`(:U'5X9"*`E94,`3A!!0+4,>8.JG*^,$))T`4/!"*2!.D;D127)N:"S`%#/ MR%QB'4*"`E.1:@@`1PD$XHB!HO%W0#$H&H%I-"@:@BD$;@P^89^@GN!&2$48 M`(^27E'4"0-NQ#@A#02"J@Q)HL%0E2(I!E4YLG"%H2I%$@BJ,B3UA*H423&H MRI'$%:I2)($`C"C)D-03JE(DQ:`J1Q:N&*I*D02"J@Q)/#$\3AF[2WKD2V1O[IPGF(HFI]R>UGL&LMEEND(LCI%? M9LVPGA8Y^J-Q:5O+7-/`9L$*F,[480N"S5UO>R,1PS!"1U;LPYJFF"X5TY!NHJQ"/4101[:V.L M$N4X#Y*J_%"<2`&$BUI\QN#IF*=K:5GJK^S*71'B##JC;+@_>:E#:+'EQD9\ MC6R15-,"R^%DPW,HB)`RR#9QM!R>*('[,R^5!-9C>:4$(+# M-=4_/PY5CMU2E.-YH;IA1CC'2$'34-944D$3QD^[;>RNGSL,PUR*:X#$9PPA M@%*KA/(XPD-ZOJ+CZCE[:.JRD#>"4@)BMO&.D6$Y3!;#0?22GJ>!% MPQ=2<$/Y1K>BB&YS1[LC.Z5ELPQ+K,5<]E10AW5#1F9]DL/H>Q\ M0YO>3&/Z&`LYE+D7A3@'D!N?@;^Z"I:O@"H3P*\*H-1Z03Y_-5VCXCP7Z;25 M4\L!#,%UCA8N;JFKN_:55]=Y.4#29G.KZU<6?5R:X6J^DP)EM\FL']O( M"**0T99`U3&:7/Q=JA;H^=+JS%/ROCNY(JW-T-.Y()I>0C[1RU`UN M99\<0"9YW?4@#BXG14A,P1KB2RX-+NUK-RY<`-63A;LZVF+"YHD-@YY[D>"W)N'_(@] MA]B()HO@HK(*/^*P3;@'D]O**OP(CJ.RP.2VL@H_`D(BRP0E;645?@0O4%D0 M;FUEY7XT>>Y'@MQ?'/0C'ZNX"5<$%Y55^)&/U:%@K%)9A1_Y6$63V^(J_`A2 M*??P15M9A1_Y/&$*Y@EJ8^%'GON1(/?[&96/>$,PXA,IA>_@'>$(RS01CA(I MA=?X*!\*1GDBI?`7']^F8'PG4@I/@3QBD0E?B%N4^VC(LVL*LCNW5UG6Y0,& MQQD1&/!0D^7.@X?-A/BH&K;)'"LH8A"6]$*2'IWE)VT!]PS)!?']`8=1$4$W M3QO/#NPXC)XUW%B>B^.=/A(4]Z.V:\9;^'& M,AF)6"V3OH-S)Q'@?]G%A$9L183@B3$1(7=N#/="RSHQ)P)A"8D(X6*/7,1> M1A&4\3<["K"W<%UW+T8K+"HNG8'J?_54W'6(\1[CHZ_8_8CR^0`0M7+6]LZ+ M[_(O9WKQ_L_L+H,03.FOOG<_AS$3,=.+]Q_P]HW0BV&.#.GFPQ9N"0BOVBYR M9_J_;^;CZ;L;RSB;].>3,W/HC,ZFH_F[LY&YF+][9TW[1G_Q'Z`,GQ-V"0^: MZO`<+O:\,+AX9F!>;CUX6E>4&IN"_U@&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;Q&Z''FF9 MEEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*WDP7,;5B M;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]ATPXVRV% M;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(NCD:"8LT` M;Q)__/QY.1`R:"'1 MBR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S(P5SX15Q/ M*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N\&DWQ%%2 MAAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$6@2(GIF) M$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G]T2Q7H7[ M#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO..UK9>$\H M8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1%0Y"G$#? M7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.CALY&2-5 M8,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL+B8GB]%1 MVVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,,3<):G#[ M8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!\*])`79T M74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A*H)^@>LY M;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04\\VI9/G> M:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WYGC"VENPL M_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F\=%]V M@9>'<][#\?KB0?;HGFLCU%#A)(HQX@-3M1C:"O_\<7.VQ,A8.M2T5P.O\",W M^&+S\9?UXS0T#0P$3I84C M,=5#`/!$4KB;`8;0!_\^B-IV%9PG(T8X;>R,<$B.V-U;)WT&4'%$! MDAXA\#Y"DO3=D.P(@?=?2+HLDF+Q_U!(2,N[=$TMW:RU.B"X>1"X&:F[QTD) M9&=/!B:_;@_XXO9+-;F'.K"CYBIHH(LF37JJV+ZBR"<) M@?BF(,&W]P?I-IT&F683WN=Q%21+7RN7V'8V<1(`.#,/X-_N.'&%\UGF6;9Z M=G+0A`OG3YY-G)P,F+>?[,10O]G)1?+LX"!9^:*E^7D MP@J-%JZ0Y+KE6][W!C&U=TV4`G>:#?U]E93@,S36L_DM]+V?)],"]-U(6_Z5 MZE8,!O6\`60 M_`$``/__`P!02P,$%``&``@````A`+2,CM[!`P``C@P``!@```!X;"]W;W)K ME76EU MMWOW[(!)K`+F;*=I__W.8*!@JCORD@3\\JB2C:?U0D7N![X=>07GI&H:MG,(ALHPG M[%$DEX*5VI!(EE,-^M695ZIE*Y(I=`65SY=JEHBB`HHCS[E^JTE=ITBV7T^E MD/28P[Y?R9(F+7=],:(O>"*%$IF>`YUGA([WO/$V'C#M=RF'':#MCF19Y#Z0 M;4Q"U]OO:H/^YNRJ>K\==1;7SY*GWWC)P&TX)TV/?[&<)9JE<'*N@R=R%.(9 M'_T*MWP(HFH`!E'_MF$>`HSB=6'ZO]N03_6Q_9!.RC)ZR?6?XOJ%\=-90Z05 MV(!N;-.W1Z82.`:(-0]6R)J('"C@TRDXYA/82%^-.I[J<^0NPOEJ[2\(P)TC M4_J)(Z7K)!>E1?&/`9&&RI`$#0E\7YOU<$Z6?G@#QZ+A@.^6PY_(X9D]U78] M4DWW.RFN#B0KJ%85Q=0G6^#]V!,P`[$/"(Y<*";8KH*#>=G[.^\%K$\:Q,$@ MX+-#D"$B;A%X>J"A$P+&3!>"8!2"AX7*#N9&/VY@Q36(H%:]).LP[-8',L"# MZ3(0'+G+WFYM/PS"9!4*C7LW!G&!9'IE"$#P4LAJ&.1C$JK9]O?%7P;OOM=*X!=@ZPEMT('BHPPIS,`@(UAFR M'BJ-6X0M9'V+$`0/A=P-PQP,(C1Y&/@;^US,>ITQ@P3!5]CD0D7P4,;&DF$0 MQH_C1Z4NYP?RW',,S3AUR4V^M MT98[5I(>&LQ`CE7Y<8<9N8,]<+H[IF,.W+&+FQC,0(Y=WAUF),=JO3@>+""? M_N=5..[!Q"YUTNNQIMDU=]:F^I=!N%DNWW-\4.\XH=S@$J*M0WLG-N^$FC%R M^RX%5C'&'6;DTDW]&&9`6TXPJK"VX6*I!SX9Y4^[WDDQTYX97PHF3RQF>:Z< M1%QP>B-@:G>W&T&PO=V]R:W-H965T2@M64341#:OA22YD135C.@KGDJA1*XG M0.=AH&//+P6?+L M&Z\99!OJ9"JP%>+10+]FYA8L]D:K'VP%?D@G8SG=E_JG.'QA?%=H*'<$CHRQ M1?9RSU0*&06:21`9IE24$`#\.Q4W6P,R0I_M\<`S7:S<<#:)8C\D`'>V3.D' M;BA=)]TK+:J_""(M%9($+0D<6Q(27$KB84#6WSW5=+V4XN#`I@%)U5"S!"#>10"J MUT=@%O4C",*.W@:Y04ABZWJJ%_;USCLU8,C(B8LPC@="B+%E[QF;7B-DP$.A M9""$F#DF?#Z-HGD'Z`G#ECK-Z'F'!CP4/O)B*A$36^&;9):0MW5GU^@:\$`W M\3M>U$4,ZH9)E,3'C/0,Q]<(&W!?."#10!@QXY*:?G[RMIS/K`'WA<(3`^@0 M,>B0)#[\NDAZ#N?7"!OP4'A84L2T)0VBZ)W,$N@%ESNVZ('RJ*@MJ/4TF\+QPRV6@A"GU'\_NM*3`.Y M>%=9],!G/*QN"VK+2T@0'A&]?05#\QKM-[K4N+ZG;2J:A6$PW-,X9G$,54SN MV"=6ELI)Q=Z,4`)MIKN+XWT#XSVPC;Q[`-.UH3OVG&ULK)K;)^`',(Q!4R%3#G\W&O'3#!-8`IVYG,O/VV M+$NR]1//,+MS,9"/UM^2NR6U93]]_7$^Y;X[?N!ZEV;>*)3R.>>R\_;NY:V9 MWZR[7QKY7!#:E[U]\BY.,__3"?)?G__^Z^G#\[\%1\<)S6(Q MV!V=LQT4O*MSH5\.GG^V0_K3?RL&5]^Q]U&C\ZE8+I4>BF?;O>2Y@NG_CH9W M.+@[Q_)V[V?G$G(1WSG9(?4_.+K70*B==[\C=[;];^_7+SOO?"6)5_?DAC\C MT7SNO#,';Q?/MU]/-.X?1M7>">WH#Y`_NSO?"[Q#6""Y(N\HCOFQ^%@DI>>G MO4LC8)<]YSN'9O[%,+=&-5]\?HHNT-9U/H+$]UQP]#YZOKL?NQ>'KC;%B47@ MU?.^,=/!GB%J7(36W2@"A]]QWT[AA3N&HV(#F_G*0Z%6+U4,,L^].D'8=9ED M/K=[#T+O_`\W,F(I+E*.1>@S%C'JA4:M5GUHU']?I1JK4`O1E4ROE,)1U^E3 M>+W?Z6,L0I^QR/W#-\3XC8I4H6\9%\QXB-VR+['?.FM,EH M4J:?HRO%OMSGK2SR@WV1W@KE1LVH/;`,0;=%GF%1PEIV:#\_^=Y'CE8!4@BN M-EM3#+-,ETRD*I>0R?M9[E+2,I47)M/,4]`I+0.:<-^?*_7R4_$[39)=;--" M&R-MT186;$8P64L''1UT==#305\'`QT,=3#2P5@'$QU,=3#3P5P'"QTL=;#2 MP5H'&QUL$Z!((99QIM#^'W%F,BS.(D(M`53@M;"WA85H8NF@HX.N#GHZZ.M@ MH(.A#D8Z&.M@HH.I#F8ZF.M@H8.E#E8Z6.M@HX-M`J2"2NM9*JBW]Q\:F(BZ;AR8O!*/EI_ M@5B6=U8R6@]5LL!D+XD2`F^#V(@-ENX+'VNEFG:/,)0R MPM4(R%B2#%<3;I0]L*E4$MYF0.:29'A;Q$:?#VPI982K%9"U)!FN-IJK:JVF M3:BME"%7J42D4Y0[$I%9IQ.1$W8H(I.E;.CUHS02`[6`=#BIJJ*E"S8]('U) ME'M,L=BH'J6846_0@6=ZI@REC.C@",A8D@Q7$VY$HU!&%7WN3*62\#8#,@>R MB,GGHUA"FQ60M22J@W#!-FE7C1+]2U^PK931\\F@`ZL[$BHR3V=4C)+E*R(+ M40=1%U$/41_1`-$0T0C1&-$$T131#-$H-4,T5PV5O*%OPPME)>27J+5"M%8-E7REII>_RDK(;U-:Z?6$'7(ELRF[ M`F;/:;3*(T:_J(&5E>B4I9`:#>R!G=@JNUKL*BTAWT/45RC#XT!8B8JQ6J]I M%?U0F$2/)Z.I,D(T5BC#W22VRA[@5&F)`.WNH3P]TGY\DEF\V_N9<@=W(.E!*EZYV^"\#]"[QH]?7_U0GJ#(_IZI#=V''KF5BK0 MS>7!\T+Q!W,@WP%Z_A<``/__`P!02P,$%``&``@````A`,SGHNGJ!0``'1<` M`!D```!X;"]W;W)K&ULK)C;CMLV$(;O"_0=!-W' M.E@^";:#M:TC6J`HTO9:*].VL)9I2-I#WCY#491)CN*X36^B[.?A+\[/X4%< M?OXHS\8;J>J"7E:F,[)-@UQRNB\NQY7YUY?PT]PTZB:[[+,SO9"5^974YN?U MK[\LWVGU4I$:0Q0N-0K\]0T5]^RZOQ$RJP>T2NYP"\'6I59`W]61ZN^5B3; MMXW*L^7:]M0JL^)B<@6_>D2#'@Y%3G8T?RW)I>$B%3EG#?2_/A776JB5^2-R M95:]O%X_Y;2\@L1S<2Z:KZVH:92YGQPOM,J>SY#WA^-EN=!N_T#R99%7M*:' M9@1R%N\HSGEA+2Q06B_W!63`;#;OO^Y(G8.C(#-RVV[D]`P=@'^-LF"E`8YD'^WSO=@WIY7ISDSCF=1- M6#`IT\A?ZX:6__`?'=:9OK';-89GUW@\'4UF]MB!=STJ,NY$X"EZX(P8\T`]$V87B*U]F/M)MV[>`IXG4/Y>=`Z?%*8#7(1WM\-T.+EU);F;NLR=;+BKX; M,-VA:.IKQA8/QV>RHB:Y27V5?J](H<"8RA.369F0/M1A#3/K;>UZBZ7U!K,A M[V(V.,91([8B@M4MD]WI(-!!J(-(![$.$AVD$K#`EMX;F"K_AS=,AGDCLMH( M()FE&2$B1).=#@(=A#J(=!#K(-%!*@'%")CNBA'#"Y:H!1:],F&JWVIA8JL) M;GC,F*]R;*BWB.P0"1`)$8D0B1%)$$EEHJ0.:2BIL_GANJ-^N7MXAC"AE3F& M)4FR19L`&Q[$%E,IR%6]V_9!?74@$B`2(A(A$B.2()+*1'$*.JTX=;](6'1K MATABPPGD+L@6D1TB`2(A(A$B,2()(JE,E$1A")5$^9(YFD&#YE3D+QL*@P=K MRH`!8U@:^8+)1-3\.8$=O<^?$X?OX^UZV,7`&$CU,5;K(^B#A%"(2(1(C$B" M2,H)[Y!B">R7/V$$U$MX42VA!/9$DZ\&=]T;&>BN='_WKN!-")$XKY5NY79 MCJ>J)OWO0C65-11OV.E=WF$'R@**7M0%BU9-X$0V@1/9!$Z\15\[`2(A:A4A M$J-6"2*IW$I)%$XQ2J+M4CEF1]FAJ2#ES!JJ.7/BP:HLU;DV!EL>Y'A]TKN> MW)HY\YDZ=`$/W[:@XU8C-H&9A(K0`^6M[XD%MKI==L%R>6&4=`AJ"ZA'N*H M"*,8HP1KI4J4Z@<[N^E^N&RC>'A+TI*6DO8\$G5:4B=B(7^W M$XF(4CHQ1<[_H!/J8(`6&@QG6XQV&`48 MA1A%&,48)1BE"E*]8,=05)C_Y0.$W31IVVR'V`[=EYD[U3Y*MK..\3OV?AM1DFJ(]F2\[DVA\XL-Q?X`[T`"$AGZ!)M`G_,MNZL/)>8#/_*`]VVOOCF<^G"8'XN<^ M'.(PC^<^',HPA\O+)W>`;]BEYA!W??C>QSJ;L0]?PY@_>?X33]CJ,X#+R6MV M)+]GU;&XU,:9',!XNYVG%;_>Y'\TW7Q]I@U<3[93]P37T`2^^VVV8Q\H;<0? M\&:KO]A>?P,``/__`P!02P,$%``&``@````A`+?3Y7Z>`@``J08``!@```!X M;"]W;W)K=>VZROGU1+'H6Q4G<% M3:(9):+CNI1=7=!?/^\N5I18Q[J2M;H3!7T6EEYO/GY8'[1YL(T0C@!#9PO: M.-?G<6QY(Q2SD>Y%!U\J;11SL#1U;'LC6.F35!NGL]EEK)CL:&#(S7LX=%5) M+FXUWRO1N4!B1,LT"O)C;:ZK'U_?DMQL*-W8AM]^&QD^55V`IH-8\(![+1^0.A]B2%(CE]DW_D!?#>D M%!7;M^Z'/GP1LFX<3'L!AM!77C[?"LNAH4`3I0MDXKJ%`N!)E,2=`0UA3P5- M05B6KBGH_#):+&?S!.!D)ZR[DTA)"=];I]6?`$I\48'+EW;+'-NLC3X0&#>@ M;<]P\R0Y$)^O!8I`[!;!!87M"#(6^O>X2;/Y.GX$T_P?YB9@X#E@D@$1@^B@ M#&KO5T8P*F-7L)2;$!C+I.=EYE,9;'KVWZ8?C6(2X$8FTBP;^$,%`>,'-?$% M66-?*)C.YCC2-[J+B3C3B>KB1#6`DHGQ['(`32H!Q7$EK\\6P5Y]:'&(@!1N MZO'DH,(QK]_'V?(M>Y@U%0B1$R_+\UZ`?JSYNA<$3Z5"Y(P7O%M'^]][N7KS M(A"!$3KRL3KR$JR&^Q1.U!`=;J1MBOT_C6?YUA^& M>/@`-T7/:O&-F5IVEK2B`LI9M(0IFG#7A(73O3_U.^W@CO"O#?P2!!RJ603@ M2FMW7.#@AY_,YB\```#__P,`4$L#!!0`!@`(````(0#6^U:O"R```&_,```8 M````>&PO=V]R:W-H965T&ULK-U;;]Q&FL;Q^P7V.QBZGUCL MUM&P/8B;YQ,6B]G=:\668R&V94A*,O/M]ZDFJUEO_K#,_%JGNAR_9 M]9)]>/WW?W[Y_.*/Z[O[F]NO;XZRGXZ/7EQ_?7_[X>;KKV^._NO_FZ-/#P[=7 M+U_>O_]T_>7J_J?;;]=?M>3C[=V7JP?]S[M?7]Y_N[N^^K!?Z;]=7[[_OM#CO_]T\^W>;^W+ M^Q_9W)>KN]]^__:W][=?OFD3O]Q\OGGXUWZC1R^^O'_5_/KU]N[JE\]ZWO_, M3J[>^VWO_PW'AY^TN9?3`^5SOGQY^5);>OOZPXV>@8O]Q=WU MQS='/V>OQFQ[>?3R[>M]0O][<_WG??#?+^X_W?Y9W=U\Z&^^7BMN[2BW"WZY MO?W-#6T^.-+*+[%VN=\%_W7WXL/UQZO?/S_\]^V?]?7-KY\>M+]/]93<,WOU MX5_Y]?U[1:K-_+0Y=5MZ?_M9#T#__\67&U<;BN3JGV^.-OK#-Q\>/KTYVI[] M='I^O,TT_,4OU_ENX?K?Z=U]ML?VC%LWE%_3NO>+H\RT?^X/F\ MGO[]L6>F`VO_"/7OJF=V.:^G?]<]LTPEL_^+[C]6/;?,[WOW'S_V[#*5R?3' MEGKYL3V7^1IQ_['R&?IJR99RV2;KZ^54W/MC);]ZN'K[^N[VSQS[)7;BC]*ICU_.&Z^=]CH>'%;^=EMYLV1=JV.B'L=['^\S/S M_3SF76*,';'S(]S!Z#:;QU#$4,90Q5#'T,30QM#%T,TRC>:9![W0SVP9D=M#L,.E0LI("4 MD`I20QI("^D@/62`C*&8Q/7D3>*/%ZT;O8_5A_%NDGFJLB]12`XI("6D@M20 M!M)".D@/&2!C*"8PE90)S+TT/:M$W89LEI-$]7@>U>-AD-\%.:2`E)`*4D,: M2`OI(#UD@(RAF'@U<3/Q/EZ/;K3-<)*P'B$YI("4D`I20QI("^D@/62`C*&8 MP%QG&$^5W*O/RJF2VXQ-4 MXWX[-LN9HH*\C`IR&76H2%)!*DD5J28UI);4D7K20!H-V:S=[#X\]!^O3M-)!&0S8_-Z$/\WOV2[EKL^-H)[+5>GX< M5^MAU%*MH&+>?+";2E)%JDD-J25UI)XTD$9#-FTWZ0_3?J):YQ[A;&DNW94( MI1S$L"/EI()4DBI236I(+:DC]:2!I&N/P7.T^;DI?)C?\ZMU:@;4'/FB>^>N ML4S1!JW0>197ZV&47S%?5O14D$I21:I)#:DE=:2>-)!&0S9M-_\/TWZB6J=V MP40:=A#[ZT8[=YW7%G!.*D@EJ2+5I(;4DCI23QI(HR&;GYO@A_FY:MWJVJ\B M6#DSS:9>P61[:!_"+G%202E)%JDD-J25UI)XTD$9#-F[7'H1Q M/U&N4S=A(@T;C+E<07D&*D@EJ2+5I(;4DCI23QI(HR&;G^L`POR>?W*=>@D3 M[:&]"*LUN@Z]RPZC_)DT)Q6DDE21:E)#:DD=J2<-I-&03=NU#V':3U3KU&V8 M2,,&9*Y64)Z!"E))JD@UJ2&UI([4DP;2:,CDMXF;K,?SVP^WO=1,T>PTNOR\ M6T8=2I)4D$I21:I)#:DE=:2>-)!&0S;2=;W4AKW43,&KS8Z4DPI22:I(-:DA MM:2.U),&TFC(YN>ZEO"0=B?0TS-W#WOMZ_UF:H#"PWVFJ%RCR_F[9=12KFRF M.*HD5:2:U)!:4D?J20-I-&3C7M=,;=A,S63*->P]ICN='%602E)%JDD-J25U MI)XTD$9#-K]4,_6\Z>F&W=1,4;G&-Y:644NYHL$J.*HD5:2:U)!:4D?J20-I M-&3C=HU/>'9XX@5KZI/,&6"F\T//NG/QNHLN"^6D@E22*E)-:D@MJ2/UI($T M&K+YQ=W4$_FQ8]K,I/F[3LSS>R'.XWM+RZBE)`\K>BHXJB15I)K4D%I21^I) M`VDT9"-UG*HDE21:E)#:DD=J2<-I-&0C=MU,#_^@J_W@:)< M)S+E"LKG%8-1!:DD5:2:U)!:4D?J20-I-&3S6]<6Z3A'?A-%)1G?2)I7#/++ M206I)%6DFM206E)'ZDD#:31D(W4=S(J2G!H>;<\?K._4C[N4@[!VI)Q4D$I2 M1:I)#:DE=:2>-)!&0S:_=6W1EFW13%%)QG>+EE$^^)Q4D$I21:I)#:DE=:2> M-)!&0S;2=6V1/KR%HQP]T&X>%51I3BI():DBU:2&U)(Z4D\:2*,AD]_)NK9H M/]Q.BF;2.ZE\L>U(^4SNHFLP&XWN*17+*+^MDE21:E)#:F>:'JJ-85TK<\)6 M9B83PS0JH'P>%<40W:LHEE%+#-.VM**GBJ-J4D-J9TK%D.I(LM/]&S,>/MV\ M_^W=K?:>'DKB>LY6'Z':WQ?X^83-R$Q!%#M2/I,N%;M/8VV.,P0S;5D#?`HE M-U.1:FPYJKQF&>"WW)K-V&I9UTF0QC0HHGT?I.J5_4`6IY+8J4LT5 M&U)K5K3/.9[])TI`)\Q##7"&?S*1>UM5<`J(;WPLH_QSSA<*5XPN3Q=^E'L, M?[R]O+RXB*JG]".6ZJE(]4*/_+7&CYK_VL7%1=2JM'[$_J_9*-?-[-T;I*-& M=";WEI\@ROCJZ#)JB7+:EE;T5/A1Y_OQ._5+?V`L+:FAZ2_ M[[=<;:-#NS6#TA443SC=N\\6/^"QHGXR42VN"ZC M<\!N&;4D-Z^X?"ZV\*,N]T=@=KK91D5:^A%+*56DVM.RZ<;3M.F+3?RNW=8/ M2%17/+/>O^MMNW_3QA/G?DZR3R8RA78>[<;=,FA)Z[">I\*/FJHA.SL]WJ+2 ML%;EUUJ*KR8UGN9MGUZTU$,QDWNKT_+"<1F=E4N_HGFEOHRZS&H9Y?]B[6GYBTWZ+\8G.;_B]_ZB M>6DX=7/A'[\,L1\>)3K/S,/73]SOGM<+3DXYJ?#D2^;\]#2JZ](/66JO(M6D MQI/?=G81O^ZT?DBB'/\M<_E3SN5GLN48SSV60;XXIM/39GN>H12G MOQ^\B%9^I>5D6'M:-MUXFD^JY_HF&_N!A=:/X*GO-)[?/^](YK1_OV&]`)FZ MBT[VNV70$MVT*?<.N^6PO8AGP/.*>F/8_LLL+K+-632DY+8K4NTW].B?:_RH M^<^=7>AL&4<\]S2)ZG3-0'@,QQ'_X_;;]SK-H,TX=9N)CNV)@HLWNWE40#FI M()6DBE23&E)+ZD@]:2"-ANRY<5UO<PI.F9DNM74;GM-TR:BG2>5O+6ZX* MCBI)%:DF-:26U)%ZTD`:#=E(W3P^+-7'9S^GT[0_O.H]4U!_.U).*D@EJ2+5 MI(;4DCI23QI(HR&;7]RFN$/]>;>Y3]G"S*1LPW*-3D2[9=12KM.V@IU2<%1) MJD@UJ2&UI([4DP;2:,C&';<\3Y0K>YO3B8)D=J2<5)!*4D6J20VI)76DGC20 M1D,V/]<\K#CW3T_DQS[I;"9[!HT;I6744I*'%3T5 M'%62*E)-:D@MJ2/UI($T&K*1QNW2$Y&R+3IC6T3*206I)%6DFM206E)'ZDD# M:31D\UO7%IVQ+9K)G"7U];BVX=TMHWS]Y:2"5)(J4DUJ2"VI(_6D@30:LI&N M:XO.V!9Y6AK&'2DG%:225)%J4D-J21VI)PVDT9#-S_4?/S[//)O:%?/"/5-X MEM1-\[@D#Z.6D@05?O/+OBA)%:DF-:26U)%ZTD`:#=E(U[4^9VQ]/"TQ[$@Y MJ2"5I(I4DQI22^I(/6D@C89L?J[_"$O2S3/=+=J57\IQ-O/J.[7+MEU*$D206I)%6D MFM206E)'ZDD#:31D(UW7]YRS[YG)E"1:H9RC"E))JD@UJ2&UI([4DP;2:,CF M%_<][O3YK&]_/6=+-%-T`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`[VG6 MZH]W;)=N>%22$T4E&4V9=O.*0U(.:D@E:2*5),:4DOJ2#UI((V&;'ZN.5U1DE,O&[[*7,ZDEY'#Z_0F M?OW;+:.6L^1A14\%1Y6DBE23&E)+ZD@]:2"-AFRD<1/\Q%'.;O=R(GT5CT]F M1\I)!:DD5:2:U)!:4D?J20-I-&3S6]>T7K)IG)3=1H[Y;1OF4#F1OA;)A[4CY:2"5)(J4DUJ2"VI(_6D M@30:LOFYSB`\2S[[?0"7Z647X'Y*2"5)(J4DUJ2"VI M(_6D@30:LFF[CB1,^XEJG1H8\YHTD:E64'X)*D@EJ2+5I(;4DCI23QI(HR&3 M7W8C!;L/$UP6#8H6(3IE^2=8]6?V)Y/[%^2A:FWY*%Z<=D M8?HU69A^3A:FWY.%Z0=E8?I%69A^4C:T*/QU35)VS"[)6UB_"R=7R\SX9G1VSH3J8+>;HDO`N M&!84\[RYI7"5/DSIPY0^3.G#E#Y,Z<.4/DSIPY0^3.F'%J6_KKW*CME?>0L; MK(2IF*=U@W&*$Z8X88H3ICAABA.F.&&*$Z8X88H3ICA#B^)S)-[I-H_`/PX):ABE\F,*'*7R8PH5UTF#0H?IO!A"A^F\&$*'Z;P80H? MIO!A"A^F\&$*/[0H?-=K_7A/EQU/O5G8U!ULB4YQSN,64YPPQ0E3G##%"5.< M,,4)4YPPQ0E3G##%"5.L3F=ZUA//R;,$Y>.?'!98G M3''.W=)R>5AQPA0G3''"%"=,<<(4)TQQPA0G3'&&%L7IVH\PSK]0RW,G$UQ= MR[)#=Q.>E^-;9L&PH)8/JWI3^#"%#U/X,(4/4_@PA0]3^#"%#U/X,(4?6A2^ M:U;"\)^JY:FY,>?E;+*@;E7+,-4R3''"%"=,<<(4)TQQPA0G3''"%"=,<<(4 M9VA1G*XS61/GU,G8.&?6$J9ICB MA"E.F.*$*4Z8XH0I3ICBA"E.F.*$*<[0HCA=_Q$6\U-QSOV*F2Y,9B^O;>.[ M<5EV&!84+$P)PY0P3`G#E#!,"<.4,$P)PY0P3`G#E'!H4<*N)5F3\-S"F(0G M,Y?7,I@*%J8X88H3ICAABA.F.&&*$Z8X88H3ICAABC,T&Z?[CGD3Y_.GOOM- M1:<&;SIBEDL26]RH6X8MM4PK,EJ9L"IA=<*:A+4)ZQ+6)VQ(V&@M"M^U)"MJ MV7VS>'SRG2VXHK[+:'G"%.>TO6!=Q0E3G##%"5.<,,4)4YPPQ0E3G##%&5H4 MIVLRUL0Y-R7AJ4%?R[Z/V!8L;L8MPX*"/:SJ30G#E#!,"<.4,$P)PY0P3`G# ME#!,"<.4<&A1PJ[O6)/PU*>8J:_[5345L3GYTE2P&*&I7P#(N;<>X3:>[4$5ZEI"EAC%/" M,"4,4\(P)0Q3PC`E#%/","4,4\*A10F[OF--PE.?8@LV[%WV78#.L#`5+$QQ MPA0G3''"%"=,<<(4)TQQPA0G3''"%&=H49RND0CC_`NSA;DG,;5\Z%/"6L;- M./W2'FL9IO!A"A^F\&$*'Z;P80H?IO!A"A^F\&$*/[0H?-=VA.$_T5MLIC;% MUO)DIE6;QP6F6L8XQ0E3G##%"5.<,,4)4YPPQ0E3G##%"5.YSYNB--<6*XE?!A6%"P,"4,4\(P)0Q3PC`E#%/","4,4\(P)0Q3PJ%%";N6 M9$W"4PMC"W:RH#@5)TP%"U.<,,4)4YPPQ0E3G##%"5.<,,4)4YPPQ1E:%*=K M,L(XWIBBAREZF**'*?K0HNA=0Q)&_]2I=VI@M$7_]-]ENHCC4K>5#%,EPQ0G3''" M%"=,<<(4)TQQPA0G3''"%"=,<886Q>DZC##.O]#$;>=NQ41]Z&#"8L:].+^J M*>;#JG[/*7V8THK:%J9BABE.F.*$*4Z8XH0I3ICBA"E.F.*$*4Z8X@QMBO/E_:?KZX?\ MZN'J[>LOUW>_7N^N/W^^?_'^]O>O.B^[B5S@+^ZN/[XYTDG@XM5^WZBX#NL< MEEVZ99?NE,%E&[=LDUZV=+NNC4LNVQEJF/32[+W++]!R_X M.-UZNB^96F_CUM,-J^0RMQ]TJR6YS.T'W3=(+G/[05>\D\O%O`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````__\"````__\#`%!+`P04 M``8`"````"$`K.8=I/(&``!K'@``&````'AL+W=O59L.1;6M@Q)V>S^ M?4G.V.2,Y,3V/F03SR%U>&9XAC(??OJVVTZ^5FU7-_O'J;B+II-JOVQ6]?[E M5^56Z;??4X_5YUTY^>?OSAX:UIOW2;JNHG9H9]]SC=]/WA M?C[OEIMJ5W9WS:':F\BZ:7=E;_YL7^;=H:W*E1NTV\YE%"7S75GOIS##?7O) M',UZ72^K3\WR=5?M>YBDK;9E;_AWF_K0'6?;+2^9;E>V7UX/LV6S.Y@IGNMM MW7]WDTXGN^7];R_[IBV?MV;=WX0NE\>YW1^#Z7?ULFVZ9MW?F>GF0'2XYFR> MSKW>E\9 MM4V>;`:>F^:+A?ZVLA^9P?/!Z,\N`W^VDU6U+E^W_5_-VZ]5_;+I3;ICLR*[ ML/O5]T]5MS2*FFGNI*.Q;+:&@/DYV=6V-(PBY3?W_UN]ZC>/4Y7N;W;_`4A84J=))$ZB#'N,RTLGF0,AM[Y/95\^/;3-V\04 MC7ED=RAM"8I[,_%Q84#CM-1S*S7L["0_VUG<7&81G4G/UR5\>"31&2)V?LR8#)7#IG6B\2 M&B](7$BUB$\`0LQ4>$C,EIC9JQ^DSPYBTJCH-+^KNAPP@33!!X1!0AF\+XT% M4VE2R1X,D`44NI:9IO&"Q.-X(4YQ0FMQ#2T+IK1X0G*``*V%#M+AY"K"<))F M9PK9MJS`$-[7RH(IJ8PG"2!`:B9$Q+0L:#Q*O&T0K;)K:%DPI264SP$4#V"` MEXHT"Q=A6*2)KWW"2A@;NEPMA^:\F!XY@F)77)GT>PJ22,)*GTFB&+'UCRW3 MC>+\_!-`-P1A\ADKK%P`!NBQS5)@$,6-=7R.WE5F+\;*,<@1%/A]^`EE<97CBZ'E"^77 MAV45FOI,2)T-*HLB5!8<."B[JXQ?#)U?*%\7R"XT=[E(O8NZ>(&30'9G.H[\ MKJ'4KK)_,?1_H=BC$ZF,UK*9IWW<#"08 M/?$T[9^`'(_=P+[HN>,]#G,N1UE+P(HIO:N:@!QI`IJIDB/HF+`LD>Q< M5#!$*C+O.90=:P07B@<-@>Y&5E:Y!%!PP@@_(2SL_K_>$]PHYEM!Z4*!(0BU MDA%_[RTHP`CEC8UR9/;__M940]L7FG7$'$'CY85!("Y%9/Z-O_BJFTS?C>+B M^:6C>'"\1_%BP=]'"YSEI*[6B5\DE8_9_@?R@9.;G_X(&_OU([NCW=NOR%BP M4!!$9DD2C*:\6".X;`.HD880LTV8(P@H9#K(G^-?D+A(38K/))@UA0LICC2' MV+L`2@@@J,!9F#RD2.+BW/NG8HW!,OSX6RDWBI5@[(_2R#!L$$KZ'H`$P_#9 MK7M3AU`C'8*_R.4(@AP;=V$F6)"XT)GV6XR6(>L2%^9XI%O$O%LH`&&.^1M% M0)46.`>$9?`M"N5W4R/1 MT"/(62#V58[\`!27BK02*_XV.8T]`HB4,)[!8)"@6#8B$`WM0/+D[\K)+Y042@`P2V%N80( M.I(#V&M!.PL`XN&1!.[\X$YL5[4O55%MM]UDV;S:^SQAOH8]?0IWC;FY:W07 M<_-3P%SU'&PO=V]R:W-H965T&ULG%C;CN(X$'U? M:?\ARCL$YPH1,!K(;:1=:;7:RW,Z&(B:Q"A)-]U_O^4X"7:%9F%>VLWQ\8E/ MN6Q7LOSV49RT=UK5.2M7.IG.=(V6&=OEY6&E__U7-)GK6MVDY2X]L9*N]$]: MZ]_6O_ZRO+#JM3Y2VFB@4-8K_=@T9]\PZNQ(B[2>LC,MH6?/JB)MX&=U,.IS M1=-=.Z@X&>9LYAI%FI>Z4/"K1S38?I]G-`T'+1HA4])0V,/_ZF)_K7JW( M'I$KTNKU[3S)6'$&B9?\E#>?K:BN%9G_XU"R*GTY@>\/8J=9K]W^&,D7>5:Q MFNV;*<@98J)CSPMC88#2>KG+P0$/NU;1_4K_3OR$6+JQ7K8!^B>GEUKZ7ZN/ M[!)7^>ZWO*00;5@GO@(OC+URZH\=AV"P,1H=M2OP1Z7MZ#Y].S5_LDM"\\.Q M@>5VP!$WYN\^`UIG$%&0F9H.5\K8"28`?[4BYZD!$4D_VO:2[YKC2K?/- M+`)T[876391S25W+WNJ&%?\*$NFDA(C9B4#;B1![:LX=XKA/J%B="K2=BFD_ M/`5@MCZ@[:>PF!)[]LP$P'"K`6VG\1.Q<#L1:'L7Y.F`>IT(M+V(^:P;V.&M M&V@[#5"[OZ"&2(XVUX*T2=?+BETTV,"P_/4YY<XI@J M)[K%L51.?(MCJYSD%L<9.`;$>0@V["(YV+=W@_-#)DR(9YISQ`A5!L&)(7<[EHNZ8[G;M"PT]T3N]MS%=<64T,%A]GSH M^"`<.KS+!,<3H3/GIN-Z:(9;01%7!D^:``,A!B(,Q!A()$`Q"B?N\T;Y(&ST M&DB1^H(CC)KNC.!5W@J"9!,#(08B#,082"1`L0EWPO,V^2!L$YV(&\&YNMCV M`#]D+1/MCJ#OY>4`7]L0`U$/W!P?][W]^*0',%UQ#]>/[/[^`<#)R+6)=NA& M<"37`A"K;=G2KFI=!I@?8B"Z+Q!C?O(E7S$.MYEL_+$3D`_"`4`7V$9PA%_/ MM&T3W4Q;0;A&*,!`B($(`S$&$@E0;"Y^QB8?A&VBLW0C.%<76PP$&`@Q$&$@ M[@&>LA/;10='\F6W8IG`1?;\TK:CL&FT=)N.)+D>(<$("0>DM66A*WQ\!&UZ4BR?3'LB@0=1^3_Q'8<=,Z% M(Y'H_X;$PQ!NV,-9@8;;TJVI!H070X\'1)1.:D"NQ:&XR8@@W2YWE$XR)XZ' M]E"@,*#@<>?6*%KR$R;$1I=,I$C8S@)E;*STDX6-*HI$Z7<=ZZJOQH[71H_' M3E12:NS0DS?P`LY/&9$HMC4G,].[/KV-[[;CR.DE1EV1<,2)1D@\0OCK/W]Z MJR._`(``#0(```8````>&PO=V]R:W-H M965T&ULE%5=;YLP%'V?M/^`>"_?A!*%5`U5MTF;-$W[>';` M@%7`R'::]M_OV@X$DZ[M7MK`/??XW',OUYN;IZZU'C'CA/:9[3N>;>&^H"7I MZ\S^]?/^ZMJVN$!]B5K:X\Q^QMR^V7[\L#E2]L`;C(4%##W/[$:(8>VZO&AP MA[A#!]Q#I**L0P(>6>WR@6%4JJ2N=0//6[D=(KVM&=;L/1RTJDB![VAQZ'`O M-`G#+1*@GS=DX"-;5[R'KD/LX3!<%;0;@&)/6B*>%:EM=<7Z2]U3AO8MU/WD M1Z@8N=7#!7U'"D8YK80#=*X6>EESZJ8N,&TW)8$*I.T6PU5FW_KK_-IVMQOE MSV^"CWSVV^(-/7YBI/Q*>@QF0YMD`_:4/DCHEU*^@F3W(OM>->`[LTIZ`/9-&*'RI,806OFS^*$DFF9*"T#QO]P+$1.27B.1, M8F@$[_Y?HTS*[&ANB1>8$G8:HX=*>IW/7A@*@&:NX'5W)!B&<'9RNEH&[$_2!,XHG`T`4#/M2?!24S3Q:DT:DYQ,B_V%YMR(@VGI&6`(2TQATK0(*GI= MH$Q:"CPW10O4&&U:S8/1NE4FJ%,WFB+A?&V,IFT5+:8IYW&C/,6IXO] M`>M=JLOC1U<&FK%NE,` MEO:`:OP-L9KTW&IQ!:F>DX#W3*]]_2#HH);+G@I8U^IG`[&ULG)9=;Z,X%(;O1YK_@+AOP!`P1$E& M`U5G1YJ55JO]N';`2:P"1K;3M/]^CS$AV)EVLWO3!OSZY3G'A\-9?WEM&^^% M"LEXM_'1(O0]VE6\9MUAX__YQ]-#YGM2D:XF#>_HQG^CTO^R_?QI?>;B61XI M51XX='+C'Y7J5T$@JR-MB5SPGG:PLN>B)0HNQ2&0O:"D'C:U31"%81JTA'6^ M<5B)>SSX?L\J^LBK4TL[94P$;8@"?GEDO;RXM=4]=BT1SZ?^H>)M#Q8[UC#U M-ICZ7ENMOA\Z+LBN@;A?T9)4%^_AXL:^997@DN_5`NP"`WH;DC07XR>Y>RW)X_\_$VP^@?K*&0;SDF?P([S9RW] M7NM;L#FXV?TTG,!OPJOIGIP:]3L__T+9X:C@N!.(2`>VJM\>J:P@HV"SB!+M M5/$&`."OUS)=&I`1\CK\/[-:'3=^G"X2',8(Y-Z.2O7$M*7O52>I>/NW$:'1 MRIA$HTD,].-Z=*])8("&^!Z)(MNUX&*7NB2Q"MP/@2F,&80GTO4@A1 MFWS5+H,7!"'A>%ZV,8[7P0NDM!HUA='`&S%ID*TH+PI]$H`W,4+@+F,,1_CS MY%^0]"8;*7*)?B)QB&X5L[`L1LB=R[A\MT`NC'K3QE_.4Y(N;83":$Q1Z5R7 MLQL6`=C,"3[.CA9#$'&/WR4:3#\>9YUF6V&2EM9YEV?4X+2[(POU<6FQS MH2RSGUL8#1[++(Q3>[VTUM,HC*9UBRO]+UQ:['+ED^_P$A1&8[B2)0[MY=): MQK-L6U38IM+OX[_7NMYDT\78.:W":`P=7H8NW7PY3^/K;HM.?\]FW>+C&M-B MFPKEUQHQ.3,:0X62*'9R6L[7LPA?MUM8N8UU7]+T)AOO)F=&,M*E21B[6;,$ M28;3:XNQ`!&TJ_L3-Z@=-*?(BU%CV![PTF4O;4&:Y>^A.5^`C\\4F1X];QP8 MVX5>C)K+H>(DN5;3<.JEHT#9[&6Q\_:_6C\R;=N"=)O(J#&048S1M4N,C,9D MC`+#O#6%:2/J?GSW.P%#RDW5.35?C!K3>%&&HM3)L!YUM,NH2#,H/`?.3#+F M2]]2<:`E;1KI5?RDIQ0$O7.Z:R:H0D]0PPPT+<``TY,#_96(`^NDU]`];`T7 M&/JK,".0N5"\'SZT.ZY@=!E^'F%4I?"Q"A<@WG.N+A?ZTSX-O]M_````__\# M`%!+`P04``8`"````"$`R3-)3OX(``"0*```&0```'AL+W=O3T` M#^=J/3S4]?MJ-*IVA_RTK1[*]_P,5U[+RVE;PY^7MU'U?LFW^V;0Z3ARQ^/9 MZ+0MSD/RL+K5#N/D[YN28GE_RXK6'^U:%XK[2WT^X6=Z?MY=O' M^V^[\O0.+EZ*8U'_;)P.!Z?=*GT[EY?MRQ%T_W`FVYWVW?PAW)^*W:6LRM?Z M`=R-:*)2\W*T'(&GI\=]`0HP[(-+_KH>/CNKS)L.1T^/38#^7>2?E?'_074H M/^-+L?];<8`/P[.!58&A"1[8_UT(4;%_OZL!YZ MLX?I?.PY8#YXR:LZ*M#E<+#[J.KR]!\R;7AD'5YO9PJ<:Y\R[V5X9.%,#X5,-G-QTP[D:!Y^W*0/=S0SA M\RYE2S4./N]3YD#)-'?$_UR=XXA2WU12L*VW3X^7\G,`RQ.26[UO<;$[*_2B M:XCBV5;5KXH*"@&]/*.;]1"$0[U4L!*^/[DS]W'T':IWIVPVTL;A%KZVP/I" MMX$-0AM$-HAMD-@@M4%F@!&$I8T-K(O_1VS0#<9&J]IH8`3+"H2VT$,"&X0V MB&P0VR"Q06J#S``L$+"V12`\*);^C4;7!(Y:#V&9&S7A<:$;LJ%-LDFY+T@@ M2"A()$@L2")(*DAF$A8"D,%"<%TZ6N-NRK1/+.UDI'9F+'=?D$"04)!(D%B0 M1)!4D,PD3#OLN$P[[A&>]]#MUS=O$^BIB8LN[`T1/&^,*IGR2/FMD1X6"!(* M$@D2"Y((D@J2F83%!=++XG*])M"::R=B%H`@@2"A()$@L2")(*D@F4F84#@! M[Q"*UEPH$2O),RO)K5&;9$%"02)!8D$205)!,I,P[7"FW:$=K;EV(F:2!0D$ M"06)!(D%201)!(X M8ZM'BK1!XX8+P2Y%=FK-+EP?BMVW30G3`Z.>7/3!0`YVNLPD5[03*T-TTS(2GVW":DPM%;= M\A]!2'T0"P4A/)W:?=V=6[NV#\<=YAJLNHH@-)TT6_W$ M'2^M0:$:!!9Z4,3\<('8S)@"OUC/U/LP)6T[9"JQOU4YK96>5-"A;F#/T:8& M4COF+*8SJY>/.C_@FHG#UN`.<8TY[\<4PD5AI,F:@=]9M>(D"C6B?FRR=%UK M[X^TA6S(\/R_1PDU4&::&@]02G"\&$JLWM?OK#HEY`L&:A0J*WSV:OBRNM2H M\]59_;+SOP?UIHC1=8B`X7<98M"[9XMVH7= M<7:^NCO^6O=7W==-G;8KFR^%>*>]L#M.964D-]"^(&YMZ4W"1@PV+NHP*%RHJM-M.*SQ\;`'O^=Q8D]1!L M[H2LA-E="Y1=(Z<[^P*%O"\2INY("8-*\,0I8;IF@O''#B'8+-+;$M:XX=N. M0K"OZ%/.ERB0*)0HDBB6*)$HE2ACB,<"FX\_EWR/^A@/6?,#0\;5"<+V_43"HO9 M.J$4,K8J7Z)`HE`A6.)ZGI&TBB5*)$JEKXQ9<83XPU?[\;"O MK,PMKD/=[B\W<6U%_;\[FTRL`S_2%MWN&4N4=.C*W5)MI>[F+NP>(-,6\MN& M9S=H7X12-F*-!_@]%DYBXSRT#FI?61E%%G2H&]@32M7GJ6?T8[&[=FYT%<82 M)1VZN\"-^F]QV(%/UWU MS+4IO@;-8X<.:GBN>L\*C1%Z!,P"4]PH'W8W]J(T(O`_VOGW+ M_[Z]O!7G:G#,7Z$PQDWW?:$WRNB/6OWB\%+6\"98\^/#`=[\R^%KV1B?Q;^6 M9:W_@`F-VG<)G_X+``#__P,`4$L#!!0`!@`(````(0`T+.&56PL``%@_```9 M````>&PO=V]R:W-H965TMVN]`\3X& MG_8[-[N^\;5L-];OZUVCYNWY_M^65A_W/9[A^/R[7'YNGM;W_?_ M7A_Z?W[^][\^_=SMOQU>UNMCCS*\'>[[+\?C^VPP.*Q>UMOEX6KWOGZC+4^[ M_79YI#_WSX/#^WZ]?*QWVKX.1L/A]6"[W+SU>8;9_B,Y=D]/F]5ZL5M]WZ[? MCCS)?OVZ/-+K/[QLW@\BVW;UD73;Y?[;]_<_5KOM.Z7XNGG='/^ND_9[V]7, M?7[;[9=?7^F\_S(FRY7(7?\!Z;>;U7YWV#T=KRC=@+]0/.>[P=V`,GW^]+BA M,V#-WMNOG^[[7XQ9-;KI#SY_JANHVJQ_'CJ_]PXONY_V?O,8;-[6U-I4)U:! MK[O=-Q;J/C*BG0>PMU57(-GW'M=/R^^OQVSWTUEOGE^.5.XIG1$[L=GCWXOU M844M2FFN1E.6:;5[I1=`__>V&]8UJ$66?]4_?VX>CR_W_?'PRI@,KRFZ]W5] M.%H;EK'?6WT_''?;__`8H\G$*:G:ZF>CG10>\:_:CG\U^QO75 M9#2]N?U=VQC4%7AEJ/$O:QU#%,20#?NQ]C%$P[(N=.%!1=L:],M%;610-?B9 MRK)\N)5$80S9PA\LZ4@T,/OEHA<\$H.&_=+L^=$7/!*U8;]\J(4'?,36%X#% M\KC\_&F_^]FCJRH=_/"^9-=H8\:RB:'/!UQ[,?C5M8`N`BS+%Y;FOD_M2./\ M0!>P'Y_'X]M/@Q]TT5DU,0\88Z@1#K$.@0ZA#I$.N0Z)#JD.F0ZU#H4.I0=4`I*EV9 ME:*>?K\68Y1%W_?IXMP9HW=JL1YXS)B_R;,A.`=9@)@@%H@-XH"X(!Z(#Q*` MA"`12`R2@*0@&4@.4H"4(%57E))2>2XH*8NFR1:]6N%!-A&NH.5Z0%DHED(=E(#I*+Y"'Y2`%2B!0AQ4@)4HJ4 M(>5(!5*)5"FDUI4M0%Q05[Y>H=25DS:$I_H0;J-$AUBP96BZHG5(!5*)5"FDEIJM3%Q0ZF8AHSN$.74J-F>W M$-0B+I!,)`O)1G*07"0/R4<*D$*D""E&2I!2I`PI1RJ02J1*(;6N;"FB6U>^ MT'_%[I$=7S:K;P\[6AVB"_*)2_:8%O2;97Z^H*&,;$YT\1!C=LYN`%&Y.[1H M:$1;.HM0U^KX-V64R&4AV4@.DHOD(?E(`5*(%"'%2`E2BI0AY4@%4HE4-<3; M7NT!;"WCG_<`OB*B]`!.G7+/V9T_O0=PFM"'MTX/N-%[0!LE>P#DLC&]TY"6 M7KL%Y8*T%)+FC<0L]B>\XH@^6;?JQGMZ2N<0YVTB.))D+CNB**';6=/_S M;CJ<:@MZG@B19^,C!9+.'"YLHLZ?8"1SB1.,D1))9XZ8BJA?GV`F0N0)YDB% MI#.'*T64.-QD.M4&7"5"ZL.I_9,M$EW0/_F:DM(_.;%#M!UH9,"4M8T2[;M@ M7T5@75;.B*D M3I?U=Q.SV9&BQ`BSD&PD!\E%\I!\I``I1(J08J0$*47*D'*D`JE$JAHZ,5UF M7^CZYSV@SJ*N9C;4G2XC+1K2YK/Z)$=&M3T`<]E(CMQ17AK'$WVZ+*-$>@]S M^4B!W+&;7GOW#F642!]AKA@ID3O*](;^UIS**)$^PUPY4B%WE.G'4WVZ+*-$ M^DK)I5Q/1I>MC-;A6K?ABZ6_F2XW.W:GRY+DV<"[H-E$G9]-6C*7.&<;R9%T MYHBNB&JG=S=3;?+OB1!Y@?.1`DEG#A=/,)*YQ`G&2(FD,T=,1=2O3S`3 M(?($X8(R5(J:!?O_1, MA,B7GB,52*6@,Q-A$8(3X=%EZ\9UN-:!8)%XWD1UEI(72":2A60C.4@NDH?D M(P5((5*$%",E2"E2AI0C%4@E4J60^L;%UG*[$^'?7!CXTF]WQLLFL32]I2+* MJ]=8O]3/992X\"Z03"0+R49RD%PD#\E'"I!"I`@I1DJ04J0,*4;KADJI.5%O$D6< MTY.',(2!3(RRD&PD!\E%\I!\I``I1(J08J0$*47*D'*D`JE$8H]XRH;F=>6/ M;/(GMK;K_?-ZOGY]/?16N^_L<0O$\I_LDFH MY4\V/+7[R6:G5C_9Z-3F)_/3&9\ZX85Q-V/+7MA(M,`T,VF]`K?0VM#,/;F% MEG5F;-$&]Z$5F1E;;\$MM)@R*T]NH>\$T&L[U2H+8SHSZ=8C9J/;O#-V$Q>W MT!W:&;O_BEOHYNJ,W3K%+71?E%Y!O670]A1ZKOE]^;P.E_OGS=NA][I^HH$V MK+\GL>=/1O,_CKOW^OL27W='>J2Y_O6%GF!?TS-3PRMZHWS:[8[B#SKTH'TF M_O-_`0``__\#`%!+`P04``8`"````"$`$6P#V>P*``!;,0``&0```'AL+W=O M__6:IJE2J_+5MNV?G8FQ_9/ZJRJQ3%NJ;/W\<#XWO MV?FRST^W3:?5:3:RTRY_W)^>;YO_^BOX8]1L7*[;T^/VD)^RV^;/[-+\\^Z? M_[AYR\]?+R]9=FV0PNERVWRY7E^]=ONR>\F.VTLK?\U.],E3?CYNK_3G^;E] M>3UGV\?"Z7AHNYW.H'W<[D]-J>"=/Z*1/SWM=YF?[[X=L]-5BIRSP_9*[;^\ M[%\O6NVX^XC<<7O^^NWUCUU^?"6)+_O#_OJS$&TVCCLO>C[EY^V7`_7[A]/; M[K1V\0?('_>[[IMWCO>QNTU MVW+I7?&Y>7_&UVWC\F^U-&T:8\B0Q\R?.OPC1Z%(BXT\_N^PHHB33^))=KL%>2#8;NV^7:W[\CS1RE)04 M<94(_50B[JC5<_O#T6=4Z'E%4^BG4AFV1OU^;S`:?KPI`R5"/Y6(\^GNT-PH M&D(_E4:OY8[Z3G\@8O*+.(R5(_W4#Z>P?\33T2$4ORC??B6$OWBHTU5/%;_H MQXY:3J_S7G,='2SQB_;\?,B=H6X`_:)D/IZYMAR0Q?CVM]?MWDI,V`A)*P](SM&$:ED6[B'(1B($GI9=+3[;!E85$::>D4A)9`5J5759J- M\G5II*4W52$K8S1=/I$Q86UG3!)Q]BH'>;?#MQQI5$FKKT@EB4`"\)H!"26Q MDMCM=%D22R,=CCD(Q4"2TJO:LYXMO2B-M'0*0DL@J]*K*MVWI=>ED9;>5(6L M)-+IT4JB//"UQ.'_^K+??7W(92%2LX!VZ6`GCWM"Q,ZM).)P7,GMP&[F1!I5 MO&$@B26]<;MP+("EX+8&LP&L-9%/UL@)/U>DG M`B^L[V5@LT2R`K(&G0V51LK>PY=$7TB?86Y MG3^%1-%O5D2'[W;&2O?-1S152)08%2VV=07H.$,4(HH^)#]'QQA1@FAAY'4? M4[1:(EHA6J/6QK*RDR@*ZNKEQJ\7/UKD^"14B,U"MK%/C)7NH(]HJA!-CFH2 MV4X>&$=CY8Q9JF?&2C\Q1!29)Q93OS5@\WZ./C&B!-'"*.OGIVBU1+1"M$:M MC65EIU24Y-64_M;Q11Q!V7*K$)NN_`!CK'2_?85^'ZC\QU:=.2K$B!)$"_,<_>@4K9:(5HC6 MJ+6QK.R\B\+_[^==71^88#Z($RL-!3;#V;XU,5:ZW[Y"77,],-5(G)._WSE# MNIN'K1:59HA"1)%"Y=XZ9&-SCCXQH@31PE:F;['8:I.BSQ+1RJ#*>.8GA+6V MDB-UY'8[XPY;3S?:IOA"QQX&XC8!A@%]E4(S310O?^6OQ97VQRL9D7B^%$C$ ME@*V=DZ48V5B^@JY\FL;<7LWU*T9D9J=\C.U@_B^SVRHNI(S_D)(E^A03%6BP)IBBA0J&?N,&:(0H7L M&PJ7S8[(6.EVS5$K1I0@6B!*+61'7]PI5*/_3I3E%01=LNIV/H@IQ4,*R%=6 ME6!-$06(9HA"A5A(V:$K,E:ZJ7/4BA$EB!:(4@O9(15U>QE2&O?OA%26^59( M):K? M!`MCI>532\N.LBC2/Q%E6=-;49:H$M*)^+*41UFA:I0!!>@X0Q0J9$>9WPM' MQDJ'88Y:,:+$.%:CS.;%PEAI^=32LJ,LBNEJE'_O:"Y+>H%2-*C&-5GFWH"V.EY5.%J&(B9.7# MM:XPWEU;"G/["D,AL6>;.L;E!R%CI1OE(YIJ),]]XY[;<=DQ,]`F9BN=(0H1 M10K1T5BW8(Y6,:+$(--!N-1:&'ECU>VR.]G4:$$BK&N(]Q.!UQ!THA1KC=A' M3"*Z[,`R,58Z##ZBJ4)T:-16`5K-$(6((M2:HU6,*$&T0*W4LK+'MG4-\'Y( ML=YW)>I;7UC`]9RRHAF@@^4CFFHDQ_;0[?5P;*LRW@C-M)=!(:)((6ML@U:, MCHE!9LS4C&VII:K*46O`]O'4R,"PMDIRRL%OK?=B@Z.A75WO%>K;HYW=84R4 M%_?4!93RG9$WI6,B?D*'6D\<6?$3.H]ZXK2) MG]"YCM2*RU76`CJ2D5K=)W2:(K6Z3Z@>))]BR6!J5$-[HNC#%E`I[8G:#S^A MBIJ>4_<)5=&>*/O0ATHQZL^PYA,JK*AM=9]0343/J?O$IU#712VD0-?QA,)< MQU/0*!CYA-?#6==RG1-7%/*0TU?&$DE3'5T-O7O::%?-7SUG7G_>G2^.0/='RU"FNX<[RY7CYQU5=QW[)K_12>W$S^T+_B"&C MF]&.N+-]RO.K_H,ZUB[_6<3=?P$``/__`P!02P,$%``&``@````A`//56^.B M!P``&"```!D```!X;"]W;W)K&ULK%G;CN)&$'V/ ME']`?M\!MS$W#42#+UR42%&T29X]8`9K`"/;,[/[]ZEV=[M=52P+FWT9AD/5 MZ:YKE]V/OWTY'CKO:5%F^6GJN`\]IY.>-ODV.[U,G;\_QY]&3J>LDM,V.>2G M=.I\34OGM]FOOSQ^Y,5KN4_3J@,,IW+J[*OJ/.EVR\T^/2;E0WY.3_#++B^. M205?BY=N>2[29%LK'0]=T>L-NLL^EJ3.IWC9K)Z.>5%\GP`N[^X M_61CN.LOC/Z8;8J\S'?5`]!UU4:YS>/NN`M,L\=M!A9(MW>*=#=UGMS)6@R= M[NRQ=M`_6?I1MO[OE/O\8U%DV]^S4PK>ACC)"#SG^:L476TE!,I=IAW7$?BS MZ&S37?)VJ/[*/Y9I]K*O(-P^6"0-FVR_AFFY`8\"S8/P)=,F/\`&X&_GF,G4 M`(\D7Z:.@(6S;;6?.M[@P1_V/!?$.\]I6<69I'0ZF[>RRH__*B%74RD23Y/` MIR9QO08-AH_==\CL MC9:92K2A2N('Z/&Q;@179"P[W#3BE=VVFV M-U>(#\G1BOH(1SU00NZ@*8F0(9%&AK4)KMLC)1*W-9`%X'1D@>IH#T-0J/;9 MYG6>J_/N0@0]6$SU,TF"#5-(OQU2,1@3PY00Q-3X(]2(K?Y((0)Y:-C#1'%# M9-WHCFT0D<%P8OU_@R4)-E@A$"2[!3&D';L1:@Q6B(">VB0`ST\M)%1^]MQ1 MG]C?YD7&RKF6GE<"9@HSA;1.K#K:G_-S?#0L!V8U;`D)`A M$4-BABP8LF3(BB'K-H(,E3,,LO2'RK]FP1[0D-M.;#$D>1M8*>.H4$-^OT[V MONB-B5)D)8Q2C'BP@7)::5?`]5#*_9)8:@B?/$,?5V!@I.._,$`4\=&HFZ3V#@Y@=QAG!I8X)PU>YR["B)MB^P@L%)&,>109"!U!O7' M0M!#R$C4&\"6R$GB#DOTX-&V1$$D3.2D#]Q&REK"H$A+">@/3>\20]+@8LME MI;YYZLA](0-_K-#4(((BJ&<3?/#0D[9>'CJ[=5BH(3%NLB'2D(>*=D0/6\MU MB]UR\&@']L?LEBRDP2@(3Q@C>N#*9W]0A"W;>&LNR/PFN!?*4DO)&>=]YGL# MCQ1%C*AQ,LMQY)K-MYVRLBBIT0IJA3'04BTHY%"DH;X]D6(DA?/+>W@--#5X&@IU3.%+WHL.`T/Q!T;)P_]MG$R(044 MT>W3KJOF!F2P@OQV4HF1G4#K,3G0BBA62A%5H:;OJ1-PS!N/$E`TV#AYT%/C M7/_.:=Y5XP*R3T$^],JF:`0=0P.MB*I-<[4="J MS;=56TV#6XR&6N$*.!1R*-)0N]J0%-X_G5#N3TCY^$`ZA89(P.C4HJ7:`3-< MUP-FI%3`(!,\>DH@:FPP4/^,@$D:$C`%M>=NP:"00Q&'8@XM.+3DT(I#:P1A M7\CA@Q;L?=U(J/FE7:T:DH-CJUI)CPRL5',V:@@V($\]T7-)PD16P.C$G&;! MH:55U,QDJE]9`<.\1C38;72:NGY"28?25-%CDSU[`BV%BH%)15H*9D.SSY@K M+CBTY-"*<*66TF\D>[R[-C0F"Q=\L:6%KBRV,E)ZFG+[ MY.%A;03X`RA=>FHKH..:?&2!NGA4'8V^9N\4(2GP=EC`ZO;SOEX`J]>P#"*"P'7 MH.+B+T-S04ITX,7(1+[ZX&RA\":R,?-?H.M.9&/EO\`][-/%]>%^MK[,)*O/ MY88O\,R]"5P"7.#O3Y[J:U["\S2"=2_],!]-X'4<$'4;#;B7/2_4L6ZB;7?6ETN\LG_,*;F3KUY=[N(%/X7JD)]]T[O*\,E_D`LV= M_NP_````__\#`%!+`P04``8`"````"$`P&JA@`(%``!8$@``&0```'AL+W=O M5\8;:KL2-RO3 MF=BF@9H"'\KFM#+__"/Z,C>-KL^;0U[A!JW,#]297]<__[2\XO:E.R/4&\#0 M="OSW/>7T+*ZXHSJO)O@"VK@S1&W==[#8WNRNDN+\L/0J:XLU[:G5IV7C4D9 MPO8S'/AX+`NTP\5KC9J>DK2HRGL8?W&MSFSQ7D_>[X><&XAP>-OBZ+%G?XV$^`SJ(#U7->6`L+F-;+ M0PD9$-F-%AU7YI,39HYC6NOE(-!?);IVPO]&=\;7N"T/OY0-`K5AGL@,/&/\ M0D+3`X&@LZ7UCH89^*TU#NB8OU;][_B:H/)T[F&Z`\B()!8>/G:H*T!1H)FX M`6$J<`4#@+]&71)K@"+Y^]!>RT-_7IF>/?'=8#9W(-YX1ET?E833-(K7KL?U MWS1J2(FSN",+M(QE.@EFMO<(B3^20#N2.)-Y$/C3^>SS(X'((1]H1Y+Y9.;8 M"^\!CNG(`2T?R*/)P/H:Q@$MYW@XF<5(`NV_3L8!2]$9)MX:)^^SX\@16Q9!W$UH=RJP5X%(!6(52%0@58%,`"R0A6L#B^#_ MT(;0$&U85AL&W,1R%2%8!.NR4X&]"D0J$*M`H@*I"F0"(`GA*4+\9:R9R2-K`K$O:W'$*;-#,*B1:%H$B MH@@4$46@B+_@WMEK2*3UBC4DT7JE&I*)O:1$9TJB9"MQ/7):^<8AAN5,.LHY M4\2'52GX7)F#+0UR?)[TCB.W;LY\)D_=G@:YXE[E!HIKHGM,"V6AQ3R(F2#A MR'<&D-X=@+)99O>8A`%(PD,J#SB,1,MJ4\2_";FEB#.]2:LA^['7K81'6DRL M(8F&I!I/)L9(B<+Q24J4.,SS)S\T&.DGITP1'[S,#;98R$;9TAC17QJRIPB8 MB5D@TF)B#4DT)-5X,C%&$H&ZC)OCOS9YZKJ!OI5+$.)3I[JK#;MF/;<^5\D4E4LGSDM*>>>!^4 MCQX883]GL[Z!8DPLIE2LN2H?C1(M-7;TX.C%G:C7+!8ESXXF*:<7N(2B,9PA MXI%+&$3"Z+\[B)1%28.8:LK_8!!T,N@UF-Y$:M2>T!9556<4^)5<<6'VUDL. MT_OWS@_A1`*"JW@0[H<:I.!)$,(N?2=^&L+FJ./)-(3-3L?AWO_DWL$WY'O` M/=P-X1RM\VR\$$Z9.O[DAT^@++RP>`9PK[_D)_1KWI[*IC,J=`11[.'0V=(O M`_2AQY?A!O>,>[C0#_^>X0L.@O.T3:KB$>.>/9`?X-^$UO\```#__P,`4$L# M!!0`!@`(````(0"I'UJ-61```$U9```9````>&PO=V]R:W-H965T;EYMP;C<_/ M5B]WF_OURY>;\W_]$?]V?7ZVVR]?[I=/FY?5S?E?J]WY[Q__^8\//S;;K[O' MU6I_1AY>=C?GC_O]Z_SB8G?WN'I>[D:;U]4+M3QLML_+/?US^^5B][I=+>\/ MG9Z?+OSQ^/+B>;E^.9<>YMOW^-@\/*SO5N'F[MOSZF4OG6Q73\L]G?_N[][C[GFY_?KM];>[S?,KN?B\?EKO_SHX/3][OIMG7UXVV^7G)[KN/[W) M\D[[/OP#W#^O[[:;W>9A/R)W%_)$\9IG%[,+\O3QP_V:KD"$_6R[>K@Y_^3- M^\G5^<7'#X<`_7N]^K&S_C[;/6Y^)-OU?;E^65&T22>AP.?-YJLPS>X%HLX7 MT#L^*-!NS^Y7#\MO3_M^\R-=K;\\[DGN*5V1N+#Y_5_A:G='$24W(W\J/-UM MGN@$Z/]GSVLQ-"@BRS\/GS_6]_O'F_/@F9]]7NWV\5JX/#^[^[;; M;Y[_(XT\Y4HZ\943^AQP\D;'0'6;Y&SN"=P?6TH.*/D\Y7"^H91=\YACRMJ/CC??&]D//N,(W#Y7[Y\<-V\^., MUD92:/>Z%"NM-Q?N]`26(_$XI?_7C*:I++Q\$FYNSJD_3=8=+4/?/_K7LP\7 MWVGIN%,VMVCCN18+;2'6">$VY"#B(.8@X2#E(.,@YZ#@H.2@XJ#FH.&@Y:#C MH+?`!ZN!)1H31%OH+B$'$0]!1Q!:(4!02:T=@S?]?0<$;UNSFFM,7-D-G8#?BMM`GFK M%%-@`20$$@&)@21`4B`9D!Q(`:0$4@&I@31`6B`=D-XFCB045D>2MZ40UN)1 MP]&"K4:WTFA*R[,EF.\*MC@:':<(D`A(#"0!D@+)@.1`"B`ED`I(#:0!T@+I M@/0V<>2AR7&"/,+Z((\.ZJTDZA'R,"^`A$`B(#&0!$@*)`.2`RF`E$`J(#60 M!D@+I`/2V\0)/`WQ$P(OK-W`2S)U[NRS@$V"HY'6*P02`8F!)$!2(!F0'$@! MI`12`:F!-$!:(!V0WB:.%K22G*"%L':UD,2>!$!"(!&0&$@")`62`EMX@2>1J\3>/&0Z_LCFC0G/N8*1ZXFDI`F]DUBPN;'T>@X M/X!$0&(@"9`42`8D!U(`*8%40&H@#9`62`>DMXDC$V6:CDQOW\.%M:N%)/;\ M`!("B8#$0!(@*9`,2`ZD`%("J8#40!H@+9`.2&\3)_`B83\A\@=S-_0*L7DP M9?/`6!TG`J((48PH090BRA#EB`I$):(*48VH0=0BZA#U#G+E$8FAG:2_/3$\ MF4?2TZV.\JU"]M1`%"**$,6($D0IH@Q1CJA`5"*J$-6(&D0MH@Y1[R!7"Y$3 MGJ"%3"$=+21B4^623Y6CE18Q%!4Q6O$L$2-$,:($48HH0Y0C*A"5B"I$-:(& M48NH0]0[R)5')(@GR*/R27NJ2&1%>2$JBF[@0T01HAA1@BA%E"'*$16(2D05 MHAI1@ZA%U"'J'>1J(;+!$[20R:,S522:^,>5;"%JM:2%A4*-3&4K0A1K9'PE MB%*%?%+<2OJOW,F9&2L].7/T52`J34?;_;7KOC)6VGV-OAI$K48F$AVB7J-# M)%S%1!IY@F(RZW04D\B29R&V@[AB"IGSC+250;%&MF+@*U563#%6>\Z,E0YI MCNX+1*7I:!0+QJQL5QDK[;Y&7PVBUG2TW;-*5&>LM/O>\>6**/+/$T24Z:HC MHD1BE3U.@F#,*U]BPX/KJI`1,=)6!L4:V;J"KU19.;H&8U9YR(R5CDR.[@M$ MI>EH7R-+W"ICI=W7Z*M!U)J.MGOV/-P9*^V^=WRYNHKTUM95;M6,Q.;6_G%] M]_5V0VK1L]_`TV%`6S)JHT8FR8[<$HF%W)(;'DBDE36S0[%S)>Z+M"1;'=EB M&1DK?9&Q0I:O!%%J.MKNV6*9&2OM/D=?!:+2=+3=LX6C,E;:?8V^&D2MZ6BY M]]C"T1DK[;Y7B!Y!";DC0&3.]@@84)J>6XY2RT3;D5HBZ?LP(!9BTX]$M%"H MT-3L0D2(8NR8($JQ8X8HQXX%HE*AR>SX.%`AJK%C@ZC%CAVBWNGH:B&2Z1.T MD+FWHX5$XFYL9H_'EOZ%=[32`R1$%&DDQ*>MU_',GX[92(ZUS>08O011:I`Y M*^^:S>E,6?G7A^,%HRF;E;EQHT^[0%0BJHQGW;%&JP91BZA#7[UCY0CJGU8# M.9B[-1"%Q`IN"_U5B$U7_MACK/1UAPKYYC84:?E>3@?LN M>DH0I8@RA8XWV2LV-G/L4R`J$56N9_IZ+KNQU-BG0=0:9(UG_JS0:2LY4J_] M8#P;L_6TUS:':+O#0-1[8!C0=RUIIHFDYX_-ZR'I>7\&)-(54M89$A*QI8"M MG0O5T9J8H4*T>NG9$6GDRR%Q.9MY7+@8/26(4D290FK6!R,V:G/L4B`J$56N MX_%HQM:N&OLTB%I$G497AWAH=Y&HDBC=5@$S@%SZ@$%&$*$:4($H198AR1`6B$E&% MJ$;4(&H1=8AZ![E:B#K,"5K(LHVCA43.=[4"GQ<41#9"2R%9F:D"*$*K&%&" M*$64(H=Y,IS6KV'D@.XX4ADK5$+966A$%&$*$:4 M($H198AR1`6B$E&%J$;4(&H1=8AZ!SE:!*>5:@[F[@.?0NRNPI*FA;$Z3A5$ M$:(848(H190ARA$5B$I$%:(:48.H1=0AZAWDRG-:$2;`(HQ"UKQ8(`H118AB M1`FB%%&&*$=4("H158AJ1`VB%E&'J'>0JP6OGKQ]AZ?@>Y\O`BQT_DP6I&()$5 MY06B$%&$*$:4($H198AR1`6B$E&%J$;4(&H1=8AZ![E:\$K#3[3`,D(@D:,% MH%!93;+]DY!B1DTI@PBIM?F^0!1J9(]2U=&@6%N9DFB"*%6(C5)6SL\!D9*^T^1E\)HM1TM-S[S'UFK+3[''T5B$K3T7;/"L*5 ML=+N:X4&OE\2G);C'LQ97B5S7'=OQ>>%=-71WEM!%&DD]PUF$W_LLZ?.6)N8 M39H$48HH4XC2?1V6'*T*1*5!)NKP]8C*N#=60<"*EK7Q12?A3(S):0GNP=P5 M0B%W1R/@M2!CI<,0(HH4HDT';16C58(H192AKQRM"D0EH@I]U8Z5&]+3DM() M)J4*39T'`X_7#)25/;8111K)L7WE3R8PMK6)-;81I8@RA>RQC58%HM(@,VIQ M;!OW8LOS>G3)[N.U<0/#FB>CO[3>TZK.W].]612DUZ M:$?:/0T`RQ=?>925,[]P*]]8:?""]L>9+(O4\$+&]9J([.7%*^S*-0I-W+/?CK:\^;,43<_138&HU&Y(B>.8&A!*79L\V'3DL6>%VO'LKFXB MS7Q+J/=MDTYDMFH_2BE$"9@Y]2!@CWT+8Z4'>H@H0A0C2A"EB#)$.:("48FH M0E0C:A"UB#I$O8-KI M:7=VM_DF?O7O4GQ!_(CE3Q+>!OY%1F/>93*GE MD)I`RR6U'*H"T')%+8=?1>0M/O6A[TL,G)M/?6CW?JCEFEH.F21XFU'+X=F2 MMP1CNM+#3RM""_UB(^WG#!R'G`WZ\L@7O3P^T,,C7S+/YT?Q2`-ZOVNH#VE` MKP(-M/@4:2D]\T8_,OEIV!>Y&O1$CH:XD'^`?YK,/PW+)4;%0(=;.M/!(4'J M#HI+V@Y*2\H."4MUN[DHU&&0J`HW%S4V;*$"VER4Q["%"E'D;>@X5$,B;T,M M5/XA;T,M5,"F/D-73T7_>3[80K7_N2A6X[G1%@`=9ZB%ROYS4:?&/E0[INL9 MBC-5@NGO!F$+O?90=(;&<^A1 M1&7>RJ8>O29),1B*&[WA2#$8:J&7$RD&0RWT1A\=9VB,TLMX=)RA%GJ/CHXS MU$*OP-%QAEKHE6TZSM"5IM0B7J_&Z-"[TW2E,ZSF"LJ46\ M%#QTG"D=9ZB%7M:EXQQ:+HXRT(_9OBZ_K*KE]LOZ97?VM'J@VQ[]["@]EV_E MS^'*?^S5]Y0_;_;T,[:'KRP_TL\6K^@G_L;BR\P/F\U>_X-.ZN+X0\@?_RL` M````__\#`%!+`P04``8`"````"$`+>W\7H$"```9!@``&0```'AL+W=O/`D.M+.%1="\9O%=M+WMM` MHGE'+<1O6C&8%S;)+J&35#_LARNFY``4.]$)^^Q),9(LOV]ZI>FN`]]/\9RR M%VZ_>$4O!=/*J-I&0$="H*\]K\B*`-.ZJ`0X<&E'FM5VX+#I-7I^]\`;YK5/&:[CO[0QV^ M<-&T%JJ=@2'G*Z^>;[EAD%"@B9+,,3'500#P1%*XSH"$T"?_/HC*MB5.EE&V MG*4QP-&.&WLG'"5&;&^LDG\"*#Y2!9+D2`+O(TFZN)2$A("\OUMJZ;K0ZH"@ M9T#2#-1U8)P#\=N&P(G#;ARXQ-#3$*N!(CRNTRPKR"-DCATQVX"!YXB)1P0! MT5$9U"Y7=F"G[%+K0MF&C:E,\K9,^C\R#ESB^23X-%N,O$$Y8'R53_S`J:D? MUR*+:]<.[R35G2MQNC@179Z)!E`\]9MFUR/H)!!0G`;R[Y(ZL%<:=.!<+.F9?5F9\ M`3:)B_E\?YYO_,U`QA\PF0-M^#>J&]$;U/$:*&?1$ISK,-MA8=7@!V2G+,RD M_VSA"N;0?[,(P+52]F7ADC5>ZNN_````__\#`%!+`P04``8`"````"$`MUZ2 M;4$(``#\(0``&0```'AL+W=OP#1BHP*V`O_-16UOWWGTFX`37`$YA)YGY]]NRU++4[662V3L/ M`QQW'ZF/6NJVG9O?OY^.O??\4A7E>=EW!J-^+S_ORGUQ?EGV__PC^FW6[U7U M]KS?'LMSONS_R*O^[ZM__N/FH[Q\JPYY7O>`X5PM^X>Z?ET,A]7ND)^VU:!\ MS<]PY;F\G+8U_+R\#*O72[[=-TZGX]`=C:;#T[8X]R7#XO(9CO+YN=CE0;E[ M.^7G6I)<\N.VAOE7A^*U0K;3[C-TI^WEV]OK;[OR]`H43\6QJ'\TI/W>:;=( M7\[E9?MTA+B_.^/M#KF;'XS^5.PN954^UP.@&\J)\ICGP_D0F%8W^P(B$++W M+OGSLG_K+!Y=IS]/G_>OAWK?Y;4#18%FX$X$ MTZX\P@3@_]ZI$*D!BFR_+_LN#%SLZ\.R[TT'$W_D.6#>>\JK.BH$9;^W>ZOJ M\O0?:=1$I$G&B@0^%8DSF$TFX^G,!Y(KCG"U&1T^E:-_U7ZJ[.%3#_35R4+F M-V/"I^9H)_O)B.>*!#X5R==53<7:\V4;RMQI4C'8UMO5S:7\Z,'^ANRH7K?BM'`6#B0!)J&D MT&GYO[(2TE&PW`J:91_6!1*N@JWTOO*FWLWP'=)_IVS6W,:Q+39H(7)=T`84 M""D042"F0$*!E`(9!>XH<$^!!PH\&L`0I-7ZPLK^'?H*&J$O*K-&H!7<)6*B M!;H$%`@I$%$@ID!"@90"&07N*'!/@0<*/!J`)28D.Q-S#/G>?6)B;@JO91]R M6^>F,QW;8JVEC2>/69%Z&X8$#`D9$C$D9DC"D)0A&4/N&'+/D`>&/)J()27( M84EY74)A+H@X!*\FO5%]'ULSDL/(">AI+FPX-H."B",+:%D$BI@@,"23B M3O7A'C(D8EXQ0Q+FE3(D,[VL0,5-A=D'7`]46-N!2D1T$,;&GMK)O=%&*'R@ M$=/-M]U"921T?E_-Y[,929-(LR!OS)!$(U=&2NV19K,9Z5`RS0(C6?I!-_D% M_82UK9]$'$A$0[^9+<1&&V&<`4-"A?B-6![<#9!%B)A+S)"$(:E-.W5'I-W( M3!=+&=$B?T&:QMS61D$DN>9$G-9*J\.A$"&93).Q/[)I(C08Z^T8(C1O-I\S<3V2I!%:F-DEYP030.H$K5KJ%"%)/7-],L,,#3JR2S2! M5#K7$P\5?M(YB]M,*I>$K$3SR3)NE)^15`&'0H1D-CC3RCN:H4E'KHDVD0KF3+[8$8F,HN*I_M.LDCXYGS?*S\B'`*$V M'T(%N7"XM@5C3@[E"!W-`9TYN3&/6RM4.4&H'3'M'I$=R:+>E4(PW3 M;:4CA_W&T488E/:/,XK;WL&B)F<3P2!4B%'>/?Y2OS5/&S]]*.K+))D\;R%Y<*ROH&%#< M#8<"!4VACFB]78>4F;"U0JZ(<\4<2EI'DYZ4YK2U0OJ,<]UQZ%Y!<']LTI.= M]=!:(?VCQ64OE^C3S>7ZR9$KVWHK]56G;T^*U)2-HZUP4D$+M=%TY+YRE&VT M-Q]/)F1?12T109RUXZ(\[IO(<.1 M[O<'M%(QSZ!=(7`' M'[:N)W[&C.'7,H^=1P*5K9YQ.IGUE+;TR=+[16!F.^1_JK,3^@ ME8IYZGDN26[Q:EEU7\`M%UJ^*I;OYT[YY27?Y,=CU=N5;^(U,'2(JQL-RW?4 M4.`6HGP!!;D"M6DA*@^_`F5E(8H&OP)OO&_=#GP-;\*;.DO&6+OPAKS+WEO`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`?T_Z^^WKK: M4"37_WA[LM0-WWY\_/SV9+7Y9;T]6RTT_-6O-P^/Q:U;Y'^43-[B=YNGOSSTR/;'V]U!_CWIDE],\_3WND2U4,OM;=/\X MZK$M_+9W__BY1[=0F8PW-M?+SVVYA:\1]X\C'Z&OEL5<+JMD?9V.Q;U_KF37 MC]?OWMS?_?E*>R`]P(?OUVY_MGCMUN*?)>.6/SQO?O2TT?/%K>6]6\W;$VU: M/2,>]&3_^[O5YNS-Z=_U_/PPC;GBF(4=L?,CW)/1K3:+(8^AB*&,H8JACJ&) MH8VABZ&/80C@5-$>\E4U_!7YNM6X?'TR5Q[FP)=1F'Z$GY+%D,=0Q%#&4,50 MQ]#$T,;0Q=#',`1@PE1I(\QS[?'2NW1?FV[6VQ/5]J$V%YMS&];5.&8UO@ZX MTMM!,D@.*2`EI(+4D`;20CI(#QE",5$J#D2Y7/YR>)'YZ6>^6Y%[:33QKJ-X MQT'N=3/8!AL[:'<8=*A82`XI("6D@M20!M)".D@/&4(QB>O!F\2?+EHW>A^K M#^-JE.E095^BD`R20PI(":D@-:2!M)`.TD.&4$Q@*BD3F'MI>E&)NA79+$>) MZG$;U>-AD-\$&22'%)`24D%J2`-I(1VDAPRAF'AUX&;B?;H>W6B;X2AA/4(R M2`XI("6D@M20!M)".D@/&4(Q@;G.,#Y4)JO$BJL;#H$,U M0G)(`2DA%:2&-)`6TD%ZR!"*"5=']R;RU;J-FL_=-#'8`!DI)Q6DDE21:E)#:DD=J2?IW-D^ MB?$!V;3=07^8]C/5.O4(F[FY=&:.=.\]K"S@CY:2"5)(J4DUJ2"VI M(_6DP9#-SQW@A_FY:EWIW*\B./+(=#'V"B;;0_L0EFM\JFF:&.PO,E).*D@E MJ2+5I(;4DCI23QH,V;A=>Q#&_4RYCMV$B31L,*9R!64+4$XJ2"6I(M6DAM22 M.E)/&@S9_%P'$.;W\IWKV$N8:`_M15BMJ_C`]3#*[TFS!2@G%:225)%J4D-J M21VI)PV&;-JN?0C3?J9:QV[#1!HV(%.U@K(%*"<5I))4D6I20VI)':DG#89, M?LNXR7HZO_UPVTM-I%UC6)+1Z>?=/.I0DJ2<5)!*4D6J20VI)76DGC08LI$> MUTLMV4M-%+S:[$@9*2<5I))4D6I20VI)':DG#89L?JE>:KUQ[V$?^WJO=]_C M9FJBJ%RCT_F[>=1-!BR<1_73"W93$UD MRA7]5<91.:D@E:2*5),:4DOJ2#UI,&3S2S53+SL\7;*;FB@JU_B-I7G47*YH ML'*.*D@EJ2+5I(;4DCI23QH,V;A=X_/S+_@NN/%T2OCJ%+T1<^Z'/LD';*&%1R=J[Z:1KF-/+\!?1&? M(YQ'^;@S4DXJ2"6I(M6DAM22.E)/&@S9+>`:GG`+/%/48W\4-@9+M$P[4D;* M206I)%6DFM206E)'ZDF#(9N?:WC"_/Z%"AY[)Y/MH9T*RS4^2;@\C)K+%91S M5$$J216I)C6DEM21>M)@R,2].JX/VP^W?=A$V@/XL':DC)23"E))JD@UJ2&U MI([4DP9#-K_CFJX5FZZ)HCUH?")P'N53SD@YJ2"5I(I4DQI22^I(/6DP9".- M^["G]Z`K]EH3F9)$%Y5Q5$XJ2"6I(M6DAM22.E)/&@S9_(YKK-QEK>.1JJ^L MJXFBDHS/]LVC_,2,E),*4DFJ2#6I(;6DCM23!D,VTKC7>J8DV4^MT!;M2!DI M)Q6DDE21:E)#:DD=J2<-AFQ^QS5/NEH4)3F2W@GWQ;:;1@643>2:YN!H-#HG MF,^C_+H*4DFJ2#6IF6B\7S8&UW6$QS;/E-'8I(3'+^YH7$_6X#'O2-E$40S1 MN:9\'C7',*Y>$SV5'%61:E(S42J&5).R6._?6'O\?/OA]ZL[;3V]4B;B6>D2 M^/U)L/>K0W_B[^O51":=<51`V31*K;Z[FGYYMD`PXQP-\&LNN.:25&'-4>75 M\P"_YL:LQE;+<9W$BIW$1,&#WY&RB=14^CN5DPI.+$D5)]:DQDRTC]D=9A_Q M#!F/RE5J_JY?K49R;XL'NX#XQ-4\RD_,9@HG1F=LR\N+BZAZ"C]B MKIZ25,WTQ*W5?M1T:Q<7%U&KTO@1^ULS49X?=V2_'VZ/["=R;]D&4<9G5^91 MARA)N:?M^!$6?=@KVB2%'S%ORY)4D6I/TZHWR[/HX+GQ(_:KMB$==_A^SL/W MB:)ZBTZ3[.914>[K< M/P,7Z^4J*M+"CPBK:[Q/09%6?M2\ZMK3N.J+97S55>,')*HK/K+>7[6PVK_I MEGCY5TOB7__/>9`]D2FT;;09=_.@.:UQ54&!Y'[46`V+S?ILA4K#K-+/"BL- MHVH_:EKW^F*[B7JKQ@])U%I\*/VR6N,1MKO"V1U:ZOX>]O;;:">]FP?-X4WS MYGK(IU'NK>K#JA:7T5ZYF-<5CHJ2*.=1_A8K3_,MUNE;Q$XN\1`7E_,MVI<& M=RS\\X?,ELU^NHK@L_9*Z]DE21:D]^ MW8N+^'6G\4,2Y?B7',N?\UA^(EN../:8CN[G/5;FY\W%D7L:=T_+U7:!4L1Z M2C]I7G7E:5YU[6G:J6[U303VFJC&CTCL^N+C^Y<]DWG8?SZ2K;MH9[^;!\UU M-\YS5TC,3]N+J&#S::+>V'?MT^)BL=Q$0PJNNR15?D5/WESM1TTWM[G0WC*. M^/!X]5#L=9OA2PS;C?*3P%",I(^6D@E22*E)-:D@MJ2/U MI,&0R74=]Q8NUY==>[!?E28'-;?:1$T+R,JJ#W3SJ4-*DG%202E)% MJDD-J25UI)XT&+(;P#4/X8O3OK`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`,H[*206I)%6DFM206E)' MZDF#(9M?JCM[6;5.W=I\6OIJ^X M[FISZ*Y\&5U-%.U`X]-;\R@_,2/EI()4DBI236I(+:DC]:3!D(WTN%9JPU9J MHF!ON2-EI)Q4D$I21:I)#:DE=:2>-!BR^<6MU#-/:?9+FY&BDHS?QIE'S25Y MF.@IYZB"5)(J4DUJ2"VI(_6DP9"-]+A^:<-^:2)3DNR7."HG%:225)%J4D-J M21VI)PV&;'ZI?NGHJU0V[)4F"B\S)&43N4]8SF>K%M$9V7P>Y8NWX+I*4C5/ M#%6*X^NB,9C^/\JL?S+K,]M@>UU'MA]N.:B+7M`61 M1J<)=].HX!J>+#51;_O;L[BYGSA>-+:Z/%^OH]U/,:_(/^#2SPK>.)]'S?<3 M-U=/H]Q'PX)'$YT@:I+K"J[AV)\:;7DGNN3$^#'W?N+TF"]T<4YT%##,*])C MMELTU>,=_0S;LK^;R'67033QV8AI5'`94^8G:I6'B4@^][=X-KVE?Z;_V5HH M_(KVOPRPS[CDS55^U),W5_N;"T XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT

4. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Equity Method Investments and Joint Ventures [Abstract]
Beginning balance	$ 32,123
Equity earnings in these joint ventures	1,102	1,067
Distribution of earnings	(3,041)	(1,866)
Ending balance	$ 30,184

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References+ Details

XML 15 R9.htm IDEA: XBRL DOCUMENT

2. NEW ACCOUNTING STANDARDS

3 Months Ended

Mar. 31, 2015

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

NEW ACCOUNTING STANDARDS

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

+ Details

EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\U-V5D-#%C,E\W-F$V7S1C86-?.#0Y8E]C8V0T M-#DP-&(U,#@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C%?3D%455)%7T]&7T)54TE.15-37T%.1%]"05-)4SPO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/C)?3D577T%#0T]53E1)3D=?4U1! M3D1!4D13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C=?4U5"4T51545.5%]% M5D5.5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C-?14%23DE.1U-?4$527U-(05)%7U1A8FQE#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/C1?24Y615-4345.5%])3E]*3TE. M5%]614Y455)%4S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/C1?24Y615-4345.5%])3E]*3TE.5%]614Y4 M55)%4S0\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/C9?1D%)4E]604Q515]-14%3 M55)%345.5%-?1&5T83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C9?1D%)4E]604Q515]-14%355)%345.5%-?1&5T83$\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I3='EL97-H965T($A2968],T0B M5V]R:W-H965T&-E M;"!84"!O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\U-V5D-#%C,E\W-F$V7S1C86-?.#0Y8E]C8V0T-#DP M-&(U,#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3=E9#0Q8S)? M-S9A-E\T8V%C7S@T.6)?8V-D-#0Y,#1B-3`X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!);F9O2`P-RP@,C`Q-#QB2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!A(%9O;'5N=&%R>2!& M:6QE'0^3F\\2=S(%)E<&]R=&EN9R!3=&%T=7,@0W5R'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q-3QS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA"!A6%B;&4L(&%C8W)U960@97AP96YS97,@86YD(&]T M:&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#(L,C6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B M;&4L(&YE="!O9B!C=7)R96YT('!O3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\U-V5D-#%C,E\W-F$V7S1C86-?.#0Y8E]C M8V0T-#DP-&(U,#@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3=E M9#0Q8S)?-S9A-E\T8V%C7S@T.6)?8V-D-#0Y,#1B-3`X+U=O'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ-"PR.30\'!E;G-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!T'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`H=7-E9"!I;BD@;W!EF%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PR.30\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&ES=&EN9R!A;F0@<'5R8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-V5D-#%C,E\W M-F$V7S1C86-?.#0Y8E]C8V0T-#DP-&(U,#@-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-3=E9#0Q8S)?-S9A-E\T8V%C7S@T.6)?8V-D-#0Y,#1B M-3`X+U=O'0O:'1M;#L@8VAAF%T:6]N+"!#;VYS;VQI M9&%T:6]N(&%N9"!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'`@ M'0M:6YD96YT.B`P+C5I;B<^5V4@<')O=FED M92!D:6%G;F]S=&EC(&EM86=I;F<@2`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`P+C5I M;B<^4F%D3F5T('!R;W9I9&5S(&YO;BUM961I8V%L+"!T96-H;FEC86P@86YD M(&%D;6EN:7-T2X@5&AR;W5G:"!T:&5S92!M86YA9V5M M96YT(&%G6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M M:6YD96YT.B`P+C5I;B<^5V4@:&%V92!D971E'!E;G-E2XF(S$V M,#L@0E)-1R!A;F0@=&AE($(F(S,X.T,@16YT:71I97,@;VX@82!C;VUB:6YE M9"!B87-IF5D("0R-2XU(&UI;&QI;VX@86YD("0R,"XV(&UI M;&QI;VX-"F]F(')E=F5N=64L(&YE="!O9B!M86YA9V5M96YT('-E2P@86YD("0R-2XU M#0IM:6QL:6]N(&%N9"`D,C`N-B!M:6QL:6]N(&]F(&]P97)A=&EN9R!E>'!E M;G-E2P@;V8@=VAI8V@@)#2!T M;R!T:&4@=&5C:&YI8V%L('!O'0M:6YD96YT.B`P+C5I;B<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2!B86QA;F-E2`D.#0N,R!M:6QL:6]N(&%N9"`D-SDN-R!M:6QL:6]N M+"!R97-P96-T:79E;'DL(&]F(&%C8V]U;G1S(')E8V5I=F%B;&4@86YD(&%P M<')O>&EM871E;'D@)#@N-R!M:6QL:6]N(&%N9"`D.2XP(&UI;&QI;VXL#0IR M97-P96-T:79E;'DL(&]F(&%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U960@ M;&EA8FEL:71I97,L(')E;&%T960@=&\@0E)-1R!A;F0@=&AE($(F(S,X.T,@ M16YT:71I97,@8V]M8FEN960N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2!B92!R97%U:7)E9"!T;R!P0T*;W!E6QE/3-$)V9O;G0Z(#AP="!4:6UE2!W:&5R92!W92!C;VYT M2!P2!B92!B87-E9"!O;B!T:&4@<')A8W1I8V4@9W)O=7`F M(S$T-CMS('!R;V9E2!P6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M:6YD96YT.B`P+C5I;B<^5&AE(&%C8V]M<&%N>6EN9R!U;F%U M9&ET960@8V]N9&5N2!F M;W(@8V]N9F]R;6ET>2!W:71H(%4N4RX@9V5N97)A;&QY(&%C8V5P=&5D(&%C M8V]U;G1I;F<@<')I;F-I<&QE2!I;G1E65A65A6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^1'5R M:6YG('1H92!P97)I;V0@8V]V97)E9"!I;B!T:&ES(')E<&]R="P@=&AE'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UEF5D M#0IB>2!"4DU'(&%N9"!T:&4@0B8C,S@[0R!%;G1I=&EE'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6]R M6]R2!O;B!H:7-T;W)I M8V%L(&-O;&QE8W1I;VX-"F5X<&5R:65N8V4I(')E;&%T960@=&\@<&%T:65N M=',@86YD(&-O<&%Y;65N="!A;F0@9&5D=6-T:6)L92!A;6]U;G1S(&9O2!P87EO6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M M:6YD96YT.B`R-"XU<'0G/B8C,38P.SPO<#X-"@T*/'`@'0M:6YD96YT.B`P+C5I;B<^3W5R(')E=F5N=64L(&YE="!O9B!C M;VYTF5D(&EN('1H92!F M;VQL;W=I;F<@=&%B;&4@*&EN('1H;W5S86YD6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#AP="<^/&(^36%R8V@@,S$L/"]B/CPO9F]N M=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#AP="<^/&(^,C`Q-3PO8CX\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@F4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=W:61T:#H@,30E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#AP M="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,30E M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-2PW-S0\+V9O;G0^ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O M;G0MF4Z(#AP="<^4V5R=FEC92!F964@6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F6QE/3-$)V)OF4Z(#AP="<^*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE/3-$ M)V9O;G0M6QE M/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^,34W+#4U-3PO9F]N=#X\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@6QE/3-$ M)W9EF4Z(#AP="<^4F5V96YU92!U;F1E M6QE/3-$)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,36QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF%B;&4@=F%L=64N#0I792!E7!E(&]F('!A>65R(&]V97(@86X@ M,3@M;6]N=&@@;&]O:RUB86-K('!E2!T M;R!P87D-"FYO2X@5&AE2!C:&%N9V4@86YD(&-A;B!H879E M(&%N(&EM<&%C="!O;B!C;VQL96-T:6]N('1R96YD6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE"!R871E"!R97!O2P@8GD@=&AE(&%M;W5N="!O M9B!A;GD@=&%X(&)E;F5F:70@=&AA="P@8F%S960@;VX@879A:6QA8FQE(&5V M:61E;F-E+`T*:7,@;F]T(&5X<&5C=&5D('1O(&)E(')E86QI>F5D+B!7:&5N M(&ET(&%P<&5A"!AF%B;&4@=F%L=64N($9O M"!P M;&%N;FEN9R!S=')A=&5G:65S+"!I;B!D971EF5D+CPO<#X-"@T*/'`@'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT M.B`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`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2X@5V4@:&%D(&YE="!L;W-S(&%T=')I8G5T86)L92!T;R!2861.970L M($EN8RX@8V]M;6]N('-T;V-K:&]L9&5R2XF(S$V,#LF(S$V M,#M792!A;'-O(&AA9"!S=&]C:VAO;&1E2X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I M;B<^5V4@;W!E&5D+6-O2!O9B!F:6YA;F-I;F<@=6YD M97(@8W)E9&ET(&%R6QE/3-$)V9O;G0Z(#AP="!4:6UE2!N965D'!E;F1I M='5R97,L#0ID96)T('-E2!T;R!M965T(&]U6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^3VX@82!C M;VYT:6YU:6YG(&)A6UE;G1S(&)U="!T:&4@9V5N97)A;"!T M:6UI;FF4@;W(@2!W:71H(&-A6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M:6YD96YT.B`P+C5I;B<^5V4@86YD(&]U2!S96-U6QE/3-$)V9O M;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$ M)V)OF4Z(#AP="<^/&(^1F%C M92!686QU93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6EN9R!686QU93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9EF4Z(#AP="<^1FER6QE/3-$)W=I9'1H.B`R M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,30E.R!T97AT+6%L:6=N.B!R:6=H M="<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE M/3-$)V9O;G0MF4Z(#AP="<^*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T M:#H@,B4G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)2<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#AP="<^ M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3@P+#`P,#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'0@6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^,36QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;FF4Z(#AP="<^)#PO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^/'4^,C`Q-"!!;65N9&UE M;G0@=&\@=&AE(%)E9FEN86YC92!!9W)E96UE;G0-"F%N9"!396-O;F0@3&EE M;B!#'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!T:&%T(&-E M0T*8GD@96YT97)I;F<@:6YT;R!A('-E8V]N9"!A;65N9&UE M;G0@=&\@=&AE(%)E9FEN86YC92!!9W)E96UE;G0@;VX@36%R8V@@,C4L(#(P M,30@*'1H92`F(S$T-SLR,#$T($%M96YD;65N="8C,30X.RD@=&\@<')O=FED M90T*9F]R+"!A;6]N9R!O=&AE'0M:6YD96YT.B`P+C5I;B<^ M/&D^)B,Q-C`[/"]I/CPO<#X-"@T*/'`@'0M M:6YD96YT.B`P+C5I;B<^/&D^4V5C;VYD($QI96X@0W)E9&ET(&%N9"!'=6%R M86YT>2!!9W)E96UE;G0N#0H\+VD^4F%D;F5T($UA;F%G96UE;G0@96YT97)E M9"!I;G1O(&$@4V5C;VYD($QI96X@0W)E9&ET(&%N9"!'=6%R86YT>2!!9W)E M96UE;G0@9&%T960@36%R8V@@,C4L(#(P,30@*'1H92`F(S$T-SM396-O;F0@ M3&EE;B!#2!2861N970@ M36%N86=E;65N="!O9B`D,3@P+C`@;6EL;&EO;B!O9B!S96-O;F0@;&EE;B!T M97)M#0IL;V%N'!E;G-E6QE/3-$)V9O;G0Z(#AP="!4 M:6UE7!E6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;B<^/&D^)B,Q-C`[/"]I/CPO<#X-"@T* M/'`@'0M:6YD96YT.B`P+C5I;B<^/&D^26YT M97)E2!T:&4@,C`Q,PT*06UE;F1M96YT+"!W:&EC:"!A M2!T:&4@,C`Q-"!!;65N9&UE;G0L('1H92!! M9&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF%T:6]N M(&]F#0IT:&4@=&5R;2!L;V%N2!T:&4@,C`Q-"!!;65N9&UE;G0L(&AA2!P87EM96YTF%T:6]N(&EN8W)E87-E9"!B>2`D,38N."!M:6QL M:6]N(&9R;VT@<')E+6%M96YD;65N="!T97)M6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!I;G1E'0M:6YD96YT.B`P+C5I;B<^/&D^4F5S=')I8W1I=F4@ M0V]V96YA;G1S+B`\+VD^26X@861D:71I;VX@=&\-"F-E2!T M:&4@,C`Q-"!!;65N9&UE;G0L('!L86-E2P@'0M:6YD96YT.B`P+C5I;B<^ M/&D^1FEN86YC:6%L($-O=F5N86YT2!T:&4@,C`Q-"!!;65N9&UE;G0@8V]N M=&%I;G,@9FEN86YC:6%L(&-O=F5N86YT'!E;F1I='5R97,N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^/&D^ M179E;G1S(&]F($1E9F%U;'0N(#PO:3Y);B!A9&1I=&EO;B!T;R!C97)T86EN M#0IC=7-T;VUA2!A;GD@ M:6YT97)E6%B;&4@=6YD97(@=&AE(%)E9FEN86YC92!!9W)E96UE;G0L(&%S M(&%M96YD960@8GD@=&AE(#(P,30@06UE;F1M96YT+"!W:71H:6X@9FEV92!D M87ES(&%F=&5R('1H92!D=64@9&%T92P@9F%I;'5R90T*;V8@86YY(&QO86X@ M<&%R='D@=&\@8V]M<&QY('=I=&@@86YY(&-O=F5N86YT(&]R(&%G2!C;VYT86EN960@:6X@=&AE M(&QO86X@9&]C=6UE;G1S(&ES(&9A;'-E(&EN(&$@;6%T97)I86P@'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^/&D^)B,Q-C`[/"]I/CPO<#X- M"@T*/'`@'0M:6YD96YT.B`P+C5I;B<^/&D^ M26YT97)E6QE/3-$)V9O;G0Z(#AP="!4:6UE6UE;G1S M+B`\+VD^5&AE6UE;G0-"F5V M96YT'0M:6YD M96YT.B`P+C5I;B<^/&D^)B,Q-C`[/"]I/CPO<#X-"@T*/'`@'0M:6YD96YT.B`P+C5I;B<^/&D^5&5R;6EN871I;VXN(#PO M:3Y4:&4@;6%T=7)I='D@9&%T92!F;W(@=&AE#0I396-O;F0@3&EE;B!497)M M($QO86YS(&ES('1H92!E87)L:65R('1O(&]C8W5R(&]F("AI*2!-87)C:"`R M-2P@,C`R,2P@86YD("AI:2D@=&AE(&1A=&4@;VX@=VAI8V@@=&AE(%-E8V]N M9"!,:65N(%1E'0M:6YD96YT.B`P+C5I;B<^/&D^4F5S=')I8W1I=F4@0V]V96YA;G1S+B`\ M+VD^26X@861D:71I;VX@=&\-"F-E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE2!L;V%N(&]R(&%N M>2!F964@;W(@;W1H97(@86UO=6YT('!A>6%B;&4@=6YD97(@=&AE(%-E8V]N M9`T*3&EE;B!497)M($QO86YS('=I=&AI;B!F:79E(&1A>7,@869T97(@=&AE M(&1U92!D871E+"!F86EL=7)E(&]F(&%N>2!L;V%N('!A2!W:71H(&%N>2!C;W9E;F%N="!O2!C;VYT86EN960@:6X@=&AE#0IL;V%N(&1O8W5M M96YT&5R8VES92!O=&AE M'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6UE;G1S(&]F#0IT:&4@2!A;F0@86UO;F<@ M4F%D;F5T($UA;F%G96UE;G0L($EN8RXL(&%S(&ES2!W97)E('-C:&5D=6QE9`T*=&\@97AP:7)E(&]N M($%P2!A;F0@86QL(&]U M='-T86YD:6YG('-E;FEO2!C97)T86EN(')E2!T:6UE+"!O;B!-87)C:"`R,"P@,C`Q-"`H M=&AE("8C,30W.T-O;G-E;G0-"E!A>6UE;G0@1&5A9&QI;F4F(S$T.#LI+B!! M6UE;G0@9&%T92!P6EN9R!A;6]U;G0@:6YC;'5D:6YG(&1I2!E>'1I;F=U:7-H;65N="!O9B!D96)T(&]F("0Q-2XU(&UI;&QI;VX@ M=V%S(')E8V]R9&5D(&EN('1H92!F:7)S="!Q=6%R=&5R#0IO9B`R,#$T+CPO M<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#AP M="!4:6UE&EM871E;'D@)#8N.2!M:6QL:6]N M(&EN('1O=&%L+"!I;F-L=61I;F<@87!P2`D-#,L,#`P(&]F M#0IA8V-R=65D(&%N9"!U;G!A:60@:6YT97)E&-L M=61I;F<@=&AE(%)E9&5M<'1I;VX@1&%T92XF(S$V,#L@07,@;V8@=&AA="!D M871E+"!W92!C;VUP;&5T960@=&AE('-A=&ES9F%C=&EO;B!A;F0-"F1I'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)V9O;G0Z(#AP="!4:6UE2!A2P@8V]N2!E=F%L=6%T:6YG('1H92!I;7!A8W0@;V8@=&AE($=!05`@=7!D871E M(&]N(&]U<@T*8V]N'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2`R,#$U+"!&05-"(&ES7!E2!A9&]P=&EO;@T*:7,@<&5R;6ET M=&5D+"!I;F-L=61I;F<@861O<'1I;VX@:6X@86X@:6YT97)I;2!P97)I;V0N M)B,Q-C`[5V4@87)E(&-U2!E=F%L=6%T:6YG('1H92!I;7!A8W0@ M;V8@=&AE($=!05`@=7!D871E(&]N(&]U'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\U-V5D-#%C,E\W-F$V7S1C86-?.#0Y8E]C8V0T-#DP-&(U,#@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3=E9#0Q8S)?-S9A-E\T M8V%C7S@T.6)?8V-D-#0Y,#1B-3`X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'`@'0M:6YD96YT.B`P+C5I;B<^16%R M;FEN9W,@<&5R('-H87)E(&ES(&)A&-E<'0@6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W!A9&1I;F6QE/3-$ M)V)OF4Z(#AP="<^/&(^5&AR M964@36]N=&AS($5N9&5D($UA6QE/3-$)W9E'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)V)OF4Z M(#AP="<^/&(^,C`Q-#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E MF4Z(#AP="<^3F5T M(&QO6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3,E.R!T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ MF4Z M(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,3,E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z(#AP="<^ M*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M XML 17 R29.htm IDEA: XBRL DOCUMENT

5. STOCK-BASED COMPENSATION (Details - RSU's) (RestrictedStockMember, USD $)	3 Months Ended
	Mar. 31, 2015
RestrictedStockMember
RSA's outstanding, beginning balance	942,023
RSA's granted	724,423
RSA's vested	(785,253)
RSA's outstanding, ending balance	881,194
Weighted-Average Remaining Contractual Term	1 year 2 months 16 days
Weighted-average fair value, beginning balance	$ 1.96
Weighted-average fair value, granted	$ 8.66
Weighted-average fair value, vested	$ 4.53
Weighted-average fair value, ending balance	$ 5.17

XML 18 R28.htm IDEA: XBRL DOCUMENT

5. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) (Outstanding Options and Warrants [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Outstanding Options and Warrants [Member]
STOCK BASED COMPENSATION
Begining Balance	2,092,509
Granted	0
Exercised	(325,000)
Canceled or expired	(25,000)
Ending Balance	1,742,509
Exercisable at the end	1,699,176
Weighted Average Exercise price Per Common Share
Begining Balance	$ 3.58
Granted
Exercised	$ 2.69
Canceled or expired	$ 2.22
Ending Balance	$ 3.76
Exercisable at the end	$ 3.80
Weighted Average Remaining Contractual Life
Ending Balance	1 year 11 days
Exercisable at the end	11 months 19 days
Aggregate Intrinsic Value
Aggregate value outstanding	$ 8,230,904
Aggregate value exercisable	$ 7,955,304

XML 19 R30.htm IDEA: XBRL DOCUMENT

5. STOCK-BASED COMPENSATION (Details Narrative) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Intrinsic value of options and warrants exercised	$ 1,900	$ 16
Unrecognized stock-based compensation expense	$ 30
Unrecognized expense weighted average period	1 year 7 months 6 days
Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards	7,944,958
Shares available for future issuance, common stock	3,055,042

XML 20 R31.htm IDEA: XBRL DOCUMENT

6. FAIR VALUE MEASUREMENTS (Details) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	$ 394,559us-gaap_DebtInstrumentFairValue	$ 399,750us-gaap_DebtInstrumentFairValue
Senior Second Lien Term Loan	180,000us-gaap_LongTermDebtFairValue	180,000us-gaap_LongTermDebtFairValue
Level 1
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	0	0
Senior Second Lien Term Loan	0
Level 2
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	395,052	394,753
Senior Second Lien Term Loan	178,200	178,200
Level 3
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	0	0
Senior Second Lien Term Loan	0	0
Total Fair Value
FAIR VALUE MEASUREMENTS
Senior First Lien Term Loan	395,052	394,753
Senior Second Lien Term Loan	$ 178,200	$ 178,200

XML 21 R8.htm IDEA: XBRL DOCUMENT

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION

Significant Accounting Policies

Revenues

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):

	Three Months Ended
	March 31,
	2015			2014

Commercial insurance	$	99,885		$	98,881
Medicare		37,036			36,202
Medicaid		5,470			5,774
Workers' compensation/personal injury		7,400			9,635
Other		15,239			8,271
Service fee revenue, net of contractual allowances and discounts		165,030			158,763
Provision for bad debts		(7,475	)		(6,893	)
Net service fee revenue		157,555			151,870
Revenue under capitation arrangements		23,712			17,006
Total net revenue	$	181,267		$	168,876

Provision for Bad Debts

Deferred Tax Assets

Deferred Financing Costs

Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Liquidity and Capital Resources

	Face Value		Discount			Total Carrying Value
First Lien Term Loans	$	394,559	$	(8,681	)	$	385,878
Second Lien Term Loans	$	180,000	$	(2,558	)	$	177,442
Total	$	574,559	$	(11,239	)	$	563,320

Our revolving credit facility has a $24.7 million aggregate principal amount outstanding as of March 31, 2015.

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

The 2014 Amendment provides for the following:

Financial Covenants. The Refinance Agreement, as amended by the 2014 Amendment contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

The Second Lien Credit Agreement provides for the following:

Senior Notes

XML 22 R32.htm IDEA: XBRL DOCUMENT

6. FAIR VALUE MEASUREMENTS (Details Narrative) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Line of credit	$ 24,700	$ 15,300

XML 23 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$ 154	$ 307
Accounts receivable, net	153,258us-gaap_AccountsReceivableNetCurrent	148,235us-gaap_AccountsReceivableNetCurrent
Current portion of deferred tax assets	17,246us-gaap_DeferredTaxAssetsGrossCurrent	17,246us-gaap_DeferredTaxAssetsGrossCurrent
Due from affiliates	1,778us-gaap_DueFromRelatedPartiesCurrent	1,561us-gaap_DueFromRelatedPartiesCurrent
Prepaid expenses and other current assets	21,884us-gaap_PrepaidExpenseAndOtherAssets	24,671us-gaap_PrepaidExpenseAndOtherAssets
Total current assets	194,320us-gaap_AssetsCurrent	192,020us-gaap_AssetsCurrent
PROPERTY AND EQUIPMENT, NET	222,171us-gaap_PropertyPlantAndEquipmentNet	223,127us-gaap_PropertyPlantAndEquipmentNet
OTHER ASSETS
Goodwill	200,304us-gaap_Goodwill	200,304us-gaap_Goodwill
Other intangible assets	46,856	47,624
Deferred financing costs, net of current portion	5,560	6,122
Investment in joint ventures	30,184	32,123
Deferred tax assets, net of current portion	38,912	35,334
Deposits and other	4,098us-gaap_DepositsAssets	4,026us-gaap_DepositsAssets
Total assets	742,405us-gaap_Assets	740,680us-gaap_Assets
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY
Accounts payable, accrued expenses and other	102,275	97,816
Due to affiliates	1,304us-gaap_DueToAffiliateCurrent	6,289us-gaap_DueToAffiliateCurrent
Deferred revenue	1,762us-gaap_DeferredRevenue	1,964us-gaap_DeferredRevenue
Current portion of notes payable	19,437us-gaap_NotesPayableCurrent	19,468us-gaap_NotesPayableCurrent
Current portion of deferred rent	2,192us-gaap_DeferredRentCreditCurrent	2,100us-gaap_DeferredRentCreditCurrent
Current portion of obligations under capital leases	5,691us-gaap_CapitalLeaseObligationsCurrent	5,637us-gaap_CapitalLeaseObligationsCurrent
Total current liabilities	132,661us-gaap_LiabilitiesCurrent	133,274us-gaap_LiabilitiesCurrent
LONG-TERM LIABILITIES
Deferred rent, net of current portion	21,798us-gaap_DeferredRentCreditNoncurrent	20,965us-gaap_DeferredRentCreditNoncurrent
Line of credit	24,700us-gaap_LineOfCredit	15,300us-gaap_LineOfCredit
Notes payable, net of current portion	545,988us-gaap_LongTermNotesPayable	551,059us-gaap_LongTermNotesPayable
Obligations under capital lease, net of current portion	4,697	6,143
Other non-current liabilities	6,022us-gaap_OtherLiabilitiesNoncurrent	6,241us-gaap_OtherLiabilitiesNoncurrent
Total liabilities	735,866us-gaap_Liabilities	732,982us-gaap_Liabilities
STOCKHOLDERS' (DEFICIT) EQUITY
Common stock - $.0001 par value, 200,000,000 shares authorized; 43,810,279, and 42,825,676 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	4us-gaap_CommonStockValue	4us-gaap_CommonStockValue
Paid-in-capital	181,572us-gaap_AdditionalPaidInCapital	177,750us-gaap_AdditionalPaidInCapital
Accumulated other comprehensive loss	(149)	(112)
Accumulated deficit	(176,834)	(172,280)
Total RadNet, Inc.'s stockholders' deficit	4,593us-gaap_StockholdersEquity	5,362us-gaap_StockholdersEquity
Noncontrolling interests	1,946us-gaap_MinorityInterest	2,336us-gaap_MinorityInterest
Total equity	6,539	7,698
Total liabilities and equity	$ 742,405	$ 740,680

XML 24 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $) In Thousands, except Share data	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income / Loss	Total Radnet Inc Equity	Noncontrolling Interest	Total
Beginning balance, value at Dec. 31, 2014	$ 4	$ 177,750	$ (172,280)	$ (112)	$ 5,362	$ 2,336	$ 7,698
Beginning balance, shares at Dec. 31, 2014	42,825,676
Issuance of common stock upon exercise of options, shares issued	260,180
Issuance of common stock upon exercise of options, value		324			324		324
Stock-based compensation		3,498			3,498		3,498
Issuance of restricted stock and other awards, shares	724,423
Distributions paid to noncontrolling interest						(468)	(468)
Change in cumulative foreign currency translation adjustment				(37)	(37)		(37)
Net (loss) income			(4,554)		(4,554)	78	(4,476)us-gaap_ProfitLoss
Ending balance, value at Mar. 31, 2015	$ 4	$ 181,572	$ (176,834)	$ (149)	$ 4,593	$ 1,946	$ 6,539
Ending balance, shares at Mar. 31, 2015	43,810,279

- Definition

Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References+ Details

- Definition

Number of share options (or share units) exercised during the current period.

+ References+ Details

ZIP 25 0001019687-15-001847-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-15-001847-xbrl.zip M4$L#!!0````(`!*!JT:F?'AK!*$``#M]!0`1`!P`D]YQ[#C5;9/XVFYR^ZD#D9"$AB)4@+2M]^O?.5A(2*)D6I:7V,IT M4IM8SKX"9-[\ZWH8D4LF%1?QVXU&K;Y!6!R(D,?]MQN_GU75W58G%)KX3\ MIFJ!*+?=N4AEP+*])`UCEOS9J/_]8_.XWFHU&ENUZQZ0<$P3&&[6&ULX@'\U M&A>-QGZ[L;^U4Q)40I-49:#JUW7[QRQ_<]V5$=_'OPE((5;[UXJ_W?"HNVK5 MA.QO-NOUQN9_/_YV'@S8D%9YK!(:!VS#K8IX_*UH76-O;V]3C[JI,S,1N(/1 MVL3A+E7YSHC@@ODSF,!HF&0+_,E;FV9P8BHOG+IMIG(W-613\Q0+:GUQN0D# M,+_1KM8;U5;#39>L-Q?E[4T8=1.Y$NUF8V<1?6:&6Y"J:I_24;:@1U573[8# MB,S6)#(P(D7$5.$:/5*P*!9QG`Z+\0H3N9F,1VP3)E5A%I,\R-;=O&AR`>"` MCXNQTR,%V,DPSD5LS`>,;ZAGH@%M.,M`;=I76F?/6(]H1=P?:/'@'E6WH':M MP@T[C$#?;BB._F*#;+JMC*4$(D[8=4)X^';C1(JAPZW>2(3YN57-X6?+6)SP M9)P]S9[S$$=Z'!R4QI)-,,\IV5'GUXV?T6AW]NI;S>TWF].+6I?/Y?*@^][Y; MWAK_E!0PR8VLE$GM:J/Y73/)$G`_3+(6V_8LMOU=:M6$Q;:7L=CV?5KL?,_X M9Y"J1`S__)PF*%C,\3Z/$DC'%/SRE4H)PE8?V;#+Y*.)).+-?@NPWFX40?.PVB]%[ M`<[_SQ/*I/D;NV11XWGH2T;:NW'VXR\`A\I@,-:$&D6:F3_+BH?6 MH0<.()A8G' M5H9UF'A"8>(AE,'E#!E!;H>+6+`"TD1UK)_6K)_2+L_8RJ1/$A8 M>)Z(X-OS$/Y4O\D]+J3UF=MXZWOO@K<>)"/Z'CO?$Q[C(:)%'11VY[MF$A)P MK^EV9^A>]_4796-K M=7ED=7FD3&PM]ZD`8\=2`Z#(!VF$3`O_)P,F$3&239`]EZR3AR(X3,Y8BJ; M<)3EQSK. M,O7+6HF>E!(]33!.N%3);YS%%TP.?Q,T?B9Z,!`R09*. M63>9>@M\#LDO2^[G#.:$+TOP\VA^(9)W_G^"1<]:ZH7#+T+FLP>F!:\A-)H[ M]?INO;G]O8O_.WGWXB$^KK/XNL7ZO9MUM7A3FW'];:"G\FV@QVT]KO7@">K! MRG.'-.9&"7X_/YX1YY!1E4KVL_T*YC[,<9NYH4D0N-N<_<\'%&KLN2`LO_2D MI6$`?J=SX(3\$O1HEK>X]A-^$Q,_6SNK1K?@P32.1;MZ0(]9+(8\O@GLS7R9 MAENTL1N?X$()AIXR&8"NWB"U$?Q87F8AX_OOM?Z?L3Z'*`T*C%_+)58_S_#S MH(L^[GE&PT\LJ9!.'-3>;,[;;A;<$5`B:=2)0W;]*QN7AN=[I+F[^>".19"B MV:-G*0VE4:_^Q^SO+R_:]E0;]WN3"I3>WW<>EI:JBX:+=IM5@*\LBGZ-Q55\#DHJ8A9VE$HA M,I0%^TGX"C!GMUFP7T24QI#MC?6GL-62X*9V*5!OPX'FG4[8/AS$;AL)P?,I2.G4O1X\IM0I6$0=*QZ$H9O$K*`#\$`WVY4 M6V`E[?;.-OBN-YNS`&X'NNB+K8M!-YJMG:V5P%[B_8$;N+*UU;XWS.8>VS\B M3J7.?1;BM[-;$CE=:P]$%(*',BN[G5*5*[-'5^72R M\7.KN35+UZVP?CBZY[^=?".9S>UZ8W>E9'ZD,>WKH\43QM09NV1Q6CIC6:AK MS;;^)R%R9`M!+8W/K9WW[?#Q4H9<3(:OGL(6&Z+YN,>-PFRWF]M[[?;>1'ZR M`-@TJZ;#A'\"[))<;S97B7?S"Z-)\;>PVMG:F,"P&<0=, M2G&JL;.C$\/;8^)9O/YDVO*9Q03TZ6V7`5N*\J7!GE+Y6>J++:&>"J%+N[S2 M##B=XU=K@%&C$*5Y(%>$92&_'@1+`^,P309"\O^;2D7F\G!>DN'^-:="[*9! MW1&K69X]#%8F:;H3G]JMW4:]N;.W`"$#Y0[(E&9/N[G;W-K>V;X[,C>D-ZMD MSX+DYO99U^H8M0`MEULXFWQ'%0\.X_"81VE2N@0HYR&J]5K#\Q`W@%X!IC>F MU`LP;2V/Z5?&^P-X?GC))"3DGU*LA3[W]%)/%'=F]5R%V&GOM)J>GBZ'T/V1 MM5@N\\B"\(+78%9-UJ*\[T1(@!&;)FLPOH`27M$`DR#83_\&J2/^%OX%M3]6 M7H4IZM*=P=;.1'RX'U0?CR%+]"MW'X$A!0#U=2U\E\;[8NUH-2<[&;?&XJ'(*/D)NF="['(GCRNG+\]ZU(68PWBMV/BO M3(?H5L"G4)L]N5TAU_9@K49KVWN[4UW'E2/Z='BQ$M5_61Q;TGX>@4D+SS*G M[KWK&ZX?Y!*W!98(83N8-K1*'KK.173FH)/'0O)D['*'8Q9(!LQ#&H[QPA\F M&\BG>%W2-3O8)+(@_&FM46Y^]8#]9\'YV5#->GQ9(E MOG^U9N*JKHX]#J_>7^.ET)2K`4[[W,,7*S]0'L\]35_6H#S2RL!<%9Y+U,Q; M[:W)VY;+X`O/CZ@:G$J!%_7#=^/?(4OHQ)]'>%D6=CL$<5U"3L'4$2#-XU1? M!M.#J\J4&SOM[%)[,27$-4>1HK5QMYVLU&&QI)8 MW3^-RW3M&WO-AZ?QA,C!HGVR.TK(!1\R13ZQ*W(FAC2NF`<5 M<@ZU7^^`#*GL\WB?U`\(0JGR&-_NA-]K6SS>^*F?''QE9&0D3T).^[$`PPT( M<*"/S5?%Y"4/``)W;>>?_MEH'<`H)$PP#T@2J"8L6_'JXUGG=07(&H[TN3$D M6:(OZ6@P)J^.+F!D)!2'TB,F;,@5OB`Z,>7T/VSM98S!-_NP0@2IZ^UX3(YHQ"'CBSFM(.!Q1)&:DPCJ MN!`>'0.*4*<#]2C??\-B-JZ0LX$`67443M;TP*!&X@\AO]5^HL/1P3\;V_6# M_*?/J;146"\"Z2I7C%`"VMJ/&+'OS1+`A?2,V=,(.&1?1B*C5(+4@$.HA)LC M5!L-T?QU3XKI4?*`4"\&^@H=/+;-8"4B$`8*+.>,?O<>?<8R]()HK(U4!$Z#BN8D!8I5W%P65)B*@:E2)5 M*13+(6P%DT'/T'I[/1YQ+1/]?COL1I!$HTA'\82F<9C;PJXOV3`E?4R+\"S'!K/ MH)4'3QBI#!4Y$B'O@2VC9_:5Z/#\R%,BC=X` M*>`F34B?@>I2U#7@MM&+,;GBR8#0U\!RE?;PA0,T.F;>V`(E,18-$1P-.1E/P1#P])]FIOGGGQ9?'E\Y[WV>2K\SWBAHE MM'.8AJF2Q0F3AZL8(`SI7[HU2RZ%EK_#13N7;!U&WVPA6C)2")$:5&M,NB!8 M%!W\K*&'#+880FH$2Q@F-!J'Q0O1=U"$15R^0LG?*>0@F)->PE*0\1A25:-* MV7=`E,7JTO$I0]^(D0RH,B++&:^QF64^L7(#'&H$@\S#>68-%@7#/.#.$,(! MI$_]6)MOC&DA!Q=G%WKJLGU@G#Q^#$\,(8)`(@:2'FJ30^1>-0T"HAOQOG$$ M@`7M*B&[D"PJI:%7G$^5>%D29P"6#*5FJ`';[4'U4)G$$CQ.!"FN2%"4Z!8T M*EWF8XY[93+IQ`X_9"DX]4PI*JB5SFZTTD(&S2YQ@QZ0K30M`9=!.L0+%#HT M9D7#OH80,@2;2:60NX8`U.WLJ1:R!N%H0_'K;%JGT8DPB\`E0=;M[>6)8%;1 M;.IF;K@C.@-QA0O!7<(XB5D?;%4[.>T^@?N@.]^8*6EREL)^V.L0F"_@+L94 MK-L10@:)EA9FUWC,S"U$.E&3E;SBTTNRDJ^B'>D(0MTU.)2$6;-J-&NM M'QU<,7&#"<]V@6M8[U.MUY-E9HT<2T>YR:4!`6T_.W(G-0W1HRXG7T?=/+T277RI<_'N)@B"5];2F2[X MH1Q'8."GXZP#HU+0B@PYO^'@(K9?/*""P%AHXA:6]9%-]G(XTV$((`UX5R=T MA/8I?M'*.EDH\;'/`;B@8PZT(W7]EQH!`\4RU"9KH'9IE'$M@"C%3$,%&PQ8 M;VHL?*7&.A:84'%I2I=%'#8T8&GC6RXG60MVF^6:<(P M8E$H->20ULW8?'@&`EGB5-3X=5@9,Q8:A6+7D&4FMD^"#R`%5LS1:2HKW1#) M]+`"/C[AI@A&C:1C8?+:F/">S@"[YNU?6[5EPD6],(VLV*ODIC6Z9E4'F>[7 M\X#1J110P64%Z41/P-7`[_`&0`+IT;>B<<38N(S%'0:W&Z.!SL5,C`.#%#T].6/D8.;W/.C?:V3`RBR`Q;_5ZC1P(&PR*G5YB MJSZ_XV,+(Z_=9WYL[1X<95O6>$<4BKEII0MW`@D&L=45;5PAE MC_ZH'7)Z4M;`6^V*G:"*^.J5\#QQ!9J:2(Y(C[$*-M15ZM5>[C#"FY649$\%+4^]I M+#SFZ8,RM([JD'Y#*W1$6)I$W!?XN&O/Q/PC".N[%C-3EU-^IT.7Y'&<6C/L MIF&?):7VJI4`IUFDN0!)D5<>"W&:I^QR4NVH3SH5>S4 M/,.=TX4R$S$]!;UAL:[WKB8ZC%;@^E-`%9VFPEP$D*FD1L%32Y2R3MAT3>$: M"7D,NEGX6"%@5='5]'?Q$!M]F@#3P(\F_-#R MD2$=&UOU;,`E\^`2M7^UGKIG.UU0\C"P&9#J`-L]F.I/GR#S/;8:Y$P'ZTRT0$H-HY:S?3*[BZ`K$CX8:>5 M*TGF*'_8WO54YXH:D+.:X15YI<)O1IFQ,1Z-73#*X_S(O#;GU',1UYSNWETC MGK_'U"?&$R'F1G$9=9#,'1R'[G0`S]#U<:%]_:_`/#2$')[OV/"05!<$=A/P M7)'N1QMD\ENXROCX+F-&&UC$A_9<"Q#)X<)4?_].;)H>/EX6!%$#IMWQS#T2 MG6]!/JA+//NTG>==C@.&)7YG$>R\76M-6O[.7FW'/2FPO.P*@DE`=5=%9[=3 M^^:;F&T]?U*Q#F/>SB,ZSK<-`HD]=#\E\G/!F\W6Q9B78B:027%=T9=.Q,PQ M@8#:)3$*@P$%:@C=+D-MM/F>W=OM)4W6$0O;V-0?K^Q;`_(.B"#T89LKU5'8 M'3G%8!D#&O6<+6?>>WZ2G34)NRR@J$+;!9J%\T86&']:M#W\)6>NATMS#AG/`I.Y/NTMGDSU[ER[: MPP'MSO*)6?/B2%\>T&ITE1_#F8+R1I6==DPNAFHA*YNS^"T6DZM--9`JZ$L] M-(T>6V2]NM4[#`0%COM5S-NGSQ7\DX3\GJ!M$GGG<6`SU-?'O"D[>5J"-N,? M$%SH9"H9FZF);!0F!E!^DC99)E>\^_*BFQ: M8%XO0TLL0\N>7=B3"=?72\8CU!:(9NTZ&3,JU>L:^5T?2-D[4I[#T[QPEUFT MW]2=>9T(9]FA+D68V&[F!RAB/YOO_?WILVMXUDB:+? M;\3]#XBZKCMR!,3FOE3-=(0LV]V:\?8D5?OVIPF(3$HH@P`;BV3.KW]GR4PD M0)`"2)"B)$[,3%D2@#QY\NQYEO1\'])\VR*#%[^C;O8=,D+QR/V)RN>2!:Q, MJ$D*ZZ,Q`Q67\CD@RZ-,^)A)$%.!+$I]WH6):=,WR!RR\NV,+$A#Y(+W',(V M)G07BOM=PN4R+7[GE!G*%EA^+(-NFS4<5DS9"F5\#TO7$=.Q6QB^DP9)/ ME")R+/C_P8HE(FC2@.$^DN`=E]#$!*X^P4$E27"?@`\%.S1>G.XC9A.\^Z M.OU_Q*+JO!6;2HI0F<(.N6J4#14K#3<-@AB>P4"]0&L.0V53SA&@M"25S_A' MXZIAACG'8S%'7#AIFN4\A(7& M=#IB?8(NY3M-*,_U7GD%RL6DSTHDH)&!>ES94NJ[57+1HSOR:>CX:R+&;VY7TD'WW4+1)ZK_E@S(-E%KXQ;&"-[^EN`4^"`J7<) MR8$)?V[HP<8&\QCYPRIFIO/HI5%$L*1L#-8`1GU").[Q'5K$D0J,FC==INB4 M.$8U#F8PA]3E%>'<([JW'R=\+799D.$TGK4\D*%S$CNF=K@1(-4[IO2^0#<5%;64%D)[$EV5R&-GNZ;ZDMS+A6(U*=Y2Y M8YQ&)G/*@"IGD?`PBX`=-'3*@>B3.1901MCUSXWNI`8SP<0;#?+%L#;$MCR, MBZ6@*XLJW55JGC2LLXC3%V1=2:"#0T:B6II5H")!VK8OC@:1D"JZ7)'&(.V? ME2X"1Y]>F;^9"X.D-UOJFHT3!!9EKKA1QJ$M)VL$&`@V2##NQ(%3BF1%9E@; M10H[\DHPYVMF*>;%F8:JJ@,$BY]+!N%,P#(I#$O'HETU2I_*O[-(PV0F[EDF MF_B/""RZXN9DA>RVS*28U"PU$T&FTK@R+N"D=BD\/.7=,?]P\F;IK:11!F<6 MH*U-YZ,AL+,!F+$'[%^24 M(\0L]-'8T;]C.%@9*$]Y*B9TOX.ODWMB@0CQR4([253`4Z:6AGPOQS^X=/BW MH3.+WMI2]*";"`_="<<#(0OFG$^::S;#=G@D7<%V0E*36@4C#BHABQ/X*5;W M06XY6JTB977`RF4)I3E,*@G,-4"%97]*#&<63?/EK'/C]]G/N7X6&#-Y+C3S M^PV@YEB5H_*`V&NE7<]IRC6K?M3E0IR"P#]5.HX>HH@F570PP6$:MY85J&,F M07(3@]^;WJV>\-)I"@,\"?([#EB2I6*'+ZU_(L5BY>-;4SMEZ&T<*"1PEAK% M&.GZ5I(J`J+?X,J[>WU08\X_Y>;\\D#3K%>I]9<(^N6+%KYG&%./29;AYNUJ MII"%,A4^!B:%>I`.&^+TDQD8@SE5SKWCNO1M?NZ1AV8`PQV M"ZYCJ>\J/E1"KACHAJ7&VB5KMY9-`U,A<):;9NTKTHTL:LS<[R[EU1;"NJ(F MR)0>>R"R)W=+OE(Z;QEWQ$[]$.V99&7-C8/W`G\=UO M5`/SNW5#U5BG**.=>21^L]2_?DG!04A"M0Q9;"#63QW@$]@?N#UQ,$N?QNY" M],:D8(_REYL]AZ`!'OS_^*6O-TVHE9"PQ:T#`X@/$S>G$=`!(4@_^SQEEW3S@[>%'0+GU8APW#!H@& M/0BTA6D2_@1U81#^9OV?#_0_16>@/B8U:;_[:UG".R_R6:M1G5RT_6ME_E2* MOS2T;S8#K=7]-6.DO%QT#@&=K1V@LR8V`^/[4Q&DK0V-[>R%C<^G,[";G?X30;^_7?;M=K/]%,9@1=%>B>KR@TMZV<^QZ$/T08_5N:4>L&_E_X2HBLB3^3S@JRZD[/8L#44U?BOM3/%N-TQO8O=[V M1OS!;[-E#VN(#SP+C5,JA>0H\U;BK]VQ!ZVRH;VC+[,A1P[L9K-LE/@PG9E5 M4+73?*7'\4##+\FWJ:9)2BR^[3&W&VWX%J5'>F)75T*/K[P-D0U;=KL_>!*4 M'@]FK:,[!'V\+?L_AM("`?`7RD#+_.K9I<-J)+O+_N4[!POF,+^0%GXEI9G& M`#TNATXC0[K#NDKN)D",MEQ&#Z8;@7.#P6Y2"=ZR&7J(Z=K<_W$,-A15_NL& M']3;,?V>JNIT0Z,>@<4[,,K_T)+T+GT'PXQ1UG,P63CNGZI%\Z4`1JHHXR]2G MRM9]"I+BY-9,W5IPJHO*LJGOV"&;DI()A$068:4Y\-PN2*:4`!P>9K7>+)PJV!!.:PA]SSFZ&+9 M/9(@]O"*5"-)HP+%[.7"_=H67"_`92<^4G!HU,H8F=Z:)C;[/A7TRHYD*IM; M'K3D`^R93S-T")2TT,&*0^%CE1.1NQ/I&F:9AAST4,^IN* MF%U_C$WQ<3\)*!DN$UM-)WPV-",$FR$@J:^DDFO5YHCVA+%BUT]@F]Y"0BQ; M-!2!MK1;W,=$+*K#(:I3WJIJ7Z,"VLF0'KQD"-^EL=3AN"I%3V!1;*CIJ4,U%<"#"@A#[G4Q<6"T4 M_CAEX**9HRAMTK;XQH+Y1[`O92$,JF\Z<"XP?!+JOKIZ&P;\5-2"FA;[&DS3 MWC,VNX/;-9)\T3P;1*4)OPTJ`];?,,?C<_A("34]#+VHO2Z M`D17/V8-C&7$X`/8KC@U)Y9,">RC0$9&$5K-F6'J&WKHY32A@5WPN)S,A6=L MEOCBA[#2AYJT4>&NN%5S;U1)'OY)CL"3PUR*(4&U8Z!4ZER%UNQ9O'39JD=[ M6^=!],K,==XQ4I]&`I*&)AFJI)ZAA%%M!*@/.E(?.IFG'DXBX&;HN@VBYTYU MKU,G[?7F!0@@&R5&\UUN-)#*7-V.C<8OL:Q]15U^/@L'F1AK8/^(<`@G%A]@ M+[^G(ILN! MAHGQ&=XM#1W%IDDX/)H*(K/TB9UU]:LI!)I+\-3P/'[ M&SA8%[55K@&F'.RA1EY'JDVSPC,W\E"`D^*_0>R[MQ0N4&6=J0F2;0*9GC.U M9=6CXU3#4?*O]$-I0Y:4(&8)1C/`(8VD+1+CQ$PY*P.\?%;2$[2X%-+2/M#L MUF40A4V;:4A%C,7EZ:!")%V@"IZ1*A?D,T2'6/7ZNUGHE@=V"JU""_EK:M@5 M[%*@_"88'H3XD7;`\W33C-KMN.#5&LN.1$=5M>G9BNZ0;8B##*]5H)#G;:X1VG:9(*. M(KW"V MTYD-RFDQNE9G&]I0[S&)$N7NJQX*-#56-M)1,S$UJI0PYB+X62`'NDC62*6G MV2E@27J^5+/TD_NOQ)V@HTK37>G*V`/]%@'?CE]7FS]JWRN[>.IVGMCU&%PM MU2+W3:O7M9O-IG;TBR*R_%R&2?(S*:CE"S=_Q>3RZ";BI`,47:%[D\1J^*@YNR](SU2D\I>66C;+`'.6E'P=-C%7U2 M!RX6-W4P M?"CJ-9,V\K?EO!Y8GGL34WQ,`BJ-3J/M/RZQXINZM7OA]M^I>2+8"]QH<8RF MAM&...UXBE%Y;+U&+H;$,2-$S\-&6U[B1.(O'<$G[:-<& MGP/Z"VXY]D>83O]Z$X0A=:915$*C$'PWP/\`3-@`C,_+H&9V#J3[`'8[6+`Q M*869$.RO>=I6H:'1[+C*.&;Z-Y.>M#M"LT&S*L_6%$AQ?7B7AG80&'27J2[V M<.=ZQ$\ZJ3L)<6Z/A,*X;=/@YE4L\[CQX2SEI^W/V7&-$O*OF8%HCWS5!GR+ M';E=8TZV,6_`3D=^IG>[\E:,6M`MTOEPU/]-+`)YUR6G%(!W.E6TH7J)*_U, M>Y/WWCFN+1@I%(&G9PBDE&?5;23&56YH7H(3J1M9-;$13T[2IUY>SGU/>9^I MB_8H#5:2%]1MCCTD]6H2T=4"#[1Y!6+@JR_'-+M^(J]K7#GM%*T8?2\@+X/9 M*3;'LV&T2-[66M$=$`+;.S+]@;H1^G=L,@+M:**3/>4SO4)3#45]LC!PQLQ& MG_DS`-UNW0/\-/A#W1OA,)_%G*^8,H`AH#`.` M=4D*1'%PC'/F;FT+TY+P01E@4W=+!K!2%*3PXN,9:#&.C/VLU469Z@$X#W#. M/37\EKR/MJRKAA4XOKPPPN:&+@8'R3+FRREME"`TO#MF10.+1G]"DKSKI78J MC.0]S23#*X?(='(_;"F5D*PH\[JL>"MGQ%D3= MG1/1Z!T@=/S/1(@9OH&/4`_2A9[:E<0X;8@.G97AF[V&X3G$H* M\OCB-HCY*@5>`)+RU80CDQOYAE8PJ>#5,CV,`OG!C<0K..P+8WRF5*)%PS*D M>\T\A',J"QQ`-P(7L6^B[*&,VT:`NO-KBHSR1I9&)KV_-TEI(CD.TTIC` M6SBM,/@A)VY.<-83G!Y]3;=BM6@>K$<6_K&AX),W%*RE0.!I^I%]=,`V^`=: M"P3:C0XB/J/2BJ?!W'O)P4>\5<,;5U20<+Y;ANU=?NE>W5]=,,H MMCZYH,&O47U\`H%?M0KLI;<6ZXRZ=J]7M8W%L57;RNKAH=W?ME7;XZM4K=]^ MZ5CO#'OV<##<`177)-\J5]15*'Z]PO#89$LYMZ]"S/H):'?UFL,FW7@^,Q/D M91[&21O45%4&?X$=,I[1D;4&`[O;W6U5^?[,S^U+GK=$Q+&:UFP+.=C$;#V6 M.>_\8$Y:K1K:XE5BKFU%]?'\3,;J=^Q.>UNCYY66J3\V3R?P[NE>/'.'M*#D M;\=ZT^ZFN69\\W5[&XI;NG/GF>)XERY3:XR[#8<"WMF8^BNX@#@KV#;=\U). M+`W@GLT]5T^6UXDX:04"%C;`O^/(N/.[%/QW89VIJP%S^JXJS*/LNC/\G7Q" MWH2:SMBY3,V!G_^6."$LQ,4!QHLX;1@KOZ,`?H8J.TJ.QW(B/8M>C[:C_,B73R[XW03_ MD3TYE8]?<.PZ?_&1,S7>P/W0(KNX,P(J1[$*_VB"L'?]`T/P5S4_OMU3*9R7 MS@3OZ3ZGHVC:^,J4`OJ/`Y-M;>O<,-*)G=>C%CG6" MP*M\Y,'O]#N].?7[X>]OK1/5$#K++*O%8F`]%T6\9C7(/Z5P)\D]6(3$B1@ M5,1$P0Y>60=4SOFXB,&DK2S3%.RE6[R7W&C#:1#:F>G$6'1S*W-ETYP7@'?Y M"#G9OM$T[]\SZ6MX#!Z*/WT-'Q4!2H`4W[JD@.]"USQC3BRM7![GQ(PD=-#^32+.;+7`]:UY4R^MP[L3#AGYYK;H.U_P M.^EF;-GOAJN\N5^'ZH>AY_-2`4F:Q$0[P@3A-4F^1V8U`;G4/IQDJ(_2AVL8 MW0R0J-ZTFBW8'$&55MKD'$`JZC=KBZ5]4Z0HT'1/0!@SAZON(,8$O;@06IXISK7JV.B*$]7`\W,PI;=H8\-&L[7.-B/YQ0L#SF^H@8ON MZY`V4U/9Q&D^+",B-8[I[!)_SH/;=:PAMOJ-WJ\TE;\D/HG2=).<3[ACN71@KM7U M4L#!Z*<@>5@/13YZ.AE`+B0_Y"5TIO$5<^G-:7^(WJ>0C&Z(I\+\;/?,31X M^8!2ARVJ-*B45JN<."R$SB;8+`S>^I"$P02S,D,PG&)\(`TBK58C;T$E))'5 M@4/\%1.646KBHU@[1=\A""I]"P//OS:L[RZUWHA4)G]:\6;Z#(]BA073^E#; M6CQP+!4[-,U`B$R]("!!U6HT?V5QN?)-V1$QEYN,>K?9Z,+;KR^BHWGHFZPI MR?-0-`:K)?&$[EVD-"*!5?7L'PNQZAXINIFBS76D['M;_YGX\B5=7O`O\'4` M!&^1EL6@4S$:]*BP'.BT^(EFDINJ^)*(0TMKC'B&G)NZ$5:%!0@O(U% M!@LVP*Z*<64TAH2%6GVCGP3W[PS%J1%)P`(O*GX`5A.L;QTK="/9[;-E:E"` MQM2H+-JFF3)<>9O`AL&^6Y`=G*J0GK&0]5GG*!QB=(SR=)]&&%E@;4W:*.)O MU>H3Z0WKA@"VDJ9F92O97&F5U"28"2IMSE3>4&L%&4Q3G7332IP3Y9$[OGY* M_)1E'6!7"/?6SWQ/>LS&]E.N)BBVO#RY-0X@%+KV`]YRD(ZGW,*0PU%@I@:A M4"[D:BMR@Y<(^Q0X5KV'"&D;T4C\@TF['Q!0BI+TQ:&] M#=>3>Q[QN4>J7?BZU])S(%I9AINI-E<3IBDOJT6&CXLA5R.DG ML8***)!*RX7T=(5_B]VPD!T<3YQZJ)6H;7:F[(TC&LX/(;4ZD[=J"1>ISQK1 M8SR"&Z!KK)*U&2696CF+@AI*2M] MU'=OA8QTO8)%5!1B+9M0+3<%M(KN[8UB:P#X)QG],57#8.>'$`F:*H+Y=)G5 MN)DXM2"6/,,A&:,9PBL]QP\Z*O6>HU*KQ:%2JI(/0.C,,)"V%->REW^UO2?` MIXY-SUU/&4!&^-M,CDFC6;+.78HMV27"3T-[#]@)>8)C-^5G540=W]+1`J(= M63M*PVQ%)''JM`"/T+ M7W"XLN#7Z)6!]Z>IWR+]Q!#S& M\7^$R3P>+[3]Y:A.^&J8*C;[($MVS"*<^W_!@O09DU9Y3`9;C@P7U7Q7<&?5 M-7%A*"-5\FB\J5X$RA];:C0S'H<)7_`Q-9(3(*@C$KF>[FPF)BY[K1/9K<*, M;,FF*>*G",>H>IE>U5[QI":[,@@/.]1Q79RZE=Z_F/%6'=TXQESKB+E:,MUQ MW=7KAB'0=4#1E.%0C44.ARZX3?[CT<;U\0IS1AT,3[XV\L!S'QCA31X MR3=%=+.+T:F"K^>WPO*BJ%?#<->QT`.3#8^%04,Y`F=%.-2,NV6LD77G^X?O M46\>[221.X=QQ8CT*'4!DM_(*C'EHL)6P3`(P"9C3U"?*6M*CBFE\*A^83FM MH2AEZ>HXE[%PS!/(`'*=HBLO`U54.',#SQ'B8MF7N7(/EV[$,$1EZ15(E56)O'*=00+YW]N56P(M/4LVJDH@B$3:(5UG:1"A;ECT\30BR6JWE6#,%B5EDGIU%=%N(7AR%*PK)>("CSYY MG4TJZ\-.FG)25A1X+'TR]6_H/H/J^Z=6$D5'II\QBU/+58] M%@0175_@=30/`LMOB&>!I8D"!(1,%DBO@M?>82]G$J3WPP]W`:W]X%/R)1N5 M8I*]-R;!9&Z:=L37M[>[9U];86QHT^_B44)&TGUA^-JX;U#H2U]<61%N*9 MG+E&]B4F`888ZN$!,N2K&XJVD$;P:!D1U##JIIPO2X\A2#K7FK($L)!T`4XB M#=@`C%";:/V(XB.9M[!@VM,!"W6#(G[.L8EJ"A>]-]R)C?@@;2;YL^,\^#):A)9"Y+=#5L'J1Z2!<<9WWHG@>[G0`E&:(=D MVE?L^6NZ"[K\=6`;9`MCU/@<#^O'CDV-]G[$H+%VUE\G$S)$3&&3KY/@620ASN MY4X7.L@8&N&&<1IN,$N!"08N!WZ0T]$*-M#SO.,`[O1DPXU8O2 M&7\#/OO6^`RB'$_UGT'XPSJG9!EJ'YT64S:+:]C.>><$D@SF@N?G3+`0)ZOA M(\40\A4K_[@:<(83["825#6&G=X@#T4E1%,EVZAC=_M=GFBD.CL0*,O=':8% M%6.9I,]1OS'H_*HCP"L(12<.RO)_H>>G<8*?IC^C1BC@KNW<)9]I`Y\D_?*F M1=`7P9LYN7O'(CU!&L$2Q$2ID]!YH#%`-/-1GJSRHU:A6\V`6@:=+CD0 ML%Z_,1SJG'D&S%5-JE.J5Z173!IJ88,:E&RE"MDF!2!+XH'X5,40[&4"S^Y' MPJ5I2CE7*H5/EN=HHR)+7J1%^+.ZCM%SZ#'YO%I@(AN*:,2;3G(DXMA+BT(I M%U'F)\JT*YVVN/Y-J7Q,>GJ:G-=(R/*1L/8E0#RW'Y%>9M:Y(_FE9L M<>QSM7[,+WP2L)CNM4`KF$*;9SVL^1Y!0=^DW'`["2).X.F%Y,(:PRCYE8*(XJ);&U0RE<2?3^^U^2Z/36<>:_O9-7 M0>])>A!%G/F3=Q@W^CK]9D2WK^'K[[Q@_..O__M_86NW?U=?`-#.>.PF(.E; M&/CPSS$'R>%+YQ2HCBY\\QEB+$]$^IL4Q88?+L7T/W[Y")8)9I&<-EOPOW'` M_^Z<=EJ__'572+K0,HSZ@WT\NWJG0HEG5W^`I]NP)!C622HIX4_*<<$_90)1 M2VE.2L+V`(J+V3R)M2A73Z0ZQK9.KI*;.)B[8VO8Z9UVFNAN`"`*"([_\YV_ MHS%KS41\%TQT]EEFMI"D=AYGA-%S$=*H(F;:$[V+M_`X*4_S3PD>Y*_JUIY^$OSV#BU4?ABZL8-,-,D3`H@H_.$0SQTZ_.@ M%GPP7=H)=>4<4V5J[:C".CDY)DK;/4U4F3[!H$W>O`$G)59V19O]FPAG5:5" M/7OA(R6!GBG#]FPR)T7K1C@`2\Z`5T5,@KF:2JYKFA@&$+1IFCS.QI:W M97+(_#U/M:,J2MCOO4MMN"0_\+QPG"FF[X@%#CUS8J5;W-G<&6ND_NWL[)O" M"&<`R#LH8_Q/"LP\D,/%U*2T[%3&=`HP#=E\?'9%.; MDV(R\DG_J5`VG>M30$(Q!)3./M:CZ+./GH'5O*"1>:G0.KEF>=7*"JNV$E;: M*7/DRTQOCD'Y&+<`7I\E$>7P`*'.^+:1,\N$3A-R8^!VNL8T"$D'G'0O"T_< MX@!+_"I=15Q(`R''F:K08XD%;_S,_48LIJ5AER06O1AD@KIQ9 M-T5O#=3XS,5"\]L@X)0L.8Z5!,%802()4^I/.55ZBDWSL!TC_.3&8[Y(NQ`T6;L.7H2^DJ2%'"TY05NK(D#ZSG1GI"Y#A[9AI3:TT"J=L)C-V9 M!/VR.MMTK1\1%G7H[-0+J<.'R/LE(&X1)]$W$5[A@-;#<3849)RFBK`A87`G MIF0N,[0>!#;DEE+9D56*?D+GBI%S&?;UQ<1(>;5@_`(9"8Z:DQ!2 M;]JVY&C$S,-WPF.C&IM-).'"-EJCLD0S1Q[*^GBY`TK8T?L!&G&.(Q'K'(FH MWC![MF/5B#M=['=RC!Y>U]_K\+J[4`CK,SQQ%UD?J`Y2UYRD"0_TKP.:(O(\ M#G*O4PA1P.[IP%X2SKJOC\BW.9152*]QV8,#;X.CVV[(9G^8F\:7.>''Z?L+ MF"`4:7?B.'1O$E;08*R;;8TR%HJ\4ZK(`5O/H=S]7,/.5M,D<O5E?7MPZ5U M]?>SRP_6V?7UY<6[/Z[/WGWZ8%U_M2[/WL-3H"Z^G#>L\Z^?/W_]8EU=?SW_ MK[]__?3^P^55219]3B?^?"'?E]1ZC%*E)-N&6+_+$(VU')Y11HN,TAAI*I,D M5$$W#NH]@0M49H1H;9_;0L5VV_:@.[`[[6TG!1[R>-V#0'33QL*/YG"W@F+`5_Y,&@?=L6=S'%*YSD!O-EJM^A!:OX=T/+WUI]@[I1SDL(J:8^XQC[B(;<^<^3RKYD]*('T3:%SI?F,3I#)$5EX1+MXG47_DSY===I&U!WNL;Z<.Y7GP:HODN.',L%CY>GYM7Q52Q M;-US-G"4CEG%NN$PNG/G1MOJ$%M@JSOU3N]7*NB2K%"C\P]4CF\Y.I MSI.NZ&;[P5=I`O*2FQ*-G5L_H*)H=^;0#CBN&S6L;V$P%5&D2DPXUX&O=;F. M,[.I-9^B*WR9%L5]0%72`>;0JQU9Z6XPLZG@#YRO@1AS,<$]EM!(_LM`T[!P M*'':!TW]\F'M]IVZUV9\.5UR'EZ2)69;?^00U_2*VD%7+Z,$.AC^^P M9;>:[:V!WW_\P8B+_&YM?L!@9G(<01K%ZIB/LH+:W2:=FM85757Q>AK"UA\I\:W6#`Z2V<=24^+)XVFI5_L M2A$XY*)X"VE`+_LTRR/>VFF9*&M;X!)5BUTF6"*+!V1'!IHOSS759^P)4OO0 MJ7$Y1$$5W5J%=T&]-VA7NNP?7T"GF\;68R\43!O7=>*11`*7VX0T7HIZ4L&3 MY"HK5Z/((2<_=SK%43GQG:LZBZ8CZ:C5,/B(TLM3FND5U(.L].2B9$9C3@#[ M/\0BS90G:#`S6H45EDFN2/SJ`=SKR"Q'8T=?;_>9V%L8"TK;7E'%ZGL@B=_V M:_/OSU5K19KV=W3GLQ[?T.[U^\_0G2^YOR^!/][D_`_. M->^.[';[.?CF%;E2-0)PGV_4Y&1HMSN#*M`_1S^W@MXUF*[Z\;[**$K/'FT= M`#BD*,H&L3ORMK>)WEV3Q^:+#37],9ZR!IA>Q^YWJIH)-<13ZC<9CGF^M>3Z MM=L5W+`@^(%M2!,AVZ!C15+V-EX'0G9A`]3/:QOS4;MGMYME^>CI.&7[,S\/ MN"LJ%J]'/%PC0P4TZ6CF:`@=J"E3GVJPJX#E#689'#MX%![>'=K>S;0G*<[X49X2S`^Z*SK8]+!U(>H)[VXV*AZMPF4LF M3$D$5!)#]9_XYKZVW2QMJ.]$^!\0+MIVJUNV0<%S<4N,"LG2A8_YDLGTD:]3 M'%4H_(BJ.B^YX3\&8B,JNGR'G4_E&*?]SX3(&HQ75)$*;@BV3KX7UC?/\:.< M!7DP>72U[1K_P<.-C#K=[SS+VN@Z_0+Q\&@]:^`+RPM`&V`+>A3NDC#F0!AZ M8AY!$@HYK]'AN1SM9K-/]*,F!683X&BP#BV!):SAO:R;U.,ZT@)*_2'013AM MAB;.Y!L`$PA43]VPSF4??%5U?4NS@R>%G\0^VK.Y%RR$G.6)D2URK>$O.'L) M)SGBO%R]`_?T=I='7]+%#G>JCG1*+8?X9'6O*O\E^*@/ M.0.Y5+!>`%G#NC*!)R#H:Y*)K%OARU'-]S3L]QZ_\!`@_%/$*K?_QE?D>%WZ M+>Y2^/*/M'DUPXO.]!5D61>S3LONCT9V:]!?'J=%T(P&C=ZOMLJE;]F#;MON M-4?9V6L9:LOR"&:TIU2';#%-U-D)LXC9>K^N`I=@*6#[BS.N(E=SL;;S']ZL=BQ+M48SU>`IUU!M$$DYRAK#G93 M%;A)S]ZET:ZO@(,JX$;-?`)GZ(@8$S%GM[?@3.(@XKV@94_"J0("OAH^R\KX MS+[)Y2CU2I_?-W#DSCE&RSE'5[R.?X8SGR MMC&J"GOTU$P4>T`)7:%LK@1JQ\(+Q.X1N;M!+C:IX!F61PSO!L/_P%SF.I&[ M>VU2PTG5IL>KY8H=MNUR6ETZ_:!=4^G`:H&[S9WBJE MSFZ.Z/IRLPV_S"3%K3#::?2J%BH>`#+KI;M]PO'"]UZ3^-RVI=#?.(6A)&&7 M1415A&W,E'*17K.LF5KW#HX[K;C38^7'CJREDG2D[M.>+(/)3(S/X$RW''AQ:FJF.6@OV?BL\=-J-*L.@CH8_#R^N[T5MF+WX*8] M:C[WGEJU"'7I:U-UAA,?1?LFHEW6;#U7UMR/:-]Z!ON+QD^S,2K;T/Q5XF=@ MCWH]N_,4,OM@NJCMI`Q59:%C?;1,TN1&@7)L+M?M.3?!O:H&EZ.)N1BD-=L3`PG[=-`,#=?!O+$:G[AFJ[IT+DG4)OYJECM"^ MZ309'.Y2X"H\S'E&&'S@1EC&TE22[E@/JN3-D25O#)CMWMMNQV?5(T:'75RU*X@V"$FMBSP= M$?JDFWK<;=9\\YKZ.U1`RRK)]CP*$Y_/D;QV]CMV05C5!6&?W7D.C_U>2#G> ML59WE]B]Q@Z=)_\\%I3N$,T#KRJ=+O2M%Z[=.W2Y=79OT69GI)._'K+ MU$;=MMUL5TV\.-86'0OT5E;(X(Y*_JO5&!WPU(%M2[O.[QS_-AM]Y6N9DELN M2R7;&,K',H#G"_G^M&QN1%]3FT$JHG_::I;/RGKF)8^#=M?NEE:9+Y'PMGBN M?M6U>:9DH_]<9R=ORX'_H$O#G;H`Q=]X-O5#@V'/;O>V34A^V05$SZU(YH!D M3[=1'VT=B&VP48)VH3-^3-.NKLLX7>9)A67)T3Z^3#;$F4FO(+WOPL>IA88P@`J;T\#%[69_*O,R)-;!' MW:X]Z@U5_K5M++DT/@MSI7GPUDW@)S+#D#-J57XG/-&QF[V>W>RV5T!O.?>. MZU%*'X(^3>(D5/G/QF&GDPRWG$>8'V^(-R%T$9)^=__#"U?2PL>SBTOK'V>? M_OA@??YP=O7'Y8?/'[Y<7UF2,GOPYED4B9@SY3W7N7$]2O"DTXB2FS_%.*;A M9"ECSH2#NR2TT$RL4/PKP>X1,I=\PHB`GW'@F@O<9[Y]YXH0J6?1L*ZS#*__ M8H6._X.RA`D*&@P7+PC"4"@8%URW,$]P2E;$BZ>R)/ULPSH;CT%!@(SP%EA3 M4+1;:^R$H4OIP#1)C!.5.3V>18[(/&)`C0@8>_!9GETGMQROVAJ.X_.%XLTT M"W<,M'<;A`B+%&_\$?@S\`W!X(E[X?&6N?["C:P(%!HL/*;15T$6T\8Y'5@& M[BY6_838,>X!%(6W^*Y2%NE$*8U@F0I!E)#^2'QG\F="F<__2@+\#VF4B%&- MIYP*&J1IJNM`N'X@/9'41)#0"5I!9*]`]>0.H5WU$"0_LU8`Q/M6_EA7'&HZ?I(\#K^`42R^9B.S'"`X\R,B=P4&'JV3%\NG# M.UFPRI`#?L?ULU]J$`Q2$REL(,`\AE)"'=^!=&6A!]]`I')M4#K($J!`=,Z" MB?!`2"2@K&EV)V`=ITZ&\'F&9^$*;V*-$U#]$IFPFI9X01@&8%P3,#`0R#SV#91;/T1*9T1"?4YU[\//#PW4PG@UZ3: M=F4)XI_)Y!:5P"LXJ&M=@7DC0'.:M2U4%AG%5+4V(35)D*05@^`VI`-^)^(F M1I9A!1U9)Z33@R0"_$9O#TR=OHZ"EEH"OSI;JC7<9[I4434;07F0B5.'U6[H1[Q M>231(XD^6WQV[5YO%_-[:M*OV^:G7XEQX$\VU*5ES[PJ;1SS55=FG`R&=KO: MV(47C(W*"N2IR.AX[O5B8]BL.GSD<--XO)<8(BXZXJ>8\_BDT>/B@M*#=-V/ M`>1C2.H80#X&D`\1;10`/2)M`Z0=H\;'J/$Q)'<`(:1!Y4JO(SZ/)'HDT6>+ MSQ'@L^HXD&/4^(F":\9 M:MLG+Z#]ZEMG\]#U+%WK?.E,O@"^YPE(-*K4C`#XV/%C%^F+!9[G*;J77`0_ M(1#_#,(?^`$7#.?;A?7-"6,?QV&=?/GGY;>W5#;VIM-J=+4$Q+(3BKTIDB7Z ML_G'*$;B(*DY:@R-=U)F1R[1PW*`>&;P0Q`NL."(ZZ69-['9/4H16;F:K#N,$RL`=UL(->HZD/E@J>QUS1"R21 M?IC!0,_)0\^)*ZN+'[72QZP'^"X6;,<@.$D^12`SPUB1;N3,9&DS_H7'RLDM MQJ'CC^$7[XS/,=&Q4,+*2Z,#3]I&0']A'59H:!O#YH0I*!FQJ4"B?^M5"0:0 M^W3;+2NHUP)=$;1TB)IUXKQE7E%5PY\NWGV]3$7ZW$LBJ]-H]WY%771RPT]C M;3?#3'_')B6_-JQO83`68@+F"W`H/6<>GGEB-+M**HM0P$ZI1T:&;C+-CUB[ MZ#T:6TM--ORT-M@(^?3=W)`[DPJG0I:/RFET2"!1,':)BK`"GN="`;XCK&_- MB(Y40ZP4^GGM\,X!6?=U^HT'*9($//,G5VG5(U;X@\""S7P+/'?L'E('!C#2 M%(M/7.?6#X#(QA;@]99E17A/%<-&O3 M4,"$&Q3,@MO0F=\MK)/S:_C+/(C<.,11@2CL\<3,1[Y]P&?\9.PA;\V`O,>N MC],AG9EZR&:B\>#\(@SSV";@H59>)__O-'06\+&IEP1A$(V#^<+HZ:$&%,Z1 MMB>H_<$06W($P!@+YH)K7HM+N*6-%@;)[1V)W=A":L$/PC=Z(XT8OMJ*@)S' MLGK:.@=[$.2J[SHV+KSP'-S-1P^,RPG\ZCV`^."$L'L\W_^$EP78AY=W`9S5 M180/TW[@CP0$*N]&4<>?&F/NR"R0M7&IHA4"H_E3-OM MR+W3*6A$.A-LY$!.+W>[F8I0=KO!%#<5C4"+)$-U8#:F@-K&WQZ$\7OF-OVW M)"I^!]S1]`^6M!73/V,C(\=?&(^0*0]V"DN95R!94B/`ND+KAQI)G0<3LA$H M)F`0T=G5N4%$!->5(%/%&K::I_B_O=-6%\!TY^20R^X-MP)(%_T\H-L%T\6" M+1XP!UT_2H!HP/X`IL,P"_P-G7I7:G!DY'2")KX%EIKEZ.@$1T:2&^I6E!<& MR7Q.(1.V):A#!(*`0LBEX$UH@8TI5U5CEA%FGJ-LX97-W+8H.82""W<.3E@" M["+?11:&U:B%D12Y]!"@25J\`E?%73AD485`^&PK*P"5=6ZC<:R\57([_P&< M2`;YA3+@/S#>C//XQ\4'4V9:,K0EI:)VJN$QZIO",*'Q\(#MI6;.GZ#2X8OW M0ZA]]8O(R=0^/P3[`1SB&SA8/#KX-ZV>MI)ZN!-HT!`,ZU^D MEG6XEJ7L%()F M&?G*@0<8V`E<^4V0F/3=&[#6EKM1%:Q8<-1\+!1A6(62WZR3%GL^\^`!G9!` MFGE2F6MND"`P\@`[,U`'9F,3X#@71)Q\T2`7U100[Q"#&6@0,,0PC$8LA\"= MM!F`-'Q'T;N;*`AOP%B,(EK=5C*5;A+8O:)IYG(W,3MG=A;*,4U`GP>Q,,,_ MX%+G^G+I,[GP%7SDX8/AJ(@B$Y@DH@4+6MSC!\`W4X%8-QPG,W3N2#5JI^$W M6F$B<%E]*H78Y0T@;>O?TB'3$FIO>/QFP(-?`I&$K?72;QE'L$QHTG1+&_G= M!0_XXH*=6%_<`J^F#B-@GP.9K%@U2K'+#7PM0'N!X@+$*E+J\7_'[IR^DZ,6 M7S>08[S@$K`A^6_>!`OP5Z`<_QY0!\R_-<#:#6]%"/Y0XWT#&1=I$#UK$D>$ MXO,[5_"@^@\_Q3@AT?45]1J^!L*6;VUDB/Q=(,=XOR>VAG.2,4>@1C"T5$]` MBE`HL>"1H1;:J<='KVB7SUX:,D_0M-J-SJ]J73.\E&T'6=!JI6&]#]7.V98& M`(A_TB5'HU\U5;`2U92,M(16/7?GPG\I-=@)ET([>`[++FTJI+[ MD'$7).9"QU4&J%#'9;"I6V,X8;V%;KTGC;UT MG;P:@I7NW!LRZ"SGUL$;*REDP<7GP!^>A.Q5J^(O#0L8%-U0::P!V25>>@V% MW33E#1HH"/0W"0J3J-&/!238RDRY$9X+'V0U)(/H6!ACX5PYI)B:@?.!WH7"B&,RC'T5_U_>NCT08U->$,R9;3,>822:% M5%\E?5NP^M-3+_1A7[XN^\_@SK?^89V'"84',+IA*C.%6J60F"5*ZBW':C&J MZ4$6^GJ3A'I:EO1'SA4R;?`I+J%X2LI.P]NA;["&E9$%,R8E31PILAZ5KU$P M$P7:!*#X[/C`V['#B13OPB#XX2U\.[V)A)4\EN2&*'ED:_%#L&9G7_ZI/K/9 MSM@%-G8GF^72P:KM&#LP](=Q3NCY\#E]T)$;3A>PE@'D#KYF(`?4A@!G9QI+ MK\^,^$C'R`CW\3\[P]_/]2<;Z:9?/CNJ^W!E$?F!?RI/$_P&,;[SN0DJ_QCA$4(180%,(H,]UB"C6DNA7UR;>W0@LQ`^IF!H&<3'6,< MCYZ:K-.TL;<,FTFD\86Z:`S$XTRPHCDI#^[%`<$!P!#RY1N,:5FH?`& M;;;$$83RFC05,,EKN`7Z+OG!:)A+:%V%L8RN)*QA1,^6CZ86[HHH%#^(YBG? M-QMI8#+"*`_\7O@)B`]UK6VVBR<0S`0X.&4RV,BG4(&$5`<]?OCH(:!7<<,- M@_&2&V5:`*SQ/_"+-^U>HY=-A6PWTVP<=;.A@?:95PT>4,8\7=<#:4E)K3)- MP.41P#-PJG<8[D%3OR!-$S,SE](N?0D>7U:O`I'82G.WSA78=OV&W`B;S5)# M:[1A5^TX6G6[IN_4#-A08+X9C8Q$&]K)<)1-O>$\+#A^#[Z#R#;0*X&@DY#: M`1-.`BF7&?.8ZRV4 M,DKU/-UII^2Y#FN*=K>GB)&!ZO95B"M=E_*#TN]? M^'*$CP&77,**[@2)XW()Y:G=I3#`*,EF-@V[:7XY<_Y@E.:@%W">3D%(DZ?9 MNLU]-Y_(;L@36PJ,55]6*6P2UL0DE[Z-&7-L3X MFB"@/OQ$,*A0P(>@KCB0WX M.77EY`-GW#G>5/&REMZKC6P=)"Q,KI?^B-3R,P=-H,QL'IUJNG2K3.%-\D-\ MCK47J&W@67!?R-$PU;J4X:_!:CV+"'L88%D]*A=,B1M%G,$`O;:KD`$DWS,L"4)2`,K.&W MFMG/Z92$W+V">9.0Y@G*()%Q'P<\XYCTF`9EL[;:`D,@'^)E)`FQ38/1:PK3PJ2-M.41KXA`+P5/"61R/?P M18!BTCT2$5]C))ZG8FX<$EA[F'I#=*7,5J81_'N01Y8_,".602>FP9)W%_)F M0L7UXL4AN-\E7"[3XG=.F:%L@>7',NBV6<,!`H2J$V.L\'7$-&?WA\*=W:#*E*&R M7$+X,N^L8@Q%?-*!4.*%J^\`N5BTF1@B_3XB;2>DSK9-?JF)7.I]=&B<$2\I. MH)4Q^A(BD8WOT#*-5(`R,R//$&$2[ZA.P1SET+:\JIM[1'_VXP2HQ1\+E`CM MH76TF*$W6:R92FD>7>=&J64:^!QI17?=DY6C=WK0;D(A/G;;R_%)51`+J_LLXFMV6?\0Z""&D5"5WGZK MB(6V08NC%L3$19<`TFB)5-\&!HX^O3+/,.>NISBNI-^S,`K0)Z7PT!'8V4##V@/V+LU!0ST2![PN/K>F;(/CQ M0X@Y?=K/V+OI@2JNXFME3AU"PS&SJ-HG98U0_C0+<&*#2(R1;%%5L7<]5Q8Z M\P]>HXQ#EW^;+DPQ(\'U1,822/#A1%Z(.Q-JW8:UI[8,62A8L0-$P,5&1GG` M*W#N"J2ZJN9#S&'UL;8\.!;&U@>+`I;=:0PIU#&FB13')(C,HK>V%#WHSL!#=\+Q0,B"N>.3YIK-1"CK?,"V0%*36@4] M8Y4XQ(GF%%/Z(+<4?DJ[%W1KN<86)*J'W6Y$*<@\$^5CN/&/!AYH\H# M)CCNQB)E!>J829#`)[QT>M4.3X+\C@.69*G8X`F8*+AB3S-?,;P67,=2WS7:G3!+%P+=L*25+I]>M;5LNI(*U;+<-<D6YD M\5WF'G(I_[,0UA6U*Z;TV`.1M;N-7G&K\GUU)N(N>R7<$3OU0[1GDI4U-\Z$ M!IQODHF$IZZGJNM33RM'>=#,<5SZDX]++]U-4T\4Z.M-US$Q@"CJ,U/4!PJ) M>A5G!E1JO/F"4:DY\?EB\!F/OD#I5QGQKWQWR[[=;I8=S_V4HKT2U;F3YTIU/;L[ M>/'3$WKV8-`]%)K;5LY]#$?(HS^+*[D.+"[+W^8 MQ\CN=\K:-8=@W:YT;Q[?ZE>\XZQH<]3A@:[W&&O^W!9&6:MGMSNC)T#0:T+R MT&X/JAJ^3S+U<_NI9%43@:Q,$M!SU1JM?@]LYQ>O-UJ]H3WHEYU2^,PUQ[?B M^Y^C+EF)L1,PG@95XR5;G-#;XUFL/HN^/1Q5G2>ZD[,X$-7TI;B/PK/5.+V! MW>MM;\0?_#9;]K"&^,"ST#BE4DB.,F\E_MH=>]`J&]H[^C*;SCNUF\VR4>+# M=&960=5.\Y4>Q\,U->E!WZ::)BFQ^+;'C!.RX*0Q/=(3N[H2>GSE;8ALV++; M_<&3H/1X,&L=W2'HXVW9_S&4%@B`)QP2G-9O/5J)E2_=^CME7)X[H?@:WCJ^ M'+3ZSIF\1U>27SZT8BYC^!J7TJ;1&MV=6R5PYLX"$[>YV8_5&IYR?K$7!#].4>_(#-ZTZZ8> MYY8.HZ!*A;-,3:5L^Z8@*4XXS=22!:>ZT"N;CH[=E2E1F$!(9&%4FI?.K69D MF@?`X6&FZ2VG&L>QF,UC8S13YKN3Z M"6S36TB(97E_$6A+N]6-@"6+JB(,ZC<2187ULAN(3R6!PPE(M?>R"?6U\_., MFI+RPT\N8B]\DHVQ\U.U"N,!4'($38GOE54F4X,4LWL%M9,`/ORA!A^5H_S MEH7,8CKE+E>TAJRF44V(8"G^@`V$(9OHNBE$3F%'82GIJ;LO5V8!#PXL:"^4>PJ5\A#*KI-)`N4'P2ZJ:D>AL&_%1I@:H& MB]&G:>,.&TF>M(`>V(S=(O!-.;7(X@E@J7C0M2-JH)=L+L322>.>N8I5$]:H M?[\3V%<5>QQB&RAK%H"D\-P?V.F0AC'@VR0I3/B%G#&,?S0^AU-D4-7)@(!2 M;`H079*7U;#+B+'4Y&6M3Y=T*1:_DY8M0JLY<$E]0T\,G"8T[0@>EV.-\(S- MNE/\$):?4(34JAG/&/V+4P^;I7._ M9MVIS7.GNAVCD[:CPMG*2O<9_4'E.&TMV;*CK5FB%6J1`G0N]1<9WP'3>`+; ME5!_'L>[-IJR2KM_L],XELX<2V>>$RJ/I3,Y[!Y+9PX?9\?2F6/IS+%TYH!J M/8ZE,\?2F6/IS,M*QCB6SAS6>1Q+9_9-<\?2F6/IS+%T9I/E7F(FU+%TYE@Z M@L8YELX<2V=*XN]8.G,LG3F6 MSKR("HUCZI&HM\Z5CO#'M@ M*`YW0,5/Y1U6".1<8?'C9$LYMZ^@PIX\D%IB#\.FW2R=GG$P)LC+/(R3-JBI MJ@S^`F][GM&1M08#N]O=;81T?^;G]N&[+1%QC`R9*8Z#3*$C6WVN0;*G>V=J\;G=OULKS.,ACO>_A MX^R9U?O60>3;',HJI#]QF?!.P=N?-Z4JB(>YJ%_FA!^G;TRS\X*(&J2%[DW" M"CH.K$MG`G^SK0M_W*!9\X$/GP%]?Q=XP&L;W@)L'N_>??RTLU74&KVILB5C M^XY:OURLM]IVM_V$:*^)WQ\-;N]#AEO5E?7MPZ5U M]?>SRP_6V?7UY<6[/Z[/WGWZ8%U_M2[/WL-3H"Z^G#>L\Z^?/W_]8EU=?SW_ MK[]__?3^P^55219]3B?^?"'?E]1ZC%*E)-N&6+\+Q`GV@@.XG5MA^BTQTC MNFDW6_!_P]W>EQZ.GJJ!^RDP*4M2*31)"=[DSP!C,^OOVK,Y!L/7&>C-1FO; M2NKC5<83GE[G0$ZO0&RMO^^H=(>1OPK!QK.?J;GKA7\OHI@JN=Z+:!RZ<\Q5 M?^F7']O%I(;-TI[U.\?C_OW4YO>]&`NRWCHMV](!UQ>5I-??*DFO;;?:58N$ M#S%'+S4)RF[]P[\2;$+O^I:0C"W;OD?"^C-PX=U[X-$$+/W#]#0?WV'+;CV+ M/F=KS,[?K[RB M'JXJ$:_NA(@MI/3?]JENGR:1HT#P'V1*Q]Y\L/,D#'&FD4/388XN5ZZ$Q>[U MJ];/'X++57)_7P)_O,GY'YS[U!W9[?9S\)\J;:^ M2`6]:S!=]>-]E9YNSQYM[:0=DJ>[:;G4-A&6M`/21IK^Z/.N`:;7L?NE9S'4 MZ//6;S(<4UUJN>YNMRNX84'P(QU'S=?368=^TV&"ISQOQ(79UQN1P>OT5CHVJ/*C2P.U9O/$EBG M4U7;FU+%WUJJ'$V!$L`\5?C[:`HS#;X\C#SMQ<@%#9&'!YR8NGA;YFW9RLLO70?]HN]/CL7#+ZUX M>),`]@NS#9XOY/MR=56],0KOS6.07S;NO_[2+QK;_0U:?;WH+J+;H;-M#RN/ M/=CCO>U&]3-5N,PE$Z8D`BJ)H?I/?'-?^ZFGN!T0+MIVJUNV1N^YN"7__I?J M^7BKVUJI.A`Q.3^_&BV.'J\V;H]3QB7K;M1S()RIL MJH)KH0N@S[@`>F,WXU5@Q[H4,\?%PH)7@*==0;2!"724-0>[J0K<].&G",=N M)*QYZ(Z/DB:#F_-`CTL^(L9$S-GM;2ANG7A/]+(GX50!`5^-SB/2SJ0"B>\T M)E)>W>R;7(Y2K_3Y?1.A=4YM(HZ,;>+EDSL]ZH`,1BY`!;@^MB1YEK)N#Q ;?>N;YVS.5(4%R#43Q1Y00E&)S95`[5AX@=@](GW"D_0U06 MF=N'T]UI@S?;6]U%V\U1V^XUCS-"Z\)HIU%YDMT!(+->NMLG'"]\[S6)SVUK M\?^&X4!1MAEQ64141=C&3"D7Z37+FJEU[^"XTV/*9)F5=F\ME:0C=9_V;%G^ MI-/N59CP6_*K97OX'APZVHW^]AE8SY>OGB_DNS8`'O7J'J>M.HFN]:-]Z?M>+ MQD^S,2K;"?15XF=@CWH]N_,4,GO]/*5-B^>JEN-="IP#,H[%A+[]A^_&T=F# M$TY>?6U>[;3ZTG/`,W]6CVQ?NEJB3;NIQO:OYYC45B%9`RRK)]CPJ&Y[/D;QV]CN64:XJH]QG>?_A ML=\+R><_%OOL$KO7(IQ9)_\\5J3L$,T#KPL9;O<]EZ[=/+SY=79OT56 M8!1X._'KS7,?==MV83/%_+]:=E<<_RF-H-42\#35K/\M>XS MKYD8M+MVM[3*?(F$M\5S]:NNS5,M&J6'A#Z=JMD-!_Y#1.49<#,7H$*RPR$F M(`^&/;O=VS:CZ65G(#^W+-L#DCW=1GVT=2"VP4897H7.^#'/J[HN&[;LUFC7 M"2A'C)OYKNW6*T!W_3)SMS-=&ZU=IZH52-9-LK`JYDSE4[(PI$L1W3.:"WSF M3SZE4ZD_"R=*0C'Y"JO@T&K8'CSP)?!#]2.`XT9;9&7MHIG\-8YIHFRO&^$% M#U:4S.`E.-Z(0B>`+W?F8`G=%/9.N$_'K26AY05PB#'>)DS$#6WU6('ZLN3UG"?MR=G-.JUP"@YR'N4 MPSFEO5YQ?1+WPK-:>SJ7%X:V]A%MFZ"M\T M2U]T?G3#*+8^N<*W*)/D4^#X50?K;G^SO/-[V58-][+E6Q_5CI@7A]+.J&WL?_?=B\7DDT2.)'CP^NW:OMXM^H#7IUVW35:[$./`G&^K2LF=>E3:.U]D;8!THY1XV/4^!B2.X`0TJ!RXN<1 MGT<2/9+HL\7G"/!9M;W@,6K\1,&U8QCQA6WS>*`O;9O["/BF:=SUYUGG,[G_ M+APOOCMW0O$UO'5\]W\H/?QK?"?"2W$O_$24SO^+-1%C=^9X MT7_\P?>&#R,51'T#(,S>*J(NQ/_DH1%0+YD:CX;"7.=\U*VX)7'6. M'@Z'K4V!NQ*^&X1?@C@'S%GT=5J:5?N=3C/+K,9G\RM^^%?BQHO/(KX+)A?^ MO8CBF?#CL]O;4-PZ,8`2CZP-N7920TR"<$6$: M^G]SX$>M7@G82P-2Q[[.P6*!A^K8WK#=&6R]O65XZM@EFW$;[ZP[:K?;6V^- M@:CQT+;<56O8ZY?AI0JPE-O<'_Y$A-X"#&7^^X7_16R[F>YH,"RQES5+EX-] M(&71/"% M+>`;=CN&:5MYX66M.`YFXE,01:CW5NP5L/]U^MZ]=R?"GT1?P_)#2F MH!Z;J-EIYG3GMG#M9Z>5S81VJSO:T4Z)(N!):=?BYTQ2J.>DVOUNUS`0URRW M#5C5T=H>-ON5P-(V4F$)^%D88H,X1/Z[1?K(-V=!A@L6@\LQ'1]P8BB]$UWX MWZB'7$E$__)@]M]?TQ8;\IOPPW<'(8BCSY2;9&R>6]Z:^[_X\A$%5];R MJW]7=2..6HWIK_\M!`YX"L35B+2"'55&6E3]8%0O>=G26DW!_A:ZX[(>ZV88 M!3[\MHH<&^UV!<36O.L=8)V_?N`X[X]JQ7F%/=>.\2PO'02Z?T;N;[[K_<\T?P2?7%^#/ MG(=BXL;ZA@;LU;$7X(7,YIX/1Z(-=?W84G6`UCUMM4OSC2*@C']]LR?K#:@JZ"TTVP-NSEG9`LX=KZI4H?1 M:;?:G=UMJMA!V[%SW&V5"$F4=82WWT%E[ZPU+!7#JM65K^=FMM5L5_?6:X.W M.J*;_<'V\%XYGHBD_PR>=#V8'+;:.=ARRVP`177\](?#0;\*%"MN$.'_8]!5 MA/>H0OGM3R**OH7!O8LW/1^#\)TS>2]NZJ+$WJ#7R_KX-8"VI]U6/Z=>:UCN MXGE/N]6?F]9\KH/N8.-3+0)J#WNL?)K]X:AS('NLAQ?[O7R\N@((-4._`6^! M"-SX/,HY^O78/;U>MT108C^!JX3JN"O/BJ;KU.@Z;D(XP4Z M8S'JY#FJX7IPEKU?*[=R??!6QNAIN]O?`F(*]K\74Q&"IW6)(:19$,:2?NO) M.6D;>5JK5MH8G.KY.=U.>7`43DU=^#Y(;N)IXIV-QT%2EYF\I,36K;@M=-NK MGRK0@0$="F#P]X+_"QZD?/*;L\!X"3B,\)LP$9-5Z1F;8K7?'@[SQOP&L.QN M1]6Y'?RI03Z#:S=[2GFC/KU_VE[V!MVYZ M48Z.RM)XNG1=X%;7_YW14FRI.KCRMB.Z#L[&H-!"47?4PA1U:];:%J[* MZ!L,LW19";@P&`LQH3!&@64`4J)>0ZK=7-)H9=>O&?3*:.[6!GC^?':+\M9H MV.ZO)Y`]@5Y=,`R:W<$.09\D.'E`%*3?[4)&Y!>L!<(-4M&;CV)T/9@&Y6 MMDLQES3Y=?HI\&_Q0A2?`^X^=^9N['A76&Q6GT?0SH>=JD!0-_35*7/4'M4& M_;D3W=%ST1U*TGO0;/"=L_C<"4/,'*8+U\VSKG.1IU*KU09BN7O.YN`)0>R4 M`7'8;;6?%(UE6&K4VA6(G+J4]Q#J\40YY>`QL(LAJ!OZZO[IL-4N@_5RX'^8 M3L4X_CK]\'-,0YTOG5A\]8N_6`_R\Q4T%0"H&_@-0C##VH!_S^G5E\+#V4]8 M:@""6I::;"YZ![D:D76K;`M1R?2>?FMCB%::_?DK[4JY4.UV*U>'O6Z=;6$J MA:5VN]-J#S:&B4WXK8EGU.VTLR92YL.55RU'(",.#)9=]5L(AH\[^?`3;XPP MP$EE.UO65K5;PV'>\U^]S+8@E2.);G^)2LN#I&*4U\Y/?H`2ZK<7+_D;I[7K M;`U4.0+:#JCED",PV-:(ZG7:O:PD7K?.MC"5PU-WV.[T-H=I.PX;=-O=7%2P MF'*W9)M!M]D?%HF396*9)?OVH10WP) M_/&6=-X9CG)>RF-+U0%:.1>OU^ET:P&-:X*ISMYX>AL3I-?+A><>7:H6V$KA MK=]J%Y]H:=@N_!B,81>O'PG-\`@8R%Z".?I_"X+)@^MYF_-;?]C+DGZ9Y>H" ML1QS#OKM?&9X=1"WQA2<8J>9A6.3MN9\_CZ,CCW";WQKS>>>\N5>=OBHM=?BL6L6V=[J$IAJ-?OY`-M5:`R M7_:,"KZ^(0`E'BA,[BBQ;LE-]XN-DU7K)N(ZT.4WVPO.G+`N_/S&,)2S M,]JYA(92,)3);]H:.\UV>U#L*)58MF:(2^%R-!BV^G4!7$>CI$&GEZ]:6I.` M]LB*Y?R^3GLT;)==D2(GQM]K<(7ZS9S=O'J-[:`IR5VYLK?RT*Q0T36@J-L? ME;(&:H:MI-O3S5\*581-7<*:VFMS9EN02GIVHWYO8Y`,@0,J MB$KI[P)O(L*(JRGK#"<^ME8=L&T:@JP*V]>YP(XM_FU:@EK3U?B)MK"/L("&GITWLWHE@X=M*>UICTN;(ZK&#!K:&KLQ:L M!'R(TZ_3>LL\AZ-\GHJY2&4(JK-2=ZG0="T$9"'7*E9Z_7:!$;Y2H#RV?O7\ MS&ZW614`T.5!5@S+QVOJQK$$SX;G>P5,I8'BC5HN<< M0'']A'K!"=GR\IV8!E@<)S\GHL^N'X34&)O/`1RR_?5$.AWTUC89VND.#@QY M&\BE_K"W5$+Z5-C+R+ZSF#MNT42DH%ARBNG,WVN$NZF'4 M;KZ!2F:-R@!L0.SM;KL"!'FRWN9".*L]\U_>9.5RL<9.I]K*RX$TP`^GU7S# MCAZ!7YFB*UWY]'*]`NJ!9W^[+!?.[.=BTL]TE_\M5_IOG"@4^+1>4-\<%W2[O^,H@`LQXR@EXQMC(D\(VV!BV>CFW MYKEA(T\;ER)V7%],/C@AMFHN[&:^K*,'[?;P95'%AGCH#SLO3%:,Q\DLH2(U MB@-BC[I0W($OZMY+=Z(<:EK/FT^6I$9=>.F^"-OIOV4?>AHF=>E,?!&7V7ZO MTW\99+'9]KN]7%>YY[;]O+0H?K,,*I:&BKR`V!P52Y[G;E!1W+"5K1_\ M5YW7H.W.("?_2ZY>(]";-&3*S?';$.CW`E0#C@;`D_(GM?<7;77;HWP:]

N4!Y=NBYPJX>Z.0ME)]#JU+`:T9LORRBW='T`;S"W_K&FN)L! MK/)G)@>LM7G8\O71N\&Q!P)W^;O@&\Q8WA>.(6S=F"=X'\L1^A/RGN M#$_CM[0!:,SEJNE@)L:.[5ZH;(?JB]`QJ.?U\#>+Z M);<'<(/VR9TM`#2[!=:69]-KC;)&8WZ53:"H3IC-;O[P'H/C6^:OBGSK,_,* MCJE@J2VAJM[OY^[P"@!&XU^):$XSLL@YKJ)E3`U%09A>1V,9N'P3T/)OT2 MQ/\4,=XG?`S"FDQF59:S%2P[VU!U>Z59^WX^"P=C]=/$^P/5L12\WP+/'2^N M`=YW'LC6LJ?QU__KQ;_/K2A>>.(_?IG"2[]9K>8\MJ[=&9@47\2#=1F`"V7S M+VSK2H3N]'=KYH2WKO^;A8\V?[=PJ5,7-`&^WVST7/^7_WL;_XX?_\N<_O5_ M6AWY_W:]('[3_/YIY/Z/^,T:SF-ZA/25!48B07,V@\^/'=^Z%&-`?;BP''\" M/[@Z%<@Z&\=6,+7`[1S9EF/!$=V&SLQZ<")+^,X87$WXFA/C'W`H7V1-V75R M/,M5IP._!(23X".H!>B9#P6400'Z2T(&'&,.[TP<"S;KW'AN=")Z$]C]I3-Q M>+="]=2.$;SDXNQB0EMQ]0>F M=`OP/J=P%OC%!A\.(LJ-U)_@'5C`BG@Q^+W&%QU!&"2W=T$"AP5[!A8$\#-G!< M97J^EI]@A)CH7)Y<^@ZVU_2%!_#@0D7)+'GN+,H"PD>%$+1L+X+A!PKX.4A MP59R.$IQGRCVMS!/W>(DPEOACV'+P41X0#VQAU>BN+NSJW,+7/K33K-A;F! M'\<';<:'4-SXX,+?8&.!?ZI+"'!=\)'LU>`$O@BDLP0ISL%<4)W_%9,`A&=GG"&$,-VW3F\.)/X)=8`"AO.HV.-8-# MQA7Q=-ZT&D/]BTD2XN<0"#@U`0<`Z+OC\Q`^,;4#&L[JM&P+E8Q-GT!=:<." MT9SEB;?`GSP&C8@%>5FAI&%=WPG`D3/CN48/`E`BG!"/A`_/25&EA'$<$`SP MXRR(!0$H6:.$]&R0FD)5D=594FF7TK?+\6:PL?``$J38C\Y8G-%^2MRN?73# M/X$,AQKKS\%CE_F-J4SZO9RY=NK0@1U"M`)=@O%6&EOKKY9CB[@U5=55W= M!6&L&J>7NK8=U(33/WR'8ZMB@H.M\85OH9BYR6Q]7[FM&+8'^8O)$K#M-OM M;$8U[5XO7RW_U/O9F+):X.>L(ZPM-J.ZK^]8W`Q[PWSSZ35@U`SRAF)G,.AV M\_V?=@_SYNGW\EW:X"[S^H@>&_[T0,QIK_CXL/V&V: M_B2O=6NZ6.CU M;@=@\;F`WQV!!S7!@$96CVW9HGO8S3=VV@R`W6VC7!W.-\2ZVFV44=_P.&V M6UG3VZ_F_91KP)CGAQKV0Y&&[T'X`S-NN#1C\TJUED)XP5O@L#'&F#IJU[Q;I(_+2Z@Q#QE\"GV^,57HLH.CKTDMUJAK9ON81N'@KKEZID"%-)(FV&S MW7\CZSI&@1'^#3\31A<\SN4K:".MQ^SA!VWP;>M` M:<7M[0^M_P#$8-+1?M$Z[+5[>T%K=GO[0ZO!-_I$D=,SK#WVJVX%#/']2D# MU(]#9QPGCH?QB[(!@D=P_]=OK7^V/[?Z[_>!W0UVN;\C`"EV3Z>?`XTX[3V8 M#Q\=-WQL2N>C%`YZ^]L**N\U6H-]G$+YC3X7Y&^L&=><1JLQZK_6T\@JEVI' M4H,66',JPT9_+Z=2$0-/I7\/Z6BZC:=0T?L[&KG\AY\B'+N1T,1!99C@#!9]," MWB^]QJV3BI:H>LJ M0%)NON-HE&_(4S\DRB31#UWX<_`;/V'6;O,C?V30=<+KH"MYPMU!KF7F?J%\^A-6]$=43]Y,.RAD+<)>)N>K1KC@X]O MKQ,DC<+%]@8BG+C>W8-19VZ8'^0E9(2K0&-3GL:W%65$#NAK0/&79W2=3>G M6EUT[0UI^P-M6R^_TK6KS'HUWI%?@1^^.R$%#,M>:+6;HW:O.:HO7K&[B]8J MJ,HE"->"JM:@^\Q0)6-'F(JR9U3U1Z/6H([X^J=[)"J#48XG#P.JP_[OW8!G=(KVON!FK" MI(G"YB]_';8[S5&SCIRRQS93B+6;QQ>Z>?RPL@NU]H"VP:@'CG`>;3O93299 M\I/[K\2=8$ZY/Y'QV4L1!4DX%M&KZKY0MM,"/N+B/S3FJ!Q899MJY!&/A#3<62+]I M];HV>$!T-K./I="ZC-`3^3J0N/E^J\Q\!YP&(3K.>F58J6(SCPP(M/6C>/1_0Q^J-]J#-1W-";>](;I M;Y/`\]+S8G=M.<,,0%\Y$O`7C2R$0,0@?H@T/8T@0,.]."M0B[D/PF M1T_@:^D;MD6],VA!@'5Y17-!Q20NWES#SV!`A/%I,B7$:J+4^'VWXFQ M0UTHDC`5PU,O>(BXET>"VKTPMUQP/I(IH`'ZN&C\.QXGNSA@F61$B<2=Y2J M1,BDCTS$G(4'XCMM5X.;03YF&%1O5]E08TR#W2TGM9@B:F>"G3G"B06"'1%Q M9-<:0243'L\(B(,`&G-'6,M#8L;#SG'C?!<@;V8D$])L2(E+1$2:53=H0B? M`TH/;@6FLO&9IG^]"<(P>,"Q'TP5]"GL%R5\-\#_`$P`I0.DW=4%R!G`C3H MQ3L9D)PZR5/6WL^]HSD'E132EPP_F92+WV/8+CA/DLY=6YKFA=8BPOOP[<` MC`EV%8PX589V?BM\P`06,H7S`&6A-4_@7Y&04"@^,,'-K:4MA,S'L[QV%SS@ M?'(;>R9%";7)8E:E/6)S@F`&4@;%+CIL>`3JF.4;=TDD>N+B/\4T/$`AN,@ MC+BQ$!`?Z=V'.Q?4O:ZN1&+`)]-.P7!E[#NI@B;>!?_0`86-H=M#?J.;4D M(V;.`@]._IZ`BH3XD1%]2CIP$Z[K.VS`@RW2;G`5RXFBA$:S,RD^B)0:Y/+! M#0Z52;\CB93V$U^DDY42\#-CM2K"4#I3M&<`)%W%#@U@OJ5#()`C0.C)AX2GZMZOYI:5Q+[!%NGQC?ILI`67ZIRF![ MH8R2L,ABX\YN:#TI3R)DP>K%+:C55&S$^"PBF!R3FZ`H5T@##X/!PQ+SP6* M9;AAG+NC"0O_A?)@0Z7K6T7Q34<^L2-X'B9^N>R@REZU1)1G2B;(!-NB4"6FKG/7@9?H#FV0 MY;``6$QO>GTSF`2TDI,E:!A87@`6!Q',"<97XDD;8HEE48TUI[IFU8KC1:] M!=H(@Q]`-Y/@P4CM;P=_%A7)ABVK ML?"\.9IX_BV&T.GG:.Z,U<^.!][W?_S"S5)_4:O?4!_3TS%@RIE'`(/ZU^^@ M92;QW6_6J/GK[U99)/R20H>`A6J9>VQ<.G:\4X+B-U!$<1S,TJ(^(3%SR@O#5HSX]?9+9;>`.`3,`[+;&L]$#'+S?`2_6Q+W"J1WGC/^ M@8!9Q&HKP2/(RAP#O'N#_\`6AAI$NO0@V&^H_'[Q][QH.1!J3Z`Q^,YR..A MU#,-HVKWS@8'AB?U:$%OM^YL5@G^O-;^-W:0KMQW]_-E,!>C9.L`[7"^-@Y[599OA(] MMX9-3-_8&/'[TR#'4Z_OU$_:8"R4%&U'GI)]7,\ZQHY?#"PN]WVP7+XOCV8 M_!;;C5YYZF+?<"-45EJG7BJFI:U)D-QXXFD(>34$E6BY-ZC@Y10>P-/IJ^/Y M;W_^)ZT6\/?3G/^&JNMX[#6P?;]C=]H;&JE[8?N\$OL+7=:DOWJ&UTU/FN&2 MX!WT?>#=JR2&;%+"@D80.M:;=M=,_;Z]#<4MI8J%KC]VYXZG\T^-JVN';AFS MEYG'.^8:03U+$4SPI4%F&&&6BN3U4&GDL7S)S+Z'G&%$8IC/C+%G,(;@3G%9_AK^C)W02(/[-C#J5Q+MXZ`]!FJ8221[GY$9F;YKT&@I'ERQ8 M$S?$#,%4#`8W8+#0`RS&=[+,SQ^3U80YNC@F10+NBSSVJX#(,GK)KPTJW MN$P\2F]Q&8`(=-Z+?M;G)CU=1P'6(K5:I)>;6/Z'$&2^=4;ED=+8?XW3,P MC3RK0R]VK!,$7-6)#7ZGWZ6;D[\?_O[6.L%\H73D:_:U@IT;[Z8:&',8Q;\2 M^#/PRHUD%QZM"_SB8-(8BD%GI>@T,!$8+,HJ?WDOW<],8"-;`9BQ1L-!,! M#LYKQ]F_M[J2&?2(KS+1\@%D(VFF0&72;_'(_!0K.M$N(@`9:+.`EM\+9X" MOA=3X,CSR]"S>B:8'E?1ZWD^HR&<\HI?)%T]9?S5/L@R01U\S(K&<:69ZQT1V<#@X/ M3A,/Y%7>YD^'C]\)A_Q1BQ<9@(4DMD^R@"%0:0A-^TFBU`G%'5+5]6Y18XJ-["`?%@ M\D5WJ858I/S04TQ`P;`LD7YO:FLR&]R`"TWD$])8%$[,]YPQ3V4GIH0/$Y&A M<-%UN8]"JF,P;L1D[(3`YA&IZV`\QIH#KDT]<=_F;96!;9VX\&M\CU;ETIHU M\P!3C"PR6:`OR9CYI/_$6&`+("E)S&7OC'#M!NMSLG-6P7#"A3:JAAO,@&3 M''D00$C\V`D71CT/+YA6VP#H)NS2\#,Q7^U/G8U2:A,`ZOGL4S:PF&+G/H^ M$5,'BY^-C9L-%O6.EOS6B\,^+Z!4XFH6ARGVD2,5E+K&JOTNHA(XW^-PO/ M+?'GCCLQ`VFQU6_T?L7S`%SXR4R>I"?BF,HV=.DQ2JPPP.JT6VLJL`HLMKKP MI=$I:^GP#B_@MYJ9I50!=.3T$XWR14>Y>`K\0-OEZILFJ-K(;(BTQ MF'#@N(]>Z1.I(C6MLI%>0&C-HV2`%5U&!@?W)?%?\QPJ@F647@D%$,&6 M^49J`Q6)6!6R6([/&DZF;51%GS@L7,\F?R8X$\'ZD(3!!`M50C`]8WP@C<>N M5H]O0H&A.>SF8-FX!5K(Q MOQ)1Z_5XX,L/4#KN#(3CU`L"$L"M1O-75@,%;Q((]/9R)1?:$\U&%]Y^?@S\ M?,2IYE;9MRPJXM9H#+9?X@D,@U"%7,:N6$]EE>Y%B(ADFQ(N!9_(PFGLQ$1 M&>L_$U^^2)[7O\`O!1#`$M,EV.C\C08]:@$%'%'\A#,'G?'3G7%-Z)M>6MYG MJ^8D0IJI:3T[%Q_"-V_`UT%;!.@6OH!EIF!=7Q7C2>\%=_VFU6\,M1U+.YB' MXM2(+V';`BI_!:86;+$X5NA&(BV<;IEV"$"3M4NFF58V\K1S2HQ>09W-R]# M_Y92JP"0+S%)D:X%8$H5$WODBME!.C"XO:&_J` M;HSZ#'8IN-/C6Y1/N,?8H78,(%@DHI>C5+H1&B%6^X42ZL!LE6;!YVY=-&YP M;P"5_I%FL!M=%FQJ/X'='CP7H".WU`9S04QNV;N2I?%J9U$Q;(I@-Z"2_./50VV)";JZAP\SY(:2EPHR$G59D[R+^K'%/@J=T`QR$769L1DFF`X1% MH2YN(:![+!$,:%$I'IU],M.P;1F(KP5(7[3[+!"[(;L;.$6Z`7\/-_:FNUH M.#$EE;O,I[&4F:HO#@'RH-MU9`6YY&5O05T6DG%\9-H=,^U'=7N^FF6O-V5( MZKI$P=2B5"6C+1+LZR[?$F)TFT'R`<:LEL829_P)DU;'0>)-I-W-<%%W)F:2K4_6,%K0[%6]R93? MO-3FVCV[UJBN4WA4M^"\OI7TN)1BHG.HV,EBHJC8'\:NKQ. M#Z=(MJN;EFQNT`J9GDD$"LT$,HE,1-UVRV=^&%FTOA\#:Q)<\5"T1V%236! MW\!CLV7ZH][!\&!JJX3C7@%S=8FFLZ#4BF.F@.P$L?,\>(E!@V0%U.WC&> MI0=4CR9[,%G2/7/4/36&+Y=JUJ+@K2Z/_U2=%:E).PV0FNMCLZJIO2[#M!: M:XSRI_=2X#66A&2$PG0OGK>W#3F5C'2MI9O<[$T71BRDWB:526ID3# M(_&T%6(F557M(PAV#AB5I88 M'XN)2>I<%Q>SGFE,[!GYA.UVKJN3=-]C/$]G;E?-R_B65 M/O8I^M&D7@0XN0=;JQ-#(![S:)]"M\TKRX`EW12-D#%2F"R9OI0FIZS-K%F7M?)P%]#:#SZE M[[-9+B:Y;!:5HF1N7/:+X(-B4>KX%I,!+6%4M5AK)(N=TB[SN; M+6D[$936:!F.GJ>K+&4%9+9G;!ME>I6V8]E=:XETNDUTUW M1G@1936!]Q4G^IBNG6ZO,5"C9!^$$C.HCK.C@.(@#7I@'%.)%ZDBLGPTTP" M;@!%H27ONC/! M$M6LU:)ME56/R\FP.`V:I@&Q2T39S?Q&I")!JJR&JLE'';O;EZ.LUS3UK3 M,LG\HWYCT/E5/;B4&2E$MLXLA>3H+%LF&S,=6:!J5P"GCR&T_98]K`ITAO MOFD1Y$7P9D[NWO'GNP[=:@KW,MAT@8B` M]?J-X5!773%@KAHY4CRY\K\EM/&F97`=4/HTE!\))X(#Y5L1[;(/#45L[M M2<EZ4HYPKA[6;BJ#:4L:9'.XD_J7@>0X_)Y]7')Y+D)!@2\490(Q)Q[7- M&2C[6V6$&TGBZ]]2M=B&O&.C:9JWT[:@XAG_HGX`>MV'B6$F'L,N&&NALB4 M?#@%-(WS+EO>BC:E&4IA!YJ2/E9S43(T1/AY'@;>1QZTA=;T1;.JI9SOH8C MLQ+(X)"T`=.3AQ(WNI(G$'CP',VQ;Z1%ZDC=0`[8@U('AKC40%8D MX2M[ZZ=VM`$XQBMC2RK^W4NR>S2Z'Z7UW^%AD)&.8Y!0DA)8+31,^HG="59 M@<0W9`HRJA/DZQ\7<\UQFT>=5F016R."8YJ$)"SH`MZ_QC(>(\CWTT%^\>< M&C"8V,I^D.4+CV\M#!R`M,#-\P42.=]9AK?E7>=&+_`(=`T%+[5[#5:PV&A M\BRCB?,+GP2L$'HMT#^F>N!YD?P]UH`KOTDU/R#L@SPRT-1\G<-YT.P0G>NYK]$PRUQJ`2['(7:$T@=3O M-[H59+ZEY7UWP/0"HIX@R(M[V7&HI+S_][^$$Y!LG]00\S-_N<%XQ]=Z]__\O,F]-S?\/_#C_\_4$L#!!0````(`!!JT:P M\1/>PA$``(3D```5`!P`&UL550)``-##%%5 M0PQ1575X"P`!!"4.```$.0$``-U=W7/;-A)_OYG['WCNW+1]D&W9<=XS=W( M%IVHE455E)WK4P[^ULL%HL/ M_O+?YUEH/4)"`XP^'+0/CP\LB#SL!^C^P\&-V^JXE[W>@44C@'P08@0_'"!\ M\-___/,?%OOWR[]:+>LJ@%_;G6QU^JA"?[9&H`9/+<^0@0)B##YV;H%8?6F\,S8+5:"FQO(?(QN1GU%FRG4?1P?G3T]/1T MB/`C>,+DSWTL!H[%\?$@PM>!/@(1G^VC[_]^Z1[?'K:;I\=/D^8"ET0L3^? M'+?/^!_X?^WVN-T^?],^/WNG^@(1#%=/.KX^3C]-R?_)0S0UW/^WQV@T&X M('K^3(,/!TL/IT>8G)_=')\W#[ZWW7?]:9P!EH!XOAX\""CXERZ-KOW[\_ M2OZ:-.(91%$' M^3:@NB%8T5FB:A,_(37E,#)AP/BHZC%H><.P1_XG0IM]/+`.@L-N\?6$<; MR7B)$<5AX#/G\R]`R"WK3B&,J$Q`6&CT@T!8<:9PBCP0+BQJ(5<:I+;AXA" M?_G1O'="CBEU)LX#CUP,2Q4[5V6U$PUXB"5PRMH$C[#'`OH,;JV@&?S.CD3 M-\+>URD.?39FV-]BUNFVTTC$<3<8`3J]"O'3]DZ6XU2'_`,V6A'H3"YB&B!( M8MU%X`&['%#`BE[L%DK,:E#KE'T..1V?-PS$(SNG>3U(7X4C-+">N0S@8$ M,=YT"(D[90%.)E19^SIDZ:%'2"/N0SWTPY0Q'(KCI;44E+".J1+>F>+#_<^ MCSRL`R@YG(2L#LFN0$"2).X:`LK43GJA3"XA42WVBN\H_!8SMO:CBD!E[7<7 M.X8LEGF!W-TVX[8[/<;@+JQ+BU5>340<-6G%5(U&'S4!%,K?+D$)NG!R#L@@ALK4H9 MPUUHH^SZE1DU./)DAL-QE!1FF6<[#TF1@77(SUP0E?RO!MX[T'%$XVU566;1 MO,3'E6136,Y@F((5:%M6D9EVU9B(I+:`Z$7APDP??9YA0(^1Q#YT,_XSKSF'=%F@;;6LC&KY5]8IK3D+:X5'0X++2\DK4I\P41>U?;[I3/HV@/7 M[O+?7??ZW;&[,-%I]\97-J6^\FVQVY6P<^$#[&W(G#(EQ`P644]E3=9)Y@` M>IZ9&[]PJ)UXO;EBBB2KRNXY$X= MXEF8^)!\.&AGSP'$6W&B_`).VN(QK.YP[8"YB,9_83@FJ6WQ)JHLX\D M.+">8'`_C1+I->8%AHI+SLRV=F$8``CN1\J=10.]&FHK>QH'%IC)Y+^I%@@_Q$C(U MN-YHA4M)<_/PBN$5TW8$0YYC#`&)`J@`EY!#:TSO6@IZ&T<6+85RVZ-9U` ME(U!A>B89NHAP0^01"]#EG0G\P:6Y#SPM)H-F)!1T1E1H90.MK(%38.I8\8 M^T]!&)8C\MK"C"&_Q/KKBAAGZ1Z`+H/6,8XUX-YA?WLA3&O4>(DI4P`C;QZ$A2%-@=2,\5Z2EDE5-PZTUZHW[:'.9!$ M`S"W2!%?7$KMFI@O]7526LPF7&.T(4/F`81 ME:5_Z^W4H'JGJU\666@[8MF=:\!I.J4=IE2#9^?],9-F>+&(=8/P!WK]TKS MV**V!I0ETTT+$"Q;T@,_2HZ56B>Z98KEA)Y;":8SSS&X,QW@QJD468J: MZYY%D,F5-<\<-)X-X/$(D6<7(-=4\LU0$I5M$X)8W:DE[26%CW3-)94@$ MJAH'RZO[H.B2_0SDV8"$MV3Q@UZ38G:Q@%U"1Z""(1]""AT[L+@?GX(2HJ6 MC$[WU$\9,C4#&(?;DGY**:M1Z5L)%/N4GN4Z>I5I7C&50@LYD M+JZHJRRW,BA-^TK>:W,,SU&]WS7_'+F(H"@L+5!Z5D9%`(MC8.D9+A3B5X MI`8E:M6&^SV(8\F.GB4%52`3T1B4H95@)=?8.)#CZKGP2EJJS,RX-D,HT0H MV=;47$O=N:7@A@`L$=U01^KX;&!G>H-P"`_A]X)2CEEA'H3BN5L9&H;!Y$ MGA?/XF1/6!I"N[=Z/-E$!@YDS%X%E;AJS'2G9ZJ0[J9B8R#>L1/I"#H9\<3 ME_1BRB"!%(!SG7Q-V\LW<9.:_XCN\K'('^Y#A`FB?8RY/,MS1MS:\2P MS##&(;@T=>@@OTIJ+J?4W4M5=2LOL5:#36,QLHI^-3N^T#2_'U;IL\^[_AP M9_'E>RLG/4\W.>EI_;#"^<ZA MT@B_$=F\P)=:FN>"((0TE5QXHB'74'>0)%\<^"D+K$?@6!>+.2_;3@H%##0 MW;&WP;K4'L;AF>9WZ#X]O"X(U05-M2Z8T,B92-UMK9GN`%)J[MQ28%VQCG/ M1Q`@7D%V4#>@R2$19@!G(CO](B'3W?%5,5+2WL#1ESD561RP:PM&W_6&NA<^ M5($IT="X[M.%#P3R$V[<@,COS'B-Y^5NZXCXZ5$^E>R5!%2$%SX]!:Z/:Z M(N.`3N3"K`IJ:[>9@QD8/5H22]WVR,AY`DU]6R^(5W?S\&F M0ZMMP[,I M0>SVDQWMRN4.G]GYSI6IG6,%36VVXR]`2O=G4D%Q(TM).EI.][N/G[:U=V M_IUMLO/OTKD>CNQ/K%WOUK9Z`_;9UK@'L$!9^8$A(9'N.D#)&9\K-JH']VA^ ML8/W,B8`4>"ERR_)I[2O^5_B^0@NMT-3S],=SQ63%S<7V MZH#NP7`M4K>DU6U/\C@_EWC.1T5I]LCGVK,A_8C/=3N,W_+=-.9"(X6K22; M;RLFFSS7=,?.Y6^?G'[7'KG?6_;O-[WQ'_H.TO#W;UV%^GD',V[C;+ICOO) MNNH[GW6>H^'OI6Z);N8F;4N7FZ8%7IH41;ML&3G<7ZM6$'!23B)W(KOWRY! M:K2"40.$^Y=#+>^\[^+X+IK$879]L1`Y`97ND:HI+6&,@[=6I?1MEP`:VYS M0R-X;UOBUUQ'+A:X&W`+(9\ZI!O0>3HE'HJ\M&]8Z(17]C,F#5&@_Q[B_DW MY>`2K9.\_;ES77OC:@7-;&NAH;JUZ,4?.>Q,UEYQ=GB_6;B36@J]+IOW6ND M@U8SGH'1NF"W7::3O`JM1JW[!3O-1.8AC,/=G<"+P`R91YQM>G)0=?RMKK M?C=/(]"C6-<_&;Y(N%WNG;A_&^,V7#(7Z-61'O/FE5++=/P_W2 M=O%-AOP5)BD6@]ZP6IV(IXR)Z MB27FQ?[Z5_"5^>I<&08OR1K7&'>\;W%`^`U[?LSEA;(13H'4T/7^BH"OKQ&K MFLR\^%8D^FL)G25F"DL057@8ND>@?OS%1C30$0CV(/235>^"Q11%3ZC"Q-#M M`UNZ0G4S&CC&1U/6J<3$T$ZKH!KG7]%0WI'D]9#F(]RB-^>4;LLN` M1#2&)CW;02TWDGD#VY+(_0!!G\]KX#$T/RE/E0+360F!)Y5I1#&=H?L8 MZT%8;"P#02[,`1+9Z0UBLO?8%RBI@R&_>&,7GQ;3Q4'"Y%"<\R"9:33\6$-W M3#:1KM4,E7')`;=C,O>@4UYW>00A[V9#2`^HW]U9:K#!7N1, M[&=O"M`]'($(.JA8_')UJW'1/8_=!.+UW<0;F,W,"^YJ,$9-BX-;F>Y5-S MYJE:2-S"/,U-1YHS3]6QRYCW7PX`O]+:F5S$E,^&^3M!V;@84%[7AY299W7' MTLK!]I^LEM4-J!=BRGBP#^U#:]`9WXQL?H+]XL;M#6S7M3H#_@Y,MY><:Q^. M;-<>C)-71#9V8I]OL$91NLTN&7SLU@W!M\ MY(?S!]W.J.LV)G/VXF_FC4EV4BAJ^WA=U--#R^Z,!DQ&UQK:(\O]U!G9C0GY M6O_OH>4KT8L-VVZO2_OFT.H-;FUWG%SDT!M8OSH]]LLM^\2\ICGC)KE[HN M[]M#ZZK3&UFWG?Z-;5W;'9<9-[E9HCD#QW<4?HN9D/9CN:1OUB5]QRQ[<^': MO]]P?[!O&Y51+=0-<1AX09E'GVT9\JP?,O[-O?A73<\QWWI>G5>G<71B`(2_3)#,=W>25@J]=8[W2#-D-J7A2?S0+* MKVOAP(M?(B$DTEW5V.3-V>L;KZ4V:?ZFBF(UKJ$?>$LY_-I]%3(BW466+;!1 M4<_04FJ)UFQ\".+9II%DC5IW?6C[7E?%2LUWO\^8?(6$+N2GI@0ITNFM56W9"9ICIC-L<9=O[H7/3M11[_L9Y60DS0U+O`2"\Z/M87,@[ MR15M-LW!K<6#=C?;%LXNDNGV8@ZQ\_EVYG]?I!7,DUR]1SK]SI@G3[0> M4^X:M?P7]+5"1!V002%%63G<]DC]M737-%)2:<=^&EA^4PT(ISFZDVB^EGCPX)( M?@DFN8Q$09$<)&G6Q?_CKL&^^3]02P,$%`````@`$H&K1FLKGN%Y#P``T-@` M`!4`'`!R9&YT+3(P,34P,S,Q7V1E9BYX;6Q55`D``T,,455##%%5=7@+``$$ M)0X```0Y`0``[5U;<^(X%G[?JOT/7J:V9N:!$'+IGLYT=LH!I\,,`0:3],Y3 MRK$%>-I8:=G.97_]2@83C"U+-A86"?V03D`Z^KYSCHZD(TO^_-OSS%$>`?)L MZ)[7F@>'-06X)K1L=W)>N]'KJM[J=&JYQNN93C0!>,0-GRA?@`F3X$/VJW!I.0#Z!E[8#D-"LP<' M^`!_,6_X3#DY.#64>IU#["UP+8ANAIVEVGO/YPU&D]/3P(/KF'9B0 M3YP.`V2"I2QD6"[P[YJ'W_]]U#X\/FXV3P^>QYA"V_#QUT>'S5/R!?G1;(Z: MS;.3YMGI1\ZF?,,/O&53A\^'BW_SZI\=V_UV1G[<&QY0L%U<[^S9L\]KP2? MC@\@FC2.#@^;C?]>=W5S"F9&W7:)?4Q0BVH16GUFI\^?6J$WT9%$R6?[Y$3 MM7'-O+7]98;7P:6/^Y6I1.T/T"FC//O-")EUH&G[HB4Q$"K4$^:L> M%:N3C^K-H_IQ\^#9LVJ1G4)E(^B`(1@KY'_L4>NO[+`^Y7GDVZ14UI M%,+8@JX''=O"?FI=&`[1K#X%P/=8`)D5A:(;&`@K9PI\VS2N@>%AVF$O9.'K%2OH)[#WP/L%CMD0<0 MK?SV8L<`QS+39KM;,6G;XS$R[IVR6,1EB8@X?&BS:PF-/GP`.:L+C$1\.+DJ M"XM?!@YJFZO-[6!;]A.2=UI35@I+`/\-KDA:AG(;X^`FC6A09[O>NZ M[AF(+%(>F;.1S:2B&:17;^NY0I5J:TK?#X!EXN;1>OTVW#:1N^ ML3$5FL!ML.%V_=R"!(X\D>)@X(L&F M5%9%B$?,[5$YQ0B;(W"&4)ZZHC%RZS:7D"S4!C(CX&F%5U%0"BC4691JH`\;B7C=4M.#/LG"3 MM;>`.&RI/@.S>X!RPHU7%8_5<)Q\",,XG&YT%?S0HOJ;-4GP=@('+^P4T;5 MXYCQQ[9KD[C!Q'+O.L78G?"QTT?XOVNMAYGU+Y7^0!NJHPXN M4!FOK"VH&,'3(@1;_>O!4+O"Y3JWFM+IX;^U:JAF[DW%B'[(293PU$?]UA]7 M_6Y;&^H_MJ?-YW17]$>>L33@6:,G$,V\2%C=)A=!T;WGT88@.O/C&,AP:9 MCS6`XWO1)^$,K7[87.S:_[#X^&X)'VL4=/"O2Z=UC'O@A&W?+0JGE6U(`#U, MEG'`7I1;A_SJ52JP"^&,YYP'Q=/`L"0&/;I%%M:Q:=Z<2VX<7/\U:I]5:WQ>P>N_;L=F MK%C7B][]4HU=^-,J8BI@TS%:83UE!P.I$Y`4`\@"O7I^\B^#WRR+A_!=(?+ MRC>4(5]^DY='DSIN5>\G'<\+@-4.$$%D`VMN:N'7RX>J-">`3)M[S5C3/&) M7+)VP_[Y5''4AEM'3YZ4(ZIZ:)VU=(,1M1AN.+5^M_!_/$O;P0I2]C0A1// M\Y`=WP7!Q;;.@G;6&K_TQJ1W%E&<:>[T0<:X,0^"0SR^(=L,-P1Q,?7)0-87 M!+W,O8HB\J1WB@UHT>S^44:[AR&Q/+-GB]M5JW.PHAG]ETJ-?FV[$(7SW/G< MM0U,!'`4N\0:&@(+S%CC`:<`Z0V;AP?-E)^D-67;]N;K%L!MFZYFB]\BMDZ M3PL[[0RYB68]CE"AN]!RKUTEVU`#!L>UW,^<'KV6DM^`:5K25W`GQMK M+'`;WRIZ,#%Q`T/L;V/A1Y'5/4KY;+;_RKL>#UU=#/4"/:+&[W3TW1=47OD(5F]$S(:##4=LPL?(A7%B7V+0XS&IW4: M1YB&]E516ZW^36_4Z7TA5NFUU6%;F!FH=SRL(FT>KB,]/E`T==C#$'5EH`T5 M_4H="GM>E7WE0PQL#W"O%>J^V==$Q.`>K\/]<!;RYT[<\;X@S:K4B(!2^/B!$XW3#63]%\H4= M"2ATNT2,Y(>-2RYB=!#<>Z>O1`OCB37M1@Q4HG!FI#J MCW!W&A_J1==;8D:?T=D:&PG_<'7?8'7=[L09X-<8!E_3B MDA]LR>(HVS/>";"L0Q/4"A4=:LE4-L,PDA]G+:HU"4'9<#T_R2,B]-$R@SDB.F6X96HVJ3C-P MSX$S@+U]HQPZ6`IT[&JM@9W?!&T%A)[&A431/I2P;VEHR.C,!E]@` MH62C1:?9"EXJ&N.2V`MA9JG4DJ=>-QG@FMD.X>?X!7I1QU(!B MX18JX\KH<(E=$EZ.6^A@I5Q/&F.;V%?)W).(&EHYFZ;`>4OA%6Q/B[;V">5] M0OG-)I3#QZO9B>2U8G(GD%,YR;:<"><4%XF3+B3D3.;[EQE%/'@K0K89Y[UUU)Y@Q[5>ZVU;1\/S'9 M,EXG6YF)8XZ:E:7K!<8`F%L#6\K[]Z!+(^`XC(CJUIU^P#;,2(7?VDW$Q@Z MHJEHX:XKI(?0<2XA(E]N,`(4:J^J2Y?RW60BAC;-L22?5_`3[@6L+:Z2FZK, MFX0[B3"G7%'N_YR##3 M'@`ADO(+DG=QN0$?FMDJO@"IO"Z1I9>MK"6S`&S=I3;W%&%+1Z:>:Y:[;5- MQ9.+J2L50>Y:'HBW[[(EZXKFMM5>4;6Q%BB57MN+AQ[Y\VOKJPG47;;@1,+ MJ\I<.!>2O1,74=@;W7=;68Q5,]/E!/#VG;9$/5%]M6CD6\Q/01$HW@JWB+7 M&)M!(;3M<=ISI.B75KMG5HV9Y@FD6"G%OB$>AY5EL-_"E$Y$#/C8NQKB2Y MR9,7LSUAL23DP^B<&B(',\[8H28Z@'$()X_"LE[DBB/&H'J/;6_5)5M!G MY>P`Q0'N.\"FRJ-V@)SW.ID@L`$CU\=#,)V/=L,;Z:B#,24TCMF;A83ZLZ] MY.M0_@PHT]CE)UTE\!@.FPO+.>=Q,PG6B-/];1+J]FG0<>@'EP&2^2QQ?;]L;ZC<_[L]%[L]%[L]%[L]%2K,W(,MA MMOVYR%V9WDOO2OMSD=LZ%UF.QZV]NXQUL5MJ\3=\6I)%>T='))IB>M"=KR:B MER!'5SYMY614CM;EW>;9MA+>F`;:1M-(HZ3BH#YCOVZJ+9HSE_Q M2\:%Z0E/G![#$+"FI7"4:F,S+E^Y4X7/\Z-[QZZ>4TDT#Y?\B$9)\RTIW3PG MQ'?LZT4T17-XR0]WE#2ED]+AF"1^!D;\GSUI=[KSZ?%F1+6>&P20/UI9J3C'5;+OGM!3%S'D4)=U&>Q7F MEGEK?'LN(?-F^!)SQWT(?"_DW61MB6=4JFACO%@7I=@TG97D07P%]%$1^QU5 M>X6P`.NTJ):4#X3'A0+ND?0-YP50AF7`L``00E#@``!#D!``#M MO7]SXSB2)OS_1=QWP/7>7G='V%7EJI[9[9J9W9`MN4HSLJ25Y.J9Z-CHH$7( MYC1-:DC9<^G/R1`4OP!@"!%D2GW7KSO;+65FWR?+"\&H^_(6%D>;;E^A[]TS>>_\U__L?_ M_E^$_;\__I_SE`;GR'[\LL:2HKL&R/1K]+B=V^>-\R$ MH16QG]^_N_@=_`#_FGWCV_B_^?8/^CZWB_ M?H3_N;-"2EB_>.''Y]#YTS<9`[]^>.,']V_?OWMW\?:O-Y/E^H$^6N>.!_VS MIM\D7"!%QG?QXX\_ON6_)J0ERN>[P$V^\>%MHDXJF?WJ:.@SFH3.QY"K-_'7 M5L3A5?D9HJ2`_SI/R,[A3^<7[\\_7+QY#NUODL;G+1CX+EW0#>%F?HQ>M@RR MH0.(^R;^VT-`-W)EW"!X"_QO/7K/.MR&#_T('[KX/7SH7^(_3ZP[ZGY#@)(! M46G7CSE9,=/;KI6=T\#Q[9'73.LB=T_JL[$31`<8D.7OW(25'UEN(^6SG)VK M/:7-6GS/UWU+L_F$-FOI#&=>;1?^.&'_RBE.GR,V$5$[41UD:1P<_Q3WN['L M5+J_SLEUP5GZ0;Y%`MN+SF'N@1F)VPM_^66VB_B\S.;JV18\;,C^XRN>WRV_^ M(\-)8E;"_I,DS.1GP?[??WR[_VH3;,66<:LV5GC'3=N%Y_>6M7T+F'M+W2A, M_L)1>/[N(IYY_R7^\R^#KU9@K]A7!L].6&@)!4T7"-.J!W"2$O2.'9U61:"D M-.1GH#H8#PI?,_6].?MN!I;5CJ::IS,O8ZI^ZFJ&'K'2!TMBYAA;.?`1[)> M!JEGN;:<@.^8QMZ6:3NA3]2]D&+.B-+KV.@>M8':A[O_0EXO/<&'N\]7C!]J`VF#UC`]$>F#Z<`)@^&(#IPY%6]3R^ ME"JE7LG+Z3I;O>O43%?L,J+>.[YLV)W`Q)"1#A0:R?%@H0]43C82N2UPHU^Q=65N'+=U/JF"I]-C4!/U<\>B M.@8T.#/1LG1LFO(08#H?>R1FPX&T!8TLQZ/VR`H\MOV3G[)6$7>[P=(IG-]A MR2C1H$FK7@E&Z_7N<>="!A$9THVS=B(<^,DH-HL>:``.-:`/U`N=)[;J7_N/ M\I!/`_Y./5A=LW+>S)09#1;K:JR#)Q=`DHD?AL>,-2YX7G5%D#%/ MU&UT4:9@/JR8I>@=(%JUY$%E00A=3L0B"X>CFK+>\;V(62$??.Z9J"E),JPD(3G6,%&)PBCB4.]%0T>)[[E:2-M+N MPHQZ9?<&I'+QD/8)7T:Y13U.D5"UCMJJG6K\"5&9QIXCZ#?=]H# M3S2X\],;48I`B4Y-]6FT.#@@_.+"L3:=0Y]M?D7#3Q[Y$5LLP,7<8-'?@]U M<,1W-=38MP2ECYI2C!3#+<;4X,(5V_N?>? MWMK4@3GA!_@'0.Z'S%3`_O2+T&)![QW0W(O@UG?!:C59%Y"J4A(0I+I'3`5 MBI7.D00D]K3\$GY_L+AB6`TL=^S9]/DO]$5I7(FN6V`HU,PCHT"$"!IRS138 MB(D)IR:,O`]T)'X,MCD2L_(_=X4%F5()!+_H>AYB4+R0)H^NSE]#4%>$Y$ M8TN!KNM^EZI9!$"."!429)HI(2&(V1+"YF^\](&.`5/$!F6N7>M>8E?A]Z[0 M(%4K04'N1Q2]+].H=!Z6T!`@ZJ.OKW9!`#HZX=IR_T:M0.T,U1=(:!V00, MCH4NA0KI3<)LB)H"?`TMS$(N5GZCK_L7SOWI+:H6^1^UQ&.Y828#^FZ7 MDQ5JYY>5"F(4(#+1L(BD<9AL3"T"G.>_`BM)>(E@[@]37WQWYT56\,)?92L> M@VCHNL600LT\=@I$B#`CUTR'E92#<)8>]ZS"%2[HU@\BQ[L7#]BI-U\\HYW ML%JE"QM92TB\&@55&+HVY"D'/&K@R26U!^8.):OV"1Z[P?J\$>!JEOH2%7, M(R9'@@@H,KT488_X#>QL"`@K_1<"`" MDX&:JI!:YF;(&1',V4>&^HR]B`6]V.Y?L[_))C(-;=Y:T=-@+\T-$5NFH$QTBMJ&K[>L==`V522<)_`U)F4G"37Y. M^+%<80M#&H45,"P2=7K%0ZI@[AY'C@(-B1JE2+0R^5HM<0$A7AG:(2($FWW MP%"H6\9'@1`93.3:E8+1MXO%:+HBF%!S984/`\^&_P/W2)XLEU_IC7(OU2AL M-^3M],Y^'7-R]_A-&-&@KHZV)10R)IYGM89_T#T[#D`.UFM_Q[19T#5EFMVY M=$JC>'RIQJ"6I>,+C97%^XPNG1@,U`2+=CL60R+KF5A< M$!+4[>@UZ\<%Y1=XYQ;3F%:!3LO2>8,E,]!3D./!W'52I:"%3MH&6(M=DX MKL/XD!K'M"MY=BCYRWU0LK6!OR"N!A("O/U+%VBRT3Y++IT]&C09:!D$5TQ M"Z&"1]0(\?E-_W7LZ3!YM-S>QV1_U.,.LW)GV2ENHDPEJ.IFTSX$@!$8\\#? MTB!Z@:H4_#H(VV1L(:K&%H[T:)CZ=8952N?=T9J>D3.J%+)DC-:S.:CQ>IO M9#`=DM%_W8[G-Z/IZHQ,1RL<,OXTXIPEY2R2TQI5,U"24&!D%JW4K%KE:? M1PM40:Y/OF]_=5R5:?N?N\1$4:DL$)+?T/1^0:%BER<_X^CNL1EZ[.\A9J(""&6N7,EC3!9")GQHX%5#V9WX#ZPLC MW[%V5X[?@V1VZT];,#_O:`\0B&8,M&%%84YE..U(LQESMXE8NH:E<642\:9U-3X5)]P/'@SJ[]\GDV&H\7R6_+=<'0]OAJOON?AV-7?T('6+/E0Q]`3,`W2$-74&,%7 M+R$Q`SL"ASNZ\M-]=&6:CXRVX_P>M;J%Q)XR(1JDZ;23I?)$ M/KI$GF3GNJ!/U%.F7I>H^@@X%%24Q1=B$CP`D>JEC!X$@@P',J8^`VGL0_4. M14K9;24%I:KY`@HE,C1(4>MFD(3J`7,R6>%`SQ[Y7G3%_J]3D52OH>_'URC4 MEGN=`C$:5%5I6"?!N>T70`ZY1,1KK4VH%=+9G>O<\U=[U;H54S=7ALR,2!_ M7TC'@09O1FH:@,[?\Y=9T-"JI!,7!"-9.UDO#OL>Q-HMM?K>4M7&5TUWK[E M,U7=/1LZV.P/ELR#6#>GL"D5E^!JS(#&M=EHF4I?CJ;?CI?C18W^$):Y9G? M^)A9SM+OLSL>%E&CP9@!DIJ-H9>A/M`>>)X=+81=BE'6):D6Y=55B[OH?:_ MH\&+1F2_V$D'!&<"`D0?.\>"NQD-[0J"Z6DG0)#HVP.(!(Z/$!1U5F]5>MOZ56STT$8.M"$#=%BHG9.%)0NK M7M[5"61:UO;M@Z_2`/`'7&6%?.WLG_G\2BI>1K5WTX`?./ZG]!_+#A[-_OWAW M]O[??CSCF2D_O#_[]_>_._O]O_T^H7:@7H0MTE;V3RH3R(WK&D>R(<+^,C% M[SC%DYY/<[DKS^<$29C2]>1\T3=5I_]/B!IR[;Y(YF6.[<<>^S%2U%54I" MNM-D++WN<0K.2D:8.OUUWN9S3G#EMT"2HD`%JO=X\[_A@/7Q:R0;@-Z`/U M0H;RL;?V'^D$+G_0:+996<^JAJ@KI>/LOR8F%C(`ZXC``]!&>DLR`1,IR$64MI_)89;(N,:12,HN@(@T:WZ-0K'Q.P"9(+V+B7-@E.#$U MDJFNC'\&;?%ZQUS$B0=1%#AWNPB..59^WIH<+4EO%^W=DB#Z%UA$\G8W>E!0-KO3ZE=^_`VJRKRF(K7I@ M?`NZZOGL,EFWQP]R)?.'#7D:-(!1%8*[XU69#'Z,IK>CG`@XS.UW.CABOG` M67!O>6KHG/TOP_&2!D_.FNI?**@EH4L\-3`M"[4:[&A06%_G4O4("(; M2I-'$?8IP1"+8]C>P6MJKNM_A4=T1=C#=D+Q<,O)H7H>^$].R'[=^,&E90_I MG?(9OH.E(D6_K@D:C@B9R&Y&R8]BE'CT'L(GNKA?.^:42_O$I(31DCL+#HSO M3G!<3&@8IK9I]"T",_XU=SVOX]A!0&CXUL\)`Y]:;DTC/55 M5YDH475Z1"Y7,7?6G2?!Y0#ERLE/`V&AC,J-S;8T8-CU[N/JA)4%M-3TG5Z7 MJU([=UM.18S&'55I6+HK-Q\M!JOQ]!,9_74^FBZQ/&T!!5-F&_W45Z#I-L(M M42\?TLX0H$&'3MRT#KD6W!?(,GWPC-"D\));(>Q#2A4[."3%-N.6X^03B-F M/1S0&694A'=A,PHJFD7+T7%!A"K5"]415.1H(%>MHZ1N`G:(?;(<#RX6S+RA M$_(J#TRUV49;6:&"I],R@2;JYVH'ZABP!5M,E"UB[CM@^I[?]"!P8F=!T3<1 M;&02V'+.42:U#?%@<$E\^)!6EOL0K6D+%)UNAZ7JYA;C^=)T+@MN5[E$'9, M)8JTX0!&:0EHNE3L>>%MM.#&M6%3J2??LOD)=?K"/#+`[&_,5=F;I>P%-&55 MI;#9DR$%3DG!TLPTF2V7WY/Q]&IV,R+7B]D-B?=LLRF2O1J_>FFZZY?3=OY` MCM%N7T:(9H;2:21[793ZY;Q-9`)%^9+".A[+ATLDK50J7D(AD: MXAUR<;"+T$#5,F=LK$WI=%^VL\6O9U; M0>31`%XX"ZA-Z:/F7H;U\LX)'R`&,]MH5@D&?%V'VXS,(; M-XYC;@R,[@M;:609`9A+ZCE^0/BKMCA@R5?>;3Y^4U)W.83@ M`,9^.7#->N2+1H<;\<0/TM/;R\I6TC'CV&MK&<:%I\'&7AV7HI8(-S0Z,%G MOSPQ$IZ&I-Q.=JA!]W>,.FW:\KVE3CZ/9MW;OMAK\ M%4^@++8[]E>7U,;Y:-O2NKN1Y%2Y3+B2Z385A=Z-8N`BG\ET"I$K"E(!,#% M@:AYX#/M-$<^68(N<5-6+`N5_:^X%A,EO62W\L#'X.C]7#SA@/>T&LCI-.[4 MU,QX5D)/5P.3Z::RN>1 MP6JU&%_>K@:7$[:LFI'%8,A^.X.%UAO"UEHWLRG)/JF/`SW)$Z[)TTB75NBL MV3)SZ+B[2/G`2R57EP@S-"&+N0H6-,[-3,_2JFRP'%_QD_#A>'[&@U)"M+Y M:$&6GP=L_7^:HS58Z2X]OG5BI;ND.TJDB#<-"42EU(/4<<215TSPMEN=H_2M( M!E=;!3M:_L3)S#0MEO`HSTXG&NY+][$K3;)XD:B72,5E;R=IT`S%4C54H<1 M?N9D2%[A3=6:.!X=LW^JCKUDA+V@HZ2H%"$I%3Z4%%73(`5(":?%`A?#)^9[ M?E?>Z#'Y?E^0W]+`\6W6UT&DF^1,7Y"_I/>.!^=;Y,YRX3+46?R?$\A2?1% MR+H-A9KV=KNV&8"$%^5!XEO`>%&-8[@+P&31:!S&_,?9EJ=VCIYIL'9"Y5ED M$T&=%^AK9&AI'-22@F@J;AZZ=XQD\%?5>$O@6=J:.RV<%$HYA:/E,4OE"$L MX:)H#EYFJP7QP_ANMR/W!GL2:`+3[;WR=OPB5-,]MD&TS1WD?Y4I?CY8A-E1U11_@,FC%W M/-OFS9&:NE)CM>XFKZ33C M\;CVE3(U'J`0$CQ7MMX][H#[B4+!.Y-\5NR)^Q\Z[=,G&MSY(=6=5$ETD]T" M_@X>RO\^SF'KZRBRV6%P'P>$(T_[H(1:R=+3??SG_SD+-CLO[79TF75UNY95 MX0/1;C5S:^O"A^N7?]KU5OA>I:>;MLIE5=EZ@I!0V( M&ZM>6F8.EI_)]63VTS)79&'ZB0RN5N,OX]58_P@8AN7D#]UFNN#0-8Y+ MGU6UNM:R=+I9,E`^M^G1T/>.KAIEC8A&1:>7?4U<"+(8MG`E&HG$-PDLD1= M74[I^I8']9CY`A(')/>5II>62V<;MGQE&Z3H985P'2>V56$MK5]!S7!96::D#2I>6#)C[70M6,.8W`K0@`\;4&OH?/KUM9)W M?/-7-W2'YQ+BSN^EQ4NY2.4+%E@6BU[.JC&(O(=!PFP$-`QI%`X\>^)8 M=X[+@Y)\3,0_K)D/9HN/`'[;?<(@=0DDS:3J:2W??P_<[V/'TT:[J/ZO+C MO:^>^[)8GE<70E@K$];G'Q/K[?UGSOBY`)LKDI]C98IT\#OH`SW289ZE%$) MR5G!V!,)Q$DB\=A+XM(+NJ;.D^8E)3/6CN.XQL84PKB5?-B6035T+NT\8T(X M^(HIL8)1Y-?RS-9(C'[CYI"Q]@M&M3%Z,);Y$-1J;.\UJA(7HYBKXH:C85I MJEZ+E)@1(%)AD`$F"YPG@DJYUG)`]8UMZSII6 M-]\_?8`#_^9YWKJT8HV/50HSDQ_70,TR_J72<3U:'@KMLB2TVLFPZ(>+")O MJ(7K+UI!"`:%@:$&`T$CI?<@\L&J5UU_&4^_C)8UKK]TF.AMO20OOXDP-#/> MWH&=5!N<,.#K-.7;U(Q?E"&ED:$+-K3:G-4^$EB4\FTTC MH>.;-'5-URL,65'LP:HK[/DV@V7(%+">2(;OMRUTNBLOG6C9^G5I5;;QC=J^-,6Z7T$N%_S[(1B1\6OQ=#"]PAB06-!M/`/.-A/?NU_1X!'RLZ$L??P6/5WO`MV!3#T170Z MB7%9-?AQ[:P::![>67M,-AO+9Y$\"43ZZX:JN7IT;C3"M5U&_D[OP@\+_"?74LR@9#;K;OUJ./C;_&M5E>W$.3:@ M5:NJSXI7/%%`K,PYTX'F6&73%E'9.9KT#?U\0G55LU[^6(44Y[,@UE&^%M M,O,Q7Q;0)]]]XM#B;,G)T0L2D7QLN1A>W[?[D%;YJ"J9]@ILX`>3A3QH'5 MJVFU/:B`$)WMU]?BN>H;SUF[)C]P>.'M9XMOQ01PQA^H:Q0?V^(W^S__U& MR\U7O65IZ8,HW?^QK-1OG)RZM3C??K6"P/PC&OS(-SAIQ'&0G&&80\\C3"4 M>!G$?5L,4J6W"_RL9U(C#8;NHYFF]'SFM^#7K!%PN]X\"@M3SKDRKS.;D58S:>>XC4ZE<+EY/N M/.`AI>5NNW5Y,1?+'3KAVO7#74#WM6#&WL8/'D6Q-LU[2(W$=/:LT0%&IJ\3 M-9#1^Z+H0,5+;WS=SN>3T0T#YV!"AN/EU62VO%V,864YFFPF>9ZMK@9K,:S M8X54E(N:VXYMF($YTFZO=]:5BY_:W7_>^]PTBA5\FI\#PCA3YN7YB;1`XT= M&7_4'UH=Z&]KJK4.E%DGW* M&X@D3D8FY,21%SC(A:F#310XYH=9<&]Y\7OE5[X7^JYC6W$UXSEK?UA;Y9X_ MM]RT1F)5+G-+LCLMHMUF<^19K!=`QK2D]T962?D9QT/KRR\F'PI5\@ M^T^@J]=YN0LASR,HA5]CBZ9(K\J6KZ)H"X'4'-# MLZ.EOA0T0Z.QZJ4@YV`5[T`O;Y?CZ6BYY.NDR\%RO(2_SA>C):RN\&Q'I_1K M_.X.5'L.?(_]<].7P3.TO#D<=?@5DP+DKL]GVVM?'M`>+13-0VK.E M?%+[E>S92%XVGT,R3T/G"),/H)L_#FBLJAFE'=$G,KBTLTX;QVRG?ORQ6;EP:+(9+;:J.XA.&4%!BP9Z M%0J6DA2FI.,GG`&=.ZW:%&53]70]XDJK?=3$J/%596?&@T64^:@EF0^6I#E MY\%BA`1-\NLS"W_&5Y^^!(__%#EN.IZ;^,::6)U75,E2+PH+21WHH'1(08 MDI'#UZ]<$DE$X7.7\B;8GQU4^L\:`A#`6F.8`:(EW-C!K%:YB&-QR`/'0)"H M]>?9F/WC"_NOVP66UPURB0.9%/L%=>$>#;_KQZ<;7@$LN3I3X9P/%=HEJ-MI M@"S0#Y.(!ORMF"&Y1A4+A>!U5BR)Y1(N^$PLA>.Z<^E-9FRNWKB-+K-M5.7_ M#Y:E-U@:'#>L6[NY#^8\=\\^C)8/&K)N^T M9G&%TKFJQ0I:-)"J4+`T0Z;D1-"C\UQ%@ZJ\EH:^3U!IO962&"VLE=>MY?+ MT7_=PFY^]`6/?Y)D5\#->>?>9#S`UB]`&8M!@MKGNDJ>3GIP0`O1PO8])X"^('@QJQ>6D MY/W(E?4L"D@))0M6ZDD[NUI4H6QZ10#5Q_K%S;"=ZV5<&6,1-$1I`JQ9[ M9P!K8%0LQJ\.,!67^$BY%()X@:%D$%2(3@FP>7Z@=H[42(N+DRQ"BPOA-?Y M?"^,-R2508^Z4CJ-?C0S,1<&J2>B=P0?IG$D;6+"!%U87 MRB88HY4&4L_L%0K+\=@F1XAX)1EMRDSP")#4_%S'F(BZ_93#!TW%T$.Y]: M4LIK1\4-C)9#M!:HK`=@1QFQJE7\%NPK<-?@[?;BHKEFY%XI, MF;%!MJ[BI9SSEO]:JJ#=)?Z$OZ#L70BJRQE[OLH76P301TMDEJ9%BZ3:K% MW?NLWUCE(@"9C.1E<+9%LID4K&5]][.#O,Y`MK)`_`C82\W50G/!_2P<#FT( M^1JBJ51LOKDUBTXKJ;O[`6%XCAKMHSB#7#K.5$X^&H%=JN#IO97,(V@ADU4 M9SC5_$3O$\YQ[2J?QB=2"!=#N`@D$U&:,RV.U.!E/L>Z@Z)F#@UOJ`5)U/:, MM<1Z%P3B=5&;_V&-V MBI6CX].&/)IV[.OJ;2MY:CV_>EU7//S>M)$JIC=]C44K,(F)@O]T+"VWG,200K9C\VBQYH MT,2+Y1G[]V$R0ZH]6):K=R#65K7T)C60]%1U2N%TV?]2+XIS&>I/,#+VC@N+ M55::ZZ0;+'&?%H)"K?>OQ[(XY%,MU_:^P>A8/;-E.R&_,:,C.#I]0L,P M35&_]H,DQ?U`,C$=@R2!LN11M;(JKV&]1%CAE;M5R:I#`17(/"6C5YUQGV.J6+:?8R6C0` MJE"PA",:/!(7TK#(AM&2)XCR8<32K6<]^D'D_)/:PWB^B?=2F3&N;8L"?TA MSL@T-0BU[-W@\D>!2X_>PTM5NF5?=4UB$T6'ACQFE3]K.'_BBS](5NO!J" M>7JDOE"JI!)=9!V38W)7ZS`@6.4I/+BR(O@ED)\L'E)HZ^4>E_&HX%GBY^2 M2\6!CI`7I?@/-CL+'(;"T,#ZT,M&+^;`][ MX(NGB?Q,JF%++9J3B'D,2$P_9"!DQ)WL:"C;T&!(;V7-L:#)K^&Z1N_^J# M\\A2=)HY4U8MER:S_[EWCAUDB7`P&YM+:AP.+HE]1P_F/J1TG'E#J]?U)6 M+7<^NO^Y=Q"H=2JG+P`%\8"DI[/GB>-!]8Z`VHXT;)[]O>-39X,T?ZEVY:=M M/%Z-9\W)R)WE0B8(\7=1&#&ORT9A3VT_I9'8/\#N0=;X.0)$9_YRO61)%BXC M(%84!<[=+H(9##8Z"\MFOYW!NU9OO@T)$_3H>R2$6TL/OFO3`,F.1_ZD0KV" MLP6>/NN#2M77U0C-,:`!GXF6I1768#F^XB]Y#\>3V]5H2:C%9G,EIFG+LA@ MM5J,+V]7@\O)BQF9#$8,BH&T^G5FV^7<&WU9C8E_";KY]ED.%IH;_DKR9)'SSP(%VE!9GL3AB"7G$ MXP)%5J%P5B`YS,XAQ-[!S3$2/5"RI8'C:Y/A.Q_V6AA4L.#K;U.%2WX`Z.(4 M4$[)`]E\DF)])GJUY>GJB#V=>3]E[`TV&[;+9-O/$,I^.+;#MJDT'(2AO^9_ M+5:HE>'@(($=HT2,L65D!9$.>V85,(1O7<\0&"RFNP-`WAX"JS)'^0:8BK'WF:2)M@8O?T'1"(Q/?\E=ZG+W^,B& MU3^IG3;#V&,F//+\CZM=$-"@]L6Y'8:`VFK&:JGVQI">Q\,;5M2>KA"T!"+ M$Y'S5S-$6A\;IS(HVAT-KV`8:/$_99WP6H=`/+:KDQS:$HY]:@;I5)H_,L MB$-W;@VM4LTB[I[R%8VCXPR@DQHY1Q@RKVRL5`^2S%1SJN-D<'\?\.:#I\%K M-5Z!LW^\2TVIQG2.#?FR2:K^K)_LOPY'336\\8HO&P-[XE]T:W,D?3]7\7% M5HCL+BP;P)4#%7'BA$S4Z+KU;!JXD!TJ?A][4]HDXJ5TS\B#?NHSY/4LZ/.:AB%@_"Z'>&O-!$&=R0:8_^V<;?@C:EGUYU80>31(TN2+[JVID,Z.1!H;F)Z-U);0NU<[2&W% MA=&<&_-!5@&I6R'NZ(AE+CB^X0HY!%)/E&T&+7EG#10.L6;AA8'LJH5E.40 MH[I;;)2(PK2>;:H2.)IDN%0([O:!]K8:HG9>DE9J[TAOW139F'"XGF'?IG@5'6ARO M7[-B;3=X=J2^(D>`+T=9KEZQ:S@5`3+R,Q#^-XXQ+:]4-`@"ICL'TN7+GF1N MO?#`()@2%P?+)-TO?->]]@/X4=%2Q_I8I_<3C]I@N:N.1_D2&K]V5/.D9>D( MVK)T[36%N!%S_"9/OG.B0R_?3$<:=>(C&"]+',M(Z?4)6&A"[Y;+`3:4KC@D%_#MT[`>5)` M'VG42+]T2IY3TU1M>D[)9]`-IZ.96#J;A34O'KI!_"ZAS#]N5,3W.IV\?- MX(JK9\/Y!V[('W5G?G.:3EK13.UZZH+'WE]@TUEHF)9Q!]N ML"+^%`?UCE:4,O_F2+(DFP?.FK+IY(H_$\'-TMT%;2EN\?W&INX?Z"OMHC> M=VB'Z:U\2R:61!)19`NR"!-&A#3"Q;V."2(S/>I:\OB3L_[KIS29U&S2(ZWH M=)]^Y2%-`]-?2:`SK!5[.L8`;U,#5(.\_::M-=#;^SRVX_;N36\09SVA,9Y8 MW.LPKZG$28WT1@WS3[U`'QUFY2"H?V,]YIJG-B(;]3(+8_Y M6CJ\IE'?Q/#?Q%$`UNWDZSXV,#+]-W:8T$.LR/CKJ::=IOT2,<1:":6K@\I MFB\H>SFZ6-!'BX>IKGR/A[)WECMQ-L415X^UKT.**F-4)Q,JOMY70`V4K3R# M2/E)1@`!"8BFE+OB6!294H-=].#S!W/X+?M,XM2<&1WF!ML"QFYFSHV'JD%K M0EGU]SI/@4&[SJO=4^!LCY-9PK;58IFI'&_.42[D_4WAW?) MT?Q-<]5>I[\YN#UZ75FGCZ.-F6Z.%SIK_HB&;$FG).ULY5RA;+I25M#UCC\# MY4K7;1-JDI(33H]H'FHGO0%8`??.Z5P266S'2GZV>-XZCK:67-TQ@\&F97H M['N=6&Z0N^H84;Y!+FI-K>U\L/_57)L-5[U`:^-K2,?H,6VM&J1T+P#1(&WB MM::^)QHE>;0QC((=/UL\^DWZ6I\^B:FU06.V,LO6^.ZKRE>M;W=Q8"^6@V]S M)4W/R%V=.H+$^:!-AV']7^_$F,](:-VLIHK_GMWK>L/1DL M'^KW)Y6PVKA%OM"06=G;F"Y^_G6,:7FC=C.F\]]^-??2F]DM']I/G/344M-. M8HUUJP?Q5 M!5%5+V_P$H&=9J:??HDYLP&C7F$"[[:[Y[^3%??V.+HWB>8[ZM?"J'$\FS" M/L+7[DG^')85]NAQZ_HOE"Y%H3!Y`Z;.C[=5R!LE^SM4,Y[ZT=^@WN/:O_?@ M_D?VA7M%;W7T[4[+8W?9G+F2VEU\&,TX[]+:XD"_]84G(1`?\Z3; MBV'_1C1'ZVYA).\]H/X3T"GRFWO6HE7,>RU#=S)^)=J\/H=@(!S[Y MFCS"DSVQ08&AT,8T@T-`N4JZ2ABS#LP&FN6X_-[OQ@_( MAG,2)V8]2U;C9^E2_(R$@I$MU:$0?>"LHV1YVMV4;W^SO=V3#AW'3A&;Z:I MKJRMP[R9:(&ZH[.!G"Y'7V,SLZ.KMA`THZ>IYLU&QUK4).#@[RG8FD;0+E_2 M?WYVV.09K!]>)O2)?5A1&MJ,$U_-Z)IZ%WL6>,1U]C.2LJ&JYU:-?:VNRA4 M5$:II.[2ZU2H+(5=GA0MRJ1JED`U&"_(E\'D=D1N1H/E[6)T,YJNECCP-1W MT3Y(7W4ZJZ3N=@VI53F_$I22HIF1]/J5YAWJ.6RFN7:","(3AWH\YY),?,O# M`::)[]V#2F!6%904M%T"2:MN%D920C0@TFFG@-"2[:[9?K>&';$OA87GO?A"&E"VG/'OB M6'>.ZT0.#:R)9C$)M0EM7K M\N.X$-.#Y:4B`$(%XGC$3Y0@%O\8#Q.Y^\^<$8]&X"^2GV-EBG3P.^@#,K>Q M1B3J/2Q#X@G\;H%G(H_^D'D_#/7+RD<582XH%.A9;&;$W(2,'IB91CZ[(N5 M]2QP/?==9_VB[(H"'D"NI[(C(>DX&TI8SD(@^1^3.[3Y&)1% M/%]LXP>/(JZMZCTPK1#XBJ7=S0XIWR"E)< M'52I9^G2=GH%$LY!X?^PTCYR4?E2<>QNNHSM=SHX-9WMJQW$56==^\&??\:(OS,H=//2K M\G>FC+CZIZ;6Q9YB[&23\!.;">"G+'\'$6S,"1D8NG'LY?Z?>4`N<^6;GWH9L#E@S59PGM94ZLXTXL+5B754 M+CO/A)JZI(%P]>J`5Q9Y.Q,'> M@"8"1?PJ$4F-XR\3"JJ>B-1.EZH4"$L`?D&DI;OT#:1\OKRHW.:1#GC4+6IWNJR\"5Z\U MUK^R5&8BBFQ!%F'"B)!&N#@$_=UZQ5/,/5NA]`&53XD5(Z.7+O6#7VD09B]& M;-E_^QY<-O[[+BB?\U5R(.M&0W5+'2CX2);Q[3SF)(UKPX#%(I$?&GO['_& MUQ4EW63M#J-D+:CZ:.)PW:;MA.]L-UKK.PB;H^PK99@Q=7Y]17O)RA%DO@ M>_18!DF%]'270QSS7^T"2;(=I>4H..;&;KT5+E>I&UG=NNB: MM:(]>VK&3)J8!K!ED3-JU&N["\RV6K]XC>C2D6+XVQJDS;NZ^$R2.6`6"U; M.HFWK60M79"U-`:Y4KQR@SIMT00DT$4!<[=+N)W'B.?ST>H5XV9NRMW1V< MO\PAT=#WLNJN_"D3"1L6WW5%-4T><5.8BQ`_#F3=TPJT?\I=GDLL-,DAH&1!UN)F>Q>X$+O(=\'U/ M6`]E6.&#I+V<8D(4;^J=2OV94I)$M^VYQ-^_XC!71I6WU/AK'=)=JI6UX0 MQR.J1Q<7@@4.8/1,^BU<$'&+BS#?A>E9O3,B'J&G-=9>XN%+U#A0E@-1GQDJ6AI9/%,BRY<.L9BUKU'&-=-.ED" M;#U1/9GPAN]Y(A%=O;>8STNJ42[F%"[JFSA-,JHJ-1R4?HDZJI:YD2\9R'<)^_=P93>10/8BT'0BW\?&>1CJ M(+$'^I.UAKV(EBPQ^+(+UF#"G,SQ15:,?"YSX>UE<V^W$>ED?5F\@)1 M&A&1!]",&%'WI4Y?PZY,7VO:AX/Z#,NOU8LQT$CU8U+5N[\7\:#HN MF;+GU@M,UP//9G\)=M2N2!IL)@EU%]@;)4O1RK9$+4\>:Z MEIYTB#DAY!KSDCUSOXLOF57[J!@\0:B+`9IS(^_("J4->Y1+.1,AP+,T_['/ M.&#)UC$OQ<;_9M2A&7K,72A3TZ33,GRXIEJA6)M3K:%$1+W)S.Y3HT#!YOP-N M(CKWGK-QUK!/%Q%4GE3G.FL&5.GS)&W(0X2#5LPHXH(+%4E,>[$<!G!9"^9 M)+)SR"<<.G:BJ?'S(]9/U![!_E<(RN`EZ9@5"29)LZ:M<[0<7<1%#]1O;5^ MH"A$\#C4@E(3BP/P)%(Y&^R<9EGA$OE2(GE,D3PXXS^<0&+T!L:/8!_3&,\ M0QJN`X<7(M7E&&;^O/A/EYN-U MS$N=T=]4B(PM&B,SB>H4O3."/\`B;]PEBPG7_#XA_0A45D]NQNV]-D%U)YY M"PCP!+#@]FRV>PJ2_^1S9C6HVO$I`=T3AUJ742"XY=4RJVH#:^$PYJK;L>G=TCVYS),%2#'1$XFFA=KD0'8:54R!G)B"&)'/)= M+$ED:_>5<,\?.BG.O\O=XZ,5@+II,9S,_!Q+F5%1DT[DA$AHV6#2FG]XOFI MF^(ZALU)Z2=(^HUL>;ST/38$&3A-&ND(0'H]"#HV=/J'C'RE-X#J,O=\NKQ\ MV9/$4>$!%!N,5VF9RVC37?$Y^:-]!-O]O:/89GJUA60^!I'9+%W\0<_>+9? M6F>^RB;`70^OXK?5?J/GK1-'E\>>B$@>`X2SR#R;<>T[I@PS'P7$ES%ET\6 MB+P(`6P?CN<)2Q]Y52!4V79<"9?/7%/F"T/IRFU<>0)6O?IUSEM&UGV,Y/5V(L"QPN=-8_1'WE=DO_8$OM8V=K3W2[XM3 MESX1>E?=H'?5#B'?H!=B![E:]@P>EPC.W.KB$#:9-1/?4_8E9192`ZZCAR* MK?'=U[#-:V+N$2#,U#@7>B054C:O(HP;KE]X9F1U8,5MW_XA8819#$?(;9; M\]O8''7)A\!VV5`QT_,1$R;O?,6"IUN>+BRQ=D8?^(V%K8??+<[M":ILQT M"WYSO5Z#PS]&<_0W:%)E)=M(KC`!CM99N20/;NDT[)_8D)^97]._L3^!X8X^\O_!U!+`P04````"``2@:M&E9WA M4:4F``"$AP(`%0`<`')D;G0M,C`Q-3`S,S%?<')E+GAM;%54"0`#0PQ154,, M455U>`L``00E#@``!#D!``#M75]SVSB2?[^J^PZZ;%WM[H.3V$YF=K(S=R5; M_?3J9G;4GYV/1J]Z<>$GA-$ M(?KI51B]^M^<Z)'__?A?1T>]"Q\%WH?>('/1N$B^F=O["S1A]Y'%"+L M)!'^9^^S$Z3T-]&%'R#<.X^6#P%$/E#_N$/O7>OWSN]HR/`L)]1Z$7X9CI: M#7N?)`\?WKSY]NW;ZS!Z=+Y%^&O\VHU@P\VB%+MH-19VO!`EOQZ__?V_3P9O M3T^/C]^_?EH0%@9.0OY\\O;X/?T#_<_Q\?SX^,.[XP_OOP=^G&2-%Y]ZNW3 MV^)_>?7, MO4=+Y\@/3XN>E7VHJ,T]3O^X8G M5]@+DR,/54(^L&_0/HFSP_$6&?ZOJKWIM6-)Y'81P%OD>4SSMS`BK9V3U" M22PB4-A1W77#B;"N4>)[SI!:U(;1U%$MX?"&'G53U/K1!33>+8/-"9BV`) MD;/L4'OA@$ZQ&-V3-OXC&I$)?8EV9H4SIGZ>)HM9$KE?[Z/`(VO&\/>4&-UN M'/%&W`]&3GQ_$43?=E>RK9%4T#\FJQ5&D\59&OLABF,RUYTYL4\^=XU13#X, MFBGE1E%!]Q2Y=&9VW2@E4W-X-\M<%^P)Q2SLJ(ZH8-#,G9\C?#LGDQP(J)8 M[570,@H?49Q0'1J%_XK\,"&^%45+"EA1Q749=9Y1)=[C\X\Q`!`"B?HIHR M"\?'F1-WA9R8L)U9H8@N;B8RUQ>K6[O1 M]L?'W+D-5'&Q.9:.&0=&+;^7UMD'1B"PN\:9"$8GJ+.V60E&(Z#K_JQI@!+' M#Q294VTP)5Q$"2)[DV\70)WW+NNQ@^DFY5'HC>PVJH[9 M#@M@FY:Y[,2Y]^4N%C\LJ!/T[Q9O)K^D(Q;G`<>^H M5_:J_DBLLI_H#Y21=T=OCXMC@;^07_V: MTS!%=S[]=)C0HY@&RDG3YI9U0JOZT,=N+\(>P@2QS]8=`"1TM9419BBP2,55+2-@[!.>$$>P$(V(O3S^C9QX&6TV!(!S; MAP#:Q,PE'S,R;#-TM]L`13ZB4U";^+1IS)=L./"`<>/3[F"[W6%"C]4QNE MW\BU"1CZA!J/4G01.'?-XJ\U`8K]G4UB;^32A+C/4TQ9O/!CUPE^00[FCZ[ M-1"$]S:!(.+=W,+[!07!SV'T+9P15S@D3>XQ1AW@+,[`)$YCN;D`%)P1P\ MGZ,@)1+$SUEN5,R#9:LI$([O[8.#P;5!]S2WWREZB'!Q^)ND7#18/8"@_,,^ M4/@R,(=-IB/G9#]BS!WXU!K"$3B!_N0:.38H'%$RV449O&J+'H>3];!0:Z) M"8]6>6\B^>4RH:PA&I-(8BH>5 MVW$&ZPUH_/BF,>JJ20KSI+=B,>>](YZJ[0[\O/Y9#P8CF?#`?UI-KD<#?IS M\H^S_F5_?#[LS3X-A_-9J[!L5<\63GR;89;&1W>.\T"5[?T;%"1Q^9LL@%O1 MNN+7OU92'5?G:]=1[`NBN$5W6.^=S:@]>_TX)E")&:FW,Q72E9+KIBTQ.%$_ MJ>V1N%"0D'9:FXLTLN7AF+!C=`BN0!"P!T47A-4I"JC?=^W@Q$<` MK+B]C(6LVT`%X-\.IXQ>G!\;_A$DV,0F;TGR3W".:]LI/B]C(6P6R`%X=\. MI#:X`GI]!N/7;1:C)@XKPB>TYS/@9$D^=KLO?- M-O?$,WJ@>Q.RT/(,C-?+6/R[E8&)^;?#P"J6+]Y<-38V%@UO@0N'6SO@^!A% MWC<_"-@8K%N8BW,#I!DQB+9)V",BK/#.)_Y_S@0QSN&3&Z0TVBX&`M;;7+Q; M&B09<=@!8+DYR.-=Z#R"=51Z.9S`7>M`70U%QJ7A@XL"#MP6]]YB$=A?['P M`Y]L&6)Z<]3W?`>3?0-A.WSWY+EL_$N<)-%[C0L%&]M,0P94U4@0#MTH7F# MOU9>V2A'M2<446V1#GD+%HG!%M`>Z,E"+-HRU]M!`=$6SY`!I(E%.\0O$KNL MN+4%)>#B9HJYD_O?2]^Y)7,R#8"1V7>['HQXJP4?`0JRMF@''&19L=AA;16J MP<>0O#Y0P+1%,J1A8)H]5EE>X@U-X MHBWFH=S=/\!=^CK0)K6W:^H&Q5M;T$4=WFRIV&&:VZN`3-RXN1<4/FWA%)C\ M1W`X]A'FD%BMMCLNNO>YDA-P2':Z3XVU&!.[XW"8GGE'("Q.D"1T;;/E3_>XO-N"4"N MFR[3[`I-MHPVO(YS23.#4#)9S)TG[LFEW$!00+7M?-N<5[:1E1U`3VG5V!!Y M90GQ"C-D.^^[O/TQI"\43FV[9FDXX1Q`T'V.T\0YP..D+9-M#1"HI>MNNM0 M7OEAA+,")`DB,'!L;[LE^#ZM-3BRN+75KLA1%2[L0(JAH?BKNVO;D"^]U%LEVW>=%!"2@FP.@)U0UM@8)=SGVX MTE"NB5UF9J?!-THTG3:IDA3[V\;(__]I6C3'F(,1.03G!'L91OP^A.'W+`# MNW-WRSM)R,8.!V"K#&(_3>Z)P_+'VLZY(&YW,EW_20UZ+&%8BEI6"ED&L;# MZ?I/M':%(E2/'KKK)8:U-U55M"H4K,8%57]^Z[2+\(ON'`O(,Y,+,Y^;^K MX9@X+Y.+WN1Z..W/1Z2!0=$_A_Y&[_DOX2S&</OHN$EQ.D!C'M>C#QB-KS MU%%$KW'TZ,?DKXL(GSG>`-WR;M'N/+!I-T8]\CP!RL<%?LA7MA#=T;7,?#Q( M0A"7(Y7PKA0K$WLP4T[6>HU2B3(KL<8FT61GSS3GUJN-0T#F[JN9-N,`5B MQQHS(-[")C.&'<4]@>C)"\<:4!LR,D?A M&"7KN;Y:[I>^PQ(B3&^5D9D>H27_NK>J\>TH/0I7!H5"M4-1Z&8IIG0CLE\: M/M&E)O7C^SQ#@C\W`[K:47148M\($D7W]XZ96(A61IL.8"$H@9O$Z6>\9JD, MWC`A'`C8@,WI9C/C14JEH3RT#>EZ3:'OI9V3E<&58J8U;6U'9,>%ND`]$T8+BKZT1.A0++0L4E+>GSIS8=\F:/_"#-.'=>!%V M-%XL5@9;H!CLL+4OR+^[)U3UZ8GC'1JGRUN$)XN,\,I]#S"4;<]T9C\>VC'#>"<58)8@P"D M+@/#!CH\WWY< MZ,9E-I^<__QIUO M&8'N&:!%0;I-CJH9ZC8`0FP8C;<#'\`[`$(#@P]AS8Y;QMAD);0KL-@C?%"XWIX68-'?_#JG M^^IIMM5E(D(;-K0S74E#2NP,'FPRFN;(B MI)A(J\3C9 M_<.<]%PINO#5DN.H)X_4KB`+F8OJ%.;R-.D8>6HF4`/(#I,G)@5"5%8C^. M`S_.-S:4;-;&YE.^,VH'M-P7C->?4Z(;:1JAZZHS>C-;SGO,<&Z\D'CU?/` MFJ19YG8HEJ9;%/HYH'A4WA]^!'AVRA&%@1_=H@3_WIB07&\]J%B2KZ2.-XP MM.#B?C="Q3(J8TG`3PG/FO3,IC1C>D72B>\O@N@;XU6Q[UM=C.S//O4N+B=? M3+XJ5DE;7?$HE4S,Q?]Q4RV68L M>RY.,M'<+DW04F'[93I@F@'>>LK^4)6`0L\MHV@\Q21!3-O M/5\SG5^@3+UT@F''S&'LY0]M.P:MF'7TT9#JLVJ#+U-%FG0=]THY=8%Y/=RU0J.VDWQEP+:MN]C1VG[-#`Y\L70BR=X(YK-5A/9 M<4R?YRO3EW8"U)0>/2AT<$I($SM#V[N>G#]=WAX?-GTP1=I6SU^'QXESUI MQ''"N;U,GY2K4,A`7%8+U-GZ"KFY=E9!6]W6CK'^YF1$H.'=K:&_\W%L9 M_GR)F#QD9?A>Y_=.>(?BJ_9PY)DCW_I.[=^D'&=J6[Q!Y?,<83NS0;D;^F2 MBNPZQ>X]X;]RZL^+S5$:]DN"/8?T@)C]_L5CDV]"-K59>E9IC0RUC%%+G( M?^27C8'U-G?J;PS;K<@!6,C=7[&VN&;UJ[&[NR4)KU8HCYD/6JBEZ1&$J MY5%M=37W0J+UVE03;_<3;MF>X[7S3-U&>D[LNCA%5>&V<=CYXYE[I=%:G9,! MHON"(_>-#UKIR(AL'E<DEVAA3R8U#>QNCXYI&44Q>M M,F,8?])0JY+P)7<`VH(C%R$O2^=J.&@&JHO,(,8?6%2G+_RLW35`.4Z\GL9 M?UM1WS1PDF-<'$IV+RRB\FR.\I!E]/&BHL87=])G1#0ZC7! MY:77_?6HZDS1VE!$:"C/:X/YG?4^4'W8=R:HO#Z()6.?U?-QVVX)ON%F/5HL M1R`A6[P56JB(!&?VPF^K[S,5O8J%@V!Z``E8GHT@\1K5]!F/"!,W2M"Q3\ M?0<7=YN@&^5BQ_R\WM>6]=FR+.)[404[43\HD/L.`+:W8KZ$#LN0UQY%7N[I M)B2\CL@OPBPX'GK-J>8TPA6O:OO`2A]K_BQ4#_<=6%3E\2G&QXY)"2XS)6$H M\+A09=IW.%->F=1(N.MAJ.%B@=QDLA@^N5F^PI3,Q).0"B;;5L?W-%3_Z`3\ M$+C<*%`=VG%**7D=QOL_^U`1B;J?I_;',,$LU&3'XJ\GJN]S;O=J!2\D)+!Y,?U\?IH= MWGUD/KJ8YIJT51PEOZ!, MBR_6@]>FX_;#0?'6%OI4!E2D0AQ,T/=;=7OL))G>GZ4QC<;3FPAG3NS'-#]O M_8T5N1L5M__1.^JMQ43^CK.#V M]70X&X[G_?EH,C98>U]&L,KXJ%.4$ZU+DXME1T?`&5XY2 M'P8H=K'_4-#>H!ISHFYGA)"O;&FT&3$?P#EX2D8W.BA0VOZ`5.#FM$-3Q8]6?K/$= M\(U/'D,'AX1$&A+-SN$:YXSCM_4YX_1U;]B?CLED,>M=#Z>]V:?^=&APMJBS M(9X"V#U,'O+4B`(8Z>+80L485(_HA'Q;MQ6UM?>Z-QI_'L[F]4;\F/O7Y,1^>$S^1=QSTTNMHPZV&0ZV^`38%6R`UE7 M&[NRQX18G\08ILVQ'<:@>M@\H1DWVRQWY&CK/>YFHSVI&^W[U\0=GIS_?$1V MR]FS55?7P_',]%9Y(SI686J`IJAE>5MKI\A+]/"Q/:[Z[@F7RV!DGY6)1U@ MXSL/;-CPU>A_9D3-=(V/CE<.#[.SNZND$.YV;PDN3$UG-:GAN]>]R[ZHVGO M<__R9MB[&O9G9!G/7K$S.#.L&%J3"K![?B^#5MU$&,!F!=T,6R0$HYJ]@>1@ MW)IFZ6V,?D_)8,-'MB&]JQO2]V2-O3F;#?]]0QWCX6?#)E3G`O#L([.'R:+C M-:(`9L/I8OH!1P$F]?+B(MZ-FPKLC.\8F#^>49&;.UZ2=>M8#&Y=@FHZ7: M`S;QL:F7W+5:70EQ-4[L77C]D1RP[T`''6%HU0XG;$T\=3@R M$Y:"OZG708=!`/(ROAILI9]QYOWO0>F0-LSN!Y(7N=:@.GETQ7:)C@[\($WH MYDW6&"4'-)W$)9=3N:/<%$>Q+I`E&VUF(Z\L[ M@#E`8@C35J\D=5-:9!:^POTS>E[Y'P,G<9I,6[1CEQS#M&>V(_@M.+;$(V/D M[?F[ZV[;9SL71NF[I=7)_`#R'@2R MF)()&/LND74FE9O0)^+]YF!/M3)?\CT0F5$-5O"87QQ:\P[YRQM)UM7,-G9 MYS:L;(>:AM[T-&@!H3#3+.$,&[3,6$SK83]I9\NBQ-. MV8S>N\_7PIEL_PT&>>7"']%.YN.![(OZ/0"4;A;REF94\"^AUL'B589C9; MZ22Y1[BEC6[V/>1\2[CL;,;ZFOR7,#M#^-%W4=N)N7F0@TS>;".(';=>EI36 MEV`YSE._">-"L0JR!P>J MH;9'(2Q10Y'T;5X.\_3M/+;>:BEL&`"H%MJ>@=B_6C"E:`?T,R=`99;M&/$J M6]0;@J-`7<22(1;CIT7C$'QM?-,X]E%\/6(OJI]&3DA(\J[55,Q"8T!M'2\4,)/,H.EB#"TRX1,"4KZR-OE1'C M"Q_'Q!Y16"[/5VAYBU@/MS!;FSYK$VA,-=XKX%A39'Z&W(BF!``%S6YN^JA, M0M(BGBW96E098H+2Q+TD)-H.M8"0\%BP"1!UR@DOEQ%[$+QT7]):U%Q'>L MFWL8GY>8WEU#0@>TS9"1NT:4&,3[=M0,0))KN M!W@WF2[?%I4SUWHOX[-I.\2;F3;<<..[4[J<7`9KU:2PYYFXYX?AM' M5H_$XQURHMQN,NZFGE0N:ZE3EHU!#SGC38&T-6;$D\\6-1X9T?9ZHX-,_VEB MU":+G:'0CW"6.<)OU<;08.[G;SAU2`..W"B8;')XAPCS^=$/S9;09'JI%?> M))!.W]FMUU[CWL[=>AR+45O0@CNX!U)<<(R2W%&G;CJ;]EHSTR=ADI4`&YFT M8P)L+DTHK4NU;J;#FSN^?MTH!#OP^H+\NWOB@O;)W.K#9%WN/Q>@O55KWS'2%OE'87RS\P">;@)B^SNE[ MOH-]0F<<1V[VVSH';!'L..Q!5'-5(MK6,\L#PG[DD2T=3LPOFO']H+(FB%> MGC:!NAMW!6IC82L[/`WFXD<^(^^1Y:A>(+)TI!@_S:E2'!PEAW'N'^I!/!V MTNM^IV-2\^O)Q;XJ>97'RH&)>O/,PKFF6^[==:X>UF]W;K&2FP>_LS>NXM MR@_T//%%Q<7S#2PQ/Q%A'D-]5:9W?OMALJQZO]_L0L72[)O/4'\E8LC6@5 MD65^QI%BE)1]H."H8W%E5L!"O$U6DBVNXJB0T,D54/]#L20:AR3A0J#DJ) M436^L7"',I9`JPU> M@.3L`-[&X3!-%T%"F'V.$S?@X=S6OCV+(J^9F^A3!99<>4J\=<.3D$RTSQ M)NV@`[48QUREOUWTH26S:F8'!HAD%BHNE=%#-Y$QTR[<'N;RM'<%!B`(6R9H MP#$IX6:RD#^'5#$V5`6LC`6I$Z[Q!A->K&G4;K=-OR:=/0^T+-JKI/W##7 MK=?AN<\+EQ^JY/7VHOQ+/?+/WK?B6R\/$-OU`'&W2_AJ>83UI=2O/L2Z7NHW M>VU77.WUJQ#LJ]1;DM)WZ;7D/MT1=VFL//\8>05.Z%W'3CAV%D" MZ@'K^)H=.M"HOULU/G7PKZ<"\63+KW'6?@VW2"ZHI^E[CSH5OQJJD!"CKJA1 M%%(RX2`4!1W,YW)OB\(H0T(^0DE`I+(5Z5MB<1D%P$6'ZQQWF]);?,[RS M!9<;U2OO@].I_KJ7M2I_)3U2\UN&J)-'3>A.HP[7KNYV,V[X_"ZXRICYA; MZD'+QZQ?=6W29@Y8,4$YGDE&9,Q=D?"TZ&3PB[?LR[V]YF M+-.7T_:K3:V%W?WLO%T%/7QZ\''69V5.^B:^QH^9OO'6J8F/`]>++IMT1R7N M;FHK;MLI36Z4H!7=/O:9P=UN5BJ:-Q9MRXW?,ITN=U.:3(3K-ZSK0NEEB MJG2)KK'O(K@$!$LHU!4KR\K;MIB(--%><71G[:<6;7Y4&<]/%'L977E$V#L M/?D=U43;4@K!ZT\2\6&>$C3&$#0INDHBC.;?[T_9U>/6_;J(.PNME(MI?9>D MP^P=`WMTOA5\'7%&Q+QOA3R,:\D)69O8MBDOJT@[(@"'X@W+1'!TG1OI&L. M]4O$BA$&,:/G8`@6JZG^HDU6BX)6!>B65-$D[WHDSM1F(DN=8)+?]&D=`U0 ML'L;?U"E5>!)`V+UM>M:SCYX6T_3>ZCK-Q=G>_\ M(@) MP#1.&64!?FA3%H`TF\YN_OIR^__E]O_+[?^7V_\OM_\ME?W+[?^7V_]:^-_Q M]K\:19HB6E7-)6M#YOTP+Y87[1G-K;^HJ>!".5\"!Q$#&$=A[NN7U7,)JVDF MOGUUK3)7C)7(.9/#L1 MD'7,JJ-LB!XRC=_Q-#^C[P#OH7L@9#)YS-:[FF`R?VQ`D+MP?SKZ%N[Y]GS>?M M_X5]W?1!B9[$JCT"9\>2/EP^!-$S0C.$'WT7-0M@-9MGO,894]6_4V&/H^07 M^I:@&]V%]')%M0@H6U?W]'G31RE:E'6OT!VXMN;6>A'AXE>T'2>#?=]TF#Y) MZ9;^1T@#'M7P_[L9CJD;^2NG\0U MN2M=<;@F&K#GY/>RX6I%)R_!0,!XN>)BV34+BZ^XK/3I['GUXR<\K)@AG%LQ8V6%7FC\"%- MXHS%8]&]%FXGTW<-6JDO"TFV5.S8.#01>M(&OA-;7KO4!=])5^`[;0/?J21\ MVHINN`[W7;#GN[C,([FNI-B05`PVANC5L!`H;+L]4! M0D$JRTF+2$=F2P'%C.D'-D550)``-##%%50PQ1575X"P`!!"4.```$.0$``.U<6W/B M.!9^WJW:_^"E:FMF'X`XE[YDDIDB8#KN)IC%).GNEREA"]#$2+0L$^A?OT>^ M<+&-8NCTAEK2#VFC<]$YYY..CH3%Q1^SL:=-,?<)HYK MCX^/%12+/[4C[[]Z[AQ='BZV>5V0!<:"`! MY.,C_4P2Y!]=[^GZ^:E^?O:V8%<"B(PU`I_YE:260CR<5QH?5XZ,CO?KYIF6'?6(\7SF$?J0 MQZZ_?_^^&E(3U@SGK,^]1/5)59+[R,<+S4`E"GY"?8&HL\;OBH7`O-9-2N ML9)V"U)A\@<>1IEJ0J MS+A`6EBCKD$%$7,Y_?@XU%_2B'M94G+('J'_L$\7#P@EH6'Q)->ULI:(KSXB MZFJ1+FU%V44UK69%>>!CUZ_A\\3CGU0$PJUH"$6C%DV"#G(82S\/2;R>JX'T.P9>;%<>#K5KMAM&VC M(9]LJV4V:CWX<%5KU=IU0[.O#:-GOX9_&=\.XN#A"`L"=C^!Q3JO&IB378#1 M?EWKXM^'"92+2A<16$12-\:6!-9=X$!RYE36$`-V6DQR.P>_'=CM`$NJZE9 M':-;ZYG`\`I6-O:R%N9X!#QDBDTHM<>X(&IYDFKXSG:!KV[==+K&-?"9=X9F MMN&S\0ID"@YK8`OF/(R8Y\.QO@6P')>!,9<.36(;[8$46)H]ZSZIVNKU3"Z M]B^:\9];L_?E%<.<87\4=-CCT43YY)?C=G;G29>S;[6FBWK_A#S9ANVRAQ; M@ZO`)Q3[/A3<5\@G$//.BH\13`5YU1"]DS4Y[+`]YH,R^!7M':M=]LU)!97 MM[;9-FQ;J[5E16;(40%VU`US<#A"C+G;D5LAQ6`#[%SJ$$4Y=Q-UX]FPF MJY%XGT;B&)`P[K5:O6[=MGMF^X.<.U&K=LXQ)EA($XAFGX'9-.L2]DFC;I1T:HN(-'"%$\IC>3 MU?'6T_$^K4`I=6?8O7")-MO:1\N$ASOX!"GG$,=U6`B5Y6&@RM;6'=74OPF MHCKJQ^FHGU6B4J@,3QUUJVAW1@U&X9V6-X<8+#MH._C;P$X8TR7<PAPY!;KZZ"H&)00G"AW,-\W&(H^0Y1S:+&)K,-E]A8 M/5@X.K4OM:N6L0@^T12+=1ZD$AL,R7:B,NO;:=XA^FTE%5CE]G4[SJOM$6/ MAXAKNAA>RX.;B&ID,F04O!X@'/&\2BJA#D-=``A7$+R.FAC!S/%`8PD]XK@V2GC07NGJ%,8M' M:A$KSJZ&+7.04!2VPUZG-NQ5DR'-`B'?OY:W`:R)),@BXUX&;'FB_2,:U)AF MSB64F^&D1VO9H\:B+L-W;A_C3E]ASH#4]8-B:(:,:M"V.\%8[@.Z]NTOK]AD M0IYET69E1B=9(XX"F%TT(DR]SQIK:I7YW+2T&7)9_(>WVEN&W$\>"R)\%E9-[.W^" M:Y79V$M8I&K%;:\0Y'0TXHX3%8@[&2V9VVB@A$TP%P3[U<3X1($@0HJOGI%H MLA^8QM7G<-E#_6U=!A'L_41?6U+_LSH)HV];)U,#]B>Y6E_V\JP.P]39UN'U MV?:3_&TL.EEU-[X95UU>C8L_IZ_/78#CC`N-9F[AJ>YB1K=(6\P)52E$Y=R M(E>6367]N'RB5V:^N[1T&R.68=C.B$1N!R.4-T(W6)$K(Q_2^&B_2NOEZKZ MSQ6L8D_X24MYJ6H7:[)70WVA6\WUY.X]YQ)F70D/#5+&!3#Q/?L]S61(\ MD`E&7LH^A\1#F-L+\Z,;\/CES"A?1C>3SP6>B2L/=B2FP&/)"2X&?1]24R"Y M/W`63"Y+D3H"+"KC/Z6.Z?)>9.@E_24N;2NT#X[>,_Z`N;^Z?0,+?$:19]_ M`K[`JPCC%@Y%M'YT>_.RY,!(("+Q,R.&93;B,^?PY]M:_'JRCWA5C#^$FPQI88H3YZN#K("XHYB85&$:B/"V+ M7-Y%\,DH1$NLR`3!Q?V?&(,V%ET\Q33`3<[&J;?G(V_5+'N+;I(JN_)"RQAR M?3PRTZDTA[Z[3S\7K$[`G1$40-9`WCJJ`4B[-NC53&SU!1EWI<58=W796-$Z'.L!HQV8'RL6)OO3@&^%_''[P]AVP]/JG"G""]N;9-P7[0( MILD+?:E0;R2_N.4V=A@4'1M-5]!?W';53TG50"='CEC4EX5X4?R4^+2]CQ$' M:(&4\`PNUD>(#K%OTO@'9N@P.FB0A2)!?>(1>90)>P)K$!,<6+>ACEYG`!IX M[YHTJ3E[L#SXX&CX^D`J5/_;/O/A&:=KI M723WW?TNEHE9;F@8#0T-D-^=H;3CD>(@$U#I2I4^`Q0````(`!!JT9?ST5P)T$```&3`P`5`!@````` M``$```"D@2C#``!R9&YT+3(P,34P,S,Q7VQA8BYX;6Q55`4``T,,455U>`L` M`00E#@``!#D!``!02P$"'@,4````"``2@:M&E9WA4:4F``"$AP(`%0`8```` M```!````I(&>!`$`&UL550%``-##%%5=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`$H&K1FN5^[<"@``4U8``!$`&``` M`````0```2!DBL!`')D;G0M,C`Q-3`S,S$N>'-D550%``-##%%5=7@+``$$ ?)0X```0Y`0``4$L%!@`````&``8`&@(``'DV`0`````` ` end XML 26 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9

1. NOTES PAYABLE (Details - Term Loans) (USD $)
In Thousands, unless otherwise specified

Mar. 31, 2015

First Lien Term Loan

Term loans face value $ 394,559

Term loans discount (8,681)

Term loan carrying value 385,878

Second Lien Term Loans

Term loans face value 180,000

Term loans discount (2,558)

Term loan carrying value 177,442

Short-term Debt [Member]

Term loans face value 574,559

Term loans discount (11,239)

Term loan carrying value $ 563,320

X

- Definition

Amount of long-term debt before deduction of unamortized discount or premium. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, with initial maturities beyond one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 16

-Article 9

+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_FirstLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=rdnt_SecondLienTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=us-gaap_ShortTermDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9

3. EARNINGS PER SHARE (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Earnings Per Share [Abstract]

Net loss attributable to RadNet, Inc.'s common stockholders $ (4,554)us-gaap_NetIncomeLoss $ (12,424)us-gaap_NetIncomeLoss

BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 42,747,329 40,010,080

Basic and diluted net loss per share attributable to RadNet, Inc.'s common stockholders $ (0.11)us-gaap_EarningsPerShareBasicAndDiluted $ (0.31)us-gaap_EarningsPerShareBasicAndDiluted

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 28 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * / var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 29 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss $ (4,476)us-gaap_ProfitLoss $ (12,375)us-gaap_ProfitLoss

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

Depreciation and amortization 14,294us-gaap_DepreciationAndAmortization 15,571us-gaap_DepreciationAndAmortization

Provision for bad debts 7,475us-gaap_ProvisionForDoubtfulAccounts 6,893us-gaap_ProvisionForDoubtfulAccounts

Equity in earnings of joint ventures (1,102) (1,067)

Distributions from joint ventures 3,041 1,866

Deferred rent amortization 925rdnt_DeferredRentAmortization 343rdnt_DeferredRentAmortization

Amortization and write off of deferred financing costs and loan discount 1,288us-gaap_AmortizationOfFinancingCosts 1,833us-gaap_AmortizationOfFinancingCosts

(Gain) loss on sale and disposal of equipment (38) 246

Loss on early extinguishment of Senior Notes 0 15,456

Stock-based compensation 3,554us-gaap_ShareBasedCompensation 1,025us-gaap_ShareBasedCompensation

Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:

Accounts receivable (12,498) (13,923)

Other current assets 2,787 (4,503)

Other assets (289) (575)

Deferred taxes (3,578) (4,536)

Deferred revenue (202) (39)

Accounts payable, accrued expenses and other 6,288 (11,075)

Net cash provided by (used in) operating activities 17,469 (4,860)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of imaging facilities 0 (360)

Purchase of property and equipment (19,826) (17,047)

Proceeds from sale of equipment 205 4

Equity contributions in existing and purchase of interest in joint ventures 0us-gaap_PaymentsToAcquireInvestments (789)us-gaap_PaymentsToAcquireInvestments

Net cash used in investing activities (19,621) (18,192)

CASH FLOWS FROM FINANCING ACTIVITIES

Principal payments on notes and leases payable (2,030) (1,929)

Proceeds from borrowings 0us-gaap_ProceedsFromIssuanceOfDebt 210,000us-gaap_ProceedsFromIssuanceOfDebt

Payments on Term Loan Debt/Senior Notes (5,190)us-gaap_RepaymentsOfDebt (204,468)us-gaap_RepaymentsOfDebt

Deferred financing costs 0us-gaap_PaymentsOfDebtIssuanceCosts (6,650)us-gaap_PaymentsOfDebtIssuanceCosts

Net proceeds on revolving credit facility 9,400us-gaap_ProceedsFromLinesOfCredit 18,100us-gaap_ProceedsFromLinesOfCredit

Distributions paid to noncontrolling interests (468)us-gaap_PaymentsToMinorityShareholders (133)us-gaap_PaymentsToMinorityShareholders

Proceeds from issuance of common stock upon exercise of options/warrants 324 29

Net cash provided by financing activities 2,036 14,949

EFFECT OF EXCHANGE RATE CHANGES ON CASH (37) (18)

NET DECREASE IN CASH AND CASH EQUIVALENTS (153) (8,121)

CASH AND CASH EQUIVALENTS, beginning of period 307 8,412

CASH AND CASH EQUIVALENTS, end of period 154 291

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid during the period for interest 8,624us-gaap_InterestPaid 14,508us-gaap_InterestPaid

SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

Purchase of equipment and leasehold improvements not yet paid for $ 12,300 $ 5,000

X

- Details

Name: rdnt_ChangesInOperatingAssetsAndLiabilitiesNetOfAssetsAcquiredAndLiabilitiesAssumedInPurchaseTransactionsAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Deferred rent amortization

+ References

No definition available.

+ Details

Name: rdnt_DeferredRentAmortization

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Purchase of equipment and leasehold improvements not yet paid for

+ References

No definition available.

+ Details

Name: rdnt_PurchaseOfEquipmentAndLeaseholdImprovementsNotYetPaidFor

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: rdnt_SupplementalDisclosureOfCashFlowInformationAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 8

-Article 9

+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Article 5

+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6401765&loc=d3e13305-112630

+ Details

Name: us-gaap_ExtinguishmentOfDebtGainLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_GainLossOnSaleOfPropertyPlantEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the purchase of all investments (debt, security, other) during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.

+ References

No definition available.

+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.

+ References

No definition available.

+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with security instruments that either represent a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes repayments of (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 30 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)

Mar. 31, 2015

Dec. 31, 2014

Statement of Financial Position [Abstract]

Common stock - par value (in Dollars per share) $ 0.0001 $ 0.0001

Common stock - shares authorized 200,000,000us-gaap_CommonStockSharesAuthorized 200,000,000us-gaap_CommonStockSharesAuthorized

Common stock - shares issued 43,810,279us-gaap_CommonStockSharesIssued 42,825,676us-gaap_CommonStockSharesIssued

Common stock - shares outstanding 43,810,279us-gaap_CommonStockSharesOutstanding 42,825,676us-gaap_CommonStockSharesOutstanding

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9

3. EARNINGS PER SHARE (Tables)
3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Three Months Ended March 31,

2015 2014

Net loss attributable to RadNet, Inc. common stockholders $ (4,554 ) $ (12,424 )

BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 42,747,329 40,010,080

Basic and diluted net loss per share attributable to RadNet, Inc. common stockholders $ (0.11 ) $ (0.31 )

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9

Document and Entity Information
3 Months Ended

Mar. 31, 2015

May 07, 2014

Document and Entity Information

Entity Registrant Name RadNet, Inc.

Entity Central Index Key 0000790526

Document Type 10-Q

Document Period End Date Mar. 31, 2015

Amendment Flag false

Current Fiscal Year End Date --12-31

Is Entity a Well-known Seasoned Issuer No

Is Entity a Voluntary Filer No

Is Entity's Reporting Status Current Yes

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 44,269,449dei_EntityCommonStockSharesOutstanding

Document Fiscal Period Focus Q1

Document Fiscal Year Focus 2015

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: rdnt_DocumentAndEntityInformationAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9

4. INVESTMENT IN JOINT VENTURES (Tables)
3 Months Ended

Mar. 31, 2015

Equity Method Investments and Joint Ventures [Abstract]

Investment in joint ventures

Balance as of December 31, 2014 $ 32,123

Equity in earnings in these joint ventures 1,102

Distribution of earnings (3,041 )

Balance as of March 31, 2015 $ 30,184

Key financial data in joint ventures
The following table is a summary of key financial data for these joint ventures as of March 31, 2015and for the three months ended March, 2015 and 2014 (in thousands):

Balance Sheet Data: March 31, 2015

Current assets $ 18,566

Noncurrent assets 49,222

Current liabilities (8,237 )

Noncurrent liabilities (5,915 )

Total net assets $ 53,636

Book value of RadNet joint venture interests $ 25,206

Cost in excess of book value of acquired joint venture interests 4,978

Total value of Radnet joint venture interests $ 30,184

Total book value of other joint venture partner interests $ 28,430

Income statement data for the three months ended March 31, 2015 2014

Net revenue $ 26,442 $ 22,806

Net income $ 3,030 $ 2,149

X

- Definition

Key financial data in joint ventures

+ References

No definition available.

+ Details

Name: rdnt_KeyFinancialDataInJointVenturesTableTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

+ Details

Name: us-gaap_CostMethodInvestmentsDescriptionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

NET REVENUE

Service fee revenue, net of contractual allowances and discounts $ 165,030 $ 158,763

Provision for bad debts (7,475) (6,893)

Net service fee revenue 157,555 151,870

Revenue under capitation arrangements 23,712 17,006

Total net revenue 181,267us-gaap_SalesRevenueNet 168,876us-gaap_SalesRevenueNet

OPERATING EXPENSES

Cost of operations, excluding depreciation and amortization 168,921us-gaap_CostOfRevenue 145,030us-gaap_CostOfRevenue

Depreciation and amortization 14,294us-gaap_DepreciationAndAmortization 15,571us-gaap_DepreciationAndAmortization

(Gain) loss on sale and disposal of equipment (38)us-gaap_GainLossOnDispositionOfAssets 246us-gaap_GainLossOnDispositionOfAssets

Severance costs 36us-gaap_SeveranceCosts1 481us-gaap_SeveranceCosts1

Total operating expenses 183,213us-gaap_OperatingExpenses 161,328us-gaap_OperatingExpenses

(LOSS) INCOME FROM OPERATIONS (1,946)us-gaap_OperatingIncomeLoss 7,548us-gaap_OperatingIncomeLoss

OTHER INCOME AND EXPENSES

Interest expense 9,996us-gaap_InterestExpenseDebt 11,772us-gaap_InterestExpenseDebt

Meaningful use incentive (3,270) (1,762)

Equity in earnings of joint ventures (1,102) (1,067)

Loss on early extinguishment of Senior Notes 0 15,456

Other expenses (income) (3)us-gaap_OtherNonoperatingIncomeExpense 2us-gaap_OtherNonoperatingIncomeExpense

Total other expenses 5,621us-gaap_OtherExpenses 24,401us-gaap_OtherExpenses

LOSS BEFORE INCOME TAXES (7,567) (16,853)

Benefit from income taxes 3,091us-gaap_IncomeTaxExpenseBenefit 4,478us-gaap_IncomeTaxExpenseBenefit

NET LOSS (4,476)us-gaap_ProfitLoss (12,375)us-gaap_ProfitLoss

Net income attributable to noncontrolling interests 78 49

NET LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ (4,554)us-gaap_NetIncomeLoss $ (12,424)us-gaap_NetIncomeLoss

BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ (0.11)us-gaap_EarningsPerShareBasicAndDiluted $ (0.31)us-gaap_EarningsPerShareBasicAndDiluted

WEIGHTED AVERAGE SHARES OUTSTANDING: Basic and Diluted 42,747,329 40,010,080

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized based on fees charged on a per capita basis.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8200-115640

+ Details

Name: us-gaap_HealthCareOrganizationCapitationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8184-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51673531&loc=SL9156464-115641

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8195-115640

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of the provision for bad debts related to patient service revenue.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of the cost of borrowed funds accounted for as interest expense for debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.8)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of Net Income (Loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount after tax of income (loss) attributable to nonredeemable noncontrolling shareholder, unit holder, partner, or other equity holder of a joint venture.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.19)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_NoncontrollingInterestInNetIncomeLossJointVenturePartnersNonredeemable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Incentive fees which are compensation paid to a trading advisor or to any practitioner who achieves investment results above a specified contractual level.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.14)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_NoninterestExpenseRelatedToPerformanceFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

This element represents a sum total of expenses not separately reflected on the income statement for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.7)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4,6)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OtherExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 35 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9

5. STOCK-BASED COMPENSATION
3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION
Stock Incentive Plans

Options and Warrants*

We have one long-term incentive plan which we refer to as the 2006 Plan. As of March 31, 2015, we have reserved for issuance under the 2006 Plan 11,000,000 shares of common stock. Certain options granted under the 2006 Plan to employees are intended to qualify as incentive stock options under existing tax regulations. In addition, we may issue non-qualified stock options under the 2006 Plan from time to time to non-employees, in connection with acquisitions and for other purposes and we may also issue restricted stock under the 2006 Plan. Stock options and warrants generally vest over two to five years and expire five to ten years from date of grant.

As of March 31, 2015, 1,699,176, or approximately 97.5%, of the 1,742,509 outstanding stock options granted under our 2006 Plan are fully vested. During the three months ended March 31, 2015, we did not grant options or warrants under our 2006 Plan.

The following summarizes all of our option and warrant transactions during the three months ended March 31, 2015:

Weighted Average Weighted Average Remaining

Exercise price Contractual Aggregate

Outstanding Options and Warrants Per Common Life Intrinsic

Under the 2006 Plan Shares Share (in years) Value

Balance, December 31, 2014 2,092,509 $ 3.58

Granted – –

Exercised (325,000 ) 2.69

Canceled, forfeited or expired (25,000 ) 2.22

Balance, March 31, 2015 1,742,509 3.76 1.03 $ 8,230,904

Exercisable at March 31, 2015 1,699,176 3.80 0.97 7,955,304

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on March 31, 2015 and the exercise price, multiplied by the number of in-the-money options or warrants, as applicable) that would have been received by the holder had all holders exercised their options or warrants, as applicable, on March 31, 2015. Total intrinsic value of options and warrants exercised during the three months ended March 31, 2015 and 2014 was approximately $1.9 million and $16,000, respectively. As of March 31, 2015, total unrecognized stock-based compensation expense related to non-vested employee awards was $30,000, which is expected to be recognized over a weighted average period of approximately 1.6 years.

Restricted Stock Awards (“RSA’s”)

The 2006 Plan permits the award of restricted stock. As of March 31, 2015, we have issued a total of 3,441,208 RSA’s of which 881,194 were unvested at March 31, 2015.

The following summarizes all unvested RSA’s activities during the three months ended March 31, 2015:

Weighted-

Average

Remaining Weighted-

Contractual Average

Shares Term (Years) Fair Value

RSA's outstanding at December 31, 2014 942,023 $ 1.96

Changes during the period

Granted 724,423 $ 8.66

Vested (785,253 ) $ 4.53

RSA's outstanding at March 31, 2015 881,194 1.21 $ 5.17



We determine the fair value of all RSA’s based of the closing price of our common stock on award date.

In sum, of the 11,000,000 shares of common stock reserved for issuance under the 2006 Plan, at March 31, 2015, we had 7,944,958 options, shares of restricted stock and other bonus awards issued and 3,055,042 shares of common stock available for future awards.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9

4. INVESTMENT IN JOINT VENTURES
3 Months Ended

Mar. 31, 2015

Equity Method Investments and Joint Ventures [Abstract]

INVESTMENT IN JOINT VENTURES

We have ten unconsolidated joint ventures with ownership interests ranging from 35% to 50%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Our investment in these joint ventures is accounted for under the equity method.

The following table is a roll forward of our investment in joint ventures during the three months ended March 31, 2015 (in thousands):

Balance as of December 31, 2014 $ 32,123

Equity in earnings in these joint ventures 1,102

Distribution of earnings (3,041 )

Balance as of March 31, 2015 $ 30,184

We earned management service fees from the centers underlying these joint ventures of approximately $2.4 million in each of the three months ended March 31, 2015 and 2014, respectively. At the end of the period we eliminate from total fees recorded the uncollected portion of these fees that are associated with our ownership interests and offset this with an increase to our equity earnings.

The following table is a summary of key financial data for these joint ventures as of March 31, 2015 and for the three months ended March, 2015 and 2014 (in thousands):

Balance Sheet Data: March 31, 2015

Current assets $ 18,566

Noncurrent assets 49,222

Current liabilities (8,237 )

Noncurrent liabilities (5,915 )

Total net assets $ 53,636

Book value of RadNet joint venture interests $ 25,206

Cost in excess of book value of acquired joint venture interests 4,978

Total value of Radnet joint venture interests $ 30,184

Total book value of other joint venture partner interests $ 28,430

Income statement data for the three months ended March 31, 2015 2014

Net revenue $ 26,442 $ 22,806

Net income $ 3,030 $ 2,149

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=49116238&loc=d3e32787-111569

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 35

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=49116238&loc=d3e32847-111569

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BRMG and B&C Entities revenues $ 25,500 $ 20,600

BRMG and B&C Entities operating expenses 25,500 20,600

Total billed net service fee revenue 99,000us-gaap_HealthCareOrganizationRevenue 89,000us-gaap_HealthCareOrganizationRevenue

Management services provided to BRMG and B&C Entities 73,500 68,500

BRMG and B&C Entities accounts receivable 84,300 79,700

BRMG and B&C Entities accounts payable 8,700 9,000

Working capital 61,700rdnt_WorkingCapital 58,700rdnt_WorkingCapital

Senior notes 563,300us-gaap_SeniorNotes

Line of credit balance outstanding $ 24,700us-gaap_LineOfCredit $ 15,300us-gaap_LineOfCredit

X

- Definition

Working capital

+ References

No definition available.

+ Details

Name: rdnt_WorkingCapital

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of expense between the reporting entity and the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of income between the reporting entity and the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph d

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name: us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The carrying amount of the consolidated Variable Interest Entity's assets included in the reporting entity's statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The carrying amount of the consolidated Variable Interest Entity's liabilities included in the reporting entity's statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (bb)

-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5710-111685

+ Details

Name: us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 38 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9

5. STOCK-BASED COMPENSATION (Tables)
3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

Weighted Average Weighted Average Remaining

Exercise price Contractual Aggregate

Outstanding Options and Warrants Per Common Life Intrinsic

Under the 2006 Plan Shares Share (in years) Value

Balance, December 31, 2014 2,092,509 $ 3.58

Granted – –

Exercised (325,000 ) 2.69

Canceled, forfeited or expired (25,000 ) 2.22

Balance, March 31, 2015 1,742,509 3.76 1.03 $ 8,230,904

Exercisable at March 31, 2015 1,699,176 3.80 0.97 7,955,304

Restricted Stock Awards

Weighted-

Average

Remaining Weighted-

Contractual Average

Shares Term (Years) Fair Value

RSA's outstanding at December 31, 2014 942,023 $ 1.96

Changes during the period

Granted 724,423 $ 8.66

Vested (785,253 ) $ 4.53

RSA's outstanding at March 31, 2015 881,194 1.21 $ 5.17

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies)
3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NATURE OF BUSINESS AND BASIS OF PRESENTATION
We provide diagnostic imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. At March 31, 2015 we operated directly or indirectly through joint ventures, 259 imaging centers located in California, Maryland, Florida, Delaware, New Jersey, Rhode Island and New York. Our operations comprise a single segment for financial reporting purposes.

The condensed consolidated financial statements include the accounts of Radnet Management, Inc. (or “Radnet Management”) and Beverly Radiology Medical Group III, a professional partnership (“BRMG”). The condensed consolidated financial statements also include Radnet Management I, Inc., Radnet Management II, Inc., Radiologix, Inc., Radnet Managed Imaging Services, Inc., Delaware Imaging Partners, Inc., New Jersey Imaging Partners, Inc. and Diagnostic Imaging Services, Inc. (“DIS”), all wholly owned subsidiaries of Radnet Management. All of these affiliated entities are referred to collectively as “RadNet”, “we”, “us”, “our” or the “Company” in this report.

Accounting Standards Codification (“ASC”) Section 810-10-15-14 stipulates that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics specified in the ASC which evidence a controlling financial interest, is considered a Variable Interest Entity (“VIE”). We consolidate all VIEs in which we own a majority voting interest and all VIEs for which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE’s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.

Howard G. Berger, M.D. is our President and Chief Executive Officer, a member of our Board of Directors and is deemed to be the beneficial owner, directly and indirectly, of approximately 12.3% of our outstanding common stock as of March 31, 2015. Dr. Berger also owns, indirectly, 99% of the equity interests in BRMG. BRMG provides all of the professional medical services at the majority of our facilities located in California under a management agreement with us, and employs physicians or contracts with various other independent physicians and physician groups to provide the professional medical services at most of our other California facilities. We generally obtain professional medical services from BRMG in California, rather than provide such services directly or through subsidiaries, in order to comply with California’s prohibition against the corporate practice of medicine. However, as a result of our close relationship with Dr. Berger and BRMG, we believe that we are able to better ensure that medical service is provided at our California facilities in a manner consistent with our needs and expectations and those of our referring physicians, patients and payors than if we obtained these services from unaffiliated physician groups. BRMG is a partnership of ProNet Imaging Medical Group, Inc., Breastlink Medical Group, Inc. and Beverly Radiology Medical Group, Inc., each of which is 99% or 100% owned by Dr. Berger.

John V Crues, III, M.D. is our Medical Director, a member of our Board of Directors and a 1% owner of BRMG. Dr. Crues owns a controlling interest in four medical groups (“Crues Entities”) which provide professional medical services at some of our facilities in Manhattan and Brooklyn, New York while Dr. Berger owns a controlling interest in two medical groups (“NY Berger Entities”) which provide professional medical services at one of our Manhattan, New York facilities. The Crues Entities and the NY Berger Entities are collectively hereinafter referred to as the “B&C Entities.”

RadNet provides non-medical, technical and administrative services to BRMG and the B&C Entities for which it receives a management fee, pursuant to the related management agreements. Through these management agreements and our relationship with both Dr. Berger and Dr. Crues, we have exclusive authority over all non-medical decision-making related to the ongoing business operations of BRMG and the B&C Entities and we determine the annual budget of BRMG and the B&C Entities. BRMG and the B&C Entities both have insignificant operating assets and liabilities, and de minimis equity. Through these management agreements, we are paid the fair market value of our services, the result of which is that generally all net cash flows of both BRMG and the B&C Entities are transferred to us.

We have determined that BRMG and the B&C Entities are VIEs, and that we are the primary beneficiary, and consequently, we consolidate the revenue, expenses, assets and liabilities of each such entity. BRMG and the B&C Entities on a combined basis recognized $25.5 million and $20.6 million of revenue, net of management service fees to RadNet for the three months ended March 31, 2015 and 2014, respectively, and $25.5 million and $20.6 million of operating expenses for the three months ended March 31, 2015 and 2014, respectively. RadNet, Inc. recognized in its condensed consolidated statement of operations $99.0 million and $89.0 million of total billed net service fee revenue relating to these VIE’s for the three months ended March 31, 2015 and 2014, respectively, of which $73.5 million and $68.5 million was for management services provided to BRMG and the B&C Entities relating primarily to the technical portion of total billed net service fee revenue for the three months ended March 31, 2015 and 2014, respectively.

The cash flows of BRMG and the B&C Entities are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at March 31, 2015 and December 31, 2014, we have included approximately $84.3 million and $79.7 million, respectively, of accounts receivable and approximately $8.7 million and $9.0 million, respectively, of accounts payable and accrued liabilities, related to BRMG and the B&C Entities combined.

The creditors of both BRMG and the B&C Entities do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of BRMG and the B&C Entities. However, because of the relationship RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.

Aside from certain centers in California and all of our centers in New York City where we contract with BRMG and the B&C Entities, respectively, for the provision of professional medical services, at all of our other centers, we have entered into long-term contracts with independent radiology groups in the area to provide physician services at those facilities. These third party radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. In these facilities we enter into long-term agreements with radiology practice groups (typically 40 years). Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee intended to compensate us for the fair market value of our services which in some instances may be based on the practice group’s professional revenue, including revenue derived outside of our diagnostic imaging centers. We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us. We have no financial controlling interest in the independent (non-BRMG or non-B&C Entities) radiology practices; accordingly, we do not consolidate the financial statements of those practices in our consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X and, therefore, do not include all information and footnotes necessary for conformity with U.S. generally accepted accounting principles for complete financial statements; however, in the opinion of our management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014 have been made. The results of operations for any interim period are not necessarily indicative of the results for a full year. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto contained in our annual report on Form 10-K for the year ended December 31, 2014 filed on March 16, 2015, as amended.

Significant Accounting Policies

During the period covered in this report, there have been no material changes to the significant accounting policies we use, and have explained, in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended. The information below is intended only to supplement the disclosure in our annual report on Form 10-K for the fiscal year ended December 31, 2014, as amended.

Revenues
Service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payors and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments. As it relates to centers affiliated with both BRMG and the B&C Entities, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by BRMG and the B&C Entities as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees from BRMG and the B&C Entities. As it relates to non-BRMG and B&C Entity centers, this service fee revenue is earned through providing the administration of the non-medical functions relating to the professional medical practice at our non-BRMG and B&C Entity centers, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

Service fee revenues are recorded during the period the patient services are provided based upon the estimated amounts due from the patients and third-party payors. Third-party payors include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage under one of our third-party payors.

Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.

Our revenue, net of contractual allowances, discounts and provision for bad debts for the three months ended March 31, 2015 and 2014 is summarized in the following table (in thousands):

Three Months Ended

March 31,

2015 2014

Commercial insurance $ 99,885 $ 98,881

Medicare 37,036 36,202

Medicaid 5,470 5,774

Workers' compensation/personal injury 7,400 9,635

Other 15,239 8,271

Service fee revenue, net of contractual allowances and discounts 165,030 158,763

Provision for bad debts (7,475 ) (6,893 )

Net service fee revenue 157,555 151,870

Revenue under capitation arrangements 23,712 17,006

Total net revenue $ 181,267 $ 168,876

Provision for Bad Debts
We provide for an allowance against accounts receivable that could become uncollectible to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of our provision for bad debt relates to co-payments and deductibles owed to us from patients with insurance. Although we attempt to collect deductibles and co-payments due from patients with insurance at the time of service, this attempt to collect at the time of service is not an assessment of the patient’s ability to pay nor are revenues recognized based on an assessment of the patient’s ability to pay. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and our estimation process.

Deferred Tax Assets
Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.

Deferred Financing Costs
Costs of financing are deferred and amortized on a straight-line basis over the life of the associated loan, which approximates the effective interest rate method.

Meaningful Use Incentive

Under the American Recovery and Reinvestment Act of 2009, a program was enacted that provides financial incentives for providers that successfully implement and utilize electronic health record technology to improve patient care. Our software development team in Canada established an objective to build a Radiology Information System (RIS) software platform that has been awarded Meaningful Use certification. As this certified RIS system is implemented throughout our imaging centers, the radiologists that utilize this software will be eligible for the available financial incentives. In order to receive such incentive payments providers must attest that they have demonstrated meaningful use of the certified RIS in each stage of the program. Once an attestation is accepted by Medicare, payments will be made in four to eight weeks to the same taxpayer identification number and through the same channels as their claims payments are made. We account for this meaningful use incentive under the Gain Contingency Model outlined in ASC 450-30. Under this model, we record within non-operating income, meaningful use incentive only after Medicare accepts an attestation from the qualified eligible professional demonstrating meaningful use. We recorded approximately $3.3 million and $1.8 million during the three months ended March 31, 2015, and 2014, respectively, relating to this incentive. These amounts were earned under a Medicare program to promote the use of electronic health record technology.

Liquidity and Capital Resources

Liquidity and Capital Resources

We had cash and cash equivalents of $154,000 and accounts receivable of $153.3 million at March 31, 2015, compared to cash and cash equivalents of $307,000 and accounts receivable of $148.2 million at December 31, 2014. We had a working capital balance of $61.7 million and $58.7 million at March 31, 2015 and December 31, 2014, respectively. We had net loss attributable to RadNet, Inc. common stockholders for the three months ended March 31, 2015 and 2014 of $4.6 million and $12.4 million respectively. We also had stockholders’ equity of $4.6 million and $5.4 million at March 31, 2015 and December 31, 2014, respectively.

We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.

Based on our current level of operations, we believe that cash flow from operations and available cash, together with available borrowings from our senior secured credit facilities, will be adequate to meet our liquidity needs. Our future liquidity requirements will be for working capital, capital expenditures, debt service and general corporate purposes. Our ability to meet our working capital and debt service requirements, however, is subject to future economic conditions and to financial, business and other factors, many of which are beyond our control. If we are not able to meet such requirements, we may be required to seek additional financing. There can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.

On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.

We and our subsidiaries or affiliates may from time to time, in our or their sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.

Included in our condensed consolidated balance sheet at March 31, 2015 is $563.3 million of senior secured term loan debt (net of unamortized discounts of $11.2 million), broken down by loan agreement as follows (in thousands):

Face Value Discount Total Carrying Value

First Lien Term Loans $ 394,559 $ (8,681 ) $ 385,878

Second Lien Term Loans $ 180,000 $ (2,558 ) $ 177,442

Total $ 574,559 $ (11,239 ) $ 563,320

Our revolving credit facility has a $24.7 million aggregate principal amount outstanding as of March 31, 2015.

As of March 31, 2015, we were in compliance with all financial covenants under our Refinance Agreement, as amended by the 2014 Amendment, and the Second Lien Credit and Guaranty Agreement, each as defined below. Also described below are details of our $200 million senior notes, redemption of which was completed in 2014.

2014 Amendment to the Refinance Agreement and Second Lien Credit and Guaranty Agreement:

On March 25, 2014, Radnet Management simultaneously entered into two agreements which resulted in the creation of a direct financial obligation as follows:

2014 Amendment of the Refinance Agreement. Radnet Management amended that certain Credit and Guaranty Agreement dated October 10, 2012, by that certain first amendment dated April 3, 2013 (the “2013 Amendment”) (collectively, the “Refinance Agreement”), and subsequently by entering into a second amendment to the Refinance Agreement on March 25, 2014 (the “2014 Amendment”) to provide for, among other things, the borrowing by Radnet Management of $30.0 million of additional first lien term loans (the “2014 First Lien Term Loans”).

Second Lien Credit and Guaranty Agreement. Radnet Management entered into a Second Lien Credit and Guaranty Agreement dated March 25, 2014 (the “Second Lien Credit Agreement”) to provide for, among other things, the borrowing by Radnet Management of $180.0 million of second lien term loans (the “Second Lien Term Loans”). The proceeds from the Second Lien Term Loans and the 2014 First Lien Term Loans were used to redeem the senior notes, as more fully described below under the heading “Senior Notes”, to pay the expenses related to the transaction and for general corporate purposes.

Revolving Credit Facility. The $101.25 million revolving credit line established in the Refinance Agreement was unaltered by the agreements above and remains in place. The termination date for the $101.25 million revolving credit facility is the earliest to occur of (i) October 10, 2017, (ii) the date the revolving credit facility is permanently reduced to zero pursuant to section 2.13(b) of the Refinance Agreement, which addresses voluntary commitment reductions and (iii) the date of the termination of the revolving credit facility due to specific events of default pursuant to section 8.01 of the Refinance Agreement. The revolver bears interest based on types of borrowings as follows: (i) unpaid principal at 6.5% per annum, (ii) letter of credit and fronting fees at 4.5% per annum, and (iii) commitment fee of 0.5% per annum on the unused revolver balance.

The 2014 Amendment provides for the following:

Interest. The interest rates payable on the 2014 First Lien Term Loans are the same as the rates payable under the Refinance Agreement, as amended by the 2013 Amendment, which are (a) the Adjusted Eurodollar Rate (as defined in the Refinance Agreement) plus 3.25% or (b) the Base Rate (as defined in the Refinance Agreement) plus 2.25%. With respect to all of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, the Adjusted Eurodollar Rate has a minimum floor of 1.0%. The Adjusted Eurodollar Rate at March 31, 2015 was 0.40%.

Payments. The scheduled amortization of the term loans under the Refinance Agreement, as amended by the 2014 Amendment, has been increased, starting in June 2014 from quarterly payments of $975,000 to quarterly payments of approximately $5.2 million, with the remaining balance to be paid at maturity. Scheduled amortization increased by $16.8 million from pre-amendment terms, representing a rise from 1% per annum to 5% per annum of the initial amount borrowed.

Guarantees and Collateral. The obligations under the Refinance Agreement, as amended by the 2014 Amendment, are guaranteed by RadNet, Inc., all of our current and future domestic subsidiaries and certain of our affiliates (other than certain excluded foreign subsidiaries). The obligations under the Refinance Agreement, as amended by the 2014 Amendment, and the guarantees are secured by a perfected first priority security interest (subject to certain permitted exceptions) in substantially all of Radnet Management’s and the guarantors’ tangible and intangible assets, including, but not limited to, pledges of equity interests of Radnet Management and all of our current and future domestic subsidiaries.

Restrictive Covenants. In addition to certain covenants, the Refinance Agreement, as amended by the 2014 Amendment, places limits on our ability to declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transactions, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Financial Covenants. The Refinance Agreement, as amended by the 2014 Amendment contains financial covenants including a maximum total leverage ratio and a limit on annual capital expenditures.

Events of Default. In addition to certain customary events of default, events of default under the Refinance Agreement, as amended by the 2014 Amendment, include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Refinance Agreement, as amended by the 2014 Amendment, within five days after the due date, failure of any loan party to comply with any covenant or agreement in the loan documents (subject to applicable grace periods and/or notice requirement), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Refinance Agreement, as amended by the 2014 Amendment, to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

The Second Lien Credit Agreement provides for the following:

Interest. The interest rates payable on the Second Lien Term Loans are (a) the Adjusted Eurodollar Rate (as defined in the Second Lien Credit Agreement) plus 7.0% or (b) the Base Rate (as defined in the Second Lien Credit Agreement) plus 6.0%. The Adjusted Eurodollar Rate has a minimum floor of 1.0% on the Second Lien Term Loans. The Eurodollar Rate at March 31, 2015 was 0.40%. The rate paid on the Second Lien Credit Agreement at March 31, 2015 is 8%.

Payments. There is no scheduled amortization of the principal of the Second Lien Term Loans. Unless otherwise prepaid as a result of the occurrence of certain mandatory prepayment events, all principal will be due and payable on the termination date described below.

Termination. The maturity date for the Second Lien Term Loans is the earlier to occur of (i) March 25, 2021, and (ii) the date on which the Second Lien Term Loans shall otherwise become due and payable in full under the Second Lien Credit Agreement, whether by voluntary prepayment per section 2.13 (a) or events of default per section 8.01 as described below.

Restrictive Covenants. In addition to certain covenants, the Second Lien Credit Agreement places limits on our ability declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase debt, incur liens and engage in sale-leaseback transaction, make loans and investments, incur additional indebtedness, amend or otherwise alter debt and other material agreements, engage in mergers, acquisitions and asset sales, enter into transactions with affiliates and alter the business we and our subsidiaries currently conduct.

Events of Default. In addition to certain events of default, events of default under the Second Lien Credit Agreement include failure to pay the outstanding principal of any loans as and on the date when due, failure to pay any interest on any loan or any fee or other amount payable under the Second Lien Term Loans within five days after the due date, failure of any loan party to comply with any covenant or agreements in the loan documents (subject to applicable grace periods and/or notice requirements), a representation or warranty contained in the loan documents is false in a material respect, events of bankruptcy and a change of control. The occurrence of an event of default could permit the lenders under the Second Lien Credit Agreement to declare all amounts borrowed, together with accrued interest and fees, to be immediately due and payable and to exercise other default remedies.

Senior Notes

On April 6, 2010, we issued and sold $200 million of 10 3/8% senior unsecured notes due 2018 at a price of 98.680% (the “senior notes”). All payments of the senior notes, including principal and interest, were guaranteed jointly and severally on a senior unsecured basis by RadNet, Inc., and all of Radnet Management’s current and future domestic wholly owned restricted subsidiaries. The senior notes were issued under an indenture dated April 6, 2010 (the “Indenture”), by and among Radnet Management, Inc., as issuer, RadNet, Inc., as parent guarantor, the subsidiary guarantors thereof and U.S. Bank National Association, as trustee. We paid interest on the senior notes on April 1 and October 1 of each year, commencing October 1, 2010, and they were scheduled to expire on April 1, 2018.

We completed the retirement of our $200 million in senior notes on April 24, 2014 and following such retirement the Company completed the satisfaction and discharge of the Indenture. The transactions leading to the retirement of the Senior Notes are described below:

Tender Offer. On March 7, 2014, we commenced a tender offer to purchase for cash any and all outstanding senior notes. In connection with the tender offer, we also commenced a consent solicitation to amend the Indenture to eliminate or modify certain restrictive covenants. On March 25, 2014, we made a payment in cash for all senior notes tendered prior to 5:00 P.M., New York City time, on March 20, 2014 (the “Consent Payment Deadline”). As of the Consent Payment Deadline, we received tenders and consents in respect of $193,464,000 aggregate principal amount of the senior notes, representing 96.73% of the outstanding senior notes, all of which were accepted for purchase. The total consideration for each $1,000 principal amount of senior notes validly tendered and not withdrawn at or prior to the Consent Payment Deadline and accepted for purchase was $1,056.88, which amount included a consent payment (the “Consent Payment”) of $30.00 per $1,000 principal amount of senior notes. In addition, all senior notes accepted for payment received accrued and unpaid interest in respect of such notes from the last interest payment date prior to the applicable settlement date to, but not including, the applicable settlement date. The tender offer expired on April 3, 2014 and between the Consent Payment Deadline and the expiration of the tender offer, no additional senior notes were tendered. With a net carrying amount including discount and unamortized issue costs of $189.2 million, a loss on early extinguishment of debt of $15.5 million was recorded in the first quarter of 2014.

Exercise of Optional Redemption on March 25, 2014. On March 25, 2014, we called for redemption all of our remaining outstanding senior notes not purchased prior to the expiration of the tender offer described above, with a redemption date of April 24, 2014 (the “Redemption Date”). Upon redemption on April 24, 2014, the holders of the senior notes being redeemed received a redemption price equal to 105.188% of the outstanding principal amount of the senior notes being redeemed (or $1,051.88 per $1,000 in principal amount of the senior notes) in accordance with the terms of the Indenture, or approximately $6.9 million in total, including approximately $43,000 of accrued and unpaid interest up to, but excluding the Redemption Date. As of that date, we completed the satisfaction and discharge of the Indenture in accordance with its terms and no senior notes remained outstanding. With a net carrying amount including discount and unamortized issue costs of $6.4 million, a loss on early extinguishment of debt of $471,000 was recorded in the second quarter of 2014.

X

- Definition

Deferred tax assets policy text block

+ References

No definition available.

+ Details

Name: rdnt_DeferredTaxAssetsPolicy

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Liquidity and Capital Resources

+ References

No definition available.

+ Details

Name: rdnt_LiquidityAndCapitalResourcesPolicyTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Meaningful Use Incentive policy text block

+ References

No definition available.

+ Details

Name: rdnt_MeaningfulUseIncentivePolicyTextBlock

Namespace Prefix: rdnt_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

+ Details

Name: us-gaap_DebtPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for assessing the timing and amount of uncollectible revenue recognized as bad debt expense.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 310

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673446&loc=SL9156395-115594

+ Details

Name: us-gaap_HealthCareOrganizationBadDebtsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9

6. FAIR VALUE MEASUREMENTS
3 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS – Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:

Level 1—Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.

Level 2—Fair value is determined by using inputs other than Level 1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.

Level 3—Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.

The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

As of March 31, 2015

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

First Lien Term Loans $ – $ 395,052 $ – $ 395,052 $ 394,559

Second Lien Term Loans $ 178,200 $ – 178,200 $ 180,000

As of December 31, 2014

Level 1 Level 2 Level 3 Total Total Face Value

First Lien Term Loans $ – $ 394,753 $ – $ 394,753 $ 399,750

Second Lien Term Loans – 178,200 – 178,200 180,000

The carrying value of our revolving credit facility at March 31, 2015 and December 31, 2014 of $24.7 million and $15.3 million, respectively, approximated its fair value.

We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9

7. SUBSEQUENT EVENTS
3 Months Ended

Mar. 31, 2015

Subsequent Events [Abstract]

SUBSEQUENT EVENTS
On April 1, 2015, RadNet purchased substantially all of the assets of New York Radiology Partners (NYRP) for $31.4 million in total consideration, consisting of $29.8 million in cash and issued a promissory note for the remainder in the amount of $1.6 million.

On April 30, 2015, RadNet entered into a joinder to its existing senior secured first lien credit agreement to provide for the borrowing of $75.0 million of incremental first lien term loans. The incremental first lien term loans will be treated as part of the same class as the existing tranche B term loans currently outstanding under the existing first lien credit agreement and will bear the same interest rate as the rate currently payable on the existing tranche B term loans under the existing first lien credit agreement, which is (a) the adjusted LIBOR rate plus 3.25% or (b) the base rate plus 2.25%. Proceeds from the incremental term loans were used to repay all the borrowings outstanding under the first lien revolving loan facility and pay approximately $1 million of fees and expenses associated with the transaction.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables)
3 Months Ended

Mar. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Service fee revenue

Three Months Ended

March 31,

2015 2014

Commercial insurance $ 99,885 $ 98,881

Medicare 37,036 36,202

Medicaid 5,470 5,774

Workers' compensation/personal injury 7,400 9,635

Other 15,239 8,271

Service fee revenue, net of contractual allowances and discounts 165,030 158,763

Provision for bad debts (7,475 ) (6,893 )

Net service fee revenue 157,555 151,870

Revenue under capitation arrangements 23,712 17,006

Total net revenue $ 181,267 $ 168,876

Loans

Face Value Discount Total Carrying Value

First Lien Term Loans $ 394,559 $ (8,681 ) $ 385,878

Second Lien Term Loans $ 180,000 $ (2,558 ) $ 177,442

Total $ 574,559 $ (11,239 ) $ 563,320

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 320

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969

+ Details

Name: us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9

1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Commercial Insurance $ 99,885us-gaap_InsuranceCommissionsAndFees $ 98,881us-gaap_InsuranceCommissionsAndFees

Medicare 37,036rdnt_HealthCareOrganizationMedicare 36,202rdnt_HealthCareOrganizationMedicare

Medicaid 5,470 5,774

Workers Compensation/Personal Injury 7,400rdnt_WorkersCompensationpersonalInjury 9,635rdnt_WorkersCompensationpersonalInjury

Other 15,239 8,271

Service fee revenue, net of contractual allowances and discounts 165,030 158,763

Provision for bad debts (7,475) (6,893)

Net service fee revenue 157,555 151,870

Revenue under capitation arrangements 23,712 17,006

Total net revenue $ 181,267us-gaap_SalesRevenueNet $ 168,876us-gaap_SalesRevenueNet

X

- Definition

Medicare

+ References

No definition available.

+ Details

Name: rdnt_HealthCareOrganizationMedicare

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Workers Compensation/Personal Injury

+ References

No definition available.

+ Details

Name: rdnt_WorkersCompensationpersonalInjury

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized based on fees charged on a per capita basis.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8200-115640

+ Details

Name: us-gaap_HealthCareOrganizationCapitationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized that is not otherwise disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationOtherRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8184-115640

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51673531&loc=SL9156464-115641

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51673510&loc=d3e8195-115640

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of the provision for bad debts related to patient service revenue.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of insurance premium revenue recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(e))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationPremiumRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Income from agency and brokerage operations (includes sales of annuities and supplemental contracts); service charges, commissions, and fees from the sale of insurance and related services; and management fees from separate accounts, deferred annuities, and universal life products.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.4)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.13(c),(d))

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InsuranceCommissionsAndFees

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 44 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9

4. INVESTMENT IN JOINT VENTURES (Details-Key financial data) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Key financial data for joint ventures

Current assets - joint ventures $ 18,566

Noncurrent assets - joint ventures 49,222

Current liabilities - joint ventures (8,237)

Noncurrent liabilities - joint ventures (5,915)

Total net assets -joint ventures 53,636

Book value of Radnet joint venture interests 25,206us-gaap_EquityMethodInvestments

Cost in excess of book value of acquired joint venture interests 4,978

Total value of Radnet joint venture interests 30,184 32,123

Total book value of other joint venture partner interests 28,430

Net revenue 26,442rdnt_NetRevenueFromJointVentures 22,806rdnt_NetRevenueFromJointVentures

Net income $ 3,030 $ 2,149

X

- Details

Name: rdnt_KeyFinancialDataForJointVenturesAbstract

Namespace Prefix: rdnt_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Net revenue from joint ventures

+ References

No definition available.

+ Details

Name: rdnt_NetRevenueFromJointVentures

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Total book value of other joint venture partner interests

+ References

No definition available.

+ Details

Name: rdnt_TotalBookValueOfOtherJointVenturePartnerInterests

Namespace Prefix: rdnt_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This element represents the aggregate cost of investments accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EquityMethodInvestmentAggregateCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of assets reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of current assets reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The amount of current liabilities reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount of liabilities reported by an equity method investment of the entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(g))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33912-111571

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph g

-Subparagraph 1, 2

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph w

-Article 1

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph bb

-Article 1

+ Details

Name: us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

+ Details

Name: us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 45 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Statement of Comprehensive Income [Abstract]

NET LOSS $ (4,476)us-gaap_ProfitLoss $ (12,375)us-gaap_ProfitLoss

Foreign currency translation adjustments (37) (18)

COMPREHENSIVE LOSS (4,513)us-gaap_ComprehensiveIncomeNetOfTax (12,393)us-gaap_ComprehensiveIncomeNetOfTax

Less comprehensive income attributable to non-controlling interests 78 49

COMPREHENSIVE LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS $ (4,591) $ (12,442)

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613674-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9

3. EARNINGS PER SHARE
3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE
Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):

Three Months Ended March 31,

2015 2014

Net loss attributable to RadNet, Inc. common stockholders $ (4,554 ) $ (12,424 )

BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS

Weighted average number of common shares outstanding during the period 42,747,329 40,010,080

Basic and diluted net loss per share attributable to RadNet, Inc. common stockholders $ (0.11 ) $ (0.31 )

For the three months ended March 31, 2015 and 2014 we excluded all outstanding options and restricted stock awards in the calculation of diluted earnings per share because their effect would be antidilutive.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9

4. INVESTMENT IN JOINT VENTURES (Details Narrative) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Equity Method Investments and Joint Ventures [Abstract]

Management service fees from centers underlying joint ventures $ 2,400us-gaap_ManagementFeesRevenue $ 2,400us-gaap_ManagementFeesRevenue

X

- Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_ManagementFeesRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 42 197 1 false 15 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://radnet.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://radnet.com/role/ConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://radnet.com/role/ConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://radnet.com/role/CondensedConsolidatedStatementOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY false false R7.htm 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 00000008 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentation 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION false false R9.htm 00000009 - Disclosure - 2. NEW ACCOUNTING STANDARDS Sheet http://radnet.com/role/RecentAccountingStandards 2. NEW ACCOUNTING STANDARDS false false R10.htm 00000010 - Disclosure - 3. EARNINGS PER SHARE Sheet http://radnet.com/role/EarningsPerShare 3. EARNINGS PER SHARE false false R11.htm 00000011 - Disclosure - 4. INVESTMENT IN JOINT VENTURES Sheet http://radnet.com/role/InvestmentInJointVentures 4. INVESTMENT IN JOINT VENTURES false false R12.htm 00000012 - Disclosure - 5. STOCK-BASED COMPENSATION Sheet http://radnet.com/role/Stock-basedCompensation 5. STOCK-BASED COMPENSATION false false R13.htm 00000013 - Disclosure - 6. FAIR VALUE MEASUREMENTS Sheet http://radnet.com/role/FairValueMeasurements 6. FAIR VALUE MEASUREMENTS false false R14.htm 00000014 - Disclosure - 7. SUBSEQUENT EVENTS Sheet http://radnet.com/role/SubsequentEvents 7. SUBSEQUENT EVENTS false false R15.htm 00000015 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationPolicies 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Policies) false false R16.htm 00000016 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Tables) false false R17.htm 00000017 - Disclosure - 3. EARNINGS PER SHARE (Tables) Sheet http://radnet.com/role/EarningsPerShareTables 3. EARNINGS PER SHARE (Tables) false false R18.htm 00000018 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Tables) Sheet http://radnet.com/role/InvestmentInJointVenturesTables 4. INVESTMENT IN JOINT VENTURES (Tables) false false R19.htm 00000019 - Disclosure - 5. STOCK-BASED COMPENSATION (Tables) Sheet http://radnet.com/role/Stock-basedCompensationTables 5. STOCK-BASED COMPENSATION (Tables) false false R20.htm 00000020 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Tables) Sheet http://radnet.com/role/FairValueMeasurementsTables 6. FAIR VALUE MEASUREMENTS (Tables) false false R21.htm 00000021 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetails 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details) false false R22.htm 00000022 - Disclosure - 1. NOTES PAYABLE (Details - Term Loans) Notes http://radnet.com/role/NotesPayableDetails-TermLoans 1. NOTES PAYABLE (Details - Term Loans) false false R23.htm 00000023 - Disclosure - 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) false false R24.htm 00000024 - Disclosure - 3. EARNINGS PER SHARE (Details) Sheet http://radnet.com/role/EarningsPerShareDetails 3. EARNINGS PER SHARE (Details) false false R25.htm 00000025 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-jointVentures 4. INVESTMENT IN JOINT VENTURES (Details-Joint ventures) false false R26.htm 00000026 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details-Key financial data) Sheet http://radnet.com/role/InvestmentInJointVenturesDetails-keyFinancialData 4. INVESTMENT IN JOINT VENTURES (Details-Key financial data) false false R27.htm 00000027 - Disclosure - 4. INVESTMENT IN JOINT VENTURES (Details Narrative) Sheet http://radnet.com/role/InvestmentInJointVenturesDetailsNarrative 4. INVESTMENT IN JOINT VENTURES (Details Narrative) false false R28.htm 00000028 - Disclosure - 5. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) Sheet http://radnet.com/role/Stock-basedCompensationDetails-outstandingOptionsAndWarrants 5. STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) false false R29.htm 00000029 - Disclosure - 5. STOCK-BASED COMPENSATION (Details - RSU's) Sheet http://radnet.com/role/Stock-basedCompensationDetails-Rsus 5. STOCK-BASED COMPENSATION (Details - RSU's) false false R30.htm 00000030 - Disclosure - 5. STOCK-BASED COMPENSATION (Details Narrative) Sheet http://radnet.com/role/Stock-basedCompensationDetailsNarrative 5. STOCK-BASED COMPENSATION (Details Narrative) false false R31.htm 00000031 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Details) Sheet http://radnet.com/role/FairValueMeasurementsDetails 6. FAIR VALUE MEASUREMENTS (Details) false false R32.htm 00000032 - Disclosure - 6. FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://radnet.com/role/FairValueMeasurementsDetailsNarrative 6. FAIR VALUE MEASUREMENTS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Process Flow-Through: 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS rdnt-20150331.xml rdnt-20150331.xsd rdnt-20150331_cal.xml rdnt-20150331_def.xml rdnt-20150331_lab.xml rdnt-20150331_pre.xml true true XML 49 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9

6. FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended

Mar. 31, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS
The table below summarizes the estimated fair value of our long-term debt as follows (in thousands):

As of March 31, 2015

Level 1 Level 2 Level 3 Total Fair Value Total Face Value

First Lien Term Loans $ – $ 395,052 $ – $ 395,052 $ 394,559

Second Lien Term Loans $ 178,200 $ – 178,200 $ 180,000

As of December 31, 2014

Level 1 Level 2 Level 3 Total Total Face Value

First Lien Term Loans $ – $ 394,753 $ – $ 394,753 $ 399,750

Second Lien Term Loans – 178,200 – 178,200 180,000

X

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a,b,bb)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2C

-URI http://asc.fasb.org/extlink&oid=36462937&loc=SL7498348-110258

+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

1. NOTES PAYABLE (Details - Term Loans) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015
First Lien Term Loan
Term loans face value	$ 394,559
Term loans discount	(8,681)
Term loan carrying value	385,878
Second Lien Term Loans
Term loans face value	180,000
Term loans discount	(2,558)
Term loan carrying value	177,442
Short-term Debt [Member]
Term loans face value	574,559
Term loans discount	(11,239)
Term loan carrying value	$ 563,320

3. EARNINGS PER SHARE (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share [Abstract]
Net loss attributable to RadNet, Inc.'s common stockholders	$ (4,554)us-gaap_NetIncomeLoss	$ (12,424)us-gaap_NetIncomeLoss
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC.'S COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period	42,747,329	40,010,080
Basic and diluted net loss per share attributable to RadNet, Inc.'s common stockholders	$ (0.11)us-gaap_EarningsPerShareBasicAndDiluted	$ (0.31)us-gaap_EarningsPerShareBasicAndDiluted

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Common stock - par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock - shares authorized	200,000,000us-gaap_CommonStockSharesAuthorized	200,000,000us-gaap_CommonStockSharesAuthorized
Common stock - shares issued	43,810,279us-gaap_CommonStockSharesIssued	42,825,676us-gaap_CommonStockSharesIssued
Common stock - shares outstanding	43,810,279us-gaap_CommonStockSharesOutstanding	42,825,676us-gaap_CommonStockSharesOutstanding

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2015	May 07, 2014
Document and Entity Information
Entity Registrant Name	RadNet, Inc.
Entity Central Index Key	0000790526
Document Type	10-Q
Document Period End Date	Mar. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer	No
Is Entity a Voluntary Filer	No
Is Entity's Reporting Status Current	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		44,269,449dei_EntityCommonStockSharesOutstanding
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
NET LOSS	$ (4,476)us-gaap_ProfitLoss	$ (12,375)us-gaap_ProfitLoss
Foreign currency translation adjustments	(37)	(18)
COMPREHENSIVE LOSS	(4,513)us-gaap_ComprehensiveIncomeNetOfTax	(12,393)us-gaap_ComprehensiveIncomeNetOfTax
Less comprehensive income attributable to non-controlling interests	78	49
COMPREHENSIVE LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS	$ (4,591)	$ (12,442)